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V 
Abstract 
This work describes further developments and applications of the catalytic asymmetric 
Fischer indolization. In the first part of this thesis, the development of an organocatalytic 
asymmetric synthesis of helicenes via a Fischer indolization is discussed. The application of a 
novel SPINOL-derived phosphoric acid, featuring extended π-surfaces as 3,3‘-substituents 
which can potentially participate in π-interactions with the polyaromatic intermediate, 
afforded the corresponding products in high yields and enantioselectivities. The second part 
of this work describes the development of a catalytic asymmetric dearomatizing synthesis of 
1,4-diketones via an interrupted Fischer indolization. Employing aryl hydrazines with α-
substituents next to the hydrazine group prevents the rearomatization which takes place in 
common Fischer indole syntheses, thus enabling the hydrolysis of the generated diimine 
species. In the presence of STRIP as catalyst, a variety of different 1,4-diketones could be 
obtained in generally high yields, diastereo- and enantioselectivities. The last part of this 
thesis deals with the development of an organocatalytic asymmetric stereodivergent 
synthesis of novel 3H- and 2H-pyrroles, applying an interrupted Fischer indolization and for 
the 2H-pyrroles a subsequent stereospecific [1,5]-alkyl shift. Employing STRIP as catalyst 
afforded the corresponding products in good to excellent yields and enantioselectivities. 
Preliminary biological investigations of these novel structure motifs in cell-based assays, 
monitoring biological signal transduction pathways showed an inhibition of the Hedgehog 
signaling pathway in a µM range.  
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VI 
Kurzzusammenfassung 
Die vorliegende Arbeit beschreibt die Weiterentwicklung und Anwendung der katalytischen 
asymmetrischen Fischer Indolisierung. Der erste Teil dieser Dissertation diskutiert die 
Entwicklung einer organokatalytischen asymmetrischen Synthese von Helicenen mittels 
einer Fischer Indolsynthese. Die Verwendung einer neuartigen SPINOL-abgeleiteten 
Phosphorsäure mit ausgedehnten π-Flächen als 3,3‘-Substituenten, welche potentielle π-
Wechselwirkungen mit dem polyaromatischen Intermediat eingehen können, lieferte die 
entsprechenden Produkte in hohen Ausbeuten und Enantioselektivitäten. Der zweite Teil 
dieser Arbeit beschreibt die Entwicklung einer katalytischen asymmetrischen 
dearomatisierenden Synthese von 1,4-Diketonen mittels einer unterbrochenen Fischer 
Indolisierung. Der Einsatz von Arylhydrazinen mit Substituenten in den ortho-Positionen zur 
Hydrazin-Gruppe verhinderte die Rearomatisierung, die in üblichen Fischer Indolsynthesen 
stattfindet und ermöglichte so die Hydrolyse der entstandenen Diimine. Unter Verwendung 
von STRIP als Katalysator konnte eine Vielzahl verschiedener 1,4-Diketone in hohen 
Ausbeuten, Diastereo- und Enantioselektivitäten erhalten werden. Der letzte Teil der 
vorliegenden Dissertation handelt von der Entwicklung einer organokatalytischen 
asymmetrischen stereodivergenten Synthese neuartiger 3H- und 2H-Pyrrole unter 
Verwendung einer unterbrochenen Fischer Indolisierung und, im Falle der 2H-Pyrrole, einer 
nachfolgenden stereospezifischen [1,5]-Alkylverschiebung. Die Anwendung von STRIP als 
Katalysator lieferte die entsprechenden Produkte in guten bis exzellenten Ausbeuten und 
Enantioselektivitäten. Vorläufige biologische Untersuchungen unserer neuartigen 
Strukturmotive in zellbasierten Assays für biologische Signaltransduktionswege zeigten eine 
Inhibition des Hedgehog Signalwegs im µM Bereich.  
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 Introduction 1.
“…The delicate white blooms of the giant Saguaro, a cactus found in the deserts of 
Arizona… first appear only when the plant is about 50 years old. An attractive parallel can be 
seen between this slowly maturing beauty and the development of asymmetric 
organocatalysis, the origin of which goes back to the emergence of the efficient 
homogeneous asymmetric catalysis.”[1] 
 
Peter I. Dalko and Lionel Moisan in 2001. 
 
The major breakthrough of asymmetric catalysis goes back to the 1970’s when 
Knowles and his colleague reported an enantioselective rhodium catalyzed hydrogenation of 
olefins, applying a chiral phosphine ligand.[2] Unclosing a completely new research area, 
asymmetric catalysis soon attracted a lot of attention in the scientific community. A few 
years later, the group of Noyori reported the catalytic asymmetric hydrogenation of ketones, 
applying a chiral ligand in the presence of a metal catalyst, whereas Sharpless and coworkers 
developed the catalytic asymmetric oxidation of olefins. In recognition of their tremendous 
contributions in asymmetric catalysis, Knowles, Noyori and Sharpless shared the 2001 Nobel 
Prize in chemistry.[3] However, despite the great developments of asymmetric catalysis, most 
approaches were based on metal catalysts and biocatalysts such as enzymes, whereas pure 
organic catalysts were completely unexplored. 
 
Although small organic molecules have been employed as catalysts since the early days 
of chemistry, their major application in asymmetric processes was only developed 
recently.[4] However, first reports of enantioselective organocatalysis go back to the year 
1912, when Breding and Fiske developed a cinchona alkaloid accelerated addition of 
hydrogen cyanide to benzaldehyde. Although the reported enantioselectivity was low for 
this transformation, Breding showed the proof of concept for asymmetric organocatalysis.[5] 
Inspired by the work of Breding, further pioneer works have been achieved by the group of 
Pracejus, who developed the cinchona alkaloid catalyzed addition of methanol to ketenes,[6] 
and Hajos and Parish as well as Eder, Sauer and Wiechert who reported a proline catalyzed 
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intramolecular aldol reaction.[7-8] Despite these great developments in asymmetric 
organocatalysis, it took almost 30 years until the catalytic activity of proline was further 
explored.[9] 
 
In 2000, the groups of List and MacMillan discovered independently that chiral 
enantiopure secondary amines, namely proline or imidazolidinone derivatives, respectively, 
can be applied as catalysts for enantioselective Aldol- and Diels-Alder reactions via enamine 
and iminium ion activation.[10-11] These major developments were a great breakthrough in 
asymmetric organocatalysis and soon numerous contributions in this field have been 
reported. In the following years, various different activation modes and new organocatalyst 
motifs could be identified. Nowadays, organocatalysis has become a powerful tool and well 
established area and can, without any doubt, be described as a third pillar in asymmetric 
catalysis.[12]  
 
To organize and differentiate the huge amount of reports in organocatalysis, the group 
of List introduced a classification based on the activation mode of the catalyst, namely 
Brønsted acid, Lewis acid, Brønsted base and Lewis base catalysis (Figure 1.1).[13] In general, 
organocatalysts which donate or accept an electron pair from the substrate can be classified 
as Lewis acids or bases whereas Brønsted acids or bases are proposed to donate or accept a 
proton. Lewis base catalysis is one of the most explored classes in organocatalysis and both, 
enamine and iminium ion catalysis, proceed via this type of mechanism.  
 
 
 
Figure 1.1 Classification of organocatalytic reactions by List et al. based on the activation 
mode. (S = Substrate, P = Product, (L)A = (Lewis) acid, (L)B = (Lewis) base). 
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A further important and rapidly grown class constitutes Brønsted acid catalysis. 
Inspired by the pioneering studies of Yamamoto and coworkers,[14] the development of 
hydrogen bonding catalysis by the group of Jacobsen[15] and the achievements of the groups 
of Terada and Akiyama in phosphoric acid catalysis,[16-17] Brønsted acid catalysis has 
attracted a lot of attention in the scientific community and tremendous contributions to this 
field have been reported in the last few years.  
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 Background 2.
 Asymmetric Brønsted Acid Catalysis 2.1.
 
Commonly, acid catalysis can be differentiated into specific and general acid catalysis, 
terms which originally derive from kinetics. Whereas general acid catalysis depends on the 
concentrations of various proton donors and the proton transfer has a direct influence on 
the reaction rate, specific acid catalysis is independent of the concentrations of respective 
proton donors and is essentially controlled by the pH of the reaction medium instead. In the 
latter case, the reactant is in a pre-equilibrium with its protonated form and the proton 
transfer is not involved in the rate-determining step.[18] Another definition of these two 
types of acid catalysis is utilized in the context of organocatalysis. Here, a general Brønsted 
acid catalyst activates the substrate (S) for nucleophilic attack (Nu) via a hydrogen bonding 
interaction in the transition sate (Scheme 2.1, left). In contrast to this, specific Brønsted acid 
catalysis proceeds through the formation of an ion pair between the substrate and the 
catalyst (Scheme 2.1, right). In both cases the activated functional group becomes more 
Lewis acidic and the substrate is thus activated via LUMO lowering effects.[19]  
 
 
Scheme 2.1  Differentiation between general (left) and specific Brønsted acid catalysis 
(right) in organocatalysis. 
The classification of a reaction in one of both activation modes strongly depends on 
the difference in the pKa values of substrate and catalyst. However, in many cases there is no 
possibility to distinguish between hydrogen bonding and proton transfer.[20] 
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 General Brønsted Acid Catalysis 2.1.1.
 
Hydrogen bonding is a fundamental activation mode in nature and can be found in 
enzyme catalysis for the enantioselective synthesis of organic molecules. Nevertheless, 
highly enantioselective approaches via general Brønsted acid catalysis were explored very 
recently in chemistry. In 1998, the group of Jacobsen explored the catalytic asymmetric 
Strecker reaction of allyl imines 1 and hydrogen cyanide, using chiral thiourea-derived 
catalyst 2 (Scheme 2.2). After the treatment with trifluoroacetic anhydride, a variety of the 
corresponding amides 3 could be obtained in good yields and enantioselectivities.[15] 
 
 
Scheme 2.2 Thiourea catalyzed Strecker reaction by Jacobsen et al.[15] 
Five years later, Rawal and coworkers reported the highly enantioselective hetero 
Diels-Alder reaction between aldehydes 4 and activated dienes 5, catalyzed by the chiral diol 
TADDOL 6 (Scheme 2.3).[21] 
 
 
Scheme 2.3 TADDOL-catalyzed Hetero Diels-Alder reaction by Rawal et al.[21] 
In the following years, various other chiral hydrogen bonding catalysts, such as 
squaramides, BINOLs or guanidines have been developed.[19,22] Today, hydrogen bonding 
catalysis is a well explored area in organocatalysis and tremendous contributions to this field  
have been achieved.   
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 Specific Brønsted Acid Catalysis 2.1.2.
 
While general Brønsted acids are rather weak acids, specific Brønsted acids can be 
classified as stronger acids and have been used as catalysts in organic chemistry for decades. 
Nevertheless, the corresponding chiral analogues have only been explored very recently. In 
2004, Akiyama et al. developed BINOL-derived phosphoric acid 10a which was applied in the 
enantioselective Mannich reaction of aryl imines 8 and silyl ketene acetal 9. The 
corresponding amino esters 11 could be obtained in high yields, diastereo- and 
enantioselectivities (Scheme 2.4).[16]  
 
Scheme 2.4 Phosphoric acid catalyzed enantioselective Mannich reaction reported by 
Akiyama et al.[16]  
At the same time, Terada and coworkers explored phosphoric acid 10b as catalyst for 
the enantioselective Mannich reaction of aryl N-Boc imines 12 and acetyl acetone 13, 
affording Boc-protected amines 14 in excellent yields and enantioselectivities (Scheme 
2.5).[17]  
 
Scheme 2.5 Phosphoric acid catalyzed enantioselective Mannich reaction reported by 
Terada et al.[17] 
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However, in 2010 the group of Ishihara found that the actual catalyst in this 
transformation was the corresponding calcium salt, rather than the phosphoric acid, which 
was accidentally formed during purification and not recognized.[23] Nevertheless, both 
discoveries marked the beginning of a new era in asymmetric catalysis. 
 
 Phosphoric Acids in Organocatalysis 2.1.3.
 
Today, phosphoric acids are well explored catalyst motifs since they can be easily 
modified by changing the 3,3’-substituents or the chiral backbone. Thus, just some selected 
examples will be discussed in the following section. In 2005, the group of Akiyama developed 
the chiral TADDOL-derived phosphoric acid 15 which was applied to Mannich type reactions 
(Figure 2.1).[24] In the same year, Antilla et al. developed the VAPOL-derived phosphoric acid 
16 which was used for imine amidations.[25] The H8-BINOL-derived phosphoric acid 17a was 
first reported by the group of Gong and applied in an enantioselective Biginelli reaction.[26] A 
few years later, Akiyama et al. reported the enantioselective synthesis of 
tetrahydroquinolines, catalyzed by the biphenol-derived phosphoric acid 18.[27] In 2010, the 
group of List developed the SPINOL-derived phosphoric acid STRIP (19a) which was applied 
to a kinetic resolution of alcohols via a transacetalization.[28] In the same year, Lin, Wang and 
coworkers reported an enantioselective Friedel-Crafts reaction, catalyzed by a related 
SPINOL-derived phosphoric acid.[29] 
 
 
Figure 2.1 Selected examples of chiral phosphoric acids with different backbones.  
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Beside the backbone and the 3,3’-substituents, also the phosphoric acid moiety can be 
modified. In 2006, the group of Terada developed the stronger phosphordiamidic acid 20 
which was applied to Mannich reactions of N-acyl imines and 1,3-dicarbonyl compounds.[30] 
In the same year, Yamamoto et al. explored N-triflyl phosphoramide 21, a very strong acid 
due to the triflyl substituent, which could be used for the asymmetric Diels-Alder reaction of 
enones and siloxydienes.[31] The group of Blanchet developed the first synthesis of 
dithiophosphoric acids 22,[32] which were later applied to the enantioselective hydroamination 
of allenes by Toste and coworkers.[33] A completely new structure motif was introduced by List 
et al. in 2012, who developed confined dimeric imidodiphosphoric acids of type 23, which 
could be applied to an asymmetric spiroacetalization (Figure 2.2).[34] 
 
 
Figure 2.2 Selected examples of modified chiral phosphoric acid catalysts. 
The huge structural diversity of chiral phosphoric acid derived catalysts and their 
versatile applications show the importance and power of these scaffolds in organocatalysis. 
Despite the examples mentioned in this part, there are various other catalyst motifs and 
applications which cannot be discussed in detail and would go beyond the scope of this 
discussion.[35-36] 
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 [3,3]-Diaza Cope Rearrangements 2.2.
 
[3,3]-Sigmatropic rearrangements are intramolecular pericyclic reactions in which one 
-bond is changed to another -bond and the π-electrons are reorganized. They are 
powerful transformations for the stereoselective construction of C-C-bonds in organic 
syntheses and two of the most common and popular examples are the Claisen and the Cope 
rearrangement, discovered in 1912 and 1940, respectively (Scheme 2.6).[37-38]  
 
 
Scheme 2.6 Claisen rearrangement of allyl vinyl ether 24 and Cope rearrangement of 1,5-
hexadiene 26. 
Both well-known transformations have been investigated intensively in the following 
years and a variety of analogous hetero-[3,3]-sigmatropic rearrangements have been 
developed. A very famous representative of these type of rearrangements is the diaza Cope 
rearrangement in which diaza-compounds of type 28-30 undergo a [3,3]-sigmatropic 
rearrangement, forming a new C-C bond (Scheme 2.7). In the latter case, the C-C-bond is 
formed at the expense of an N-N-bond, rendering this process, unlike most [3,3]-sigmatropic 
rearrangements, irreversible. A well-known reaction, involving this type of diaza Cope 
rearrangement is the Fischer indole synthesis which will be discussed in the following 
chapter. Due to the variety of nitrogen containing natural products and pharmacophores, 
aza Cope rearrangements are of high interest in organic syntheses.  
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Scheme 2.7 Different types of [3,3]-sigmatropic diaza Cope rearrangements. 
 
 The Fischer Indole Synthesis 2.2.1.
 
One of the most famous applications of diaza Cope rearrangements is the Fischer 
indole synthesis which was discovered in 1883 by the German chemist Emil Fischer. He 
found that upon heating of phenylhydrazone 34 in hydrochloric acid a new compound was 
formed.[39] Although he realized that the product had lost one molecule of ammonia, the 
structure remained unclear until 1884 when Fischer and Hess were able to identify it as 
indole-3-carboxylic acid 35 (Scheme 2.8).[40] 
 
 
Scheme 2.8 Fischer indole synthesis discovered by Emil Fischer in 1883. 
Although the reaction received a lot of attention in the scientific community and was 
used for a variety of applications, the mechanism was unclear for decades. In 1924, 
Robinson and Robinson suggested a possible mechanistic scenario which is still largely 
accepted today (Scheme 2.9).[41] 
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Scheme 2.9 Possible mechanism of the Fischer indole synthesis proposed by Robinson and 
Robinson. 
Upon protonation, hydrazone [34·HX]C=N is in equilibrium with enehydrazine [34·HX]C=C 
which can undergo a [3,3]-sigmatropic rearrangement, forming a non-aromatic diimine 
species. After rearomatization via a proton shift, a 5-exo-trig cyclization takes place, followed 
by the release of ammonia and the acid which affords indole 35. 
 
Being the first methodology for the synthesis of indoles, the Fischer indolization was 
investigated intensively in the following years. Beside hydrochloric acid, a variety of other 
acids could be identified to promote the reaction as well. Amongst others, Lewis acids like 
boron trifluoride, copper or zinc chloride and Brønsted acids such as formic acid, acetic acid 
or polyphosphoric acid were found to be equally effective.[42-44] Nevertheless, approaches, 
employing catalytic amounts of acid, have been elusive until recently. 
 
 Chiral Indole-Derived Compounds 2.2.2.
 
Indole itself is a simple molecule which does not feature any stereogenic centers, thus 
the question about catalytic asymmetric approaches to these scaffolds might seem to be 
odd. However, potential chiral indole-derived compounds such as tetrahydrocarbazoles, 
oxindoles or indolines are ubiquitous in nature and are part of various pharmacophores and 
biologically active compounds. For instance, indole alkaloid (+)-ajmaline (36), first isolated in 
1931 by Siddiqui and coworkers, is nowadays widely used as a cardiovascular drug (Figure 
2.3).[45-46] The indole alkaloid physostigmine (37) which exhibits an indolenine core structure 
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and was first isolated in 1864, is an acetylcholinesterase inhibitor and is employed for the 
treatment of cholinergic diseases.[47-48] 
 
 
Figure 2.3 Selected examples of chiral indole derived alkaloids and drugs. 
Moreover, Aspidospermidine (38), an aspidosperma alkaloid has been investigated 
intensively in the last years and numerous synthetic approaches to this compound have 
been developed so far.[49] MacMillan and coworkers reported the up to now shortest total 
synthesis of (+)-Aspidospermidine (38), applying an elegant organocatalyzed cascade 
reaction involving an imidazolidinone salt 44 catalyzed Diels-Alder/5-exo-heterocyclization 
step (Scheme 2.10).[49]  
 
 
Scheme 2.10 Organocatalytic key step in MacMillan’s total synthesis of (+)-Aspido-
spermidine (38).[49] 
The tetrahydrocarbazole-derived compound (R)-Frovatriptan (39), a 5HT1 receptor 
agonist, is commonly used for the treatment of cluster headache.[50-51] Although the (R)-
enantiomer is used exclusively as a drug, the synthesis of Frovatriptan (39) is based on a 
racemic Fischer indole synthesis, followed by resolution of the enantiomers and 
manipulation of the functional groups (Scheme 2.11).[52] An enantioselective approach to 
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these scaffolds would be highly appreciated due to economic aspects, the yield and the 
associated costs since half of the product is discarded in this process. 
 
 
Scheme 2.11 Industrial synthesis of (R)-Frovatriptan (39). 
Despite the importance of chiral indole-derived compounds in the pharmaceutical 
industry, a straightforward asymmetric variation of the Fischer indole synthesis was 
undeveloped until a few years ago when Garg and List started the first investigations in this 
field.[53-54]  
 
 The Catalytic Asymmetric Fischer Indole Synthesis 2.2.3.
 
The Fischer indole synthesis is a powerful methodology for the synthesis of indole 
derivatives and can be promoted by various Lewis and Brønsted acids. Nevertheless, an 
asymmetric variant of this reaction was elusive until the group of Garg developed the first 
example of an enantioselective Fischer indolization using chiral phosphoric acid 10c as 
promoter. Although an excess of the Brønsted acid 10c (1.2 equivalents) was necessary and 
the enantioselectivity of the product 50 was quite low, it was the proof of principle which 
showed that stereoinduction is indeed possible in this transformation.[53]  
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Scheme 2.12 Chiral phosphoric acid 10b promoted enantioselective Fischer indole synthesis 
developed by Garg and coworkers. 
In 2011, List and coworkers achieved a significant breakthrough in the field of catalytic 
asymmetric Fischer indole syntheses. They found that the major challenge of this 
transformation was the stoichiometric release of ammonia during the course of reaction 
which led to a poisoning of the catalyst via salt formation. This observation also explains why 
in Garg’s approach an excess of the phosphoric acid was necessary to achieve full conversion 
of the hydrazone. List et al. investigated different approaches to overcome this problem but, 
initially, with little success. Amongst others, refluxing conditions in order to liberate the 
released ammonia from the reaction mixture and the use of N-protected enehydrazines to 
generate less basic ammonia-derived by-products were tested.[55] After a few setbacks, List 
and coworkers finally found that the cation exchange resin Amberlite® CG50 was able to 
regenerate the catalyst via a proposed exchange of the ammonium ion by a proton. Applying 
this weakly acidic resin, the group of List developed the first catalytic asymmetric Fischer 
 
 
Scheme 2.13 The catalytic asymmetric Fischer indolization by List and coworkers. 
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indole synthesis, using N-protected preformed hydrazones of type 51. In the presence of 
catalytic amounts of chiral SPINOL-derived phosphoric acid 19b, the corresponding 
tetrahydrocarbazoles 52 were generated in high yields and enantioselectivities (Scheme 
2.13). Remarkably, SPINOL-derived phosphoric acids 19, independently introduced by the 
groups of List,[28] Lin and Wang[29] in 2010, led to generally much higher enantioselectivities 
in this transformation. Employing the corresponding BINOL-derived phosphoric acid 10h 
afforded the desired product 52b in a significantly lower enantiomeric ratio of 85:15, 
compared to 93.5:6.5, applying non-optimized reaction conditions.[54]  
 
In the mechanism proposed by List and coworkers, the catalyst 19b accelerates the 
hydrazone-enehydrazine tautomerization, forming two possible diastereomeric ion pairs 
[(S)-51·(R)-19b] and [(R)-51·(R)-19b] via a dual activation mode. The benzyl group (R1) at the 
anilinic nitrogen of the enehydrazine is assumed to play an important role by increasing the 
basicity and ensuring a protonation at this position. Recent studies on the mechanism of the 
Fischer indolization show that a protonation of the other nitrogen leads to a different  
 
 
Scheme 2.14 Proposed mechanism of the catalytic asymmetric Fischer indolization by List 
and coworkers. 
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reaction pathway.[54,56] One of the two ion pairs [(S)-51·(R)-19b] and [(R)-51·(R)-19b] 
undergoes the irreversible enantiodetermining [3,3]-sigmatropic rearrangement at a higher 
rate, leading to a dynamic kinetic resolution (Scheme 2.13). The release of ammonia affords 
the desired tetrahydrocarbazoles 52 in high enantiomeric ratios and forms a salt with the 
catalyst [19b·NH3], which is afterwards regenerated by a cation exchange with CG50. 
Another possible scenario in which only one enehydrazine enantiomer of both would 
preferentially be formed and rearrange was assumed to be unlikely due to mechanistic 
studies of Hughes who found that the hydrazone-enehydrazine isomerization is only rate 
determining under extremely acidic conditions.[54-55,57] 
 
The catalytic asymmetric Fischer indole synthesis developed by List et al. was not only 
found to be a mild and powerful approach to enantiopure tetrahydrocarbazoles but could be 
applied to other scaffolds as well. In 2013, the same group reported the versatile synthesis 
of chiral indoline-derived compounds, utilizing a catalytic asymmetric Fischer indolization 
(Scheme 2.15a).[58] In contrast to the previously reported transformation, the preformation 
of the hydrazone was not necessary in this case and hydrazine 53b and α-substituted ketone 
56 could be applied as starting materials. Using 5 mol% of the SPINOL-derived catalyst STRIP 
(19a) in the presence of CG50 afforded the corresponding indoline derivatives 57 in high 
yields and enantioselectivities. Remarkably, also an intramolecular interrupted variation of 
this transformation was developed, generating complex bridged indolines 59 in high 
enantiomeric ratios and yields (Scheme 2.15b).[58] 
 
 
Scheme 2.15 Enantioselective synthesis of indoline-derived compounds, applying a catalytic 
asymmetric Fischer indole synthesis (a) and an interrupted variant (b). 
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The catalytic asymmetric Fischer indole synthesis is a mild and efficient methodology 
for the organocatalytic synthesis of enantioenriched indole derivatives and the expansion to 
interrupted processes even broadens the applicability of this methodology. Further 
developments of the catalytic asymmetric Fischer indole synthesis are objectives of this work 
and will be discussed in the course of this thesis.  
 
 The Catalytic Asymmetric Benzidine Rearrangement 2.2.4.
 
Inspired by the development of a catalytic asymmetric Fischer indole synthesis by List 
and coworkers,[54,58] the groups of Kürti and List independently reported a catalytic 
asymmetric benzidine rearrangement, furnishing enantioenriched BINAM derivatives 61. In 
both transformations, chiral phosphoric acid 10c proved to be the best catalyst in terms of 
yield and enantioselectivity. Kürti and coworkers conducted the reaction in toluene at a 
temperature of −20 °C. The use of 20 mol% of catalyst 10c afforded the corresponding 
BINAM-derived compounds 61 in good enantiomeric ratios and high yields (Scheme 
2.16a).[59] However, List et al. found that the addition of the cation exchange resin CG50 
accelerated the reaction without diminishing the enantioselectivity which enabled both, a 
reduced catalyst loading to 5 mol%, and a decrease of the temperature to −50 °C (Scheme 
2.16b). In this case, the desired products 61 could be obtained in higher enantioselectivities 
and similar yields.[60]  
 
 
Scheme 2.16 Catalytic asymmetric benzidine rearrangement by the groups of Kürti (a) and 
List (b). 
 2. Background  
18 
Diaza Cope rearrangements are powerful transformations for the construction of C-C 
bonds in organic syntheses and especially enantioselective approaches are of high interest. 
The reaction allows a broad application by modifying the starting materials and the reaction 
conditions. The development of new catalytic asymmetric approaches of the diaza Cope 
rearrangement is part of this work and will be discussed in the course of this thesis.  
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 Catalytic Asymmetric Dearomatization Reactions 2.3.
 
Dearomatization reactions are important transformations in organic syntheses and 
have attracted considerable attention in the last few years. The simple starting materials are 
easily accessible and can be readily transformed into complex and functionalized 
compounds, rendering dearomatization reactions common in natural product syntheses.[61-
63] Despite the importance of this transformation, catalytic enantioselective dearomatization 
reactions are rather challenging, due to the high resonance energy of aromatic 
compounds.[64] The high energy barrier usually requires harsh reaction conditions which 
render a control of stereochemistry rather difficult. Moreover, most enantioselective 
approaches rely on chiral starting materials or metal catalysis while organocatalytic 
methodologies are rather limited and often based on oxidative processes or cycloaddition 
reactions.[62] A further limitation is the use of engineered starting materials which makes a 
broad application difficult. 
 
In 2009, the group of Buchwald developed an intramolecular palladium catalyzed 
asymmetric dearomatization of naphthalene-derived compounds 62. The deprotonation of 
the aniline is believed to increase the electron density of the naphthalene moiety which 
would enable an intramolecular aromatic substitution-type reaction, generating 
enantioenriched indolenines of type 64. Applying chiral ligand 63 in this transformation, 
furnished the corresponding products in high experimental and optical yields (Scheme 
2.17).[65] 
 
 
Scheme 2.17 Palladium catalyzed asymmetric dearomatization of naphthalene derivatives 
reported by Buchwald and coworkers.[65] 
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One year later, You and coworkers reported the iridium catalyzed allylic 
dearomatization of indoles 65, generating enantioenriched spiroindolenines 67. The desired 
products could be obtained in generally high yields, diastereo- and enantioselectivities, using 
chiral phosphoramidite ligand 66 in the presence of an Ir-catalyst. (Scheme 2.18).[66] 
 
 
Scheme 2.18 Ir-catalyzed allylic dearomatization of indole derivatives reported by You and 
coworkers.[66] 
In 2013, the group of Kita reported the asymmetric dearomatization of naphthol-
derived compounds 68, applying a chiral spirobiindane-based hypervalent iodine catalyst. 
Using 5 to 15 mol% of diiodide 69 in the presence of mCPBA afforded the desired 
spirolactones 70 in moderate to good yields and enantioselectivities (Scheme 2.19).[67]  
 
 
Scheme 2.19 Hypervalent iodine catalyzed asymmetric dearomatizing spirolactonization of 
naphthol derivatives reported by Kita and coworkers.[67] 
In the same year, Toste and Phipps developed a fluorinative dearomatization of phenol 
derivatives 71 utilizing a chiral phase-transfer catalyst. The desired products 73, bearing a 
quaternary fluorine stereocenter, were generated in generally high yields and 
enantioselectivities, using 5 mol% of the BINOL-derived phosphoric acid 10d in the presence 
of Selectfluor 72 (Scheme 2.20).[68] 
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Scheme 2.20 Phase-transfer catalyzed fluorinative dearomatization of phenols reported by 
Toste and Phipps.[68] 
Despite the great importance of dearomatization reactions in chemistry, there are still 
just a few catalytic asymmetric approaches, especially exploiting organocatalysis. The 
developed methodologies are often based on oxidations and cycloaddition reactions or are 
applied to heteroaromatic compounds such as indoles which results in a limited substrate 
scope. Therefore, new catalytic asymmetric dearomatizing approaches would be highly 
valuable in synthetic chemistry.  
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 Helicenes 2.4.
 
 Applications and Properties 2.4.1.
 
Molecules featuring helical chirality are interesting scaffolds which possess unique 
properties and are one of the most important elements in our life by being part of our DNA. 
Interestingly, helicenes are optically active compounds although they do not possess any 
stereogenic center and are consequently classified as axially chiral molecules. The chirality 
derives from the handedness of the helicene itself which can be left-handed (minus – M) or 
right-handed (plus – P) (Figure 2.4).[69]  
 
 
Figure 2.4 Right-handed (P) and left-handed (M) [6]helicenes 74. 
Due to their unique structural and stereochemical features, helicenes play an essential 
role in biology, optoelectronics and material sciences.[70-71] In particular, their application in 
catalysis has attracted a lot of attention in the last few years. In 1997, Reetz et al. developed 
the first application of a helically chiral ligand 76 in the hydrogenation of itaconic acid ester 
75, affording the corresponding product 77 in a moderate enantiomeric ratio of 69.5:30.5 
(Scheme 2.21).[72]  
 
Scheme 2.21 Enantioselective hydrogenation of itaconic acid ester 75, using helical 
phosphine 76 as ligand developed by Reetz and coworkers.[72] 
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In the following years, numerous approaches have been developed, employing 
helically chiral compounds as catalysts or ligands to induce stereochemistry.[70-71] In 2010, 
Takenaka and coworkers developed the addition of 4,7-dihydroindole derivatives 78 to 
nitroalkenes 79, applying helical 2-aminopyridinum ion 80 as catalyst (Scheme 2.22).[73] 
Using 2 mol% of the hydrogen bond donor catalyst 80, followed by an oxidation step 
afforded the desired products 81 in high yields and enantioselectivities.  
 
 
Scheme 2.22 Application of chiral helical hydrogen bond donor catalyst 80 reported by 
Takenaka and coworkers.[73] 
One year later, the group of Carbery reported a kinetic resolution of aryl alcohols 82, 
using the helical chiral DMAP-derived catalyst 83. With a catalyst loading of only 0.5 mol%, 
the desired products could be obtained with an S-factor of up to 116 (Scheme 2.23).[74] 
 
 
Scheme 2.23 Kinetic resolution of secondary aryl alcohols 82, applying a helical DMAP-
derived organocatalyst 83 developed by the group of Carbery.[74] 
Due to the increasing importance of helicenes in catalysis and in other fields of 
research, approaches to their syntheses, especially in an enantioselective fashion, are of 
great interest and have been target of numerous research groups in the last few years. 
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 Approaches to Enantiopure Helicenes 2.4.2.
 
The first reported synthesis of helicenes dates back to the year 1903, when 
Meisenheimer and Witte investigated the reduction of 2-nitronaphthalenes which afforded 
azahelicenes 85 and 86.[71,75] A few years later, in 1918, Weitzenböck and Klingler reported 
the first all-carbon based [5]helicene 87,[76] followed by Newman and coworkers, who 
developed the synthesis and resolution of the corresponding [6]helicene 74 in the 1950s 
(Figure 2.5).[71,77-79]  
 
 
Figure 2.5 Selected examples of first synthesized helicenes reported in literature. 
Two major breakthroughs in helicene syntheses were achieved by the groups of 
Scholz[80] and Martin[81] in 1967 and Katz in 1990.[79,82] Inspired by the work of Wood and 
Mallory in 1964,[83]who reported the photocyclization of stilbenes to phenanthrene 
derivatives, Scholz, Martin and coworkers applied this methodology to the first 
photoinduced synthesis of helicenes.[79-81,84] Almost 20 years later, Katz and Liu developed 
another important transformation to access racemic helicenes, employing an intermolecular 
Diels-Alder reaction to access helical bisquinones.[79,82] Several stereoselective approaches 
have been explored in the following years, involving the use of circularly polarized light or 
chiral starting materials for stereoinduction.[85-87] Despite the development of numerous 
enantio- or diastereoselective methodologies, most of them suffered from low asymmetric 
induction. Thus, a resolution of enantiomers was in many cases the method of choice to 
access enantiopure helicenes. 
 
In 2001, the group of Carreño reported a chiral auxiliary-based approach to access 
quinonehelicenes 90 in an highly enantioselective Diels-Alder reaction of vinyl 
dihydrophenanthrenes 88 and chiral 1,4-benzoquinone derivatives 89 followed by an in situ 
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elimination of the sulfoxide (Scheme 2.24). The products 90 could be further oxidized to 
polyaromatic systems without loss of enantioselectivity.  
 
 
Scheme 2.24 Chiral auxiliary approach reported by Carreño and coworkers.[88] 
A nowadays well established method for the construction of helicenes is the transition 
metal-catalyzed [2+2+2] cycloaddition of alkynes or arynes. The first example of a catalytic 
asymmetric [2+2+2] cycloaddition to access helicenes was reported in 1999 by Stará and 
Starý. In the presence of a nickel catalyst and the chiral BINOL-derived ligand 93, triyne 91 
cyclized to helicene 92 in moderate yield and enantioselectivity (Scheme 2.27).[89]  
 
 
Scheme 2.25 First catalytic asymmetric [2+2+2] cycloaddition of triynes 91 reported by the 
group of Stará and Starý.[89] 
Since this seminal report, a lot of different approaches applying this methodology have 
been described.[71,87] In 2012, Tanaka et al. developed an intermolecular double [2+2+2] 
cycloaddition, using Segphos derived ligand 97 in the presence of a rhodium catalyst. The 
corresponding helicenes 96 could be obtained in good enantioselectivities and yields 
(Scheme 2.26).[90] 
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Scheme 2.26 Intermolecular double [2+2+2] cycloaddition developed by Tanaka and 
coworkers.[90] 
Another example for [2+2+2] cycloaddition reactions is the highly diastereoselective 
synthesis of helicenes 99 developed by Stará and Starý in 2012. Using chiral triyne 98 as 
starting material in the presence of a nickel catalyst afforded the corresponding helicene 99 
as a single diastereoisomer. Remarkably, this approach can be applied to the 
diastereoselective synthesis of [6]- and [7]heterohelicenes as well. 
 
 
Scheme 2.27 Diastereoselective [2+2+2] cycloisomerization of triynes 98 developed by the 
groups of Stará and Starý.[91] 
Despite all efforts to stereoselective syntheses of helicenes, there is still a high demand 
for general approaches, especially in a catalytic asymmetric fashion. One reason for this 
might be that asymmetric catalysis is rather challenging for the synthesis of helically chiral 
molecules. In contrast to common approaches in asymmetric catalysis which are used to 
create a specific carbon center, helicenes require a control of their screw sense. Therefore, 
there are specific length-scale requirements for the catalyst to enable a stereocontrol on the 
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nanoscale. Nevertheless, an expanded structural diversity and new approaches to these 
important scaffolds would be highly appreciated. Most metal-based catalytic asymmetric 
transformations to helicenes still require high catalyst loadings, thus an organocatalytic 
alternative would be valuable. Interestingly, there was not a single report of an 
organocatalytic asymmetric synthesis of helicenes prior to this work. 
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 2H- and 3H-Pyrroles 2.5.
 
Pyrroles are core structure of various biologically active compounds, natural products 
and pharmaceutical agents.[92-99] However, beside the well-developed 1H-pyrroles, the less 
familiar nonaromatic 2H- and 3H-pyrroles are important scaffolds as well. For instance, 3H-
pyrroles 100 are part of Precorrin-6B (102), a macrocyclic precursor of vitamin B12
[100-101] 
whereas 2H-pyrroles 101 can be found in alkaloids such as Calyciphylline G (103)[102] or 
Chamobtusin A (104) (Figure 2.6).[103]  
 
 
Figure 2.6 Selected examples of 3H- and 2H-pyrroles in natural products. 
3H-Pyrroles 100 are compounds with interesting chemical properties and can be 
applied to various transformations such as rearrangements or addition and cycloaddition 
reactions. In 1971, the group of Wong reported the rearrangement of 3H-pyrroles to 2H-
pyrroles under thermal induction.[104] Almost 20 years later, Sammes et al. developed a 
multi-stage synthesis to racemic 3H- and 2H-pyrroles, employing a Paal-Knorr-type reaction, 
followed by an acid- and thermally induced rearrangement. Although the authors reported 
some selectivity and stability issues, several 2H- and 3H-pyrroles could be obtained in 
moderate yields.[105-106] In 2006, Shirinian and coworkers reported the transformation of 3H-
benzothienopyrroles to 2H-benzothienopyrroles via a Lewis acid promoted [1,5]-shift.[107] 
Although numerous synthetic routes are known for the enantioselective synthesis of chiral 
1H-pyrroles, corresponding approaches to nonaromatic 3H- 100 and 2H-pyrroles 101 are 
vastly underdeveloped. 
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In 2015, the first enantioselective approach to 3H-pyrroles, applying a [3+2] cyclization 
of allenoates 105 and isocyanides 106, was reported by Zhao and coworkers. Using 10 mol% 
of Ag2O as catalyst in the presence of chiral ligand 107 afforded the desired 3H-pyrroles 108 
in high yields and enantioselectivities (Scheme 2.28).[108] 
 
 
Scheme 2.28 Enantioselective synthesis of 3H-pyrroles 108 via a [3+2] cyclization of 
allenoates 105 and isocyanides 106 reported by Zhao and coworkers.[108] 
In 2012, the You group reported the first iridium catalyzed intramolecular asymmetric 
allylic dearomatization of 1H-pyrroles, generating enantioenriched spiro-2H-pyrroles.[109] 
This approach was further applied to a highly regio- and enantioselective intermolecular 
variant, generating polysubstituted 2H-pyrroles 112 via a dearomatization of 1H-pyrroles 
109. Employing a palladium catalyst in the presence of Segphos ligand 111 afforded the 
corresponding products 112 in high yields and enantiomeric ratios (Scheme 2.29).[110] In 
2015, the same group reported a further approach, applying a highly diastereo- and 
enantioselective synthesis of five-membered spiro-2H-pyrroles via the same strategy.[111] 
 
 
Scheme 2.29 Enantioselective synthesis of 2H-pyrroles 112 via an asymmetric 
dearomatization of 1H-pyrroles 109 developed by the group of You.[110] 
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Despite the recent developments in the synthesis of 3H- and 2H-pyrrole derivatives 
(100, 101), enantioselective approaches are still very limited which renders further 
investigations of these compound classes very difficult. Organocatalytic asymmetric 
approaches to 3H- and 2H-pyrroles of type 100 and 101 would be of high interest but have 
not been reported prior to this work.  
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 Objectives of this PhD Thesis 3.
 The Organocatalytic Asymmetric Approach to Helicenes  3.1.
 
The catalytic asymmetric Fischer indolization developed by List and coworkers provides 
a novel access to enantiopure indole-derived compounds which are important scaffolds in 
pharmacophores and natural products.[54-55,58] We wanted to apply this transformation to 
the catalytic asymmetric synthesis of helicenes, a compound class with interesting 
properties and applications which is hard to access in a catalytic asymmetric fashion. In 
contrast to common reactions in asymmetric catalysis, the stereocontrol of helicenes is a 
nanoscale phenomenon since the screw sense, not a specific stereocenter, has to be 
controlled. Thus, particular length-scale requirements of the catalyst are necessary to enable 
a high stereochemical induction. New methodologies for the enantioselective synthesis of 
helicenes would be highly appreciated and would expand the structural diversity of these 
compounds. Especially organocatalytic asymmetric approaches to helicenes are unexplored 
and would be of high interest. 
 
We hypothesized that common phosphoric acids were too short-ranged to control the 
enantioselectivity in our envisioned transformation. In order to get a high level of 
stereocontrol, the catalyst should bear extended π-substituents in the 3,3’-positions which 
could engage in potential π-interactions with the polyaromatic system present in the formed 
enehydrazine. In this manner, the intermediate should be kept in a chiral nanometer sized 
pocket which would enable the induction of the screw sense of the helicene (Figure 3.1). 
 
  
Figure 3.1 Concept and 3D-model for the catalytic asymmetric synthesis of azahelicenes 
via a long-range control by the catalyst. 
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We envisioned that N-protected hydrazines of type 113 would in situ form a hydrazone 
with polyaromatic ketones of type 114. In the presence of a chiral phosphoric acid, bearing 
extended π-substituents at the 3,3’-positions, the hydrazone would be in an equilibrium with 
the corresponding conjugated enehydrazine which would undergo the enantiodetermining 
[3,3]-sigmatropic rearrangement, furnishing enantiopure azahelicenes of type 115 (Scheme 
3.1). The released ammonia by-product would then be removed via cation exchange with 
the weakly acidic Amberlite® CG50, enabling the regeneration of the catalyst as previously 
reported by List and coworkers.[54-55,58] 
 
 
Scheme 3.1 Envisioned synthesis of azahelicenes 115 via a catalytic asymmetric Fischer 
indolization. 
The development of an organocatalytic asymmetric approach to helicenes, applying a 
Fischer indolization was one objective of this work (see: chapter 4.2). This approach would 
give a completely new approach to enantioenriched helicenes and would broaden the 
structural diversity of these important scaffolds. 
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 Catalytic Asymmetric Dearomatizing Synthesis of 1,4-Diketones 3.2.
 
Dearomatization reactions are of great importance in organic syntheses due to the 
simple and readily accessible starting materials which can be readily transformed into 
complex functionalized products. Nevertheless, dearomatizing catalytic asymmetric 
approaches are rather challenging due to the usually high resonance energy of aromatic 
compounds and thus, require harsh reaction conditions. In most cases, catalytic asymmetric 
approaches are based on transition metal catalysis whereas organocatalytic transformations 
are less developed and mainly achieved via oxidative processes.  
 
The Fischer indole synthesis is inherently a dearomatizing process in which 
nonaromatic diimine species are generated after the enantiodetermining [3,3]-sigmatropic 
rearrangement. In common Fischer indolizations, these intermediates usually rearomatize 
via a proton shift, followed by a 5-exo-trig cyclization to furnish indoles.  
 
 
Scheme 3.2 Enantioselective dearomatizing synthesis of 1,4-diketones 118 via an 
interrupted catalytic asymmetric Fischer indolization. 
 3. Objectives of this PhD Thesis   
34 
We envisaged to develop an interrupted catalytic asymmetric variant, by hydrolyzing 
the formed nonaromatic diimine intermediates in situ, thus giving access to enantioenriched 
1,4-diketones 118 which are very important building blocks in organic chemistry. The use of 
hydrazines of type 116 should prevent the rearomatization due to the substituents in α-
position to the hydrazine group. In the presence of a chiral phosphoric acid as catalyst, 
hydrazines 116 and ketones 117 would form a hydrazone and undergo the 
enantiodetermining [3,3]-sigmatropic rearrangement, generating dearomatized diimine 
species as intermediates. We envisioned that upon treatment with water, these diimines 
should be hydrolyzed in situ thus generating enantiopure 1,4-diketones 118 (Scheme 3.2). 
The realization of this concept was one objective of this work and will be discussed in the 
course of this thesis (see: chapter 4.3). 
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 The Divergent Enantioselective Synthesis of 2H- and 3H-Pyrroles 3.3.
 
Pyrroles are important scaffolds since they are core structures of various natural 
products, bioactive compounds and pharmacophores. Although numerous enantioselective 
approaches are known for the synthesis of chiral 1H-pyrrole-derived compounds, 
methodologies to the corresponding nonaromatic 2H- and 3H-pyrroles are barely developed 
and mainly based on transition metal catalysis.  
 
We envisaged to access these scaffolds via an interrupted Fischer indole synthesis, 
applying a chiral phosphoric acid as catalyst. The use of hydrazines of type 116 should 
prevent the rearomatization after the [3,3]-sigmatropic rearrangement as previously 
 
 
Scheme 3.3 Organocatalytic asymmetric divergent synthesis of enantioenriched 2H- and 
3H-pyrroles via a Fischer indole synthesis and an in situ [1,5]-alkyl shift. 
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described in chapter 3.2. In the absence of water, the formed diimine intermediates should 
be converted to enantioenriched 3H-pyrroles 119 via the release of ammonia (Scheme 3.3).  
 
Previous reports in literature show that 3H-pyrroles can be transformed to the 
corresponding 2H-pyrroles via an acid or thermally induced intramolecular [1,5]-alkyl shift. 
Although there was no proof of the retention of enantioselectivity, we hypothesized that the 
generated enantioenriched 3H-pyrroles 119 could be converted to the corresponding 2H-
pyrroles 120 via an acid mediated [1,5]-alkyl shift without loss of enantioselectivity. This 
approach would give access to both, enantioenriched 2H- 119 and 3H-pyrroles 120 at once. 
To the best of our knowledge, this would be the first organocatalytic asymmetric synthesis of 
2H- 119 and 3H-pyrroles 120. 
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 Results and Discussion 4.
 Synthesis of Novel SPINOL-Derived Phosphoric Acids 4.1.
 
SPINOL-derived phosphoric acids were first introduced by the groups of List, Lin and 
Wang in 2010[28-29] and since then a variety of different catalyst motifs has been developed. 
This chapter describes the synthesis of novel SPINOL-derived phosphoric acids bearing 
diverse 3,3’-substituents. 
 
The synthetic route to SPINOL-derived diiodide 130 is literature known and was 
conducted following a slightly modified literature procedure.[28-29,55,112-113] The synthesis of 
SPINOL 128 was initiated with a modified Claisen-Schmidt condensation of aldehyde 121 and  
 
 
Scheme 4.1 Synthesis of SPINOL 128. 
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acetone 122 which yielded the desired dienone 123 in 59% isolated yield. The subsequent 
reduction was conducted using Raney-Ni under a hydrogen atmosphere which afforded the 
corresponding ketone 124 in quantitative yield. The following bromination, using bromine in 
the presence of pyridine, furnished compound 125 in 96% yield. The cyclization of ketone 
125 was achieved by the treatment with MsOH, generating 56% of the desired SPINOL-
derived compound 126. Applying a lithium halogen exchange with n-BuLi, followed by a 
protic workup afforded the O-methylated SPINOL 127 in 98% yield. The following 
deprotection was achieved, using BBr3 which generated the desired racemic SPINOL 128 in 
quantitative yield. In contrast to the literature reported approach, the separation of both 
enantiomers was conducted via preparative HPLC, affording both enantiomers in optical 
purity (Scheme 4.1). 
 
We envisaged that diverse 3,3’-substituents could be introduced by transition metal 
catalyzed cross coupling reactions. Thus, both enantiomers of SPINOL 128 were separately 
converted to the corresponding diiodide 130. When SPINOL 128 was treated with MOMCl in 
the presence of Cs2CO3, the corresponding MOM-protected SPINOL 129 was obtained in 95% 
yield. Treatment of 129 with s-BuLi, TMEDA and iodine in THF finally yielded 86% of the 
common precursor diiodide 130 (Scheme 4.2).  
 
 
Scheme 4.2 Synthesis of SPINOL-derived diiodide 130. 
Catalysts of type 19c, bearing an extended π-surface at the 3,3’-position are interesting 
target molecules which could be potential catalysts for the enantioselective synthesis of 
helicenes (see chapter 4.2). The preparation of catalyst 19c was straightforward and started 
with the Suzuki coupling of diiodide 130 and the corresponding commercially available 
boronic acid which afforded the desired product 131 in 92% yield. A subsequent 
deprotection of 131 with concentrated hydrochloric acid furnished the corresponding diol in 
92% yield. The synthesis of 1-pyrenyl-substituted SPINOL-derived phosphoric acid 19c was 
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achieved by treating the corresponding diol with POCl3 in the presence of pyridine at 80 °C, 
followed by the addition of water and 1,4-dioxane to hydrolyze the formed phosphoryl 
chloride, furnishing 57% of phosphoric acid 19c. Compound 19c was found to consist of 
different rotameric species, presumably due to slow rotation around the Ar-Ar bond at room 
temperature, and was subsequently used as a mixture. 
 
 
Scheme 4.3 Synthesis of 1-pyrenyl-substituted SPINOL-derived phosphoric acid 19c. 
To avoid the presence of different rotamers, the corresponding symmetric phosphoric 
acid 19d was prepared for the investigation of a catalytic asymmetric synthesis of helicenes. 
The synthesis first required the preparation of 2-pyreneboronic acid 134 via a borylation 
following a literature reported procedure by Marder and coworkers.[114] Treating pyrene 132 
with B2pin2 in the presence of an iridium pre-catalyst and dtbpy as ligand, afforded the 
corresponding boronic ester 133 in 33% yield which was afterwards converted to the desired 
boronic acid 134 in 83% yield using NaIO4 and HCl (Scheme 4.4). 
 
 
Scheme 4.4 Synthesis of 2-pyreneboronic acid 134. 
Phosphoric acid 19d was synthesized following the same procedure as described for 
compound 19c, applying a Suzuki coupling with boronic acid 134 and diiodide 130 which 
afforded product 135 in 88% yield. The following deprotection was conducted using 
concentrated hydrochloric acid and a different solvent mixture (MeOH/CHCl3 3:4) due to 
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solubility issues which generated 83% of the corresponding diol. Treating the diol with POCl3 
and pyridine and subsequent hydrolysis finally afforded phosphoric acid 19d in 96% yield 
(Scheme 4.5). It should be noted that phosphoric acid 19d was found to be poorly soluble in 
most organic solvents. 
 
 
Scheme 4.5 Synthesis of 2-pyrenyl-substituted SPINOL-derived phosphoric acid 19d. 
Another interesting target molecule is phosphoric acid 19e, bearing sterically more 
demanding 3,3’-substituents. Recently, the group of List described the synthesis of the 
corresponding BINOL-derived phosphoric acid which proved to be a good catalyst for the 
desymmetrization of epoxides.[115] Previous developments of sterically more hindered 
phosphoric acids showed that, in most cases Suzuki couplings are not successful for the 
introduction of the 3,3’-substituents and often Kumada couplings are the method of choice 
as already reported for the synthesis of TRIP (10f)[116] and STRIP (19a).[28,55] Therefore, the 
introduction of the substituents was achieved via a Kumada coupling with the corresponding 
Grignard reagent in the presence of a nickel catalyst. The corresponding product 136 could 
be isolated in 67% yield and was afterwards deprotected by treatment with concentrated 
 
 
Scheme 4.6 Synthesis of SPINOL-derived phosphoric acid 19e. 
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hydrochloric acid, generating 99% of the corresponding diol. The conversion to phosphoric 
acid 19e was conducted as described before, using POCl3 and pyridine followed by the 
hydrolysis of the phosphoric acid chloride which afforded the poorly soluble catalyst 19e in 
70% yield. 
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 The Organocatalytic Asymmetric Approach to Helicenes  4.2.
 
The results reported in this section were obtained in collaboration with M. J. Webber, 
A. Martínez and C. De Fusco. 
 
 Concept 4.2.1.
 
Catalytic asymmetric approaches to helicenes are of high interest but mainly limited to 
a few metal-catalyzed methodologies whereas organocatalytic transformations were 
undeveloped prior to these studies. One reason for this might be that the induction of 
stereochemistry in helical molecules is more challenging than in common stereoselective 
reactions since the screw sense of the helicenes has to be controlled which is in fact a 
phenomenon of the nanoscale. We hypothesized that we could apply the recently developed 
catalytic asymmetric Fischer indolization to access helical compounds enantioselectively.[54-
55] We envisioned that common phosphoric acids with phenyl-derived substituents at the 
3,3’-position are too short ranged to control the enantioselectivity in these kind of 
transformations. We speculated that the catalyst would need extended π-substituents in the 
3,3’-position which could engage in potential π-interactions with the polyaromatic system 
present in the formed enehydrazine. In this way, the intermediate is kept in a chiral 
nanometer sized pocket which enables the induction of the screw-sense of the helicene by 
the catalyst (Figure 4.1), thus, a high level of stereocontrol should be possible.  
 
  
 
Figure 4.1 Envisioned concept and 3D model for the catalytic asymmetric synthesis of 
helicenes. 
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 Preparation of Starting Materials 4.2.2.
 
 Synthesis of Hydrazines 4.2.2.1.
 
Commercially available hydrazines 137 were protected applying a literature procedure 
reported by Gribble and Perni, using NaHCO3 and the corresponding aryl bromide 138 
(Scheme 4.7).[117] A variety of N-protected hydrazines 113 was synthesized for the 
investigation of different protecting groups. The products 113 were generally obtained in 
moderate to good yields (37%-70%) due to regioselectivity issues. 
 
 
Scheme 4.7 Synthesis of N-protected hydrazines 113. 
Non-commercially available hydrazines were synthesized via different synthetic 
pathways which were optimized for the individual compounds. For the synthesis of TMS-
containing hydrazine 113g, aryl dibromide 139 was monosubstituted with TMS, using n-BuLi 
and TMSCl (Scheme 4.8).[118] The desired product 140 could be obtained in a quantitative 
yield and was used for the cross-coupling with hydrazine monohydrate. Following a modified 
literature procedure,[119] using a palladium catalyst, Mor-DalPhos as ligand, NaOtBu as base 
and hydrazine monohydrate solution, hydrazine 141 was obtained and directly protected 
without further purification. Treating compound 141 with NaNH2 and PIBBr finally afforded 
22% of the desired product 113g over two steps.[120] 
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Scheme 4.8 Synthesis of TMS-containing N-protected hydrazine 113g. 
The synthesis of diphenyl-substituted hydrazine 143 turned out to be quite 
challenging. The conversion of amine 142 to the corresponding hydrazine 143 via a 
diazonium salt,[121] a common method for the synthesis of hydrazines, failed and mainly 
decomposition was observed under several conditions (Scheme 4.9).  
 
 
Scheme 4.9 Attempted conversion of amine 142 to hydrazine 143. 
It is known that aryl hydrazines can be obtained from the corresponding phenols 
applying high temperature and pressure. Thus, an alternative approach to access hydrazine 
143 was the conversion of phenol derivative 145 to hydrazine 143 under microwave 
conditions, applying hydrazine monohydrate solution. A Suzuki coupling of dibromide 144 
with phenyl boronic acid afforded diphenyl-substituted phenol 145 in 94% yield. 
Unfortunately, the subsequent conversion of phenol 145 to hydrazine 143 at 210 °C under 
microwave conditions, using hydrazine monohydrate solution in the presence of p-TsOH 
failed and only yielded various decomposition products (Scheme 4.10).  
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Scheme 4.10 Attempted conversion of phenol 145 to hydrazine 143 under microwave 
irradiation. 
Recently, the group of Stradiotto reported the cross coupling of hydrazine 
monohydrate with aryl halides and tosylates as already described for the synthesis of 
compound 141.[119] To apply this methodology, phenol 145 was converted to the 
corresponding tosylate, using TsCl and DABCO which afforded compound 146 in quantitative 
yield (Scheme 4.11). Applying the literature reported procedure, using a palladium catalyst in 
the presence of Mor-DalPhos as ligand and NaOtBu as base, aryl tosylate 146 was converted 
to the corresponding free hydrazine 143 which was found to be highly unstable and directly 
protected with p-iodobenzyl bromide to afford 13% of N-protected hydrazine 113h over 2 
steps. Compound 113h was found to be highly unstable, leading to decomposition upon 
storage. 
 
 
Scheme 4.11 Synthesis of N-protected hydrazine 113h. 
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A further promising hydrazine for the synthesis of helicenes is polyaromatic hydrazine 
153 bearing a helical structure. In the first step, a Horner-Wadsworth-Emmons reaction was 
applied, following a literature procedure.[122] The corresponding stilbene 149a was obtained 
in 92% yield and applied to a photocyclization affording 68% of compound 150.[123] A 
subsequent deprotection with BBr3 furnished polyaromatic phenol 151 in 98% yield. 
Unfortunately, the conversion of 151 to hydrazine 153 under microwave conditions failed. 
Thus, compound 151 was converted to aryl tosylate 152, using TsCl and DABCO, generating 
compound 152 in 98% yield which was used for the coupling with hydrazine monohydrate 
solution as described for hydrazines 141 and 143.[119] However, in this case, aryl hydrazine 
153 could only be obtained in trace amounts due fast decomposition of the product. Thus, 
no protection and subsequent application of this compound was possible. 
 
 
Scheme 4.12 Approaches towards the synthesis of polyaromatic hydrazine 153. 
Also the application of heterocyclic hydrazines in the catalytic asymmetric synthesis of 
helicenes seemed to be interesting since examples in literature show the employment of 
DMAP-derived helicenes as catalyst for the kinetic resolution of alcohols.[74] Quinoline-
derived hydrazine 113i could be readily prepared, starting from the corresponding amine 
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154 via the formation of a diazonium salt.[121] Treating amine 154 with sodium nitrite and 
tin(II) chloride afforded the desired hydrazine 155 in 76% yield (Scheme 4.13). A subsequent 
protection[120] with a p-iodobenzyl group afforded 30% of N-protected hydrazine 113i which 
could be tested in the catalytic asymmetric synthesis of helicenes. Unfortunately, the 
corresponding pyridine-derived hydrazine could not be obtained following this procedure. 
 
 
Scheme 4.13 Synthesis of quinoline-derived hydrazine 113i. 
Moreover, the application of bis-hydrazines in a catalytic asymmetric synthesis of 
helicenes would be interesting, giving access to bis-azahelicenes via a double Fischer 
indolization. However, the synthesis of bis-hydrazines turned out to be more challenging 
than for simple mono-hydrazines. The conversion of the corresponding biphenol 156 to 
unprotected hydrazine 157, using hydrazine monohydrate and pTsOH was successful, 
generating bis-hydrazine 157 in 45% yield (Scheme 4.14).[124] Unfortunately, several different 
procedures for the selective protection of the phenylic nitrogen failed, resulting in a 
complicated reaction profile.  
 
 
Scheme 4.14 Envisioned synthesis of compound 158a via protection of hydrazine 157. 
An alternative approach to access compound 158a was the coupling of 
benzylhydrazine hydrochloride which would avoid the subsequent protecting step (Scheme 
4.15). Therefore, aryl tosylate 159 was synthesized from the corresponding biphenol 156 via 
the treatment with TsCl and DABCO, which yielded compound 159 in 81%. Unfortunately, 
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the following coupling step, applying benzylhydrazine hydrochloride in the presence of a 
palladium catalyst, failed, resulting in a complex reaction mixture. 
 
 
Scheme 4.15 Envisioned synthesis of hydrazine 158a via a cross-coupling of 
benzylhydrazine hydrochloride. 
To overcome the selectivity problem during the protection step, a literature reported 
procedure for the palladium-catalyzed cross coupling of free ammonia with aryl tosylates 
was applied.[125] Although the coupling of similar compounds had been reported, this 
approach was unsuccessful in our system, giving no detectable product (Scheme 4.16). 
 
 
Scheme 4.16 Attempted synthesis of diamine 160 via a cross-coupling of aryl tosylate 159 
and ammonia. 
The last attempt to access bis-hydrazine 158a was the cross-coupling of aryl-tosylate 
159 with benzylamine[126] followed by the conversion to the corresponding hydrazine 158a 
(Scheme 4.17). This approach has the advantage of an already introduced protecting group 
in the final molecule. Fortunately, the palladium-catalyzed coupling to diamine 161a was 
successful, generating the desired product 161a in 94% yield. The following conversion to N-
nitroso compound 162a was conducted using sodium nitrite in water and acetic acid which 
afforded 98% of compound 162a which was used without further purification. The reduction 
step of N-nitroso compound 162a turned out to be challenging and common methods such 
as the use of Zn, SnCl2 or LiAlH4 failed, leading to decomposition or no conversion at all. 
However, examples in literature show that it is possible to reduce bis-N-nitroso compounds 
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to the corresponding hydrazine, employing TiCl4 and Mg.
[127] Following this approach, bis-
hydrazine 158a was finally obtained in 44% yield over two steps. 
 
 
Scheme 4.17 Successful synthesis of bis-hydrazine 158a via a cross-coupling of aryl-tosylate 
159 with benzylamine. 
Fortunately, the procedure described for the synthesis of bis-hydrazine 158a could also 
be applied to the synthesis of thiophene-derived bis-hydrazine 158b. Small modifications of 
the coupling conditions were necessary due to the use of an aryl bromide (163) instead of an 
aryl tosylate. The cross-coupling was conducted at higher temperature, using Pd(OAc)2 as 
catalyst which afforded the corresponding diamine 161b in 89% yield (Scheme 4.18). The 
subsequent transformation to hydrazine 162b was straightforward, generating the desired 
product 158b in 42% yield over two steps. 
 
 
Scheme 4.18 Synthesis of thiophene-derived bis-hydrazine 158b. 
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 Synthesis of Polyaromatic Ketones 4.2.2.2.
 
The synthesis of polyaromatic ketones 114 was conducted, following a literature 
reported procedure (Scheme 4.19).[122] In the first step, a Horner-Wadsworth-Emmons 
reaction was applied, using phosphonate 147 and the appropriate aldehydes 148 to 
generate the corresponding stilbenes 149 in high yields. The following photocyclization 
under irradiation with UV-light (300 nm) afforded polyaromatic ketones 114a-114c, although 
in generally low yields.  
 
 
Scheme 4.19 General synthesis of polyaromatic ketones of type 114. 
A possible mechanistic scenario for the photochemical synthesis of polyaromatic 
ketones of type 114 is proposed by Ho and coworkers.[122] They suggest an isomerization of 
stilbenes (E)-149 to (Z)-149 upon irradiation, followed by a photoinduced conrotatory 
electrocyclization, forming dihydrophenanthrene-derived intermediates 114-I1 (Scheme 
4.20). A subsequent acid catalyzed formal [1,9]hydrogen shift delivers intermediates 114-I2 
which undergo hydrolysis, followed by an acid catalyzed formal [1,3]hydrogen shift, 
generating the corresponding polyaromatic ketones 114.  
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Scheme 4.20 Possible reaction pathway for the photochemical synthesis of polyaromatic 
ketones 114. 
The synthesis of polyaromatic ketone 114e was slightly modified, using dibromo-
substituted aldehyde 148d for the Horner-Wadsworth-Emmons reaction, generating the 
corresponding dibromo-stilbene 149d in 75% yield (Scheme 4.21). Since the photocyclization 
of this compound failed and led to decomposition of the starting material, a cross-coupling 
step was conducted to introduce phenyl-substituents in the 1- and 3-position of compound 
149d. A subsequent photocyclization of stilbene 149e finally afforded 23% of the 
polyaromatic ketone 114e. 
 
Scheme 4.21 Synthesis of polyaromatic ketone 114e. 
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 Optimization of the Reaction Parameters 4.2.3.
 
At the outset of our studies, hydrazine 113a and polyaromatic ketone 114a were 
chosen as model substrates for initial explorations. We started our investigations testing 
different BINOL- 10 and SPINOL-derived phosphoric acids 19, running the reaction in toluene 
at room temperature. Indeed, a variety of catalysts were identified that could accelerate the 
desired process. The use of a simple phenyl-substituted BINOL- derived phosphoric acid 10e 
generated the desired product 115a with low enantioselectivity (Table 4.1, entry 1). 
Increasing the steric bulkiness by employing TRIP (10f) as catalyst did not improve the 
enantioselectivity significantly (Table 4.1, entry 2). Switching to catalysts with more 
extended π-substituents such as a phenanthryl group afforded the desired product 115a in 
an enantiomeric ratio of 68.5:31.5 (Table 4.1, entry 3). The change to SPINOL-derived 
phosphoric acids 19 led to a generally improved enantioselectivity, generating the desired 
product 115a in 82.5:17.5 er, employing an anthracenyl-substituted phosphoric acid 19b as 
catalyst (Table 4.1, entry 7). Changing the solvent from toluene to dichloromethane afforded 
azahelicenes 115a in an improved enantiomeric ratio of 85.2:14.8 (Table 4.1, entry 8). As 
expected, the obtained results showed a notable increase of the enantioselectivity when the 
π-surface of the 3,3’-substituents was extended. However, 2-pyrenyl-substituted catalyst 
19d showed a reduced enantioselectivity of 78:22 er, indicating that an ortho-substituent on 
the 3,3’-substituents has a beneficial effect on the enantioselectivity. The application of 
novel catalyst 19c, bearing 1-pyrenyl substituents finally afforded the desired product 115a 
in a promising enantiomeric ratio of 91:9 at room temperature which could be increased to 
95.5:4.5 by lowering the temperature to −7 °C (Table 4.1, entry 11). 
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Table 4.1 Optimization of reaction conditions for the catalytic asymmetric synthesis of 
helicene 115a.a) 
 
Entry Catalyst Substituent Solvent T (°C) erb) 
1 10e Ph toluene 25 53.5:46.5 
2 10f 2,4,6-(iPr)3-C6H2 toluene 25 57:43 
3 10g 9-phenanthryl toluene 25 68.5:31.5 
4 10h 9-anthracenyl toluene 25 52.5:47.5 
5 10c 3,5-(CF3)2-C6H3 toluene 25 53.5:46.5 
6 19a 2,4,6-(iPr)3-C6H2 toluene 25 68.5:32.5 
7 19b 9-anthracenyl toluene 25 82.5:17.5 
8 19b 9-anthracenyl CH2Cl2 25 85.2:14.8 
9 19d 2-pyrenyl CH2Cl2 25 78:22 
10 19c 1-pyrenyl CH2Cl2 25 91:9 
11c) 19c 1-pyrenyl CH2Cl2 –7 95.5:4.5 
a) Reactions were carried out on a 0.01 mmol scale using 5 mg Amberlite
®
 CG50. b) Determined by HPLC analysis on a chiral 
stationary phase. c) 3 days were required for full conversion. 
 
A screening of the catalyst loading showed no significant effect on the 
enantioselectivity, while the yield decreased considerably, lowering the catalyst loading to 
2 mol%. Thus, 5 mol% of catalyst 19c were used in the following transformations (Table 
4.2, entry 1). 
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Table 4.2 Screening of the catalyst loading for the synthesis of helicene 115a.a) 
 
 
Entry Loading NMR yieldb) erc) 
1 5 mol% 39% 90:10 
2 2 mol% 27% 89.5:10.5 
3 10 mol% 51% 90:10 
a) Reactions were carried out for 18 h on a 0.01 mmol scale using 5 mg Amberlite
®
 CG50. b) Determined by 
1
H-NMR analysis 
using 1,3,5-trimethoxy benzene as internal standard. c) Determined by HPLC analysis on a chiral stationary phase. 
 
The investigation of different protecting groups revealed a p-iodobenzyl group (PIB) to 
be the best in terms of enantioselectivity (Table 4.3, entry 1). Removing the 4-substitent or 
changing it to a bulkier tBu-group led to a significant decrease in the enantioselectivity 
 
Table 4.3 Screening of different protecting groups.a) 
 
Entry Compound R erb) 
1 115a 4-I 93.5:6.5 
2 115b H 87.5:12.5 
3 115c 4-tBu 87.5:12.5 
4 115d 4-CF3 93:7 
5 115e 3,5-CF3 77.5:22.5 
a) Reactions were carried out on a 0.02 mmol scale. b) Determined by HPLC analysis on a chiral stationary phase. 
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 (Table 4.3, entries 2-3) while a CF3-group afforded the corresponding product 115d with a 
similar enantiomeric ratio (Table 4.3, entry 5). Thus, a p-iodobenzyl substituent was chosen 
as protecting group in our transformation. 
 
In conclusion, phosphoric acid 19c was found to be the best catalyst for the catalytic 
asymmetric synthesis of azahelicenes 115, which is consistent with our hypothesis that an 
extended π-surface is necessary in order to induce stereoselectivity. A p-iodobenzyl 
substituent proved to be the best protecting group in terms of enantioselectivity, running 
the reaction in CH2Cl2 at −7 °C for 3 d. 
 
 Substrate Scope of Azahelicenes 4.2.4.
 
Calculations were performed in collaboration with Y. Zheng (AK Prof. Thiel, MPI Mülheim). 
 
With the optimized conditions in hand, we further investigated the scope of this 
transformation. Hydrazine 113a reacted smoothly with a variety of different polyaromatic 
ketones 114, furnishing the corresponding azahelicenes 115a,f-h in generally good yields and 
enantioselectivities. Using thiophene-derived ketone 114b afforded azahelicene 115f in 66% 
yield and a high enantiomeric ratio of 96:4 (Scheme 4.22). The absolute configuration of 
both, helicenes 115a and 115f, could be assigned unambiguously by X-ray crystallography, 
showing (M) helicity if the (S) enantiomer of the catalyst was employed. The use of 
polyaromatic ketone 114c furnished the corresponding azahelicene 115g in an excellent 
yield of 98% and a high enantiomeric ratio of 96:4. Employing naphthalene-derived 
hydrazine 113b afforded azahelicenes 115i-115l in slightly decreased yields and 
enantioselectivities. Also the use of a TMS-substituted hydrazine 113g was possible, 
generating the corresponding product 115m in a diminished yield of 40% and an 
enantiomeric ratio of 87.5:12.5. Applying the phenyl-substituted hydrazine 113h afforded 
azahelicene 115n in an enantiomeric ratio of 88:12 although the product was found to be 
unstable and could not be obtained in pure form. The use of quinoline-derived hydrazine 
113i turned out to be challenging and the desired product could only be obtained as 
racemate, using stoichiometric amounts of diphenyl phosphate. One reason for this might be 
the basic nitrogen which could potentially form a salt with the catalyst. 
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Scheme 4.22 Substrate scope of catalytic asymmetric synthesis of azahelicenes 115. 
Encouraged by these results, we became interested in extending our approach to the 
catalytic asymmetric synthesis of bis-azahelicenes 165 via a double Fischer indolization. 
Interestingly, the treatment of bis-hydrazine 158a and commercially available ketone 164 
with 20 mol% of catalyst 19c, afforded a bis-azahelicene 166 bearing just one benzyl group 
and being sensitive towards oxidation. Thus, a subsequent controlled oxidation with 
chloranil was applied to directly access polyaromatic bis-azahelicene 165a. As expected, 
compound 165a was obtained as the mono-benzylated product and could be isolated in 43% 
yield over two steps and with an enantiomeric ratio of 94:6 (Scheme 4.23). Interestingly, the 
fully benzylated product 165b was just obtained in trace amounts whereas the completely 
debenzylated compound could not be observed at all.  
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Scheme 4.23 Catalytic asymmetric synthesis of bis-azahelicene 165a. 
The selective loss of one benzyl group enabled modifications at the free nitrogen such 
as the introduction of different substituents. Using NaH and the corresponding aryl bromide 
afforded the helicenes 165b and 165c in high yields (Scheme 4.24). Potentially, also other 
groups than benzyl or p-iodobenzyl could be introduced which would further broaden the 
substrate scope of this transformation. 
 
 
Scheme 4.24 Modification of bis-azahelicene 165a. 
We were interested in investigating the fate of the lost benzyl group and decided to 
carefully study the mechanism of this transformation. Following the reaction via mass 
spectrometry (MS) revealed that benzyl amine is released during the reaction. A possible 
explanation for this would be the attack of the free amine on the benzyl imine which is 
formed after the [3,3]-sigmatropic rearrangement and which is stabilized by the hydrazine, 
the formed hydrazone or the indole, depending on when benzyl amine is released. A release 
in the first cyclization step could be explained by the following scenario: hydrazine 158a is 
converted to the corresponding mono- or bis-hydrazone. After the [3,3]‐sigmatropic 
rearrangement the formed benzyl imine could be stabilized by the hydrazone or the 
hydrazine (C7). Due to this stabilization, the attack of the free amine (C2‘) on the benzyl 
iminium ion (C2) could be favored over the usually reversed attack. Thus, instead of 
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ammonia, benzyl amine would be released during this step, leading to indole A2 bearing 
only one benzyl group. (HRMS: 528.259642 (M+H+), referring to A2 and A3). The second 
cyclization step would then occur via the conventional Fischer indolization pathway, leading 
to the desired product 165a after a subsequent oxidation (Scheme 4.25).  
 
 
Scheme 4.25 Possible pathway for the release of benzyl amine in the first cyclization step. 
Another possible pathway could be the release of benzyl amine in the second Fischer 
indolization step. In this scenario, the first cyclization step of the reaction would occur via 
the common Fischer indolization, generating intermediate B2 after the release of ammonia 
(HRMS: 608.306025 (M+H+), referring to B2 and B3). After the second [3,3]‐sigmatropic 
rearrangement, the present indole could stabilize the benzyl iminium ion, therefore favoring 
the attack of the free amine on the benzyl iminium ion (B3). The release of benzyl amine 
would then generate helicene 166a, bearing just one benzyl group (Scheme 4.26). Based on 
these results, we assume that the release of benzyl amine is responsible for the selective 
generation of mono-benzylated helicene 165a. Yet, a clear statement about which 
cyclization step is preferred for the release of benzyl amine cannot be given at this stage. 
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Scheme 4.26 Possible pathway for the release of benzyl amine in the second cyclization 
step.  
Interestingly, bis-azahelicene 165a showed, in contrast to the rest of our products 
(Scheme 4.22), a positive specific optical rotation (   25D  +535.2), indicating that in this 
case the (P)-enantiomer is preferentially formed. Unlike in common chiral molecules, the 
specific optical rotation of helicenes is usually consistent with their absolute 
configuration.[128] Thus, (P)-helicenes typically show a positive (plus) specific rotation 
whereas (M)-helicenes have a negative (minus) specific rotation. To unambiguously assign 
the absolute configuration of our product we decided to conduct CD spectroscopical 
investigations of bis-azahelicene 166a, comparing the CD characteristics of our experimental 
CD spectrum (red line) with those of the corresponding TD-DFT calculated CD spectrum (blue 
line) (Figure 4.2). Indeed, we found a significant agreement of the CD characteristics 
between the experimental and the calculated CD spectrum for (P)-166a, indicating that in 
this case the opposite enantiomer is preferentially formed, using the same enantiomer of 
19c as catalyst. 
 4. Results and Discussion   
60 
 
Figure 4.2 Determination of the absolute configuration of bis-azahelicene 166a via CD 
spectroscopy (calculated: blue line, experimental: red line). 
A possible explanation for this observation could be the generation of a different 
intermediate. In contrast to the corresponding mono-azahelicenes 115, the protected 
nitrogen is in this case connected to the polyaromatic part after the first cyclization step. 
This could lead to a different transition state and the preference of the opposite enantiomer 
due to different π-interactions or steric repulsion (Figure 4.3). 
 
 
Figure 4.3 Proposed transition state model for azahelicene 115 and bis-azahelicene 166. 
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The catalytic asymmetric synthesis of bis-azahelicene 165a encouraged us to further 
investigate the synthesis of other bis-azahelicenes via this methodology. Unfortunately, the 
use of indanone 167 and bis-hydrazine 158a afforded a complex mixture and no pure 
compound could be obtained. Also the application of bis-hydrazine 158b turned out to be 
challenging, generating complex reaction mixtures upon treatment with ketones 164 or 167 
and no desired products could be isolated (Scheme 4.27). 
 
 
Scheme 4.27 Attempts towards various bis-azahelicenes 166 via a catalytic asymmetric 
double Fischer indolization. 
 
 Investigations of Azahelicenes 4.2.5.
 
 Oxidation to Polyaromatic Helicenes 4.2.5.1.
 
To access enantioenriched polyaromatic helicenes via our methodology, we decided to 
convert (P)-115a, derived from (R)-19c, into the corresponding oxidized helicene 168. The 
use of chloranil in the presence of diphenyl phosphate (DPP) in CHCl3 successfully afforded 
the desired azahelicene 168 in 76% without loss of enantioselectivity (Scheme 4.28). The use 
of DDQ as an oxidant mainly led to decomposition of the starting material.  
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Scheme 4.28 Oxidation of aza-helicene 115a with chloranil. 
 
 CD-Spectroscopic Investigations 4.2.5.2.
 
To compare our products to literature reported helicenes, we decided to investigate 
the CD-spectra of compounds (P)-115a, (P)-168 and (M)-115a. We found a significant 
agreement of the CD characteristics between (P)-115a, (blue line) (P)-168 (red line) and 
those reported for (+)-(P)-[6]helicene.[129-130] As expected, the spectra of (M)-115a (blue 
dashed line) and (P)-115a (blue line) are perfect mirror images of each other (Figure 4.4). In 
this way we could independently ascribe the P (dextrorotatory) and M (levorotatory) helicity 
of our corresponding products by both, CD spectroscopy and X-ray crystallography.  
 
 
Figure 4.4 CD spectra of (P)-115a (blue line), (P)-168 (red line) and (M)-115a (blue 
dashed line). 
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 Thermal Racemization Study 4.2.5.3.
 
It is known in literature that several helicenes can undergo thermal racemization over time 
and the free energy for this process can be measured. For instance, [6]helicene has a 
racemization energy of 154.5 kJ mol-1 at 188 °C[131-133] which made us curious about the 
racemization barrier of our compounds. We chose polyaromatic azahelicene 168 for further 
investigations due to its stability towards oxygen and the comparison to literature known 
[6]- and [7]helicenes. The racemization of (P)-168 was studied by following the change of the 
enantiomeric ratio over time at 240 °C, using tetraglyme as solvent (Figure 4.5). From the 
obtained data we were able to determine the racemization barrier for (P)-168 which was 
found to be 172 ± 0.4 kJ mol-1. This value is comparable to the literature known racemization 
energy of [7]helicene which is reported to be 175.1 kJ mol-1.[131] It has to be mentioned that 
the racemization of non-oxidized azahelicenes 115a turned out to be more challenging due 
to partial oxidation during the racemization process at 240 °C. 
 
 
 
Figure 4.5 Thermal racemization of polyaromatic azahelicene (P)-168. 
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 Nonlinear Effect Studies 4.2.5.4.
 
For a better understanding of the reaction, we further conducted nonlinear effect 
studies of our model reaction. The reaction was performed under the optimized reaction 
conditions, using different mixtures of (R)- and (S)-19c. Afterwards, the enantiomeric excess 
of the catalyst 19c was plotted against the enantiomeric excess of the corresponding 
product 115a. From the obtained data, a linear graph was obtained, indicating that there is 
no nonlinear effect present in our reaction (Figure 4.6).  
 
 
 
 
Figure 4.6 Nonlinear effect study of the catalytic asymmetric synthesis of 
azahelicene 115a. 
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 Summary 4.2.6.
 
In conclusion, we developed a mild and powerful approach for the catalytic 
asymmetric synthesis of helicenes 115, using the novel SPINOL-derived phosphoric acid 19c 
as catalyst. The catalyst, featuring extended π-surfaces at the 3,3’-substituents was specially 
designed for this reaction and allows a high level of stereocontrol in this transformation. A 
variety of different azahelicenes 115 could be obtained in good yields and high 
enantioselectivities. Remarkably, the synthesis of a bis-azahelicene 165a via a double Fischer 
indolization and a subsequent oxidation could be realized. The products were further 
investigated via CD spectroscopy and the racemization barrier of azahelicene 168 was 
determined under thermal conditions. To the best of our knowledge, this is the first example 
of an organocatalytic asymmetric synthesis of helicenes which provides a novel access to, 
and allows a broader structural diversity of, these important scaffolds.   
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 Catalytic Asymmetric Dearomatizing Synthesis of 1,4-Diketones 4.3.
 
The results reported in this section were obtained in collaboration with S. Huang and C. K. De. 
 
 Concept 4.3.1.
 
The catalytic asymmetric Fischer indolization is a mild yet powerful transformation to 
access chiral indole-derived compounds enantioselectively.[54-55,58] Considering the 
mechanism of this reaction, dearomatized diimine species 170 are generated as 
intermediates after the enantiodetermining [3,3]-sigmatropic rearrangement. Usually, 
rearomatization via a proton shift, followed by a 5-exo-trig cyclization takes place, releasing 
ammonia and generating the corresponding indole. However, the introduction of 
substituents in α-position to the hydrazine group (R1, R2) should prevent a rearomatization, 
allowing the hydrolysis of diimines 170 which would give access to enantioenriched 1,4-
diketones 118 which are important building blocks in organic syntheses (Scheme 4.29). This 
chapter describes the development of such a catalytic asymmetric dearomatizing synthesis 
of 1,4-diketones 118 applying an interrupted Fischer indolization. 
 
 
Scheme 4.29 Concept of the catalytic asymmetric synthesis of 1,4-diketones 118, applying 
an interrupted Fischer indolization. 
 Preparation of the Starting Materials 4.3.2.
 
Non-commercially available hydrazines were prepared following a literature procedure 
reported by Demers and Klaubert, applying a Grignard reaction.[134] Treating 
azodicarboxylate 171 with the corresponding aryl magnesium bromide afforded Boc-
protected hydrazines 172a-f which were directly deprotected, employing hydrochloric acid 
in dioxane (Scheme 4.30). Following this procedure, a variety of different hydrazine 
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hydrochloride salts (116a-f·HCl) were synthesized. Due to their poor stability towards oxygen 
and light, the salts were stored under argon atmosphere and shielded from light. The 
corresponding free hydrazines 116 were obtained via basic extraction under argon 
atmosphere and were used as freshly prepared stock solutions. The synthesis of more 
electron rich hydrazines, such as methoxy-substituted derivatives failed since the products 
were found to be unstable and decomposed to the corresponding amine. Also attempts 
towards a bromination of Boc-protected hydrazine 172a were unsuccessful, leading to a 
complex reaction mixture, applying various bromination conditions.  
 
 
Scheme 4.30 Synthesis of hydrazine salts 116·HCl for the catalytic asymmetric synthesis of 
1,4-diketones 118. 
Most of the ketones used in our transformation were commercially available and were 
directly used as supplied. Tosyl-substituted piperidone 173b was synthesized following a 
literature procedure described by O’Neill and coworkers,[135] using potassium carbonate and 
tosyl chloride which delivered ketone 173b in 95% yield (Scheme 4.31). 
 
 
Scheme 4.31 Synthesis of tosyl piperidone 173b. 
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 Optimization of the Reaction Conditions 4.3.3.
 
Employing hydrazine 116a, bearing a methyl substituent in ortho-position to the 
hydrazine group and cyclohexanone (117a) as model substrate for our reaction, we started 
to investigate our envisioned transformation. Applying TRIP (10f) as catalyst in the presence 
of Amberlite® CG50 indeed afforded our desired product 118a albeit with low yield and 
moderate enantioselectivity. Unfortunately, the employment of other BINOL-derived 
phosphoric acids neither improved the enantioselectivity, nor the yield (Table 4.4, entries 1-
3). However, changing to the SPINOL-derived catalyst STRIP (19a) generated 1,4-diketone 
118a with a good enantioselectivity of 95.2:4.8 and a diastereomeric ratio of >10:1 but still 
with a low yield of 40% (Table 4.4, entry 6). A careful analysis of the reaction mixture 
revealed that the poor yield derived from low conversion and the formation of various side 
products which were identified to be different pyrrole species (see: chapter 4.4). To improve 
the conversion without decreasing the enantioselectivity, we envisioned that a more acidic 
catalyst, featuring the same steric bulkiness would be required. Recent examples in 
literature show the presence of cooperative effects between carboxylic acids and phosphoric 
acids in organocatalysis.[115,136-140] In 2014, the group of List reported the formation of 
heterodimers between the chiral phosphoric acid TRIP (10f) and carboxylic acids. The 
authors propose that the heterodimer formation leads to a HOMO raising and a more acidic 
catalyst species. This concept was applied to the enantioselective opening of epoxides and 
aziridines, interestingly without any catalyst degradation, presumably due to the 
heterodimerization.[115,136] Inspired by this approach, we tested benzoic acid as an additive in 
our transformation. Remarkably, the addition of one equivalent benzoic acid had a beneficial 
effect on both, conversion and yield, without diminishing the diastereo- and 
enantioselectivity, generating 1,4-diketone 118a in 52% yield and with an enantiomeric ratio 
of 95.1:4.9 (dr>10:1) (Table 4.4, entry 7). However, we could still observe the formation of 
various pyrrole species as side products which limited the yield significantly. Reconsidering 
our envisioned reaction pathway, formally two equivalents of water would be necessary for 
an efficient hydrolysis of diimine intermediate 169C=N. However, only one equivalent of 
water is released during the formation of the hydrazone. Thus, the addition of water should 
enhance the hydrolysis of diimine 169C=N, preventing the formation of the corresponding  
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pyrroles. Indeed, adding an excess of water to our reaction mixture afforded the desired 
product 118a in 65% yield and 94.4:5.6 er (dr>10:1) (Table 4.4, entry 9) without the 
formation of pyrroles as side products and 10 equivalents of water were found to be best in 
terms of yield and enantioselectivity while higher or lower amounts led to a decrease in 
Table 4.4 Optimization of reaction parameters for the catalytic asymmetric synthesis of 
1,4-diketones 118.a) 
 
Entry Catalyst Substituent H2O PhCO2H T (°C) Yield
b) erc) 
1 10f 2,4,6-(iPr)3-C6H2 - - 45 43% 82:18 
2 10g 9-phenanthryl - - 45 20% 76.3:23.7 
3 10c 3,5-(CF3)2-C6H3 - - 45 48% 77:23 
4 19e 3,5-(CF3)2-C6H3 - - 45 44% 58.5:41.5 
5 19c 1-pyrenyl - - 45 40% 82:18 
6 19a 2,4,6-(iPr)3-C6H2 - - 45 40% 95.2:4.8 
7 19a 2,4,6-(iPr)3-C6H2 - 1 eq. 45 52% 95.1:4.9 
8 19a 2,4,6-(iPr)3-C6H2 1 eq. 1 eq. 45 55% 94.6:5.4 
9 19a 2,4,6-(iPr)3-C6H2 10 eq. 1 eq. 45 65% 94.4:5.6 
10 19a 2,4,6-(iPr)3-C6H2 20eq. 1 eq. 45 62% 91.3:8.7 
11 19a 2,4,6-(iPr)3-C6H2 10 eq. 0.3 eq. 40 66% 95:5 
12 19a 2,4,6-(iPr)3-C6H2 10 eq. 0.3 eq. 30 67% 93:7 
13d) 19a 2,4,6-(iPr)3-C6H2 10 eq. 0.3 eq. 40 56% 95:5 
14e) 19a 2,4,6-(iPr)3-C6H2 10 eq. 0.3 eq. 40 70% 96:4 
a) Reactions were conducted on a 0.05 mmol scale with 50 mg Amberlite
®
 CG50. The diastereomeric ratio was determined by 
1
H-NMR analysis of the crude reaction mixture (dr >10:1 in all cases). b) Yield determined by 
1
H-NMR analysis using 
CHCl2CHCl2 as internal standard. c) Determined by HPLC analysis on a chiral stationary phase. d) Benzene was used as 
solvent. e) p-Xylene was used as solvent.  
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enantioselectivity or yield, respectively. Lowering the reaction temperature to 40 °C and 
reducing the amount of benzoic acid to 0.3 equivalents yielded 1,4-diketone 118a in 66% 
and 95:5 er (Table 4.4, entry 11). The change of the solvent to p-xylene finally afforded the 
desired product 118a in 70% yield, a high enantiomeric ratio of 96:4 and a good 
diastereomeric ratio of 17:1 (Table 4.4, entry 14). 
 
 Substrate Scope of 1,4-Diketones 4.3.4.
 
Having the optimized conditions in hand, we further investigated the scope of our 
transformation. Naphthalene-derived hydrazine 116a reacted smoothly with a variety of 
cyclic ketones, generating the desired products in good yields and stereoselectivities 
(Scheme 4.32). Substituents in the 4-position of the ketone were found to have a beneficial 
effect on the enantioselectivity, furnishing 1,4-diketone 118b with an enantiomeric ratio of 
99:1 and an excellent diastereomeric ratio of >20:1. Also 1,4-diketone 118c, featuring an 
acetal in 4-position of the ketone, was obtained with a high enantiomeric ratio of 97:3 and 
excellent diastereoselectivity. Moreover, heterocyclic ketones were found to be suitable 
substrates for our transformation. Whereas a thio-substituted ketone delivered diketone 
118d in 61% yield and an enantiomeric ratio of 97:3 (dr>20:1), the corresponding oxygen-
substituted product 118e showed a slightly decreased enantiomeric ratio of 87.3:12.7 
(dr = 20:1). Applying different nitrogen-substituted ketones afforded the diketones 118f-h in 
good yields, diastereo- and enantioselectivities. The structure and absolute configuration of 
both, product 118e and 118h could be assigned unambiguously by X-ray crystallography. 
Changing the ring size to a five-membered ring led to a diminished yield of only 29%, a low 
enantiomeric ratio of 78.4:21.6 (118i) and a reduced diastereomeric ratio of 2:5. The 
introduction of substituents on the hydrazine moiety was also possible and the 
corresponding products 118j-l were isolated in moderate to good yields, enantioselectivities 
and excellent diastereoselectivities, depending on the position of the substituent. The 
application of a phenyl-derived hydrazine turned out to be challenging, delivering the 
desired product 118o in poor yield and a low enantiomeric ratio of 77.6:22.4, albeit with an 
excellent diastereomeric ratio of >20:1. A further limitation of this transformation is the use 
of noncyclic ketones such as acetone. Although the corresponding racemic product 118p  
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Scheme 4.32 Substrate scope of catalytic asymmetric synthesis of 1,4-diketones 118.               
a) Reaction was conducted using diphenyl phosphate (2 equiv.). b) Reaction was performed using 20 mol% 
of 19e as catalyst at 50 °C for 3 d. 
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could be obtained in 57% yield using two equivalents of diphenyl phosphate, no product was 
observed in the presence of catalyst 19a. However, applying 20 mol% of the more acidic 
phosphoric acid 19e afforded the desired diketone 118p in low yield but a promising 
enantiomeric ratio of 70:30, running the reaction at an increased temperature of 50 °C. 
Various other noncyclic ketones did not yield any desired product (118q-t) at all. Applying 
different BINOL- (10) and SPINOL-derived phosphoric acids (19) and running the reaction at 
higher temperature led in most cases to decomposition of the starting material. 
 
A possible mechanistic scenario for this transformation is shown in Scheme 4.33. After 
the formation of the hydrazone, catalyst 19a accelerates the tautomerization between the 
hydrazone [169aC=N·19a] and the enehydrazine [169aC=C·19a] which undergoes the 
enantiodetermining [3,3]-sigmatropic rearrangement, forming dearomatized diimine species 
[170a·19a]. Due to the substituent on the naphthalene moiety, rearomatization via a proton 
shift cannot occur and, in the presence of water, a subsequent hydrolysis to diketone 118a 
takes place. After the release of enantioenriched product 118a, the catalyst is regenerated 
by a cation exchange with Amberlite® CG50.  
 
 
Scheme 4.33 Possible mechanism for the catalytic asymmetric dearomatizing synthesis of 
1,4-diketones 118. 
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The generally high diastereoselectivity of this transformation can be explained by 
considering two different possible conformations of enehydrazine [169aC=C]. In general, the 
[3,3]-sigmatropic rearrangement can proceed via a chair like [169aC=C]
1 or a boat like 
[169aC=C]
2 conformation of protonated enehydrazine [169aC=C] (Figure 4.7). Considering the 
chair like conformer [169aC=C]
1, the axial substituent causes steric repulsion with the 
cyclohexene ring, disfavoring this conformation. Hence, the boat like conformation 
[169aC=C]
2 should be favored, generating the corresponding observed anti-1,4-diketones 
118a. 
 
 
Figure 4.7 Stereochemical model for the catalytic asymmetric synthesis of 1,4-diketones 
118a. 
To investigate the stability of our products, we performed epimerization studies, using 
diketone 118e. Under equilibrating conditions with diphenyl phosphate (DPP) or 1,8- 
diazabicyclo[5.4.0]undec-7-ene (DBU) both, anti-118e and syn-118e afforded a 1:1 mixture 
of the two diastereoisomers anti-118e and syn-118e (Scheme 4.34). However, submitting 
enantiopure anti-118e to our standard reaction conditions, using hydrazine 116a and 
cyclohexanone 117a afforded the corresponding product 118a and enantiopure diketone 
anti-118e, whereas syn-118e was not observed. This result shows that our products are 
stable towards epimerization under the optimized reaction conditions. Moreover, it 
indicates that our transformation is under kinetic rather than thermodynamic control. 
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Scheme 4.34 Epimerization study of 1,4-diketones 118e. 
 
 Summary 4.3.5.
 
In conclusion, we have developed a mild and efficient methodology to access 1,4-
diketones of type 118, enantioselectively. The concept for the transformation is based on an 
interrupted catalytic asymmetric Fischer indolization, followed by an in situ hydrolysis of the 
non-aromatic diimine intermediate 170. Applying the SPINOL-derived phosphoric acid STRIP 
(19a) afforded a variety of different 1,4-diketones 118 in generally high yields and 
stereoselectivities.   
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 The Divergent Enantioselective Synthesis of 2H- and 3H-Pyrroles 4.4.
 Concept 4.4.1.
 
Inspired by our work on the catalytic asymmetric dearomatizing synthesis of 1,4-
diketones 118 via an interrupted Fischer indolization, we became interested in applying this 
approach to the enantioselective synthesis of the corresponding pyrroles 119 which have 
been observed as side products in this transformation. We hypothesized that running the 
reaction in the absence of water would prevent the hydrolysis and thus give access to the 
corresponding enantioenriched 3H-pyrroles 119 which are interesting scaffolds with 
potential bioactivities (Scheme 4.35). Interestingly, examples in literature show that 3H-
pyrroles can be converted to the corresponding 2H-pyrroles via a suprafacial thermally or 
acid induced [1,5]-shift.[104-107] Assuming that this shift is stereospecific, our strategy would 
potentially provide a selective access to both, enantioenriched 3H- 119 and 2H-pyrroles 120. 
The development of a catalytic asymmetric dearomatizing synthesis of 3H- 119 and 2H-
pyrroles 120 will be described in this chapter. 
 
 
Scheme 4.35 Concept of the catalytic asymmetric synthesis of 3H- 119 and 2H-pyrroles 120. 
 
 Enantioselective Synthesis of 3H-Pyrroles 4.4.2.
 
 Optimization of the Reaction Parameters 4.4.2.1.
 
The hydrazines used in this transformation were synthesized following the procedure 
described in chapter 4.3.2. Choosing hydrazine 116a and ketone 117a as model substrates 
for our envisioned transformation, we started our investigations towards the selective 
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synthesis of 3H-pyrrole 119a. Having identified SPINOL-derived phosphoric acid STRIP (19a) 
as best catalyst for the catalytic asymmetric synthesis of 1,4-diketones 118a, we applied this 
catalyst for further investigations of our new transformation. Conducting the reaction 
without the addition of water afforded a complex mixture of different pyrrole species 119a, 
exo-119a and 120a as well as the corresponding 1,4-diketone 118a (Table 4.5, entry 1). 
Interestingly, 3H-pyrrole 119a partially converted to the corresponding 2H-pyrrole 120a 
under our reaction conditions. Moreover, small amounts of exo-3H-pyrrole exo-119a were 
formed as side product. As already shown in the development of a catalytic asymmetric 
synthesis of 1,4-diketones 118a (see: chapter 4.3), the addition of carboxylic acids was found 
to have a beneficial effect on the reactivity of the transformation without diminishing the  
 
Table 4.5 Screening of additives for the selective synthesis of 3H-pyrrole 119a (Part 1).a) 
 
Entry 
 
Addit.1 
(equiv.) 
Addit.2 
(mg/mmol) 
t 
 
T 
(°C) 
Conv. 
 
NMR yield/erb) 
 
1 / / 3 d 45 60% 
A 27%  -   95:5 
B 3%    -   95:5 
C 3%    -   n.d. 
D 6%    -   82:18 
2 
AcOH 
(0.5) 
/ 3 d 45 95% 
A 38%  -   97:3 
B 11%  -   95.5:4.5 
C 4%    -   n.d. 
D 23%  -   96:4 
3 
PhCO2H 
(0.5) 
/ 3 d 45 99% 
A 32%  -   96:4 
B 16%  -   98.5:1.5 
C 5%    -   n.d. 
D 28%  -   77:23 
4 
PhCO2H 
(1.0) 
/ 3 d 30 full 
A 30%  -   96:4 
B 25%  -   94:6 
C 4%    -   n.d. 
D 5%    -   n.d. 
a) Reactions were conducted using Amberlite
®
 CG50 (500 mg/mmol). b) Conversions and yields were determined by 
1
H-NMR 
analysis after basic extraction with KOH (3M), using 1,3,5-trimethoxybenzene as internal standard; er determined by HPLC 
analysis on a chiral stationary phase. 
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enantioselectivity (Table 4.5, entries 2-4). However, the desired product 119a was only 
obtained in low yields due to the formation of 2H-pyrrole 120a and 1,4-diketone 118a as 
side products. Reducing the temperature to 30 °C and increasing the amount of benzoic acid 
to one equivalent afforded 25% of 3H-pyrrole 119a whereas the amount of the 
corresponding 2H-pyrrole 120a was decreased to 5%, showing that the formation of 2H-
pyrrole 120a is favored at higher temperatures. 
 
The addition of activated 4Å molecular sieves was found to prevent the formation of 
1,4-diketone 118a effectively, generating the desired product 119a in 51% yield and an 
enantiomeric ratio of 96.5:3.5 (Table 4.6, entry 1) although the reactivity was reduced 
significantly, presumably due to the basicity of the products. Reducing the amount of 
benzoic acid to 0.5 equivalents and increasing the amount of Amberlite® CG50 did not 
improve the yield of the desired product 119a and had no influence on the formation of the 
corresponding 2H-pyrrole 120a (Table 4.6, entries 2-3). Decreasing the temperature to 20 °C 
reduced the amount of by-product 120a, generating 3H-pyrrole 119a in 53% yield and an 
enantiomeric ratio of 95.5:4.5 (Table 4.6, entry 4). Applying 10 mol% of STRIP (19a) and 
changing the solvent to p-xylene finally afforded the desired 3H-pyrrole 119a in 56% isolated 
yield and an excellent enantiomeric ratio of 98:2 (Table 4.6, entry 6). It has to be mentioned 
that the reaction concentration was found to have no effect on both, product- and 
enantioselectivity of 3H-pyrrole 119a. Interestingly, however, the amount of side product 
120a was found to have an influence on the enantiomeric ratio of 3H-pyrrole 119a due to a 
kinetic resolution of 3H-pyrrole 119a via a [1,5]-alkyl shift as side reaction, increasing the 
enantiomeric ratio of product 119a upon formation of 2H-pyrrole 120a (see: chapter 
4.4.3.5). Since in most cases small amounts of 2H-pyrrole 120a were generated as side 
product, we decided to perform a catalyst screening for the catalytic asymmetric synthesis 
of 2H-pyrroles 120a which makes the comparison of the enantioselectivity more consistent 
(see: chapter 4.4.3.1). In accordance with the catalytic asymmetric synthesis of 1,4-diketones 
118a which proceeds via a similar reaction pathway, STRIP (19a) was found to be the best 
catalyst for this transformation as well. 
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Table 4.6 Screening of reaction conditions for the selective synthesis of 3H-pyrrole 119a 
(Part 2).a) 
 
Entry 
 
Addit.1 
(equiv.) 
Addit.2 
(mg/mmol) 
Solvent 
 
t 
 
T 
(°C) 
Conv. 
 
NMR yield/erb) 
 
1 
PhCO2H 
(1.0) 
4Å MS 
(500) 
toluene 3 d 30 74% 
A 0%    -   n.d. 
B 51%  -   96.5:3.5 
C 5%    -   n.d. 
D 10%  - 77.5:22.5 
2 
PhCO2H 
(0.5) 
4Å MS 
(500) 
toluene 4 d 30 82% 
A 0%    -   n.d. 
B 41%  -   97.8:2.2 
C 3%    -   n.d. 
D 12%  - 81.5:18.5 
3c) 
PhCO2H 
(0.5) 
4Å MS 
(500) 
toluene 4 d 30 79% 
A 0%    -   n.d. 
B 40%  -   98:2 
C 3%    -   n.d. 
D 12%  - 79.5:20.5 
4 
PhCO2H 
(1.0) 
4Å MS 
(500) 
toluene 5 d 20 78% 
A 0%    -    n.d. 
B 53%   - 95.5:4.5 
C 8%     -    n.d. 
D <5%   -   67:33 
5d) 
PhCO2H 
(1.0) 
4Å MS 
(500) 
toluene 4 d 20 82% 
A 0%     -    n.d. 
B 50%   -  97:3 
C 8%     -    n.d. 
D <5%  - 73.5:26.5 
6d) 
PhCO2H 
(1.0) 
4Å MS 
(500) 
p-xylene 7 d 20 full 
A 0%     -    n.d. 
B 56%e) -   98:2 
C n.d.     -    n.d. 
D <5%    -    n.d. 
a) Reactions were conducted using Amberlite
®
 CG50 (500 mg/mmol). b) Conversions and yields were determined by 
1
H-NMR 
analysis after basic extraction with KOH (3M), using 1,3,5-trimethoxybenzene as internal standard; er determined by HPLC 
analysis on a chiral stationary phase. c) 1g/mmol CG50 was used. d) 10 mol% of STRIP (19a) were used. e) Isolated yield.  
  
 4. Results and Discussion   
79 
 Substrate Scope of 3H-Pyrroles 4.4.2.2.
 
Having the optimized conditions in hand, we proceeded to investigate the scope of our 
envisioned transformation. Naphthalene-derived hydrazine 116a reacted smoothly with a 
variety of different cyclic ketones, affording the corresponding products in good yields and 
excellent enantioselectivities (Scheme 4.36). Substituents in the 4-position of the ketone 
were well tolerated, generating methyl-substituted product 119b in 83% yield and an 
enantiomeric ratio of 99:1 as well as n-propyl-substituted 3H-pyrrole 119c in 76% yield and 
97:3 er. The use of a fluorine-substituted ketone afforded the corresponding product 119d in 
42% yield and an excellent enantiomeric ratio of 99.5:0.5, running the reaction at 30 °C. 
Substituents on the naphthalene moiety were tolerated as well, generating 3H-pyrroles 
119e-f in good yields and excellent enantiomeric ratios of 99:1 (119e) and >99.5:0.5 (119f). 
However, the use of heterocyclic and noncyclic ketones was found to be difficult due to low 
reactivity or selectivity issues of the obtained products. Also the application of phenyl-
derived hydrazines was challenging, furnishing no desired products. 
 
 
Scheme 4.36 Substrate scope for the catalytic asymmetric synthesis of 3H-pyrroles 119.
  a) (R)-STRIP (19a) was used as catalyst. b) Reaction conducted at 30 °C. 
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 Enantioselective Synthesis of 2H-Pyrroles 4.4.3.
 
 Optimization of the Reaction Conditions 4.4.3.1.
 
Encouraged by the development of a catalytic asymmetric synthesis of 3H-pyrroles we 
became interested in extending this approach to the enantioselective synthesis of 2H-
pyrroles 120a, applying a [1,5]-alkyl shift. It has previously been shown that 3H-pyrroles can 
be converted into 2H-pyrroles via an acid mediated or thermally induced [1,5]-alkyl shift[104-
107] which would give access to the corresponding 2H-pyrroles 120a. [1,5]-Shifts are known 
to be sigmatropic rearrangements which occur suprafacially in the ground state thus, 
preservation of the enantiopurity should be expected. However, in contrast to [1,5]-H-shifts 
which have been studied intensively,[141-148] the stereospecifity of [1,5]-alkyl shifts has, to the 
best of our knowledge, never been confirmed prior to this work. We started our 
investigations with an initial experiment, treating enantioenriched 3H-pyrrole 119a with 
stoichiometric amounts of diphenyl phosphate. Remarkably, after 15 h, full conversion to 
the corresponding 2H-pyrrole 120a was observed without loss of enantiopurity, proving the 
preservation of enantiopurity in this transformation (Scheme 4.37). The application of this 
methodology should enable a conversion of enantioenriched 3H-pyrroles 119a to 
enantioenriched 2H-pyrroles 120a upon addition of diphenyl phosphate to the reaction 
mixture after full conversion of the hydrazone. This methodology would give a direct access 
to enantioenriched 2H-pyrroles of type 120a. 
 
 
Scheme 4.37 Stereospecific [1,5]-alkyl shift of 3H-pyrrole 119a. 
Indeed, we found that upon addition of diphenyl phosphate to the reaction mixture 
after full conversion of the hydrazone, all 3H-pyrrole 119a was fully converted to the 
corresponding 2H-pyrrole 120a. To enhance the reactivity and to get full conversion of the  
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hydrazone, the reaction was conducted at an increased temperature of 40 °C. Applying this 
reaction sequence, we tested different solvents and catalysts for our new approach. Using 
TRIP (10f) for an initial solvent screening revealed that the use of chlorinated solvents such 
as CH2Cl2 or chlorobenzene led to generally lower enantioselectivities of our desired product 
(Table 4.7, entries 1-2). The best result was obtained using p-xylene, generating 
 
Table 4.7 Catalyst and solvent screening for the synthesis of 2H-pyrrole 120a. 
 
Entry Catalyst Substituent Solvent era) NMR yieldb) 
1 10f 2,4,6-(iPr)3-C6H2 CH2Cl2 80:20 62% 
2 10f 2,4,6-(iPr)3-C6H2 chlorobenzene 83:17 57% 
3 10f 2,4,6-(iPr)3-C6H2 toluene 86:14 69% 
4 10f 2,4,6-(iPr)3-C6H2 p-xylene 88:12 51% 
5c) 10g 9-phenanthryl p-xylene 69:31 n.d. 
6c) 10h 9-anthracenyl p-xylene 58.5:41.5 n.d. 
7 10i 2-naphthyl p-xylene 65:35 61% 
8 19c 1-pyrenyl p-xylene 81:19 44% 
9 19e 3,5-(CF3)2-C6H3 p-xylene 69.5:30.5 57% 
10 19a 2,4,6-(iPr)3-C6H2 p-xylene 90:10 60%
d 
a) Determined by HPLC analysis on a chiral stationary phase. b) Yield determined by 
1
H-NMR analysis after basic 
extraction with KOH (3M), using 1,3,5-trimethoxybenzene as internal standard. c) Reaction was very slow, full 
conversion after 19 d. d) Isolated yield. 
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2H-pyrrole 120a in an enantiomeric ratio of 88:12 (Table 4.7, entry 4). BINOL-derived 
phenanthryl- and anthracenyl-substituted catalysts showed a very low reactivity and 19 d 
were required to get full conversion of the hydrazone, affording the desired product 120a in 
poor enantioselectivities (Table 4.7, entries 5-6). Changing to SPINOL-derived phosphoric 
acid STRIP (19a) finally furnished 2H-pyrrole 120a in 60% isolated yield and an enantiomeric 
ratio of 90:10, using p-xylene as solvent (Table 4.7, entry 10). 
 
 Substrate Scope of 2H-Pyrroles 4.4.3.2.
 
After careful optimization of the reaction conditions, the developed protocol was 
applied to different substrates. Naphthalene-derived hydrazine 116a reacted smoothly with 
a variety of different cyclic ketones, generating the corresponding products 112a-j in good 
yields and enantioselectivities (Scheme 4.38). As already shown in the catalytic asymmetric 
synthesis of 3H-pyrroles 119, substituents in the 4-position of the ketone were found to have 
a beneficial effect on the enantioselectivity, generating 2H-pyrrole 120b in 90% yield and an 
enantiomeric ratio of 95:5, running the reaction at a decreased temperature of 30 °C. 
Remarkably, compound 120b could be isolated with an excellent enantiomeric excess of 
98%, applying a two-step procedure at 20 °C and isolating compound 119b prior to treating 
it with diphenyl phosphate. Also the application of a seven-membered ring was possible, 
generating 2H-pyrrole 120d in 53% isolated yield and an enantiomeric ratio of 90:10. 
Employing a fluorine-substituted ketone afforded the corresponding product 120e in 53% 
yield and an enantiomeric ratio of 94:6 whereas the use of acetal-substituted ketone 
furnished compound 120f in a decreased yield of 41% and 89:11 er. Remarkably, also 
heterocyclic ketones such as oxygen-, sulfur- or nitrogen substituted cyclohexanones could 
be applied although the corresponding products 120g-j were obtained in generally lower 
yields and enantioselectivities. Moreover, ethyl-substituted hydrazine 116f could be 
employed, yielding the corresponding 2H-pyrrole 120l in 83% and 80:20 er. Substituents on 
the hydrazine moiety were generally well tolerated, affording, for example, product 120n in 
83% yield and 95:5 er when the reaction temperature was decreased to 30 °C.  
 4. Results and Discussion   
83 
 
Scheme 4.38 Substrate scope of 2H-pyrroles 120 via an in situ [1,5]-methyl shift.  
  a) Reaction conducted at 30 °C. b) (R)-STRIP (19a) was used as catalyst 
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In general, a variety of different 2H-pyrroles 120 could be obtained, although the 
enantioselectivities were in most cases lower than for the corresponding 3H-pyrroles 119. 
Possible explanations for this observation could be the higher reaction temperature or small 
amounts of non-reacted hydrazone which converts to racemic 2H-pyrroles 120 upon 
addition of diphenyl phosphate. Moreover, it has to be mentioned that a kinetic resolution 
of 3H-pyrroles 119 via a [1,5]-alkyl shift takes place as a side reaction, leading to a higher 
enantioselectivity of products 119 upon formation of 2H-pyrrole 120. This could be one 
reason for the generally high observed enantioselectivity of 3H-pyrroles 119 (see: chapter 
4.4.3.5). Additionally, 2H-pyrroles 120p-t were synthesized as racemates under non-
optimized reaction conditions, using stoichiometric amounts of diphenyl phosphate and 
were used for investigations on their biological activity. 
 
A possible mechanism for the catalytic asymmetric synthesis of 3H- 119 and 2H-
pyrroles 120 is shown exemplary for products 119a and 120a (Scheme 4.39). After the 
formation of the hydrazone, the hydrazone-enehydrazine tautomerization is accelerated by 
the catalyst, followed by the enantiodetermining [3,3]-sigmatropic rearrangement, 
generating dearomatized diimine specie [170a·19a]. Due to the substituent on the 
naphthalene moiety, rearomatization via a proton shift cannot occur and in the absence of 
 
 
Scheme 4.39 Possible mechanism for the catalytic asymmetric synthesis of 3H- 119 and 2H-
pyrroles 120. 
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water no hydrolysis to the corresponding diketone 118a is possible. Thus, a cyclization to 3H-
pyrrole 119a and the release of one equivalent of ammonia takes place. The catalyst is 
afterwards regenerated by the weakly acidic cation exchange resin Amberlite® CG50. Upon 
addition of diphenyl phosphate, 3H-pyrrole 119a is converted to the corresponding 2H-
pyrrole 120a via a suprafacial [1,5]-alkyl shift, preserving the enantiopurity of our product. 
 
 Structure Determination of 2H-Pyrroles 4.4.3.3.
 
NMR investigations were performed in collaboration with M. Leutzsch. 
 
To carefully determine the structure of our novel 2H-pyrroles 120 and to confirm the 
[1,5]-alkyl shift, NMR spectroscopic experiments were conducted (Figure 4.8). For the 
structure assignment of 2H-pyrroles 120, compound 120b was fully characterized by NMR-
spectroscopy. The [1,5]-methyl shift could be confirmed by 1H-15N-HMBC measurements 
which showed the coupling of protons H11 of the methyl group to N12, indicating that the 
methyl group is positioned next to the N-atom. Additionally, the cross peaks of H3, H11 and  
 
 
Figure 4.8 Structure determination of 2H-pyrrole 120b via NMR analysis. 
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H9 to C7 in the 1H-13C-HMBC suggest a [1,5]-shift of the methyl group. Moreover, the shift of 
C13 is in perfect agreement with literature reported 2H-pyrroles (literature reported values: 
between 169.6-179.9 ppm, observed: 173.1 ppm)[106] suggesting the shown structure of 
novel 2H-pyrrole 120b. In comparison to this, the shift of this carbon center (C13) in 3H-
pyrroles is reported to be between 149.4 and 157.2 ppm[106] which is in agreement with the 
shifts observed in 3H-pyrrole 119b (147.8 ppm). 
 
 Biological Evaluations 4.4.3.4.
 
Biological screenings were conducted in collaboration with S. Sievers at the Compound 
Management and Screening Center (COMAS) in Dortmund. 
 
3H- and 2H-pyrroles are core structure of various pharmacophores and bioactive 
compounds[93-99] which encouraged us to investigate potential bioactivities of our novel 
structure motifs. We were particularly interested in potential anti-tumor activities of this 
new compound class, focusing on the Hedgehog signaling pathway at the outset of our 
studies. The Hedgehog signaling pathway is of high importance for the regulation of 
differentiation and proliferation during the embryonic development. However, a mutation or  
 
Table 4.8 Biological evaluation of rac-2H-pyrrole 120b in Hedgehog pathway inhibition. 
 
Entry 
Hh IC50 
(µM)a) 
Hh IC50 
(µM)a) 
Hh IC50 
(µM)a) 
mean Hh 
IC50 (µM) 
std. dev. 
(µM) 
Hh VIA 
IC50 (µM)
b) 
Hh VIA 
IC50 (µM)
b) 
Hh VIA 
IC50 (µM)
b) 
1 5,89 6,45 6,37 6,23 0,30 inactive inactive > 10 µM 
2 3,15 4,84 4,93 4,31 1,00 inactive > 10 µM > 10 µM 
a) Inhibition of the Hedgehog pathway as determined in an osteogenesis assay, using mouse embryonic mesoderm fibroblast 
C3H10T1/2 cells. b) Influence on the viability of C3H10T1/2 cells as determined upon treatment with the compounds using the 
CellTiter-Glo assay. 
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deregulation, such as an abnormal activation of this signaling pathway can contribute to 
different types of cancer and promote tumor growth.[149] Thus, therapeutic strategies that 
target or inhibit the Hedgehog pathway are currently of high demand.[150] To identify a new 
compound class of Hedgehog inhibitors, we subjected several different 3H- 119 and 2H-
pyrroles 120 to cell-based assays monitoring signal transduction pathways.[151-152] 
Remarkably, rac-2H-pyrrole 120b showed an initial inhibition of the Hedgehog signaling 
pathway with a half-maximal inhibitory concentration (IC50) in µM range (4.31±1.00-
6.23±0.30 µM) (Table 4.8), representing a completely new class of Hedgehog signaling 
inhibitors. Yet, it has to be considered that these results are preliminary and have to be 
confirmed in a third screening. Further investigations on the bioactivity and the mode of 
action of these novel compounds are still ongoing. 
 
 Kinetic Resolution of 3H-Pyrroles 4.4.3.5.
 
Encouraged by the development of a divergent catalytic asymmetric synthesis of 3H- 
119 and 2H-pyrroles 120, we became interested in extending this approach to a kinetic 
resolution of 3H-pyrroles 119 via a [1,5]-alkyl shift, applying a chiral phosphoric acid as 
catalyst (Scheme 4.40). This investigation also delivers more insights into the reaction 
mechanism, showing the influence of a kinetic resolution as side reaction. In fact, we could 
observe the conversion of 3H-pyrrole 119a to 2H-pyrrole 120a, employing 5 mol% of chiral 
phosphoric acid STRIP (19a) in toluene at 45 °C. Remarkably, an s-factor of 6 could be 
achieved for this transformation under non-optimized reaction conditions. This result also 
shows that there is a significant side reaction in the catalytic asymmetric synthesis of 3H-
pyrroles 119 if the reaction is conducted at higher temperature. Moreover, the formation of 
2H-pyrroles 120 as side products leads to a higher enantiomeric excess of 3H-pyrroles 119 
due to a kinetic resolution as a side reaction, preferring the minor enantiomer of 3H-pyrroles 
119 for the [1,5]-methyl shift. Thus, (S)-STRIP (19a), leading to (R)-119 as major enantiomer 
in the catalytic asymmetric synthesis of 3H-pyrroles 119, preferentially converts (S)-119 to 
the corresponding 2H-pyrrole (S)-120, resulting in a higher enantiomeric ratio of (R)-119. 
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Scheme 4.40 Kinetic resolution of 3H-pyrrole 119a via a [1,5]-methyl shift.  
 
 Determination of the Absolute Configuration of 2H- and 3H-Pyrroles 4.4.4.
 
The determination of the absolute configuration of our novel compounds turned out 
to be challenging since all products were obtained as oils which rendered crystallizations 
difficult. Thus, we applied different approaches towards the assignment of the absolute 
configuration of 3H- 119 and 2H-pyrroles 120 which will be discussed in the following 
chapters. 
 
 Experimental Investigations 4.4.4.1.
 
In general, it should be possible to infer the absolute configuration of 3H-pyrroles 119 
via comparison to the corresponding 1,4-diketones 118. Considering that both products are 
generated via a similar reaction pathway, involving the same diimine intermediate [170·19a], 
3H-pyrroles 119 and 1,4-diketones 118 should show the same absolute configuration. Thus, 
the absolute configuration of 3H-pyrrole 119 was assigned via comparison to the 
corresponding 1,4-diketone 118 whose absolute configuration is known (see: chapter 4.3.4). 
We performed a reaction without the addition of molecular sieves to afford a mixture of 
pyrroles 119a, exo-119a and 120a as well as the corresponding 1,4-diketone 118a (Scheme 
4.41). As described in chapter 4.3.4, the absolute configuration of diketone 118a was found 
to be (S), using the (R)- enantiomer of STRIP (19a) which was confirmed by X-ray  
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Scheme 4.41 Determination of absolute configuration via comparison to 1,4-diketone 118a. 
crystallography of the corresponding diketones 118e and 118h. Considering that the 
enantiodetermining step of the catalytic asymmetric synthesis of 3H-pyrroles 119 proceeds 
via the same transition state as for the corresponding 1,4-diketones 118, the major 
enantiomer of 3H-pyrrole 119 should be (S)-configured as well. Thus, the absolute 
configurations of 3H-pyrroles 119 were assigned as (S), using (R)-STRIP (19a) as catalyst. 
 
Assuming that the [1,5]-alkyl shift occurs in a suprafacial fashion, the absolute 
configuration should be preserved during this step, generating (S)-2H-pyrroles 120, derived 
from (S)-3H-pyrroles 119. However, in order to prove the suprafaciality of the [1,5]-alkyl 
shift, an unambiguous assignment of the absolute configuration of 2H-pyrroles 120 was 
required. 
 
 Attempts towards Crystallization 4.4.4.2.
 
The determination of the absolute configuration of our novel 2H-pyrroles 120 turned 
out to be challenging and initial attempts towards crystallization failed since all products 
were obtained as oils. Since a direct crystallization of our pyrroles was not possible, we tried 
to obtain crystals containing 2H-pyrrole 120n via salt formation with different acids, bearing 
heavy atoms such as a bromine atom or featuring a known stereogenic center. 
Unfortunately, applying different acids such as TRIP (10f), bromo acetic acid (174), (R)-
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mandelic acid (175) or 4-bromo benzoic acid (176) did not lead to crystallization of pyrrole 
salt 120n·HX, employing different solvents and temperatures (Figure 4.9).  
 
 
Figure 4.9 Different acids for the crystallization of pyrrole-salt 120n·HX. 
A further attempt to access crystals from 2H-pyrroles 120 was the introduction of 
groups which presumably favour the crystallinity of our products. Thus, we attempted to 
synthesize 2H-pyrrole 120u, featuring a sulfonyl group. Unfortunately, the corresponding 
product 120u could only be obtained in low enantioselectivity, applying our optimized 
reaction conditions using STRIP (19a) as catalyst. Presumably, the SO2-group interferes with 
our catalyst, preventing a stereochemical induction in this system. Thus, compound 120u 
could not be used for the determination of the absolute configuration of 2H-pyrroles 120. 
 
 
Figure 4.10 Catalytic asymmetric synthesis of sulfone-containing 2H-pyrrole 120u. 
The last attempt to obtain crystals from our products was the derivatization of 2H-
pyrrole 120n to access crystalline material. The introduction of a bromine atom in our 
system seemed to be promising and could provide a potentially crystalline compound. Thus, 
2H-pyrrole 120n was brominated, applying N-bromosuccinimide (NBS) in CHCl3 (Scheme 
4.42). Interestingly, we selectively obtained compound 178a, bearing two bromine atoms on 
the cyclohexene moiety, regardless of how many equivalents of NBS were employed. For 
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instance, the use of just one equivalent of NBS led to half conversion of the starting material 
to dibromo compound 178a whereas the corresponding monobrominated analogue could 
not be isolated. Dibromo-2H-pyrrole 178a was found to be highly unstable and crystalized as 
decomposed compound 179, featuring no stereocenter anymore. Presumably, the release of 
HBr upon hydrolysis leads to further decomposition and the subsequent loss of the methyl 
group. 
 
 
Scheme 4.42 Attempts towards the derivatization of 2H-pyrrole 120n. 
In light of the instability of dibromo-2H-pyrroles 178, we decided to conduct a 
subsequent elimination step, generating the presumably more stable monobromo-2H-
pyrrole 181. The treatment of compound 178b with potassium tert-butoxide (KOtBu) finally 
afforded the corresponding elimination product 180 as a yellow solid in 42% yield (Scheme 
4.43). However, decomposition of the compound 180 was observed during the reaction 
which rendered the purification and an upscaling of this process difficult. Moreover, several 
attempts to crystalize 2H-pyrrole 180, applying different solvents and temperatures failed.  
 
 
Scheme 4.43 Bromination and subsequent elimination to 2H-pyrrole 120b. 
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 CD-Spectroscopy 4.4.4.3.
 
Computational studies were performed in collaboration with Y. Zheng (AK Prof. Thiel, MPI 
Mülheim). 
 
For an independent determination of the absolute configuration of our products, we 
decided to conduct CD spectroscopical investigations (Figure 4.11). Thus, the CD-spectra of 
119b (er = 98.5:1.5) and 120b (er = 98.5:1.5), both synthesized using (R)-STRIP (19a) as 
catalyst, were recorded and compared with the corresponding TD-DFT calculated CD spectra 
of both possible conformers of (S)-119b1-2 and (S)-120b1-2 which were found to be very 
similar in energy (difference ≈0.1-0.2 kcal/mol) and presumably coexist in the reaction. After 
a UV correction of −9 to −17 nm and a correction of the -value of 0.3 to 0.4 eV, the CD 
characteristics of the calculated spectra (blue graph) were in good agreement with the 
experimental spectra (red graph), thus allowing the assignment of the absolute configuration 
of pyrroles 119b and 120b, which were found to be (S)-configured, using the (R)-enantiomer 
of STRIP (19a). This result is in perfect agreement with our investigations on the catalytic 
asymmetric synthesis of 1,4-diketones 118 (see: chapter 4.4.4.1). Moreover, it indicates that 
the [1,5]-alkyl shift is indeed stereospecific and occurs in a suprafacial mode, preserving the 
absolute configuration in our system. 
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Figure 4.11 Determination of the absolute configuration of pyrroles 119b and 120b via CD 
spectroscopy. 
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 Investigations of the [1,5]-Methyl Shift 4.4.5.
 
Computational studies were performed in collaboration with Y. Zheng (AK Prof. Thiel, MPI 
Mülheim) 
 
Experimental investigations of the [1,5]-alkyl shift showed that under more acidic 
conditions and upon heating the amount of 2H-pyrroles 119 increased. To determine the 
energy barrier of the [1,5]-alkyl shift under protonated and non protonated conditions, we 
decided to perform computational studies of the shift, using our model substrate 3H-pyrrole 
119a (Scheme 4.44). The DFT calculations were conducted for two different possible 
conformers 119a-1 and 119a-2 which were found to be similar in energy and presumably 
coexist in the reaction. For both conformers, the calculated energy barrier of the [1,5]-
methyl shift was determined to be approximately 30 kcal mol-1 under non protonated 
conditions (Table 4.9). 
 
 
 
 
 
 
 
Scheme 4.44 Calculated [1,5]-methyl shift of 3H-pyrrole 119a in the non protonated state. 
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Table 4.9 Computed relative energy (E), enthalpy (H) and free energy (G) at the B3LYP-
D3/TZVP level (energy in kcal mol-1). 
Compound E H G 
119a-1 0 0 0 
TSa-1 29.7 29.7 29.8 
120a-1 -5.1 -5.2 -4.9 
119a-2 0 0 0 
TSa-2 29.7 29.7 29.7 
120a-2 -4.9 -5.0 -4.8 
 
In analogy, the [1,5]-methyl shift of both conformers of the corresponding protonated 
3H-pyrrole species 119 were calculated (Scheme 4.45). Remarkably, upon full protonation of 
the nitrogen with a strong acid, the calculated activation barrier of the [1,5]-methyl shift was 
found to be lowered significantly to approximately 20 kcal mol-1 (Table 4.10). This result 
clearly suggests that the [1,5]-alkyl shift is indeed acid-catalyzed although the energy barrier 
is lowered less applying weaker acids such as diphenyl phosphate. 
 
 
 
 
 
 
Scheme 4.45 Calculated [1,5]-methyl shift of 3H-pyrrole 119a in the protonated form. 
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Table 4.10 Computed relative energy (E), enthalpy (H) and free energy (G) at the B3LYP-
D3/TZVP level (energy in kcal mol-1). 
Compound E H G 
119a-H1 0 0 0 
TSa-H1 19.2 19.3 19.0 
120a-H1 -9.2 -9.2 -9.1 
119a-H2 0.1 0.1 0.1 
TSa-H2 19.2 19.3 19.0 
120a-H2 -9.0 -9.0 -9.0 
 
 
 Summary 4.4.6.
 
In conclusion, we developed a divergent catalytic asymmetric synthesis of 3H- 119 and 
2H-pyrroles 120 via an interrupted Fischer indolization and a subsequent [1,5]-alkyl shift. 
Applying SPINOL-derived phosphoric acid STRIP (19a), we could obtain a variety of different 
pyrroles in good to excellent yields and enantioselectivities. The [1,5]-alkyl shift was found to 
be suprafacial, preserving the absolute configuration of our products. Moreover, DFT 
calculations show that the [1,5]-methyl shift is acid catalyzed. Remarkably, initial biological 
evaluations in cell-based assays revealed rac-2H-pyrrole 120b as an inhibitor of the 
Hedgehog signaling pathway with a half-maximal inhibitory concentration (IC50) in the µM 
range (4.31-6.23 µM). Further investigations on the biological activity of these novel 
structure motifs are still ongoing. To the best of our knowledge, this is the first 
organocatalytic approach to 3H- and 2H-pyrroles. 
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 The Organocatalytic Asymmetric Approach to Helicenes 5.1.
 
Helicenes are interesting compounds with unique properties which have attracted 
considerable attention in fields such as catalysis, material science or biology in the last few 
years. However, catalytic asymmetric approaches to helically chiral molecules are still 
challenging, since the screw sense and not a common stereogenic center has to be 
controlled. Thus, most approaches to enantiopure helicenes are still based on chiral 
auxiliaries, chiral starting materials or on transition metal catalysis, whereas organocatalytic 
approaches were unprecedented prior to this work. 
 
We developed a completely new access to these important scaffolds, applying a 
catalytic asymmetric Fischer indolization.[54-55] Considering the challenges of this 
transformation, we hypothesized that a catalyst with special length-scale requirements 
should be able to control the screw sense of our helicenes, which is indeed a phenomenon 
of the nanoscale. Thus, we assumed that the catalyst would need extended π–substituents 
which could potentially engage in π-stacking interactions with the formed polyaromatic 
enehydrazine intermediate, creating a chiral nanometer sized pocket. Indeed, applying novel 
SPINOL- derived phosphoric acid 19c, which was specially designed for this transformation  
 
 
Scheme 5.1 Catalytic asymmetric synthesis of azahelicenes 115. 
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and bears extended π-surfaces at the 3,3’-substituents, afforded a variety of different 
azahelicenes 115 in high yields and enantioselectivities (Scheme 5.1). The modular nature of 
this approach allows a variation of the apical substituent (R2) or the terminal substituents on 
the hydrazine and ketone (R1, R3), respectively which enables a broad substrate scope for 
this transformation. Moreover, the obtained azahelicenes 115 can be readily converted to 
the corresponding polyaromatic compounds 168 using chloranil as an oxidant. 
 
Remarkably, the methodology could be extended to the catalytic asymmetric synthesis 
of bisazahelicenes 165, generating compound 165a in 94:6 er (Scheme 5.2). Interestingly, 
compound 165a was obtained as mono benzylated product, losing one benzyl group during 
the reaction, presumably due to the release of benzyl amine via a different reaction 
pathway. The selective loss of one benzyl group allowed modifications of compound 165a 
such as the introduction of different groups on the free nitrogen, generating bisazahelicenes 
165b and 165c in high yields. 
 
 
 
 
Scheme 5.2 Catalytic asymmetric synthesis of bisazahelicenes 165. 
We further investigated our novel helicenes, applying a racemization study of 
polyaromatic helicene 168. The energy barrier of compound 168 was found to be 172.2 ± 
0.4 kJ mol-1, a value which is similar to the racemization barrier reported for [7]helicenes 
(175.1 kJ mol-1).[131-132] Moreover, CD spectra of compounds (P)-115a, (M)-115a and (P)-168 
were recorded and compared to the literature known CD spectrum of (P)-[6]helicene, 
showing a significant agreement in the CD characteristics.[129-130] Thus, we could ascribe 
independently (P) (dextrorotatory) and (M) (levorotatory) helicity of our products, applying 
both, CD spectroscopy and X-ray crystallography. 
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 Catalytic Asymmetric Dearomatizing Synthesis of 1,4-Diketones 5.2.
 
A further objective of this work was the development of an interrupted variation of the 
catalytic asymmetric Fischer indolization, generating enantiopure 1,4-diketones 118. 
Considering the mechanism of the Fischer indolization, nonaromatic diimine species 170 are 
generated after the enantiodetermining [3,3]-sigmatropic rearrangement. We developed a 
methodology to hydrolyze these intermediates in situ, giving access to enantioenriched 1,4-
diketones 118 via an interrupted Fischer indolization (Scheme 5.3). The introduction of 
substituents ortho to the hydrazine group was found to be crucial and prevents the common 
rearomatization, therefore allowing the trapping of dearomatized diimines 170.  
 
 
Scheme 5.3 Concept of the catalytic asymmetric synthesis of 1,4-diketones 118. 
Applying the SPINOL-derived phosphoric acid STRIP (19a), a variety of different 1,4-
diketones 118 could be obtained in generally high yields, diastereo- and enantioselectivities 
(Scheme 5.4). Interestingly, the addition of benzoic acid was found to have a beneficial effect 
on the reactivity without diminishing the enantioselectivity. Moreover, the addition of water 
was found to be necessary to enable the complete hydrolysis of diimines 170 without side 
product formation. Remarkably, the reaction also tolerates heterocyclic ketones, generating 
the corresponding products in good yields and enantioselectivities.  
 
 
Scheme 5.4 Catalytic asymmetric dearomatizing synthesis of 1,4-diketones 118. 
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 The Divergent Enantioselective Synthesis of 2H- and 3H-Pyrroles 5.3.
 
Inspired by the development of a catalytic asymmetric synthesis of 1,4-diketones 118 
via an interrupted Fischer indolization, we envisioned a similar approach to the 
corresponding 3H-pyrroles 119 which were indeed formed as side products if the reaction 
was conducted without the addition of water. Thus, running the reaction in the absence of 
water should exclusively provide the corresponding enantiopure 3H-pyrroles 119, interesting 
and novel structure motifs with potential bioactivities. Additionally, we envisioned that a 
subsequent [1,5]-alkyl shift of compounds 119 would give access to 2H-pyrroles 120 as well.  
 
Indeed, applying the SPINOL-derived phosphoric acid STRIP (19a) afforded the desired 
3H-pyrroles 119 in good yields and excellent enantioselectivities (Scheme 5.5). As already 
described previously (chapter 4.3), the addition of benzoic acid was found to accelerate the 
reaction without diminishing the enantioselectivity. Moreover, the addition of molecular 
sieves was crucial to prevent the formation of the corresponding 1,4-diketones 118.  
 
 
Scheme 5.5 Catalytic asymmetric synthesis of 3H-pyrroles 119. 
Previous reports in literature show the conversion of 3H-pyrroles to 2H-pyrroles via a 
thermally or acid induced sigmatropic [1,5]-alkyl shift.[104-107] However, in contrast to [1,5]-H-
shifts, the stereospecifity of [1,5]-alkyl shifts has, to the best of our knowledge never been 
confirmed prior to this work. Remarkably, treating enantiopure 3H-pyrrole 119a with 
stoichiometric amounts of diphenyl phosphate afforded the corresponding 2H-pyrrole 120a 
in full conversion and without loss of enantiopurity (Scheme 5.6) which gives a selective 
access to both, enantioenriched 3H- 119 and 2H-pyrroles 120.  
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Scheme 5.6 Stereospecific [1,5]-methyl shift of 3H-pyrrole 119. 
Employing STRIP (19a) as catalyst and adding diphenyhl phosphate to the reaction 
mixture after full conversion of the hydrazone, afforded a variety of different 2H-pyrroles 
120 in good yields and enantioselectivities (Scheme 5.7). In this case, also the use of 
heterocyclic ketones was also possible, although the products were obtained in slightly 
lower yields and enantioselectivities. Remarkably, rac-2H-pyrrole 120b was found to inhibit 
the Hedgehog signaling pathway with a half-maximal inhibitory concentration (IC50) in the 
µM range (4.31-6.23 µM) in initial cell-based assays. Further biological investigations and 
studies on the mode of action of these novel structure motifs are still ongoing.  
 
 
Scheme 5.7 Catalytic asymmetric synthesis of 2H-pyrroles 120. 
The absolute configurations of pyrroles 119b and 120b were determined via CD 
spectroscopy, comparing the experimental CD spectra with TD-B3LYP-D3/TZVP calculated CD 
spectra. Both pyrroles 119b and 120b were found to be (S)-configured, using the (R)-
enantiomer of the catalyst which is in agreement with our work on the catalytic asymmetric 
synthesis of 1,4-diketones 118 (see: chapter 4.3.4). Moreover, this result clearly indicates 
that the [1,5]-methyl shift is stereospecific and occurs in a suprafacial mode. 
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The work described in the previous chapters shows the potential and generality of the 
catalytic asymmetric Fischer indolization. It is a mild yet powerful transformation with plenty 
of interesting opportunities and challenges and beside the presented results there is still a 
lot to be discovered. Moreover, transformations such as [1,5]-alkyl shifts have been 
investigated which open new and interesting research projects. 
 
 Further Developments of the Catalytic Asymmetric Synthesis of 6.1.
Helicenes 
 
Regarding the catalytic asymmetric synthesis of azahelicenes 115 via a Fischer 
indolization, a more detailed insight into the reaction would be interesting to reveal the 
interactions between the catalyst and the intermediate in the transition state. In general, 
catalysts with extended π-substituents were found to have a beneficial effect on the 
enantioselectivity which could be due to potential π-interactions between the substituents 
and the intermediate. To gather more information about these interactions, a detailed 
computational study of the transition state would be highly appreciated and would show 
which specific interactions are involved in our transformation.  
 
Moreover, an extension of this concept to helical polymers 182 would be an 
interesting project (Scheme 6.1). The successful application of a double Fischer indolization 
could already be realized (see: chapter 4.2.4), generating the corresponding bisazahelicene 
165a in good yield and enantiomeric excess. Applying bishydrazine 158a and bisketone 181 
could potentially provide the corresponding helical polymer 182 after a subsequent 
oxidation step. Moreover, other bishydrazines and bisketones could be employed for this 
transformation as well. 
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Scheme 6.1 Potential polymerization via a catalytic asymmetric Fischer indolization. 
 
 Further Developments of the Dearomatizing Catalytic Asymmetric 6.2.
Synthesis of 1,4-Diketones 
 
The development of a catalytic asymmetric dearomatizing synthesis of 1,4-diketones 
118 shows the potential of Fischer indolization reactions. However, a current limitation is 
still the use of phenyl derived hydrazines and noncyclic ketones which deliver the 
corresponding products in low yields and enantioselectivities. An extension of this powerful 
methodology to these scaffolds would be highly appreciated and would show the generality  
 
 
Scheme 6.2 Potential further developments of the catalytic asymmetric synthesis of 1,4-
diketones 118 via an interrupted Fischer indolization. 
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of this transformation (Scheme 6.2). Initial experiments revealed that the more acidic 
phosphoric acid 19e is able to catalyze the reaction of hydrazine 116a and acetone, although 
in low yield and enantioselectivity. Therefore, further investigations of more acidic Brønsted 
acids seem to be promising for this transformation.  
 
 Kinetic Resolution of 3H-Pyrroles via a [1,5]-Alkyl Shift 6.3.
 
[1,5]-Alkyl shifts are powerful transformations in organic syntheses however, to the 
best of our knowledge, they have never been applied to a kinetic resolution. Initial 
experiments show the possibility of a kinetic resolution of 3H-pyrrole 119a via such a 
sigmatropic [1,5]-methyl shift (Scheme 6.3a). Remarkably, applying SPINOL-derived 
phosphoric acid STRIP (19a) as catalyst results in a promising s-factor of 6 under non-
optimized reaction conditions. An extension of this methodology and the development of a 
kinetic resolution of simple 3H-pyrroles of type 185 via this strategy would be of huge 
interest and would provide a new access to enantiopure 3H- 185 and 2H-pyrroles 186 
(Scheme 6.3b). 
 
 
Scheme 6.3 Potential kinetic resolution of 3H-pyrroles 185 via a [1,5]-alkyl shift. 
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 Kinetic Resolution of Indolenines via a Wagner-Meerwein 6.4.
Rearrangement 
 
Inspired by the kinetic resolution of 3H-pyrrole 119a via a [1,5]-alkyl shift, we 
envisioned a similar approach to enantioenriched indolenines 187. The application of a chiral 
Brønsted acid should enable a kinetic resolution of these scaffolds via a Wagner-Meerwein 
rearrangement. Initial experiments indeed show the possibility of this transformation, 
affording indolenine 187a in a promising enantiomeric ratio of 63:37, employing 
imidodiphosphoric acid 23b as catalyst (Scheme 6.4a). A more careful investigation and 
optimization of the reaction parameter would readily provide a new access to enantiopure 
indolenines 187, interesting scaffolds with potential bioactivities (Scheme 6.4b). 
 
 
Scheme 6.4 Potential kinetic resolution of indolenines 187 via a Wagner-Meerwein 
rearrangement. 
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 Biological Evaluation of Further 2H- and 3H-Pyrrole Derivatives 6.5.
 
Initial biological investigations in cell-based assays monitoring biological signal 
transduction processes revealed rac-2H-pyrrole 120b as an inhibitor of the Hedgehog 
singaling pathway with a half maximal inhibitory concentration (IC50) in the µM range (4.31-
6.23 µM). More investigations of potential biological activities of these novel structure 
motifs and corresponding structure–activity relationship studies would be of huge interest 
and could be a further future project (Figure 6.1). For instance, different substituents on the 
hydrazine moiety (R1, R2, R3) could have an effect on the biological activity. Moreover, 
different ring sizes and heteroaromatic ketones could be investigated as well. Also the use of 
the corresponding pyrrole salts and the evaluation of both optically pure enantiomers could 
be interesting to study.  
 
 
Figure 6.1 Chemical library of 3H- 119 and 2H-pyrroles 120 for structure-activity 
relationship studies. 
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 Experimental Part 7.
 General Experimental Conditions 7.1.
 
Solvents and Reagents 
All solvents applied in the reactions were dried using standard procedures or purchased 
from commercial suppliers. Dichloromethane and chloroform were distilled over CaH2. THF 
was dried over Mg-anthracene. Chlorobenzene was distilled over P2O5. Ethanol and 
methanol were dried over magnesium. Diethyl ether, toluene and n‐hexane were dried over 
sodium. Anhydrous acetone, acetonitrile, benzene, cyclohexane, DMF, DME, DMSO, pyridine 
and 1,4‐dioxane were purchased from Sigma‐Aldrich and used as received. Air and moisture 
sensitive reactions were conducted under inert Ar atmosphere using standard Schlenk 
techniques in flame‐dried glassware. Dry argon was purchased from Air Liquide with >99.5% 
purity. Reagents were purchased from different commercial suppliers and used without 
further purification unless otherwise stated.  
 
Thin Layer Chromatography (TLC) and Preparative Thin Layer Chromatography (PTLC) 
Reactions were monitored by thin layer chromatography on silica gel or aluminium oxide 
pre-coated plastic sheets (0.2 mm, Macherey-Nagel). Visualization was accomplished by 
irradiation with UV light at 254 nm and staining reagents. Phosphomolybdic acid (PMA) 
stain: PMA (10 g) was dissolved in EtOH (100 mL). Preparative thin layer chromatography 
was conducted on silica gel pre-coated glass plates SIL G‐25 UV254 and SIL G‐100 UV254 with 
0.25 mm and 1.0 mm SiO2 layers (Macherey-Nagel) or aluminium oxide pre-coated glass 
plates ALOX-25 UV254 with 0.25 mm Al2O3 layers (Macherey-Nagel). 
 
Column Chromatography (CC) 
Column chromatography was performed using silica gel (60, particle size 0.040‐0.063 mm, 
Merck) or aluminum oxide (neutral, activated Brockmann I, Sigma-Aldrich) as stationary 
phase; (Activity II: 3% H2O, Activity III: 6% H2O). The exact solvent mixtures are given in the 
corresponding experiments. 
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High Performance Liquid Chromatography (HPLC) 
All measurements were conducted at 25 °C, using commercial HPLC-grade solvents. Specific 
solvent mixtures are given in the individual experiments. Reversed phase HPLC analyses 
were conducted on a Shimadzu LC 2010 C system. Following stationary phases were used: 
Daicel Chiralcel OD‐RH, Daicel Chiralcel OD‐3R, chiralpak AD-3R and cellucoat RP. Normal 
phase HPLC analyses were performed on a Shimadzu LC 2010 C system. Following stationary 
phases were used: Daicel Chiralcel OD3 and Daicel Chiralcel AD3. Preparative HPLC was 
performed on a Shimadzu LC‐8A system equipped with a FRC‐10A fraction collector. 
 
Nuclear Magnetic Resonance Spectroscopy (NMR) 
Proton, carbon and phosphorus NMR spectra were recorded on Bruker Avance III 600 MHz, 
Bruker Avance III 500 MHz‐, Bruker Avance III 400 MHz‐ and Bruker Avance III HD 300 MHz‐
spectrometer in deuterated solvents. Proton chemical shifts are reported in ppm (δ) relative 
to tetramethylsilane (TMS) with the solvent resonance employed as the internal standard 
(CD2Cl2, δ = 5.32 ppm; CDCl3 δ = 7.26 ppm, CD3CN δ = 1.94, DMSO δ = 2.50 ppm, D2O δ = 
4.79). Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = 
triplet, q = quartet, m = multiplet, b = broad), coupling constants (Hz) and integration. 13C 
chemical shifts are reported in ppm (δ) from tetramethylsilane (TMS) with the solvent 
resonance as the internal standard (CD2Cl2, δ = 53.84 ppm; CDCl3, δ = 77.16 ppm, CD3CN δ = 
118.26, DMSO δ = 39.52 ppm). The 15N-spectra and 19F-spectra were referenced indirectly to 
the referenced proton frequency with the Ξ-scale with the factors 0.10136767 for 15N 
((MeNO2) = 0 ppm) and 0.94094011 for 
19F ((CFCl3) = 0 ppm).
[153-154] The 15N chemical shifts 
were determined from the indirect dimension of a 1H,15N-HMBC. Phosphorous chemical 
shifts (31P) are reported in ppm (δ) relative to H3PO4 without using an internal standard. The 
calibration of the x-axis was used as received from the automated data processing.  
 
Mass Spectrometry (MS) 
Electron impact (EI) mass spectra were recorded on a Finnigan MAT 8200 or a Finnigan MAT 
8400 spectrometer. Electrospray ionization (ESI) mass spectrometry was conducted on a 
Bruker ESQ 3000 spectrometer. High resolution mass spectra were recorded on a Finnigan 
MAT 95 or Bruker APEX III FTMS (7 T magnet). Some reaction controls were conducted using 
ASAP-MS (Advion Expression Compact Mass Spectrometer L, APCI/ASAP). 
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Optical Rotations (αD) 
Optical rotations were measured on an Autopol IV automatic polarimeter (Rudolph Research 
Analytical). Unless otherwise stated, the optical rotations were measured at 25 °C at a 
wavelength of λ = 598 nm, using a 50 mm cell with temperature control. The concentrations 
are calculated in 10 mg mL-1. 
 
X‐Ray Crystallography 
X-Ray crystal structure analyses were performed on a Proteum X8 diffractometer - Bruker 
AXS Apex 2/SAINT and P11 Beamline, Petra III synchrotron, DESY-P11 GUI/XDS (in Hamburg). 
The software used for data collection and structure refinement consisted of SHELXS, SHELXL 
and SHELXT. 
 
Circular dichroism (CD) 
The CD spectra were recorded at 20 °C using a JASCO J-810-150s spectropolarimeter and 
precision cells (quartz suprasil, 2 mm, Hellma). Solvents (HPLC grade) and concentrations are 
given in the corresponding experiments. 
 
Catalysts 
Chiral BINOL-derived phosphoric acids 10 were kindly supplied by coworkers from the List 
group and prepared according to, or in analogy with the literature procedures described by 
Akiyama, Terada and colleagues.[24,155-161] SPINOL-derived phosphoric acids were synthesized 
according to, or in analogy with reported literature procedures.[28,55,112-113] Literature known 
phosphoric acid STRIP 19a was generously provided by technicians and synthesized following 
a literature procedure.[28,55] 
 
Biological Screenings 
Biological screenings were conducted by the Compound Management and Screening Center 
(COMAS) in Dortmund under the supervision of Dr. S. Sievers.  
Signal transduction assays through the Hedgehog pathway were conducted, using mouse 
embryonic mesoderm fibroblast C3H10T1/2 cells. Upon treatment with the SMO agonist 
Purmorphamine, these multipotent mesenchymal progenitor cells can differentiate into 
osteoblasts. During differentiation, osteoblast specific genes such as alkaline phosphatase 
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(ALK) are highly expressed. The alkaline phosphatase activity can be monitored via substrate 
hydrolysis which generates a highly luminescent product. An inhibition of the Hedgehog 
pathway leads to a reduced luminescence.[152,162-164]  
Small molecule inhibitor screenings of the Hedgehog pathway were conducted in 384 well 
format. 800 Cells per well were seeded and grown overnight after which the compounds 
were added to a final concentration of 10 µM using acoustic nanoliter dispenser ECHO 520. 
After one hour, Purmorphamine was added to a final concentration of 1.5 µM, whereas the 
corresponding control cells were not treated with Purmorphamine. After four days, the cell 
culture medium was aspirated, a commercial luminogenic ALK substrate (CDP-Star, Roche) 
was added and after one hour, luminescence was read. At the same time, cell viability 
measurements were conducted to identify and exclude toxic compounds which also lead to 
a reduced luminescent signal. For the cell viability assay 200 cells per well were seeded, 
following the same procedure as described for the Hedgehog assay, using cell culture 
medium alone as control. Cell Titer Glo reagent (Promega), determining the cellular ATP 
content, was used to measure the cell viability. Hits were defined showing at least a 50% 
reduction in the luminescent signal in the Hedgehog assay and a minimum of 80% cell 
viability. A three-fold dilution curve, starting from 10 µM, was used to carry out dose-
response analysis for hit compounds. For the calculations of the IC50 values, Quattro 
software suite (Quattro Research GmbH) was used.  
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 Synthesis of SPINOL-Derived Phosphoric Acids 7.2.
 
 
Racemic SPINOL (128) was synthesized following a literature reported procedure by Birman 
and coworkers with minor modifications.[28,55,113] The resolution of racemic SPINOL (128) was 
accomplished by preparative HPLC (Chiralpak IA, iso-hexane/ethanol 85:15, flow rate 50.0 
mL/min). For the MOM‐protection and diiodination of enantiomercially pure SPINOL (128), 
the protocol reported by Zhou and co‐workers was followed with minor 
modifications.[28,55,112] 
 
4,4,5,5-Tetramethyl-2-(pyren-2-yl)-1,3,2-dioxaborolane (133) 
 
Compound 133 was synthesized following a literature procedure.[114] 
Purification: hexane:CH2Cl2 (2:1), colourless solid, 1.24 g, 33% yield. 
1H NMR (500 MHz, CDCl3) δ = 8.67 (d, J = 15 Hz, 1H), 8.64 (d, J = 15 Hz, 1H), 8.17 (d, J = 7.6 
Hz, 2H), 8.12 (d, J = 9.0 Hz, 2H), 8.06 (d, J = 9.0 Hz, 2H), 8.02 (t, J = 7.7 Hz, 1H), 1.48 (s, 12H) 
ppm. 
13C NMR (125 MHz, CDCl3) δ = 131.8, 131.5, 130.5, 127.9, 127.4, 126.51, 126.48, 125.0, 
124.7, 84.3, 25.2 ppm. 
MS (EI) m/z (%): 328 (66), 269 (7), 242 (11), 228 (100), 202 (11), 59 (20), 41 (26). 
HRMS (ESI) m/z calculated for C22H21O2BNa (M+Na
+) 351.152679, found 351.152670.  
The obtained data are in agreement with those reported in literature.[114] 
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Pyren-2-ylboronic acid (134) 
 
Compound 134 was synthesized following a literature procedure.[114] 
Purification: Filtration, washing with hexane, colourless solid, 520 mg, 83% yield. 
Compound 134 was not fully characterized due to dimer and trimer formation of the boronic 
acid and was directly used as a mixture for the subsequent coupling step. 
MS (EI) m/z (%): 684 (100), 202 (10). 
 
(S)-7,7'-Bis(methoxymethoxy)-6,6'-di(pyren-1-yl)-2,2',3,3'-tetrahydro-1,1'-spirobi[indene] 
(131) 
 
A Schlenk tube was charged with pyrene-1-boronic acid (935 mg, 3.79 mmol), K3PO4 
(805 mg, 3.79 mmol) and (S)‐6,6'‐Diiodo-7,7'‐bis(methoxymethoxy)‐2,2',3,3'‐tetrahydro‐1,1'‐
spirobiindane (S)-130 (250 mg, 0.42 mmol). The solids were set under argon, taken up in 
toluene (15 mL) and degassed for 15 min. Pd2(dba)3 (7.69 mg, 0.008 mmol) and SPhos 
(13.8 mg, 0.034 mmol) were added and degassing was continued for 10 min. The mixture 
was stirred at 100 °C for 20 h. After cooling down to room temperature, H2O and CH2Cl2 
were added and the layers were separated. The aqueous layer was extracted with CH2Cl2 
and the combined organic layers were washed with brine and dried over Na2SO4. The solvent 
was removed under reduced pressure and the residue was purified by column 
chromatography on SiO2. 
 
Due to the presence of different rotamers, NMR assignment was not possible. The 
compound was used without further characterization for the next step.  
 
Purification: hexane:EtOAc (2:1→EtOAc), yellow solid, 279 mg, 90% yield. 
 7. Experimental Part   
113 
MS (EI) m/z (%): 740 (79), 664 (100), 319 (97), 305 (83), 289 (20), 45 (48). 
HRMS (ESI) m/z calculated for C53H40O4Na (M+Na
+) 763.281882, found 763.282050.  
 
(S)-7,7'-Bis(methoxymethoxy)-6,6'-di(pyren-2-yl)-2,2',3,3'-tetrahydro-1,1'-spirobi[indene] 
(135) 
 
Compound 135 was synthesized following the same procedure as described for compound 
131, applying (S)-diiodide 130 (190 mg, 0.32 mmol) and boronic acid 134 (630 mg, 
2.56 mmol). 
 
Purification: hexane:EtOAc (2:1), yellow solid, 209 mg, 88% yield. 
1H NMR (500 MHz, CDCl3) δ = 8.40 (s, 4H), 8.20 (d, J = 7.6 Hz, 4H), 8.13 (d, J = 9.0 Hz, 4H), 
8.11 (d, J = 9.0 Hz, 4H), 8.01 (t, J = 7.7 Hz, 2H), 7.41 (d, J = 7.6 Hz, 2H), 7.18 (d, J = 7.6 Hz, 2H), 
4.38 (d, J = 5.4 Hz, 2H), 4.22 (d, J = 5.5 Hz, 2H), 3.24-3.20 (m, 4H), 2.83-2.74 (m, 2H), 2.67 (s, 
6H), 2.48-2.43 (m, 2H) ppm. 
13C NMR (125 MHz, CDCl3) δ = 152.4, 145.8, 142.8, 137.8, 133.4, 131.5, 131.3, 131.2, 127.7, 
127.6, 126.0, 125.2, 124.7, 123.7, 120.6, 99.0, 60.3, 56.6, 39.8, 31.5 ppm. 
MS (ESI) m/z: 763 (M+Na+). 
HRMS (ESI) m/z calculated for C53H40O4Na (M+Na
+) 763.281879, found 763.282130.  
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(S)-7,7'-Bis(methoxymethoxy)-6,6'-di(1,2,3,4,5,6,7,8-octahydro-1,4:5,8-diethanoanthracen-
9-yl)-2,2',3,3'-tetrahydro-1,1'-spirobi[indene] (136) 
 
The corresponding aryl bromide (9-bromo-1,2,3,4,5,6,7,8-octahydro-1,4:5,8-
diethanoanthracene) was developed and generously provided by M. R. Monaco.[115] 
 
A flame-dried three neck flask was charged with freshly smashed Mg (77.0 mg, 3.15 mmol) 
and set under argon. A minimum amount of anhydrous THF, 9-bromo-1,2,3,4,5,6,7,8-
octahydro-1,4:5,8-diethanoanthracene in THF (≈0.1 mL) and a few drops of 1,2-
dibromoethane were added and the Grignard was initiated by local heating (heat gun). The 
remaining THF (3 mL in total) and 9-bromo-1,2,3,4,5,6,7,8-octahydro-1,4:5,8-
diethanoanthracene in THF (200 mg, 0.63 mmol in total) were added dropwise to keep the 
reaction refluxing. After complete addition, the reaction was refluxed for 16 h and cooled to 
ambient temperature. A flame dried Schlenk tube was charged with Ni(PPh3)2Cl2 (12.5 mg, 
0.019 mmol) and (S)-130 (75 mg, 0.126 mmol) in anhydrous THF (1.3 mL) and the Grignard 
solution was added dropwise. The reaction was refluxed for 16 h, cooled to ambient 
temperature and quenched by addition of H2O and sat. NH4Cl-solution. The aqueous layer 
was extracted with CH2Cl2 and the combined organic layers were washed with brine and 
dried over Na2SO4. The solvent was removed under reduced pressure and the crude mixture 
was purified by column chromatography.  
 
Purification: hexane:CH2Cl2 (4:1), colourless solid, 69 mg, 67% yield. 
1H NMR (500 MHz, CDCl3) δ = 7.01 (d, J = 7.5 Hz, 2H), 6.89 (d, J = 7.5 Hz, 2H), 6.88 (s, 2H), 
4.00 (d, J = 4.5 Hz, 2H), 3.85 (d, J = 4.4 Hz, 2H), 3.33-3.27 (m, 2H), 3.11-3-04 (m, 2H), 2.95 (bs, 
4H), 2.82-2-76 (m, 4H), 2.72-2.71 (m, 2H), 2.50 (s, 6H), 2.35-2.29 (m, 2H), 1.78-1.56 (m, 18H), 
1.45-1.26 (m, 14H) ppm. 
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13C NMR (125 MHz, CDCl3) δ = 151.8, 145.3, 143.2, 141.4, 141.0, 139.6, 138.7, 131.4, 130.8, 
130.0, 119.8, 118.6, 98.0, 60.7, 56.3, 42.0, 34.62, 34.57, 32.0, 31.2, 30.7, 27.2, 26.93, 26.89, 
26.42, 26.38, 25.3, 25.2 ppm. 
MS (EI) m/z (%): 812 (24), 736 (100), 369 (24), 341 (12). 
HRMS (ESI) m/z calculated for C57H64O4Na (M+Na
+) 835.469679, found 835.469630.  
 
(S)-6,6'-Di(pyren-1-yl)-2,2',3,3'-tetrahydro-1,1'-spirobi[indene]-7,7'-diol (189) 
 
To a solution of (S)-1,1'-(7,7'-bis(methoxymethoxy)-2,2',3,3'-tetrahydro-1,1'-spirobi[indene]-
6,6'-diyl)dipyrene (S)-131 (285 mg, 0.38 mmol) in a mixture of MeOH (5.5 mL) and CHCl3 (3.5 
mL), conc. HCl (2.8 mL) was added dropwise. The reaction was heated to reflux for 6 h. After 
cooling to room temperature H2O was added, the layers were separated and the aqueous 
layer was extracted with CH2Cl2. The organic layer was washed with NaHCO3 and brine and 
dried over Na2SO4. The solvent was removed under reduced pressure and the residue was 
purified by column chromatography on SiO2. 
 
Due to the presence of different rotamers, no clear assignment of the signals was possible. 
Purification: hexane:EtOAc (15:1), yellow solid, 240 mg, 97% yield. 
1H NMR (500 MHz, CDCl3) δ = 8.32-7.63 (m, 16H), 7.37 (d, J = 9.3 Hz, 1H), 7.28-7.22 (m, 2H), 
7.04-7.02 (m, 3H), 5.08-4.87 (m, 2H), 3.29 -3.10 (m, 4H), 2.67-2.52 (m, 4H) ppm. 
13C NMR (125 MHz, CDCl3) δ = 150.34, 150.29, 150.2, 145.9, 145.8, 145.75, 145.65, 132.82, 
132.76, 132.6, 132.5, 132.4, 132.2, 131.9, 131.8, 131.5, 131.45, 131.40, 131.24, 131.16, 
131.12, 131.09, 130.8, 129.74, 129.66, 129.4, 129.3, 128.8, 128.6, 128.5, 128.4, 128.2, 128.0, 
127.91, 127.86, 127.8, 127.69, 127.66, 127.53, 127.47, 126.3, 126.2, 126.0, 125.9, 125.8, 
125.7, 125.6, 125.53, 125.45, 125.32, 125.29, 125.22, 125.18, 125.10, 125.05, 124.97, 
124.94, 124.86, 124.8, 117.34, 117.28, 117.22, 117.17, 58.9, 58.8, 38.5, 38.2, 37.9, 37.8, 31.6 
ppm. 
MS (EI) m/z (%): 652 (100), 345 (9), 326 (26), 307 (19), 202 (7). 
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HRMS (EI) m/z calculated for C49H32O2 (M
+) 652.240228, found 652.240693.  
 
(S)-6,6'-Di(pyren-2-yl)-2,2',3,3'-tetrahydro-1,1'-spirobi[indene]-7,7'-diol (190) 
 
Compound 190 was synthesized following the same procedure as described for compound 
189, employing MOM-protected compound 135 (180 mg, 0.24 mmol). 
 
Purification: hexane:CH2Cl2 (1:1), yellow to greenish solid, 130 mg, 83% yield. 
1H NMR (500 MHz, CDCl3) δ = 8.30 (s, 4H), 8.17 (d, J = 7.6 Hz, 4H), 8.07 (d, J = 9.0 Hz, 4H), 
8.04 (d, J = 9.0 Hz, 4H), 7.99 (t, J = 7.5 Hz, 2H), 7.45 (d, J = 7.6 Hz, 2H), 7.07 (d, J = 7.6 Hz, 2H), 
5.39 (s, 1H), 5.30 (s, 1H), 3.25-3.15 (m, 4H), 2.61-2.47 (m, 4H) ppm. 
13C NMR (125 MHz, CDCl3) δ = 149.9, 145.8, 135.3, 132.5, 131.6, 131.5, 131.2, 127.9, 127.5, 
127.3, 126.0, 125.8, 125.2, 124.6, 123.8, 117.9, 58.8, 38.1, 31.5 ppm. 
MS (EI) m/z (%): 652 (100), 345 (10), 307 (10). 
HRMS (ESI-) m/z calculated for C49H31O2 (M-H
+) 651.232955, found 651.232450. 
 
(S)-6,6'-Di(1,2,3,4,5,6,7,8-octahydro-1,4:5,8-diethanoanthracen-9-yl)-2,2',3,3'-tetrahydro-
1,1'-spirobi[indene]-7,7'-diol (191) 
 
Compound 191 was synthesized, following a slightly modified procedure as described for 
compound 189, employing MOM-protected compound 136 (68 mg, 0.08 mmol). Due to 
solubility issues, a concentration of 0.02 M was used. The reaction was heated to reflux for 
24 h. Compound 191 was used in the next step without any further purification. 
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Colourless solid, 58 mg, 99% yield. 
1H NMR (500 MHz, CDCl3) δ = 6.93 (s, 2H), 6.88 (d, J =7.5 Hz, 2H), 6.85 (d, J = 7.5 Hz, 2H), 4.55 
(s, 2H), 3.11-3-08 (m, 4H), 2.98-2.97 (m, 2H), 2.94-2.93 (m, 2H), 2.75-2.74 (m, 2H), 2.67-2.66 
(m, 2H), 2.50-2.44 (m, 2H), 2.35-2-31 (m, 2H), 1.74-1.52 (m, 16H), 1.40-1-31 (m, 10H), 1.28-
1.20 (m, 6H) ppm.13C NMR (125 MHz, CDCl3) δ = 150.5, 144.8, 141.9, 141.7, 140.6, 140.4, 
133.2, 129.8, 125.9, 123.5, 119.5, 116.1, 59.1, 38.8, 34.6, 34.5, 31.5, 30.9, 30.6, 26.7, 26.55, 
26.52, 26.44, 26.37, 26.3, 26.1 ppm. 
MS (EI) m/z (%): 724 (100), 695 (7), 314 (25). 
HRMS (ESI) m/z calculated for C53H56O2Na (M+Na
+) 747.417249, found 747.417540.  
 
(R)-12-Hydroxy-1,10-di(pyren-1-yl)-4,5,6,7-tetrahydrodiindeno[7,1-de:1',7'-
fg][1,3,2]dioxaphosphocine 12-oxide (19c) 
 
At 0 °C POCl3 (447 μL, 4.83 mmol) was added to a solution of diol (R)‐189 (1.05 g, 1.6 mmol) 
in anhydrous pyridine (6.5 mL) and the resulting mixture was heated to 80 °C in a stopper 
sealed flask. After 24 h a colourless precipitate was formed and the mixture was again 
cooled to 0 °C. 1,4‐dioxane (10 mL) and H2O (2 mL) were added and the reaction was heated 
to 100 °C for 24 h until the precipitate was completely dissolved. At ambient temperature 
the mixture was acidified with 10% HCl and extracted with CH2Cl2. The combined organic 
layers were dried over MgSO4, the solvent was removed under reduced pressure and the 
residue was purified by column chromatography on SiO2 using CH2Cl2:MeOH (50:1 to 20:1) 
as eluent. The obtained product was dissolved in CH2Cl2 (150 mL) and thoroughly washed 
with 4 M HCl to remove salt impurities and completely protonate the catalyst. The organic 
layer was separated and evaporated to dryness. The residue was dried in vacuo to give 
catalyst (R)‐19c (850 mg, 74%) as a light yellow solid. 
 
The NMR-spectra were recorded at 60 °C in DMSO-d6. Due to the presence of different 
rotamers, no clear assignment of the signals was possible. Based on NMR analysis, we 
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assume that there are two pairs of closely modified rotamers, which give a total of four 
signals for each atom. These signals often overlap, which makes an assignment difficult. The 
purity of the catalyst was confirmed by HPLC (Chiralpak AD-3, n-heptane:i-propanol:TFA 
96:4:0.1, 1mL/min).  
 
  25D  +1020 (c = 0.20, CH2Cl2).  
1H NMR (500 MHz, DMSO-d6, 60 °C) δ = 8.25-7.76 (m, 18H), 7.34-7.23 (m, 4H), 3.36-3.27 (m, 
2H), 3.08-3.01 (m, 2H), 2.59-2.55 (m, 2H), 2.32-2.23 (m, 2H) ppm. 
13C NMR (125 MHz, DMSO-d6, 60 °C) δ = 145.1, 145.1, 144.9, 144.0, 143.94, 143.89, 143.8, 
141.0, 140.2, 133.9, 133.8, 133.6, 133.5, 132.74, 131.66, 131.6, 131.0, 130.9, 130.6, 130.5, 
130.4, 130.2, 130.1, 129.7, 129.5, 129.3, 128.8, 127.8, 127.0, 126.93, 126.90, 126.8, 126.7, 
126.3, 125.81, 125.78, 125.7, 125.6, 125.1, 124.7, 124.44, 124.38, 124.2, 124.0, 123.73, 
123.70, 123.4, 123.2, 121.5, 120.6, 59.3, 59.2, 38.7, 38.4, 29.6 ppm. 
31P NMR (202 MHz, DMSO-d6, 60 °C) δ = −12.8, −13.0, −13.2 ppm. 
MS (EI) m/z (%): 714 (100), 357 (31), 289 (9). 
HRMS (ESI) m/z calculated for C49H32O4P (M+H
+) 715.203271, found 715.202905.  
 
(S)-12-Hydroxy-1,10-di(pyren-2-yl)-4,5,6,7-tetrahydrodiindeno[7,1-de:1',7'-
fg][1,3,2]dioxaphosphocine 12-oxide (19d) 
 
Compound 19d was synthesized, following the same procedure as described for compound 
19c, starting from SPINOL-derived compound 190 (107 mg, 0.16 mmol). 
 
Purification: hexane:EtOAc (1:1 → 1:2). 
The obtained product was redissolved in CH2Cl2 and thoroughly washed with 4 M HCl to 
remove salt impurities and completely protonate the catalyst. The organic layer was 
separated and evaporated to dryness. The residue was dried in vacuo, affording catalyst (S)‐ 
19d (110 mg, 96%) as a light yellow solid. 
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1H NMR (500 MHz, DMSO-d6) δ = 8.36 (s, 4H), 8.21 (d, J = 7.7 Hz, 4H), 8.10 (s, 8H), 7.99 (t, J = 
7.6 Hz, 2H), 7.57 (d, J = 7.7 Hz, 2H), 7.36 (d, J = 7.7 Hz, 2H), 3.29-3.22 (m, 2H), 3.02-2.98 (m, 
2H), 2.48-2.45 (m, 2H), 2.23-2.17 (m, 2H) ppm. 
13C NMR (125 MHz, DMSO-d6) δ = 145.6 (d, J = 2.1 Hz), 143.1 (d, J = 8.4 Hz), 141.0 (d, J = 3.0 
Hz), 136.0, 134.2 (d, J = 3.2 Hz), 130.6, 130.5, 130.3, 127.6, 127.2, 126.2, 126.1, 125.0, 123.6, 
122.7, 122.3, 59.5, 38.8, 29.9 ppm. 
31P NMR (202 MHz, DMSO-d6,) δ = −13.2 ppm. 
MS (ESI-) m/z: 713 (M-H+). 
HRMS (ESI-) m/z calculated for C49H30O4P (M-H
+) 713.188724, found, 713.188970. 
 
(S)-12-Hydroxy-1,10-di(1,2,3,4,5,6,7,8-octahydro-1,4:5,8-diethanoanthracen-9-yl)-4,5,6,7-
tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocine 12-oxide (19e) 
 
Compound 19e was synthesized, following the same procedure as described for compound 
19c, starting from SPINOL-derived compound 191 (60 mg, 0.08 mmol). 
 
Purification: hexane:EtOAc 3:1, colourless solid, 44 mg, 70% yield. 
1H NMR (500 MHz, DMSO-d6) δ = 7.18 (d, J = 7.5 Hz, 2H), 6.95 (d, J = 7.5 Hz, 2H), 6.89 (s, 2H), 
3.20-3.13 (m, 2H), 2.94-2.87 (m, 8H), 2.72-2.71 (m, 2H), 2.37-2.33 (m, 2H), 1.96-1.90 (m, 2H), 
1.74-1.23 (m, 32H) ppm. 
13C NMR (125 MHz, DMSO-d6) δ = 144.3, 143.8, 140.9, 140.0, 139.5, 139.2, 138.6, 131.7, 
130.2, 128.9, 121.3, 118.6, 59.4, 38.5, 33.8, 33.6, 30.6, 30.3, 29.5, 26.3, 26.2, 26.1, 26.0, 25.7, 
25.5, 24.9 ppm. 
31P NMR (202 MHz, DMSO-d6) δ = −12.5 ppm. 
MS (EI) m/z (%): 786 (100), 757 (72), 677 (23), 393 (11). 
HRMS (ESI-) m/z calculated for C53H54O4P (M-H
+) 785.376524, found 785.377080.  
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 The Organocatalytic Approach to Helicenes 7.3.
 Synthesis of Hydrazines 7.3.1.
 
Hydrazines 113a-f were prepared according to the following procedure. 
 
Procedure A: 
Unless otherwise stated, non-commercially available hydrazines were synthesized from the 
corresponding amines following a literature procedure.[165] The corresponding aniline 
(7.0 mmol) was dissolved in concentrated HCl (12 mL). To the solution, cooled in an ice bath, 
a solution of NaNO2
 (7.7 mmol) in H2O (3 mL) was added dropwise over 15 min. After stirring 
the mixture at 0 °C for 10 min, a solution of SnCl2 (15.4 mmol) in conc. HCl (3.4 mL) was 
added dropwise and the reaction was stirred for 30 min at 0 °C. The formed precipitate was 
separated by filtration, dried under vacuum and was used directly for the following step. 
 
 
 
Procedure B: 
Unless otherwise stated, N-protected hydrazines 113 were synthesized following a literature 
procedure.[117] Hydrazine 137 or its hydrochloride salt 137·HCl (4.0 mmol) was treated with 
NaHCO3 (1 equiv. for the free hydrazine, 2 equiv. for the hydrochloride salt) and the 
appropriate aryl bromide 138 (8.0 mmol) in H2O (4.5 mL) at 100 °C under vigorous stirring. 
After 3 h the mixture was allowed to cool to room temperature and diluted with MTBE 
(30 mL). The organic layer was separated, dried over MgSO4 and concentrated under 
reduced pressure. The residue was purified by column chromatography on SiO2.  
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1-(3,5-Dimethylphenyl)-1-(4-iodobenzyl)hydrazine (113a) 
 
Compound 113a was synthesized following procedure B. 
Purification: pentane:MTBE (4:1), pale brown solid, 974 mg, 70% yield. 
1H‐NMR (500 MHz, CDCl3) δ = 7.66 (d, J = 8.5 Hz, 2H), 7.06 (d, J = 8.5 Hz, 2H), 6.67 (s, 2H), 
6.50 (s, 1H), 4.50 (s, 2H), 3.55 (s, 2H), 2.28 (s, 6H) ppm.  
13C NMR (125 MHz, CDCl3) δ = 152.1, 139.2, 138.13, 138.05, 130.2, 121.3, 111.8, 93.0, 60.3, 
22.1 ppm. 
MS (EI) m/z (%): 352 (24), 217 (9), 135 (100). 
HRMS (EI) m/z calculated for C15H17N2 I (M
+) 352.043646, found 352.043555. 
 
1-(4-Iodobenzyl)-1-(naphthalene-2-yl)hydrazine (113b) 
 
Compound 113b was synthesized following procedure B. 
Purification: pentane:MTBE (4:1), red solid, 415 mg, 37% yield. 
1H NMR (300 MHz, CDCl3) δ = 7.76-7.72 (m, 2H), 7.68-7.64 (m, 3H), 7.44-7.37 (m, 2H), 7.31-
7.26 (m, 2H), 7.07 (d, J = 8.4 Hz, 2H), 4.64 (s, 2H), 3.31 (b,s 2H) ppm.  
13C NMR (125 MHz, CDCl3) δ = 149.3, 137.8, 137.1, 134.6, 130.0, 129.0, 128.0, 127.5, 126.6, 
126.4, 123.1, 117.1, 107.7, 92.9, 59.9 ppm. 
MS (EI) m/z (%): 374 (29), 217 (8), 157 (100), 128 (51). 
HRMS (ESI) m/z calculated for C17H15N2INa (M+Na
+) 397.017217, found 397.017385. 
 
1-Benzyl-1-(3,5-dimethylphenyl)hydrazine (113c) 
 
Compound 113c was synthesized following procedure B. 
Purification: hexane:MTBE (9:1), yellow oil, 210 mg, 47% yield. 
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1H-NMR (500 MHz, CDCl3) δ = 7.38-7.29 (m, 5H), 6.77 (s, 2H), 6.52 (s, 1H), 4.58 (s, 2H), 3.53 
(b,s, 2H), 2.32 (s, 6H) ppm.  
13C NMR (125 MHz, CDCl3) δ = 152.1, 138.8, 138.0, 128.8, 128.0, 127.4, 120.8, 111.7, 60.6, 
21.9 ppm.  
MS (EI) m/z (%): 226 (37), 135 (83), 91 (100). 
HRMS (ESI) m/z calculated for C15H18N2Na (M+Na
+) 249.136214, found 249.136000. 
 
1-(4-(tert-Butyl)benzyl)-1-(3,5-dimethylphenyl)hydrazine (113d) 
 
Compound 113d was synthesized following procedure B. 
Purification: hexane:MTBE (9:1), colourless solid, 513 mg, 45% yield. 
1H NMR (500 MHz, CDCl3) δ = 7.37 (d, J = 8.3 Hz, 2H), 7.25 (d, J = 8.3 Hz, 2H), 6.77 (s, 2H), 
6.50 (s, 1H), 4.53 (s, 2H), 3.50 (b, s, 2H), 2.30 (s, 6H), 1.33 (s, 9H) ppm. 
13C NMR (125 MHz, CDCl3) δ = 152.2, 150.4, 138.8, 134.8, 127.8, 125.7, 120.7, 111.8, 60.2, 
34.6, 31.5, 21.9 ppm. 
MS (EI) m/z (%): 282 (35), 147 (41), 135 (100). 
HRMS (ESI) m/z calculated for C19H27N2 283.216872 (M+H
+), found 283.216712. 
 
1-(3,5-Dimethylphenyl)-1-(4-(trifluoromethyl)benzyl)hydrazine (113e) 
 
Compound 113e was synthesized following procedure B. 
Purification: hexane:MTBE (4:1), dark yellow oil, 808 mg, 69% yield. 
1H NMR (500 MHz, CDCl3) δ = 7.60 (d, J = 8.1 Hz, 2H), 7.43 (d, J = 8.0 Hz, 2H), 6.67 (s, 2H), 
6.52 (s, 1H), 4.63 (s, 2H), 3.63 (s, 2H), 2.29 (s, 6H) ppm.  
13C NMR (125 MHz, CDCl3) δ = 151.9, 142.6, 139.1, 129.7 (q, J = 33 Hz), 128.1, 125.6 (q, J = 
3.8 Hz), 123.2, 121.1, 111.4, 60.1, 21.9 ppm. 
MS (EI) m/z (%): 294 (30), 159 (50), 135 (100), 105 (40). 
HRMS (ESI) m/z calculated for C16H18F3N2 295.141658 (M+H
+), found 295.141704. 
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1-(3,5-Bis(trifluoromethyl)benzyl)-1-(3,5-dimethylphenyl)hydrazine (113f) 
 
Compound 113f was synthesized following procedure B. 
Purification: hexane:MTBE (4:1), dark yellow oil, 728 mg, 50 % yield. 
1H NMR (500 MHz, CDCl3) δ = 7.81 (s, 3H), 6.65 (s, 2H), 6.57 (s, 1H), 4.64 (s, 2H), 3.69 (b,s, 
2H), 2.31 (s, 6H) ppm.  
13C NMR (125 MHz, CDCl3) δ = 151.9, 141.8, 139.3, 131.9 (q, J = 33 Hz), 128.0, 123.5 (q, J = 
271 Hz), 121.8, 121.4 (sep, J = 3.8 Hz), 111.5, 60.2, 21.8 ppm. 
MS (EI) m/z (%): 362 (35), 227 (16), 135 (100). 
HRMS (ESI) m/z calculated for C17H16F6N2Na (M+Na
+) 385.110988, found 385.111507. 
 
Synthesis of 1-(4-Iodobenzyl)-1-(7-(trimethylsilyl)naphthalen-2-yl)hydrazine (113g) 
 
 
(7-Bromonaphthalen-2-yl)trimethylsilane (140) 
 
Compound 140 was synthesized following a modified literature procedure.[118] 
 
An oven-dried flask was charged with 2,7-dibromonaphthalene 139 (2.00 g, 7.00 mmol) in 
anhydrous THF (18 mL) and n-BuLi (c = 2.5 M in hexane, 2.90 mL, 7.34 mmol) was added 
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dropwise at –78 °C. After stirring the reaction at this temperature for 20 min, TMSCl (1.4 mL, 
11.2 mmol) was slowly added at −78 °C. The mixture was stirred for further 15 min at −78 °C 
before it was allowed to warm to room temperature. After stirring for 2 h at room 
temperature, the reaction was stopped by the addition of water. The aqueous layer was 
extracted with MTBE and the combined organic layers were washed with brine and dried 
over Na2SO4. The crude mixture was purified by flash column chromatography on SiO2. 
 
Purification: hexane, colourless solid, 1.94 g, quantitative yield. 
1H NMR (500 MHz, CDCl3) δ = 8.03 (d, J = 1.7 Hz, 1H), 7.02 (s, 1H), 7.79 (d, J = 8.2 Hz, 1H), 
7.69 (d, J = 8.7 Hz, 1H), 7.63 (dd, J = 8.1, 1.0 Hz, 1H), 7.55 (dd, J = 8.7, 2.0 Hz, 1H), 0.36 (s, 9H) 
ppm. 
13C NMR (125 MHz, CDCl3) δ = 139.6, 134.1, 132.9, 132.1, 130.4, 130.2, 129.7, 129.5, 126.9, 
119.8, −1.01 ppm.  
MS (EI) m/z (%): 280 (24), 278 (23), 265 (100), 263 (100), 183 (34), 167 (20), 155 (20), 141 
(17), 115 (13). 
HRMS (EI) m/z calculated for C13H15BrSi (M
+) 278.012652, found 278.012614. 
 
(7-(Trimethylsilyl)naphthalen-2-yl)hydrazine (141) 
 
Compound 141 was synthesized following a modified literature procedure.[119] 
 
An oven-dried flask was charged with Mor-DalPhos (62.2 mg, 0.13 mmol) and 
[Pd(cinnamyl)Cl]2 (46.3 mg, 0.09 mmol) in anhydrous toluene (0.1 M). The solution was 
degassed for 15 min and NaOtBu (244 mg, 3.58 mmol) and aryl bromide 140 (500 mg, 1.79 
mmol) were added. The mixture was stirred for 10 min, after which hydrazine monohydrate 
solution (174 µl, 3.58 mmol) was added dropwise. The reaction was stirred at 65 °C for 20 h, 
cooled to room temperature and filtered over celite (EtOAc). The solvent was removed 
under reduced pressure.  
 
The compound was used without any further purification due to stability issues. 
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1-(4-Iodobenzyl)-1-(7-(trimethylsilyl)naphthalen-2-yl)hydrazine (113g) 
 
Compound 113g was synthesized following a modified literature procedure.[120] 
 
A solution of crude hydrazine 141 (412 mg, 1.79 mmol) in anhydrous THF (25 mL) was added 
dropwise to a suspension of NaNH2 (73.3 mg, 1.88 mmol) in anhydrous THF (10 mL) at 0 °C. 
After degassing the reaction for 15 min, a solution of p-iodobenzyl bromide (558 mg, 1.88 
mmol) in anhydrous THF (10 mL) was added dropwise at room temperature. The mixture 
was stirred at 30 °C for 10 h after which it was diluted with MTBE and H2O. The organic layer 
was separated, washed with H2O and brine and dried over Na2SO4. The crude mixture was 
purified by flash column chromatography. 
 
Purification: Aluminium oxide (neutral), hexane:EtOAc (20:1 → 10:1), orange solid, 159 mg, 
22% yield over 2 steps. 
1H NMR (500 MHz, CD2Cl2) δ = 7.83 (s, 1H), 7.71-7.66 (m, 4H), 7.44 (dd, J = 9.1, 2.5Hz, 1H), 
7.38 (dd, J = 8.1, 1.0Hz, 1H), 7.25 (d, J = 2.4 Hz, 1H), 7.10 (d, J = 8.3 Hz, 2H), 4.66 (s, 2H), 3.70 
(b,s, 2H), 0.32 (s, 9H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 149.9, 138.7, 138.1, 137.8, 134.5, 132.8, 130.4, 128.9, 128.4, 
127.3, 126.7, 117.8, 107.8, 92.9, 60.1, -1,05 ppm. 
MS (EI) m/z (%): 446 (22), 229 (100), 217 (8), 185 (33). 
HRMS (ESI) m/z calculated for C20H24N2ISi (M+H
+) 447.075222, found 447.074795. 
  
 7. Experimental Part   
126 
Synthesis of 1-((l1-Boranyl)iodophosphanyl)-1-([1,1':3',1''-terphenyl]-5'-yl)hydrazine (113h) 
 
 
 
5-Phenylbiphenyl-3-ol (145) 
 
Compound 145 was synthesized following a modified literature procedure.[166] 
 
A Schlenk tube was charged with 3,5-dibromophenol 144 (300 mg, 1.19 mmol), 
phenylboronic acid (580 mg, 4.76 mmol), K2CO3 (740 mg, 5.36 mmol) and PdCl2(PPh3)2 
(8.35 mmol, 0.01 mmol) and a mixture of dioxane/H2O (4 mL/1 mL) was added. The reaction 
was refluxed for 23 h, cooled to ambient temperature and MTBE was added. The aqueous 
layer was extracted with MTBE and the combined organic layers were washed with H2O and 
brine and dried over Na2SO4. The solvent was removed under reduced pressure and the 
crude product was purified by column chromatography on SiO2. 
 
Purification: hexane:EtOAc (3:1), colourless solid, 246 mg, 94% yield. 
1H NMR (500 MHz, CD2Cl2) δ =7.66-7.64 (m, 4H), 7.48-7.45 (m, 4H), 7.423-7.417 (m, 1H), 
7.40-7.37 (m, 2H), 7.08 (d, J = 1.4 Hz, 2H), 5.51 (s, 1H) ppm. 
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13C‐NMR (125 MHz, CD2Cl2) δ = 156.9, 143.7, 141.1, 129.2, 128.0, 127.5, 119.0, 113.3 ppm. 
HRMS (EI) m/z calculated for C18H14OS (M
+) 246.104463, found 246.104249. 
The obtained data are in agreement with those reported in literature.[166] 
 
[1,1':3',1''-Terphenyl]-5'-yl 4-methylbenzenesulfonate (146) 
 
Compound 146 was synthesized following a modified literature procedure.[167] 
 
A solution of tosyl chloride (110 mg, 0.57 mmol) in anhydrous CH2Cl2 (3.5 mL) was added 
dropwise at 0 °C to a mixture of phenol 145 (118 mg, 0.48 mmol) and DABCO (108 mg, 
0.96 mmol) in anhydrous CH2Cl2 (3.5 mL). After complete addition, the reaction mixture was 
stirred at room temperature for 1 h after which MTBE and HCl (10%) were added. The 
aqueous layer was extracted with MTBE and the combined organic layers were washed with 
sat. NaHCO3 and brine and dried over Na2SO4. The solvent was removed under reduced 
pressure and the product was used in the next step without any further purification. 
 
Colourless oil, 190 mg, 99% yield. 
1H NMR (500 MHz, CD2Cl2) δ =7.79-7.76 (m, 2H), 7.73 (t, J = 1,6 Hz, 1H), 7.53-7.50 (m, 4H), 
7.47-7.43 (m, 4H), 7.41-7.37 (m, 4H), 7.16 (d, J = 1.6 Hz, 2H), 2.47 (s, 3H) ppm. 
13C‐NMR (125 MHz, CD2Cl2) δ = 150.9, 146.3, 143.7, 139.9, 132.6, 130.3, 129.3, 129.0, 128.5, 
127.5, 125.0, 120.1, 21.8 ppm. 
HRMS (ESI) m/z calculated for C25H20O3SNa (M+Na
+) 423.102535, found 423.102710. 
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[1,1':3',1''-Terphenyl]-5'-ylhydrazine (143) 
 
Compound 143 was synthesized following the same procedure as described for compound 
141, applying aryl tosylate 146 (0.43 mmol). After 17 h, the reaction was filtered over celite 
(EtOAc) and the solvent was removed under reduced pressure. Compound 143 was used in 
the next step without any further purification.  
 
It has to be mentioned that pure compound 143 can be obtained via salt formation with HCl 
(6 M), filtration and washing (CH2Cl2). Afterwards, the salt is dissolved in sat. NaHCO3 and 
CH2Cl2 and the aqueous layer is extracted with CH2Cl2 and dried over Na2SO4. Following this 
procedure, pure hydrazine 143 could be obtained and was characterized via NMR 
spectroscopy. However, fast decomposition of hydrazine 143 was be observed.  
 
Yellow oil, 32.3 mg, 36% yield (after salt formation and basic extraction). 
1H NMR (500 MHz, CD2Cl2) δ =7.67-7.65 (m, 4H), 7.47-7.44 (m, 4H), 7.38-7.35 (m, 2H), 7.26 
(t, J = 1.5 Hz, 1H), 7.06 (d, J = 1.5 Hz, 2H), 5.43 (b, 1H), 3.70 (b, 2H) ppm. 
13C‐NMR (125 MHz, CD2Cl2) δ = 152.8, 143.0, 141.8, 129.1, 127.8, 127.5, 117.5, 110.3 ppm. 
 
Due to decomposition, compound 143 could not be characterized via mass spectrometry. 
 
1-((l1-Boranyl)iodophosphanyl)-1-([1,1':3',1''-terphenyl]-5'-yl)hydrazine (113h) 
 
Compound 113h was synthesized following the same procedure as described for compound 
113g, applying crude hydrazine 143 (0.14 mmol). 
 
Purification: hexane:EtOAc (30:1 → 20:1 → 10:1), yellow solid, 13% yield (over 2 steps). 
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1H NMR (500 MHz, CD2Cl2) δ = 7.70 (d, J = 8.2 Hz, 2H), 7.64 (d, J = 7. 5 Hz, 4H), 7.45 (t, J = 7.5 
Hz, 4H), 7.37-7.344 (m, 2H), 7.27-7.26 (m, 3H), 7.14 (d, J = 8.2 Hz, 2H), 4.68 (s, 2H), 3.74 (s, 
2H) ppm. 
HRMS (ESI) m/z calculated for C25H22N2I (M+H
+) 477.082233, found 477.082643. 
The product was found to be highly unstable and stored under argon at −20 °C. Due to 
stability issues, no 13C-NMR spectra could be obtained. 
 
6-Hydrazinylquinoline (155) 
 
Hydrazine 155 was synthesized from the corresponding amine 154, following procedure A on 
a 3.50 mmol scale. The obtained salt was dissolved in a mixture of CH2Cl2 and NaOH and the 
aqueous layer was extracted with CH2Cl2. The combined organic layers were dried over 
Na2SO4 and the solvent was removed under reduced pressure. 
Yellow solid, 426 mg, 76% yield (after basic extraction). 
 
1H NMR (500 MHz, CD2Cl2) δ = 8.44 (dd, J = 1.6, 4.2 Hz, 1H), 7.99 (d, J = 8.4 Hz, 1H), 7.87 (d, J 
= 9.1 Hz, 1H), 7.29 (dd, J = 4.2, 8.3 Hz, 1H), 7.19 (dd, J = 2.6, 9.1 Hz, 1H), 7.09 (d, J = 2.6 Hz, 
1H), 5.60 (b, 1H), 3.69 (b, 2H) ppm. 
13C‐NMR (125 MHz, CD2Cl2) δ = 149.7, 147.1, 144.5, 134.3, 130.6, 130.2, 121.8, 119.7, 103.8 
ppm. 
Due to stability issues, compound 155 could not be characterized via MS spectrometry. 
 
6-(1-(4-Iodobenzyl)hydrazinyl)quinoline (113i) 
 
Compound 113i was synthesized following the same procedure as described for compound 
113g, employing hydrazine 155 (2.63 mmol).  
Purification: column chromatography (SiO2) hexane:EtOAc (2:1),yellow solid, 298 mg, 
30% yield. 
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1H NMR (500 MHz, CD2Cl2) δ = 8.54 (dd, J = 1.4, 4.1 Hz, 1H), 7.97 (d, J = 8.4 Hz, 1H), 7.92 (d, J 
= 9.4 Hz, 1H), 7.69-7-66 (m, 3H), 7.29 (dd, J = 4.2, 8.3 Hz, 1H), 7.19 (d, J = 2.8 Hz, 1H), 7.10-
7.09 (m, 2H), 4.69 (s, 2H), 3.74 (b, 2H) ppm. 
MS (ESI) m/z (%): 375 (21), 217 (17), 184 (5), 158 (100), 130 (28), 90 (13). 
HRMS (ESI) m/z calculated for C16H14N3INa (M+Na
+) 398.012459, found 398.012673. 
 
Synthesis of 2,7-Bis(1-benzylhydrazinyl)naphthalene (158a) 
 
 
Naphthalene-2,7-diyl bis(4-methylbenzenesulfonate) (159) 
 
Compound 159 was synthesized following a modified literature procedure.[167] 
 
Tosyl chloride (11.9 g, 62.5 mmol) was dissolved in anhydrous CH2Cl2 (100 mL) and added 
dropwise to a solution of naphthalene-2,7-diol 156 (4.00 g, 25.0 mmol) and DABCO (11.2 g, 
100 mmol) in anhydrous CH2Cl2 (100 mL) at 0 °C. The reaction was stirred at room 
temperature for 4 h. The mixture was diluted with MTBE and 10% aq. HCl was added. The 
organic layer was washed with an aqueous solution of NaHCO3, brine and dried over Na2SO4. 
The solvent was removed under reduced pressure and the residue was dissolved in EtOAc, 
precipitated by addition of hexane and isolated by filtration. 
 
Purification: precipitation (EtOAc, hexane), colourless solid, 9.42 g, 81% yield. 
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1H NMR (500 MHz, CD2Cl2) δ = 7.77 (d, J = 9.0 Hz, 2H), 7.70 (d, J = 8.3 Hz, 4H), 7.38 (d, J = 2.2 
Hz, 2H), 7.34 (d, J = 8.2 Hz, 4H), 7.12 (dd, J = 9.0, 2.2 Hz, 2H), 2.45 (s, 6H) ppm. 
13C‐NMR (125 MHz, CD2Cl2) δ = 148.5, 146.4, 134.1, 132.5, 130.7, 130.3, 130.1, 128.8, 122.1, 
120.2, 21.9 ppm.  
HRMS (ESI) m/z calculated for C24H20O6S2Na (M+Na
+) 491.059358, found 491.059564. 
 
N2,N7-Dibenzylnaphthalene-2,7-diamine (161a) 
 
Compound 161a was synthesized following a modified literature procedure.[126] 
 
A stock solution (1.0 x 10-2 M) of Pd[P(o-tol)3]2 (10.7 mg, 0.015 mmol) and CyPF-tBu 
(8.32 mg, 0.015 mmol) in anhydrous toluene was prepared. An oven-dried flask was charged 
with naphthyl tosylate 159 (2.00 g, 4.27 mmol) and sodium tert-butoxide (1.23 mg, 
12.8 mmol). The flask was evacuated and flushed with argon three times after which 
anhydrous toluene (7 mL) was added to the mixture. The stock solution (850 µL) was added 
to the reaction, followed by the slow addition of freshly distilled benzylamine (2.80 mL, 
25.6 mmol). The reaction was stirred at room temperature for 24 h and filtered over a pad of 
Celite. The crude mixture was purified by flash chromatography on SiO2. 
 
Purification: EtOAc:hexane (4:1), colourless solid, 1.35 g, 94% yield. 
1H NMR (500 MHz, CD2Cl2) δ = 7.50 (d, J = 8.7 Hz, 2H), 7.45 (d, J = 7.4 Hz, 4H), 7.40 (t, J = 7.5 
Hz, 4H), 7.33 (t, J = 7.2 Hz, 2H), 6.67 (dd, J = 8.7, 2.3Hz, 2H), 6.64 (d, J = 2.2 Hz, 2H), 4.42 (s, 
4H), 4.23 (b,s, 2H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 146.9, 140.1, 137.3, 129.0, 128.9, 127.9, 127.5, 121.9, 114.1, 
103.5, 48.5 ppm. 
MS (ESI) m/z (%): 338 (100), 261 (4), 220 (10), 91 (35). 
HRMS (ESI) m/z calculated for C24H23N2 (M+H
+) 339.185576, found 339.185553. 
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N,N'-(Naphthalene-2,7-diyl)bis(N-benzylnitrousamide) (162a) 
 
A solution of bisbenzylamine 161a (1.05 g, 3.10 mmol) in THF (16 mL) was added dropwise at 
0 °C to a solution of sodium nitrite (964 mg, 14.0 mmol) in H2O (10 mL). After stirring the 
mixture at 0 °C for 15 min, acetic acid (621 µL, 10.9 mmol) was added dropwise at 0 °C. The 
reaction was stirred for 4 h at room temperature. The mixture was diluted with EtOAc and 
the organic layer was washed with brine and dried over Na2SO4. The crude mixture was 
filtered over a short plug of silica (EtOAc) and the solvent was removed under reduced 
pressure. 
 
Compound 162a was used in the next step without further purification and characterization. 
 
2,7-Bis(1-benzylhydrazinyl)naphthalene (158a) 
 
Compound 158a was synthesized following a modified literature procedure.[127] 
 
To a mixture of anhydrous CH2Cl2 (20 mL) and anhydrous Et2O (8 mL), TiCl4 (2.72 mL, 
24.8 mmol) was added dropwise. The solution was stirred for 15 min, after which Mg 
(603 mg, 24.8 mmol) was added in portions. After stirring for 30 min at room temperature, 
bisnitrosamine 162a (1.23 g, 3.10 mmol), dissolved in anhydrous CH2Cl2 (12 mL) was added. 
The reaction was stirred at room temperature for 4 h, followed by the slow addition of HCl 
(10 mL, 0.3 M). The mixture was stirred for 1 h, diluted with EtOAc and NaOH (2 M) was 
added until the reaction medium was basic. The aqueous layer was extracted with EtOAc 
and the combined organic layers were washed with brine and dried over Na2SO4. The 
solution was filtered over a pad of celite and the solvent was removed under reduced 
pressure. The crude mixture was purified by flash chromatography on SiO2. 
 
Purification: hexane:EtOAc (2:1), brown solid, 498 mg, 44% yield (over 2 steps). 
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1H NMR (500 MHz, CD2Cl2) δ = 7.59 (d, J = 9.0 Hz, 2H), 7.36-7.32 (m, 8H), 7.30-7.27 (m, 2H), 
7.22 (dd, J = 2.4, 9.0 Hz, 2H), 7.13 (d, J = 2.3 Hz, 2H), 4.68 (s, 4H), 3.69 (b,s, 4H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ =150.5, 138.1, 136.4, 129.0, 128.6, 128.4, 127.7, 122.5, 114.3, 
106.6, 60.5 ppm. 
MS (EI) m/z (%): 368 (65), 277 (100), 186 (59), 157 (39). 
HRMS (ESI) m/z calculated for C24H24N4Na (M+Na
+) 391.189315, found 391.189040. 
 
Synthesis of 2,8-Bis(1-benzylhydrazinyl)dibenzo[b,d]thiophene (158b) 
 
 
 
N2,N8-Dibenzyldibenzo[b,d]thiophene-2,8-diamine (161b) 
 
A stock solution (1.0 x 10-2 M) of Pd(OAc)2 (1.12 mg, 0.005 mmol) and CyPF-tBu (2.78 mg, 
0.005 mmol) in anhydrous toluene was prepared. An oven-dried flask was charged with the 
corresponding aryl bromide 163 (500 mg, 1.46 mmol) and sodium tert-butoxide (491 mg, 
5.11 mmol). The flask was evacuated and flushed with argon three times, after which 
anhydrous toluene (4.5 mL) was added to the mixture. The stock solution (6 µL) was added 
to the reaction, followed by the slow addition of freshly distilled benzyl amine (480 µL, 
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4.39 mmol). The reaction was stirred at 100 °C for 24 h after which more benzylamine 
(480 µL, 4.39 mmol) was added. After stirring the reaction at 110 °C for 2 d, the crude 
mixture was directly purified by flash chromatography on SiO2. 
 
Purification: hexane:EtOAc (8:1), colourless solid, 510 mg, 89% yield. 
1H NMR (500 MHz, CD2Cl2) δ = 7.56 (d, J = 8.5 Hz, 2H), 7.47-7.44 (m, 4H), 7.41-7-35 (m, 4H), 
7.33-7.28 (m, 2H), 7.25 (d, J = 2.3 Hz, 2H), 6.82 (dd, J = 6.3, 8.5 Hz, 2H), 4.44 (s, 4H), 4.25 (b, 
2H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 146.3, 140.1, 136.9, 129.6, 129.0, 128.0, 127.6, 123.7, 115.3, 
104.3, 49.1 ppm. 
MS (EI) m/z (%): 394 (100), 303 (64), 212 (27), 158 (12), 91 (27). 
HRMS (ESI) m/z calculated for C26H23N2S (M+H
+) 395.157641, found 395.157710. 
 
N,N'-(Dibenzo[b,d]thiophene-2,8-diyl)bis(N-benzylnitrous amide) (162b) 
 
A solution of bisbenzylamine 161b (508 mg, 1.29 mmol) in THF (8 mL) was added dropwise 
at 0 °C to a solution of sodium nitrite (401 mg, 5.81 mmol) in H2O (5 mL). After stirring the 
mixture at 0 °C for 15 min, acetic acid (258 µL, 4.52 mmol) was added dropwise at 0 °C and 
the reaction was stirred for 6 h at room temperature. The mixture was diluted with EtOAc 
and the organic layer was washed with brine and dried over Na2SO4. The crude mixture was 
filtered over a short plug of silica (EtOAc) and the solvent was removed under reduced 
pressure. 
 
Compound 162b was used in the next step without further purification and characterization. 
 
MS (EI) m/z (%):392 (100), 301 (62), 286 (18), 197 (20), 91 (36). 
HRMS (ESI) m/z calculated for C26H20N4O2SNa (M+Na
+) 475.119918, found 475.120040. 
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2,8-Bis(1-benzylhydrazinyl)dibenzo[b,d]thiophene (158b) 
 
Compound 158b was synthesized following the same procedure as described for compound 
158a, applying bisnitrosamine 162b (1.27 mmol). 
Purification: hexane:EtOAc (3:1), colourless solid, 225 mg, 42% yield (over 2 steps). 
1H NMR (500 MHz, CD2Cl2) δ = 7.82 (d, J = 2.5 Hz, 2H), 7.67 (d, J = 8.7 Hz, 2H), 7.38-7.35 (m, 
8H), 7.33-7.28 (m, 4H), 4.67 (s, 4H), 3.65 (b, 4) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 150.3, 138.0, 137.0, 130.8, 129.0, 128.6, 127.8, 123.4, 115.9, 
106.4, 61.6 ppm. 
MS (EI) m/z (%): 424 (55), 333 (87), 242 (100), 213 (22), 184 (68), 91 (18). 
HRMS (ESI) m/z calculated for C26H24N4SNa (M+Na
+) 447.161384, found 447.161880. 
 
 Synthesis of Polyaromatic Ketones 7.3.2.
 Synthesis of Stilbenes 7.3.2.1.
 
General procedure for the Horner-Wadsworth-Emmons reaction:[122] 
 
To a suspension of tBuOK (2.5 equiv.) in DMF (0.95 M), a solution of the 4-
methoxybenzylphosphonate (147) (1.5 equiv.) in DMF (0.2 M) was added. After 10 min a 
solution of the corresponding aldehyde 148 (1 equiv.) in DMF (0.2 M) was added and the 
mixture was stirred at room temperature for 5 h until the starting material was consumed 
(monitored by TLC, eluent: hexane:EtOAc 20:1). Water was added and the mixture was 
extracted with MTBE. The combined organic layers were washed with brine, dried over 
MgSO4 and concentrated under reduced pressure. The product was purified by 
recrystallization from EtOAc.  
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(E)-2-(4-Methoxystyryl)naphthalene (149a) 
 
Purification: recrystallization (EtOAc), colourless solid, 95% yield. 
1H NMR (500 MHz, CDCl3) δ = 7.83-7.80 (m, 4H), 7.73 (d, J = 8.6 Hz, 1H), 7.75 (d, J = 8.6 Hz, 
2H), 7.49-7.42 (m, 2H), 7.21 (d, J = 16.3 Hz, 1H), 7.15 (d, J = 16.3 Hz, 1H), 6.93 (d, J = 8.7 Hz, 
2H), 3.85 (s, 3H) ppm.  
13C‐NMR (125 MHz, CDCl3) δ = 159.5, 135.3, 133.9, 133.0, 130.3, 128.7, 128.4, 128.0, 127.9, 
127.8, 126.8, 126.4, 126.3, 125.8, 123.6, 114.3, 55.5 ppm.  
MS (EI) m/z (%): 260 (100), 245 (8), 229 (11), 215 (24), 202 (22), 189 (6). 
HRMS (EI) m/z calculated for C19H16O (M
+) 260.120112, found 260.120257. 
 
(E)-5-(4-Methoxystyryl)benzo[b]thiophene (149b) 
 
Purification: recrystallization (EtOAc), colourless solid, 98% yield. 
1H NMR (500 MHz, CDCl3) δ = 7.89 (s, 1H), 7.84 (d, J = 8.4 Hz, 1H), 7.54 (d, J = 8.2 Hz, 1H), 
7.48 (d, J = 8.6 Hz, 2H), 7.44 (d, J = 5.4 Hz, 1H), 7.33 (d, J = 5.4 Hz, 1H), 7.14 (d, J = 16.4 Hz, 
1H), 7.09 (d, J = 16.3 Hz, 1H), 6.92 (d, J = 8.6 Hz, 2H), 3.84 (s, 3H) ppm.  
13C‐NMR (125 MHz, CDCl3) δ = 159.4, 140.3, 138.7, 134.3, 130.3, 128.0, 127.8, 127.0, 126.8, 
124.1, 122.7, 122.6, 121.7, 114.3, 55.5 ppm.  
MS (EI) m/z (%): 266 (100), 251 (10), 223 (15), 208 (6), 189 (6), 133 (7). 
HRMS (EI) m/z calculated for C17H14OS (M
+) 266.076541, found 266.076266. 
 
(E)-9-(4-Methoxystyryl)phenanthrene (149c) 
 
Purification: recrystallization (EtOAc), colourless solid, 95% yield. 
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1H NMR (500 MHz, CDCl3) δ = 8.75 (d, J = 7.9 Hz, 1H), 8.68 (d, J = 8.0 Hz, 1H), 8.28-8.27 (m, 
1H), 7.96 (s, 1H), 7.93-7.91 (m, 1H), 7.74 (d, J = 15.9 Hz, 1H), 7.71-7.61 (m, 4H), 7.58 (d, J = 
8.7 Hz, 2H), 7.19 (d, J = 15.9 Hz, 1H), 6.97 (d, J = 8.7 Hz, 2H), 3.87 (s, 3H) ppm.  
13C‐NMR (125 MHz, CDCl3) δ = 159.6, 134.4, 132.1, 131.8, 131.0, 130.6, 130.2, 128.7, 128.1, 
127.5, 126.9, 126.7, 126.6, 126.5, 124.8, 124.31, 124.26, 123.2, 122.7, 114.3, 55.5 ppm.  
MS (EI) m/z (%): 310 (100), 279 (19), 265 (18), 252 (14), 239 (8), 202 (12), 155 (6). 
HRMS (EI) m/z calculated for C23H18O (M
+) 310.135765, found 310.135702. 
 
 (E)-1,3-Dibromo-5-(4-methoxystyryl)benzene (149d) 
 
Purification: recrystallization (EtOAc), colourless solid, 75% yield. 
1H NMR (500 MHz, CDCl3) δ = 7.53 (s, 2H), 7.50 (s, 1H), 7.43 (d, J = 8.7 Hz, 2H), 7.04 (d, J = 
16.3 Hz, 1H), 6.90 (d, J = 8.7 Hz, 2H), 6.80 (d, J = 16.3 Hz, 1H), 3.83 (s, 3H) ppm.  
13C‐NMR (125 MHz, CDCl3) δ = 160.0, 141.5, 132.3, 131.2, 129.2, 128.2, 127.9, 123.6, 123.3, 
114.4, 55.5 ppm.  
MS (EI) m/z (%):368 (100), 353 (4), 288 (4), 208 (11), 165 (55), 104 (15). 
HRMS (EI) m/z calculated for C15H12OBr2 (M
+) 365.925514, found 365.925735. 
 
(E)-5'-(4-Methoxystyryl)-1,1':3',1''-terphenyl (149e) 
 
A Schlenk tube was charged with (E)-1,3-dibromo-5-(4-methoxystyryl)benzene (149d) 
(400 mg, 1.1 mmol), phenyl boronic acid (536 mg, 4.4 mmol) and K2CO3 (1.82 g, 13.2 mmol). 
The solids were set under argon and taken up in toluene (8 mL), H2O (4 mL) and EtOH (2 mL). 
The mixture was degassed for 15 min and Pd(PPh3)4 (128 mg, 0.11 mmol) was added. The 
reaction was heated to reflux for 18 h. After cooling to room temperature, H2O was added 
and the aqueous layer was extracted with EtOAc. The combined organic layers were washed 
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with brine, dried over MgSO4 and evaporated to dryness. The residue was purified by 
column chromatography on SiO2. 
 
Purification: hexane → hexane:EtOAc (50:1), colourless solid, 345 mg, 87% yield. 
1H NMR (500 MHz, CDCl3) δ = 7.60-7.58 (m, 7H), 7.41-7.37 (m, 6H), 7.31-7.28 (m, 2H), 7.11 
(d, J = 16.3 Hz, 1H), 7.01 (d, J = 16.3 Hz, 1H), 6.83 (d, J = 8.5 Hz, 2H), 3.75 (s, 3H) ppm.  
13C‐NMR (125 MHz, CDCl3) δ = 159.6, 142.4, 141.3, 138.8, 130.2, 129.1, 129.0, 128.0, 127.7, 
127.5, 126.5, 125.4, 124.3, 114.3, 55.5 ppm.  
MS (EI) m/z (%):362 (100), 289 (3), 241 (14), 215 (3), 181 (2). 
HRMS (EI) m/z calculated for C27H22O (M
+) 362.167068, found 362.166786. 
 
 Photocyclization 7.3.2.2.
 
The photocyclization was conducted following a literature procedure.[122] 
 
The corresponding stilbene 149 (500 mg) was added to a 0.5 M solution of conc. HCl in 
500 mL of degassed acetonitrile. The reaction flask was placed in a Rayonet photoreactor 
and irradiated for 39 h at 300 nm. After full consumption of the starting material (monitored 
by TLC) the mixture was neutralized with Na2CO3 (aq) and extracted with CH2Cl2. The organic 
layer was washed with brine and dried over Na2SO4. The product was purified by column 
chromatography on SiO2. 
 
3,4-Dihydrobenzo[c]phenanthren-2(1H)-one (114a) 
 
Purification: hexane:EtOAc (9:1), yellow solid, 108 mg, 23% yield. 
1H NMR (500 MHz, CDCl3) δ = 8.49-8.47 (m, 1H), 7.92-7.90 (m, 1H), 7.77 (d, J = 7.9 Hz, 1H), 
7.70 (d, J = 9.0 Hz, 1H), 7.68 (d, J = 8.9 Hz, 1H), 7.62-7.58 (m, 2H), 7.50 (d, J = 7.9 Hz, 1H), 4.50 
(s, 2H), 3.36 (t, J = 6.8 Hz, 2H), 2.61 (t, J = 6.8 Hz, 2H) ppm.  
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13C‐NMR (125 MHz, CDCl3) δ = 210.7, 136.2, 133.7, 132.3, 129.92, 129.85, 129.6, 128.5, 
127.8, 127.4, 127.3, 126.8, 126.6, 126.3, 125.5, 46.6, 37.3, 29.7 ppm.  
MS (EI) m/z (%): 246 (100), 217 (21), 203 (64), 189 (37). 
HRMS (EI) m/z calculated for C18H14O (M
+) 246.104464, found 246.104692. 
 
8,9-Dihydrophenanthro[3,4-b]tiophene-10(11H)-one (114b) 
 
Purification: hexane:CH2Cl2 (4:1), yellow solid, 73 mg, 15% yield. 
1H NMR (500 MHz, CDCl3) δ = 8.20 (d, J = 5.6 Hz, 1H), 7.91 (d, J = 8.7 Hz, 1H), 7.84 (d, J = 8.2 
Hz, 1H), 7.74 (d, J = 8.7 Hz, 1H), 7.62 (d, J = 5.6 Hz, 1H), 7.40 (d, J = 8.2 Hz, 1H), 4.35 (s, 2H), 
3.34 (t, J = 7.0 Hz, 2H), 2.76 (t, J = 7.0 Hz, 2H) ppm.  
13C‐NMR (125 MHz, CDCl3) δ = 210.1, 140.4, 134.4, 134.0, 133.6, 131.4, 129.0, 128.9, 128.2, 
126.3, 126.2, 125.0, 120.9, 45.4, 38.6, 30.3 ppm. 
MS (EI) m/z (%): 252 (100), 210 (61). 
HRMS (EI) m/z calculated for C16H12OSNa (M+Na
+) 275.050105, found 275.050258. 
 
7,8-Dihydrobenzo[g]chrysen-9(10H)-one (114c) 
 
Purification: hexane:EtOAc (4:1), colourless solid, 124 mg, 26% yield. 
1H NMR (500 MHz, CD2Cl2) δ = 8.62-8.55 (m, 3 H), 8.49 (d, J = 8.3 Hz, 1H), 8.17 (d, J = 8.2 Hz, 
1H), 7.67-7.62 (m, 3H), 7.59-7.54 (m, 2H), 4.36 (s, 2H), 3.32 (t, J = 7.0 Hz, 2H), 2.50 (t, J = 7.0 
Hz, 2H) ppm. 
13C‐NMR (125 MHz, CDCl3) δ = 210.7, 137.2, 131.3, 130.0, 129.93, 129.90, 129.8, 129.7, 
129.0, 128.9, 127.5, 127.2, 127.1, 126.6, 125.6, 123.5, 123.2, 123.1, 121.2, 47.0, 37.0, 29.2 
ppm. 
MS (EI) m/z (%): 296 (100), 279 (20), 252 (43), 239 (33). 
HRMS (EI) m/z calculated for C22H16O (M
+) 296.120114, found 296.120389. 
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5,7-Diphenyl-1,2-dihydrophenanthren-3(4H)-one (114e) 
 
Purification: hexane:EtOAc (9:1), colourless solid, 79 mg, 23% yield. 
1H NMR (500 MHz, CDCl3) δ = 8.06 (s, 1H), 7.86 (d, J = 8.0 Hz, 1H), 7.75 (d, J = 7.6 Hz, 2H), 
7.65 (s, 1H), 7.49-7.44 (m, 5H), 7.41-7.37 (m, 4H), 3.22 (s, 2H), 3.20 (t, J = 6.6 Hz, 2H) 2.49 (t, J 
= 6.5 Hz, 2H) ppm. 
13C‐NMR (125 MHz, CDCl3) δ = 210.5, 144.5, 140.1, 139.8, 136.7, 135.9, 134.4, 130.0, 129.42, 
129.37, 129.1, 128.9, 128.4, 128.3, 127.5, 127.4, 127.2, 127.1, 126.3, 45.7, 37.4, 29.8 ppm.  
MS (EI) m/z (%): 348 (100), 305 (18), 291 (27). 
HRMS (EI) m/z calculated for C26H20O (M
+) 348.151648, found 348.151412. 
 
 Enantioselective Synthesis of Azahelicenes 7.3.3.
 
General procedure for the asymmetric synthesis of azahelicenes: 
 
A reaction vial was charged with catalyst (S)-19c (1.79 mg, 0.0025 mmol), Amberlite® CG50 
(25 mg), the corresponding hydrazine 113 (0.05 mmol) and the appropriate ketone 114 
(0.05 mmol). CH2Cl2 (0.1 M) was added and the mixture was stirred for 3 d at –7 °C. The 
crude reaction mixture was directly submitted to column chromatography on SiO2. 
 
General procedure for the racemate synthesis: 
 
The racemates were prepared using a stoichiometric amount of diphenyl phosphate with 
respect to the hydrazine 113 and the ketone 114. The reaction was performed at room 
temperature for 4 h. The crude reaction mixture was directly submitted to column 
chromatography on SiO2.  
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(M)-7-(4-Iodobenzyl)-9,11-dimethyl-6,7-dihydro-5H-phenanthro[3,4-c]carbazole (115a) 
 
Purification: hexane:MTBE (19:1), yellow solid, 20.8 mg, 74% yield. 
95.5:4.5 er,   25D  −454.2 (c = 0.38, CH2Cl2). 
1H NMR (500 MHz, CD2Cl2) δ = 8.35 (d, J = 8.5 Hz, 1H), 7.77 (d, J = 7.8 Hz, 1H), 7.67 (d, J = 
8.3 Hz, 2H), 7.65-7.59 (m, 2H), 7.60 (d, J = 7.7 Hz, 1H), 7.50 (d, J = 7.7 Hz, 1H), 7.38 (t, J = 7.4 
Hz, 1H), 6.93-6.86 (m, 4H), 6.38 (s, 1H), 5.42 (d, J = 17.3 Hz, 1H), 5.37 (d, J = 17.1 Hz, 1H), 
2.99-2.84 (m, 4H), 2.31 (s, 3H), 1.17 (s, 3H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 139.9, 137.9, 137.84, 137.81, 136.8, 132.6, 132.3, 131.5, 
131.11, 131.06, 128.3, 128.1, 127.3, 126.9, 126.6, 126.1, 126.1, 125.7, 124.9, 124.2, 123.8, 
123.8, 114.4, 106.9, 92.5, 46.3, 31.7, 21.2, 21.1, 19.4 ppm. 
MS (EI) m/z (%): 563 (100), 346 (39), 217 (5). 
HRMS (ESI) m/z calculated for C33H26NINa (M+Na
+) 586.100213, found 586.100602.  
HPLC: Chiralcel OD‐RH column, MeCN/H2O = 80/20, 1.0 mL/min, λ = 196 nm, τmaj = 20.5 min, 
τmin = 23.2 min. 
 
(M)-7-Benzyl-9,11-dimethyl-6,7-dihydro-5H-phenanthro[3,4-c]carbazole (115b) 
 
This reaction was conducted on a 0.02 mmol scale. 
Purification: hexane:MTBE (19:1), 3.5 mg, 40% yield. 
87.5:12.5 er. 
1H NMR (500 MHz, CD2Cl2) δ = 8.37 (d, J = 8.5 Hz, 1H), 7.76 (d, J = 7.8 Hz, 1H), 7.65 (d, J = 8.8 
Hz, 1H), 7.62 (d, J = 8.8 Hz, 1H), 7.59 (d, J = 7.7 Hz, 1H), 7.50 (d, J = 7.7 Hz, 1H), 7.39-7.33 (m, 
3H), 7.29-7.26 (m, 1H), 7.13 (d, J = 7.4 Hz, 2H), 6.94-6.92 (m, 2H), 6.37 (s, 1H), 5.49 (d, J = 
17.1 Hz, 1H), 5.44 (d, J = 17.1Hz, 1H), 3.01-32.90 (m, 4H), 2.31 (s, 3H), 1.17 (s, 3H) ppm. 
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13C‐NMR (125 MHz, CD2Cl2) δ = 140.2, 138.0, 137.9, 136.9, 132.6, 132.34, 132.30, 131.6, 
131.0, 130.9, 128.9, 128.3, 127.4, 127.3, 126.9, 126.6, 126.1, 126.07, 126.01, 125.6, 124.8, 
124.2, 123.73, 123.67, 114.2, 107.0, 46.7, 31.7, 21.3, 21.2, 19.5 ppm. 
MS (EI) m/z (%): 437 (100), 346 (29), 91 (7). 
HRMS (EI) m/z calculated for C33H27NNa (M+Na
+) 460.203570, found 460.203745. 
HPLC: Chiralcel OD‐3R column, MeCN/H2O = 80:20, 1.0 mL/min, λ = 237 nm, τmaj = 11.8 min, 
τmin = 13.0 min. 
 
(M)-7-(4-(tert-Butyl)benzyl)-9,11-dimethyl-6,7-dihydro-5H-phenanthro[3,4-c]carbazole 
(115c) 
 
This reaction was conducted on a 0.02 mmol scale. 
Purification: hexane: EtOAc (15:1), yellow solid, 6.4 mg, 65% yield. 
87.5:12.5 er. 
1H NMR (500 MHz, CD2Cl2) δ = 8.37 (d, J = 8.5 Hz, 1H), 7.76 (d, J = 7.8 Hz, 1H), 7.65 (d, J = 8.8 
Hz, 1H), 7.62 (d, J = 8.8 Hz, 1H), 7.59 (d, J = 7.7 Hz, 1H), 7.50 (d, J = 7.7 Hz, 1H), 7.39-7.35 (m, 
3H), 7.06 (d, J = 8.2 Hz, 2H), 6.94-6.90 (m, 2H), 6.36 (s, 1H), 5.46 (d, J = 17.0 Hz, 1H), 5.40 (d, J 
= 17.0 Hz, 1H), 2.99-2.94 (m, 4H), 2.31 (s, 3H), 1.29 (s, 9H), 1.17 (s, 3H) ppm. 
13C‐NMR (125 MHz, CD2Cl2) δ = 150.8, 140.6, 138.2, 137.2, 135.3, 132.9, 132.7, 132.6, 132.0, 
131.3, 131.2, 128.6, 127.6, 127.2, 126.9, 126.5, 126.4, 126.2, 126.0, 125.9, 125.8, 125.1, 
124.5, 124.1, 124.0, 114.4, 107.4, 46.7, 32.1, 31.5, 21.6, 21.5, 19.8 ppm. 
MS (EI) m/z (%): 493 (100), 346 (35), 147 (4). 
HRMS (ESI) m/z calculated for C37H35NNa (M+Na
+) 516.266171, found 516.265858. 
HPLC: Chiralcel OD‐3 column, iPrOH/heptane = 99:1, 1.0 mL/min, λ = 254 nm, τmin = 6.26 min, 
τmaj = 7.39 min. 
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(M)-7-(4-(tert-Butyl)benzyl)-9,11-dimethyl-6,7-dihydro-5H-phenanthro[3,4-c]carbazole 
(115d) 
 
This reaction was conducted on a 0.02 mmol scale. 
Purification: hexane: EtOAc (8:1), yellow solid, 6.9 mg, 68% yield. 
93:7 er. 
1H NMR (500 MHz, CD2Cl2) δ = 8.34 (d, J = 8.5 Hz, 1H), 7.77 (d, J = 7.8 Hz, 1H), 7.67-7.60 (m, 
5H), 7.50 (d, J = 7.7 Hz, 1H), 7.38 (t, J = 7.3 Hz, 1H), 7.24 (d, J = 8.0 Hz, 2H), 6.92 (t, J = 7.3 Hz, 
1H), 6.89 (s, 1H), 6.39 (s, 1H), 5.55 (d, J = 17.5 Hz, 1H), 5.50 (d, J = 17.5 Hz, 1H), 3.00-2.84 (m, 
4H), 2.31 (s, 3H), 1.18 (s, 3H) ppm. 
13C‐NMR (125 MHz, CD2Cl2) δ = 142.6, 140.2, 138.1, 137.2, 132.9, 132.7, 132.6, 131.8, 131.5, 
131.4, 128.7, 127.7, 127.2, 126.9, 126.8, 126.5, 126.2, 126.1, 126.0, 125.3, 124.6, 124.2, 
124.1, 114.9, 107.2, 46.7, 32.1, 21.6, 21.5, 19.8 ppm. 
MS (EI) m/z (%): 505 (100), 346 (24), 159 (4). 
HRMS (ESI) m/z calculated for C34H26NF3Na (M+Na
+) 528.190956, found 528.191223. 
HPLC: Chiralcel OD‐3 column, iPrOH:heptane = 99.5:0.5, 1.0 mL/min, λ = 235 nm, τmin = 17.8 
min, τmaj = 21.0 min. 
 
(M)-7-(3,5-Bis(trifluoromethyl)benzyl)-9,11-dimethyl-6,7-dihydro-5H-phenanthro[3,4-
c]carbazole (115e) 
 
This reaction was conducted on a 0.02 mmol scale. 
Purification: hexane: EtOAc (8:1), yellow solid, 6.9 mg, 60% yield. 
77.5:22.5 er. 
1H NMR (500 MHz, CDCl3) δ = 8.34 (d, J = 8.5 Hz, 1H), 7.81 (s, 1H), 7.76 (d, J = 7.8 Hz, 1H), 
7.64 (d, J = 2.5 Hz, 2H), 7.61 (d, J = 7.8 Hz, 1H), 7.54 (s, 2H), 7.48 (d, J = 7.7 Hz, 1H), 7.38 (t, J = 
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7.3 Hz, 1H), 6.94 (t, J = 7.5 Hz, 1H), 6.81 (s, 1H), 6.43 (s, 1H), 5.59 (d, J = 17.5 Hz, 1H), 5.51 (d, 
J = 17.5 Hz, 1H), 3.01-2.79 (m, 4H), 2.33 (s, 3H), 1.22 (s, 3H) ppm.  
13C‐NMR (100 MHz, CD2Cl2) δ = 141.5, 139.5, 139.2, 137.9, 137.2, 132.9, 132.7, 132.6, 132.5, 
132.3, 131.9, 131.7, 131.6, 128.8, 127.7, 127.2, 126.9, 126.54, 126.45, 126.1, 125.4, 125.0, 
124.6, 124.2, 122.0, 115.7, 107.0, 46.2, 32.0, 21.6, 21.4, 19.8 ppm. 
MS (EI) m/z (%): 573 (100), 346 (20), 227 (4). 
HRMS (EI) m/z calculated for C35H25NF6Na (M+Na
+) 596.178336, found 596.178695. 
HPLC: Chiralcel OD‐3 column, iPrOH/heptane = 99:1, 1.0 mL/min, λ = 254 nm, τmaj = 11.3 min, 
τmin = 14.3 min. 
 
(M)-7-(4-Iodobenzyl)-9,11-dimethyl-6,7-dihydro-5H-thieno[2´,3´:7,8]naphtho[2,1-
c]carbazole (115f) 
 
Purification: hexane:CH2Cl2 (9:1), 18.8 mg, 66% yield. 
96:4 er,   25D  −528.5 (c = 0.41, CH2Cl2). 
1H NMR (500 MHz, CD2Cl2) δ = 7.81 (d, J = 8.7 Hz, 1H), 7.70-7.68 (m, 2H), 7.66 (d, J = 8.4 Hz, 
2H), 7.55 (d, J = 5.5 Hz, 1H), 7.46 (d, J = 8.0 Hz, 1H), 7.10 (d, J = 5.5 Hz, 1H), 6.92 (s, 1H), 6.87 
(d, J = 8.3 Hz, 2H), 6.51 (s, 1H), 5.42 (d, J = 17.7 Hz, 1H), 5.36 (d, J = 17.2 Hz, 1H), 2.96-2.93 
(m, 2H), 2.86-2.81 (m, 2H), 2.35 (s, 3H), 1.45 (s, 3H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 140.4, 138.0, 137.8, 137.6, 137.4, 136.5, 136.1, 131.9, 
131.05, 130.94, 130.7, 128.1, 128.0, 126.1, 125.2, 125.1, 124.7, 124.1, 122.6, 119.9, 113.5, 
107.0, 92.6, 46.3, 32.0, 21.3, 21.2, 19.6 ppm. 
MS (EI) m/z (%): 569 (100), 352 (20), 217 (6). 
HRMS (EI) m/z calculated for C31H24NISNa (M+Na
+) 592.056638, found 592.056951. 
HPLC: Chiralpak AD-3R column, MeCN/H2O = 65:35, 1 mL/min, λ = 254 nm, τmin = 40.8 min, 
τmaj = 46.5 min. 
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(M)-9-(4-Iodobenzyl)-11,13-dimethyl-8,9-dihydro-7H-triphenyleno[2,1-c]carbazole (115g) 
 
Purification: hexane:MTBE (19:1), 30.0 mg, 98% yield. 
96:4 er,   25D  −574.4 (c = 0.50, CH2Cl2). 
1H NMR (500 MHz, CD2Cl2) δ = 8.49 (d, J = 7.6 Hz, 1H), 8.46 (d, J = 7.7 Hz, 1H), 8.38 (d, J = 8.2 
Hz, 1H), 8.22 (d, J = 7.9 Hz, 1H), 8.10 (d, J = 8.4 Hz, 1H), 7.59-7.53 (m, 4H), 7.46 (d, J = 8.0 Hz, 
1H), 7.32 (t, J = 7.5 Hz, 1H), 6.82-6.77 (m, 4H), 6.28 (s, 1H), 5.33 (d, J = 17.3 Hz, 1H), 5.29 (d, J 
= 17.3 Hz, 1H), 2.93-2.79 (m, 4H), 2.21 (s, 3H), 1.24 (s, 3H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 140.2, 138.3, 138.2, 138.1, 137.6, 132.5, 132.1, 131.5, 131.4, 
130.8, 130.5, 130.30, 129.99, 128.4, 128.3, 127.7, 127.6, 127.1, 126.7, 126.6, 125.4, 124.1, 
123.9, 123.7, 123.5, 123.1, 119.5, 114.9, 107.2, 92.9, 46.6, 31.7, 21.6, 21.5, 19.7 ppm. 
MS (EI) m/z (%): 613 (100), 396 (27), 217 (4). 
HRMS (EI) m/z calculated for C37H28NINa (M+Na
+) 636.115865, found 636.115964. 
HPLC: Chiralcel OD‐RH column, MeCN/H2O = 95:5, 1.0 mL/min, λ = 235 nm, τmaj = 10.2 min, 
τmin = 29.4 min. 
 
(M)-9-(4-Iodobenzyl)-11,13-dimethyl-1,3-diphenyl-8,9-dihydro-7H-naphtho[2,1-c]carbazole 
(115h) 
 
Purification: hexane:EtOAc (19:1), 30.1 mg, 91% yield. 
83.5:16.5 er. 
1H NMR (500 MHz, CD2Cl2) δ = 8.02 (d, J = 1.9 Hz, 1H), 7.83-7.80 (m, 2H), 7.75 (d, J = 8.0 Hz, 
1H), 7.72-7.70 (m, 2H), 7.60 (d, J = 2.0 Hz, 1H), 7.51-7.48 (m, 4H), 7.40-7.36 (m, 1H), 6.88 (d, J 
= 8.4 Hz, 2H), 6.76-6.69 (m, 2H), 6.59 (b, s, 1H), 6.51 (s, 1H), 6.47 (b, 1H), 6.39 (s, 1H), 5.18 (d, 
J = 16.9 Hz, 1H), 5.08 (d, J = 16.9 Hz, 1H), 2.97-2.67 (m, 4H), 2.25 (s, 3H), 1.87 (s, 3H) ppm. 
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13C‐NMR (125 MHz, CD2Cl2) δ = 142.3, 142.1, 141.0, 138.3, 138.2, 138.0, 137.8, 137.0, 135.8, 
135.7, 132.2, 130.7, 130.6, 129.2, 129.1, 129.0, 128.1, 127.74, 127.65, 127.4, 127.2, 126.6, 
125.8, 125.5, 125.4, 124.8, 123.4, 115.4, 106.1, 92.9, 46.4, 31.7, 21.53, 21.48, 20.7 ppm. 
MS (EI) m/z (%): 665 (100), 448 (17), 217 (7). 
HRMS (EI) m/z calculated for C41H32INNa (M+Na
+) 688.147167, found 688.147838 
HPLC: Chiralcel OD-3R column, MeCN/H2O = 90:10, 1 mL/min, λ = 236 nm, τmin = 11.0 min, 
τmaj = 9.66 min. 
 
(M)-7-(4-Iodobenzyl-6,7-dihydro-5H-benzo[c]phenanthro[4,3-g]carbazole (115i) 
 
Purification: hexane:MTBE (19:1), 19.8 mg, 56% yield. 
89.5:10.5 er,   25D −536.7 (c = 0.36, CH2Cl2). 
1H NMR (500 MHz, CD2Cl2) δ = 8.29 (d, J =8.5 Hz, 1H), 7.76-7.59 (m, 8H), 7.49 (d, J = 8.9 Hz, 
1H), 7.46 (d, J = 8.8 Hz, 1H), 7.08 (t, J = 7.4 Hz, 1H), 6.98 (t, J = 7.4 Hz, 1H), 6.92 (d, J = 8.5 Hz, 
1H), 6.85 (d, J = 8.1 Hz, 2H), 6.48-6.44 (m, 2H), 5.59 (d, J = 17.7 Hz, 2H), 5.55 (d, J = 17.8 Hz, 
2H), 3.09-2.95 (m, 4H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 138.9, 138.0, 137.6, 137.5, 133.2, 132.6, 132.4, 131.8, 131.2, 
129.4, 128.5, 128.0, 127.8, 127.4, 127.2, 127.0, 126.5, 126.4, 125.82, 125.77, 125.6, 124.4, 
123.8, 123.6, 122.65, 122.59, 119.9, 116.0, 110.9, 92.7, 46.6, 31.9, 21.2 ppm.  
MS (EI) m/z (%): 585 (100), 368 (63), 217 (9). 
HRMS (EI) m/z calculated for C35H24NINa (M+Na
+) 608.084564, found 608.084892. 
HPLC: Chiralcel OD‐RH column, MeCN/H2O = 80:20, 1.0 mL/min, λ = 237 nm, τmin = 19.3 min, 
τmaj = 16.5 min. 
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(M)-9-(4-Iodobenzyl)-8,9-dihydro-7H-benzo[c]triphenyleno[1,2-g]carbazole (115j) 
 
The reaction was conducted on a 0.05 mmol scale. 
Purification: hexane:CH2Cl2 (9:1), 9.7 mg, 61% yield. 
90:10 er,   25D  −789.9 (c = 0.44, CH2Cl2). 
1H NMR (500 MHz, CD2Cl2) δ = 8.64-8.60 (m, 2H), 8.42 (d, J = 8.1 Hz, 1H), 8.32 (d, J = 8.1 Hz, 
1H), 8.14 (d, J = 8.3 Hz, 1H), 7.71-7.70 (m, 2H), 7.66 (d, J = 8.5 Hz, 2H), 7.64 (d, J = 8.1 Hz, 1H), 
7.60 (d, J = 8.0 Hz, 1H), 7.48 (d, J = 8.9 Hz, 1H), 7.46 (d, J = 8.9 Hz, 1H), 7.13 (d, J = 8.4 Hz, 1H), 
7.10 (t, J = 7.5 Hz, 1H), 6.99 (t, J = 7.4 Hz, 1H), 6.86 (d, J = 8.3 Hz, 2H), 6.51-6.45 (m, 2H), 5.62 
(d, J = 17.7 Hz, 1H), 5.58 (d, J = 17.7 Hz, 1H), 3.14-2.98 (m, 4H) ppm. 
13C‐NMR (125 MHz, CD2Cl2) δ = 138.8, 138.0, 137.8, 137.6, 133.4, 131.7, 131.5, 130.6, 130.3, 
130.2, 129.9, 129.3, 128.4, 128.0, 127.8, 127.3, 127.3, 127.0, 126.7, 126.4, 126.2, 124.5, 
124.1, 123.8, 123.5, 123.3, 122.8, 122.64, 122.60, 119.6, 119.5, 116.1, 110.8, 92.7, 46.6, 
31.4, 21.3 ppm. 
MS (EI) m/z (%): 635 (100), 418 (43), 217 (5). 
HRMS (EI) m/z calculated for C39H26INNa (M+Na
+) 658.100216, found 658.100460. 
HPLC: Chiralcel OD-RH column, MeCN/H2O = 95:5, 1.0 mL/min, λ = 254 nm, τmaj = 9.70 min, 
τmin = 38.2 min. 
 
(M)-7-(4-Iodobenzyl)-8,9-dihydro-7H-benzo[c]thieno[2´,3´:7,8]naphtho[1,2-g]carbazole 
(115k) 
 
Purification: hexane:CH2Cl2 (9:1), 16.0 mg, 54% yield. 
12.5:87.5 er,   25D  −546.7 (c = 0.28, CH2Cl2). 
1H NMR (500 MHz, CD2Cl2) δ = 7.89 (d, J = 8.7 Hz, 1H), 7.81 (t, J = 8.1 Hz, 2H), 7.72 (d, J = 8.1 
Hz, 1H), 7.66 (d, J = 8.3 Hz, 2H), 7.56-7.50 (m, 3H), 7.37 (d, J = 5.5 Hz, 1H), 7.14 (d, J = 8.5 Hz, 
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1H), 7.09 (t, J = 7.4 Hz, 1H), 6.87 (d, J = 8.2 Hz, 2H), 6.64 (d, J = 5.7 Hz, 1H), 6.61 (d, J = 7.9 Hz, 
1H), 5.60 (d, J = 17.2 Hz, 1H), 5.55 (d, J = 17.3 Hz, 1H), 3.06-2.94 (m, 4H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 139.7, 138.4, 138.3, 137.9, 137.2, 136.2, 133.4, 132.2, 130.8, 
129.9, 129.0, 128.4, 127.9, 127.6, 126.5, 126.3, 125.74, 125.69, 124.9, 124.0, 123.2, 122.9, 
122.4, 121.2, 120.6, 115.4, 111.4, 93.1, 47.0, 32.5, 21.6 ppm. 
MS (EI) m/z (%): 591 (100), 374 (56), 217 (9). 
HRMS (EI) m/z calculated for C33H22NISNa (M+Na
+) 614.040986, found 614.041543. 
HPLC: Chiralpak AD-3R column, MeCN/H2O = 70:30, 1 mL/min, λ = 366 nm, τmin = 25.9 min, 
τmaj = 31.5 min. 
 
(M)-9-(4-Iodobenzyl)-1,3-diphenyl-8,9-dihydro-7H-benzo[c]naphtho[1,2-g]carbazole (115l) 
 
Purification: hexane:EtOAc (19:1), 25.9 mg, 75% yield. 
76:24 er,   25D  −185.3 (c = 0.15, CH2Cl2). 
1H NMR (500 MHz, CD2Cl2) δ = 8.03 (d, J = 1.6 Hz, 1H), 7.77 (d, J = 8.0 Hz, 1H), 7.72 (d, J = 7.3 
Hz, 2H), 7.62 (d, J = 7.5 Hz, 1H), 7.61 (d, J = 8.3 Hz, 2H), 7.50 (d, J = 8.0 Hz, 1H), 7.41 (t, J = 7.7 
Hz, 2H), 7.32 (d, J = 1.8 Hz, 1H), 7.30 (t, J = 7.4 Hz, 1H), 7.20 (d, J = 8.8 Hz, 1H), 7.15 (d, J = 7.1 
Hz, 1H), 7.12 (d, J = 7.9 Hz, 1H), 6.99 (d, J = 8.8 Hz, 1H), 6.85 (t, J = 7.3 Hz, 1H), 6.77 (d, J = 8.3 
Hz, 2H), 6.47 (t, J = 7.4 Hz, 2H), 6.32 (b, s, 1H), 6.23 (b, s, 1H), 6.05 (b, s, 1H), 5.28 (d, J = 17.0 
Hz, 1H), 5.16 (d, J = 17.0 Hz, 1H), 2.99-2.72 (m, 4H) ppm. 
13C‐NMR (125 MHz, CD2Cl2) δ = 142.3, 142.0, 141.2, 138.1, 138.0, 137.3, 137.1, 136.5, 135.6, 
133.2, 131.7, 129.8, 129.5, 129.2, 129.0, 127.9, 127.8, 127.7, 127.6, 126.9, 126.2, 125.6, 
125.4, 124.8, 124.1, 123.0, 121.8, 121.4, 116.6, 110.4, 93.1, 46.7, 31.9, 21.5 ppm. 
MS (EI) m/z (%): 687 (100), 470 (18), 217 (5). 
HRMS (EI) m/z calculated for C43H30INNa (M+Na
+) 710.131514, found 710.130804. 
HPLC: Chiralcel OD-3R column, MeCN/H2O = 85:15, 1 mL/min, λ = 254 nm, τmaj = 26.7 min, 
τmin = 29.2 min. 
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(M)-7-(4-Iodobenzyl)-13-(trimethylsilyl)-6,7-dihydro-5H-benzo[c]phenanthro[4,3-
g]carbazole (115m) 
 
This reaction was conducted on a 0.02 mmol scale. 
Purification: Aluminium oxide neutral, hexane:EtOAc (10:1), 5.2 mg, 40% yield. 
12.5:87.5 er,   25D  −400.9 (c = 0.23, CH2Cl2). 
1H NMR (600 MHz, CD2Cl2) δ =8.35 (d, J = 8.5 Hz, 1H), 7.76 (d, J = 8.7 Hz, 1H), 7.73 (d, J = 7.7 
Hz, 1H), 7.68 (d, J = 8.8 Hz, 1H), 7.66-7.62 (m, 4H), 7.61 (d, J = 7.7 Hz, 1H), 7.49 (s, 2H), 7.32 
(s, 1H), 7.15 (d, J = 8.0 Hz, 1H), 7.09 (t, J = 7.3 Hz, 1H), 6.85 (d, J = 8.3 Hz, 2H), 6.47 (t, J =7.7 
Hz, 1H), 5.61 (d, J = 17.9 Hz, 1H), 5.58 (d, J = 18.0 Hz, 1H), 3.09-2.96 (m, 4H), −0.22 (s, 9H) 
ppm. 
13C NMR (150 MHz, CD2Cl2) δ =139.7, 138.3, 138.0, 137.9, 135.6, 133.7, 133.2, 132.7, 132.0, 
131.7, 130.0, 129.8, 128.5, 128.3, 128.1, 127.9, 127.7, 127.4, 127.3, 126.9, 126.7, 126.14, 
126.11, 126.0, 124.1, 122.8, 120.7, 116.2, 111.5, 93.0, 47.0, 32.5, 21.6, -1.55 ppm. 
MS (EI) m/z (%): 657 (100), 530 (5), 440 (16), 366 (13), 217 (9). 
HRMS (ESI) m/z calculated for C38H32NISiNa (M+Na
+) 680.124093, found 680.124131. 
HPLC: Chiralcel OD-3R column, MeCN/H2O = 85:15, 1 mL/min, λ = 236 nm, τmin = 18.0 min, 
τmaj = 15.5 min. 
 
(M)-7-(4-Iodobenzyl)-9,11-diphenyl-6,7-dihydro-5H-phenanthro[3,4-c]carbazole (115n) 
 
This reaction was conducted on a 0.03 mmol scale. 
Purification: hexane: EtOAc (5:1), yellow solid. 
88:12 er. 
MS (EI) m/z (%): 687 (100), 560 (6), 470 (45), 392 (10). 
HRMS (ESI) m/z calculated for C43H30NINa (M+Na
+) 710.131518, found 710.131922. 
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HPLC: Chiralpak OD-3R column, MeCN/H2O = 85:15, 1 mL/min, λ = 254 nm, τmaj = 22.4 min, 
τmin. = 32.5 min. 
Due to stability and purification problems of compound 115n, no full characterization was 
possible and no reliable yield can be given. 
 
(P)-7-Benzyl-7,12-dihydrobenzo[c]benzo[5,6]carbazolo[4,3-g]carbazole (165a) 
 
A reaction vial was charged with catalyst (S)-19e (4.29 mg, 0.006 mmol), Amberlite® CG50 
(30 mg), hydrazine 158a (11.1 mg, 0.03 mmol) and β-tetralone 164 (8.77 mg, 0.06 mmol). 
CH2Cl2 (0.1 M) was added and the mixture was stirred for 7 d at −7 °C. The crude reaction 
mixture was directly filtered over SiO2 (CH2Cl2). After removing the solvent under reduced 
pressure, chloranil (110 mg, 0.45 mmol) and CHCl3 (3 mL) were added to the residue. The 
reaction mixture was stirred at 50 °C for 10 h after which it was diluted with CH2Cl2 and 
extracted with aq. NaOH (2 M). The combined organic layers were washed with H2O, brine 
and dried over Na2SO4. The solvent was removed under reduced pressure and the residue 
was submitted to column chromatography on SiO2.  
 
The racemate was prepared using each two equivalents of diphenyl phosphate and of β -
tetralone 164 with respect to the hydrazine 158a and CG50 (0.5 g/1 mmol). The reaction was 
performed in CH2Cl2 at rt for 1 d. After removing the solvent under reduced pressure, 
chloranil (10 equiv.) and CHCl3 (0.01 M) were added to the residue. The reaction mixture was 
stirred at 50 °C for 10 h after which it was diluted with CH2Cl2 and extracted with aq. NaOH 
(2 M). The solvent was removed under reduced pressure and the residue was submitted to 
column chromatography on SiO2 resulting in a mixture of the double (56%) and the mono-
benzylated compound (39%).  
 
Purification: hexane:EtOAc (6:1), 6.4 mg, 43% yield. 
4:96 er,   25D  +535.2 (c = 0.15, CH2Cl2). 
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1H NMR (300 MHz, CD2Cl2) δ = 9.12 (s, 1H), 8.14 (d, J = 8.1 Hz, 2H), 7.89 (d, J = 8.5 Hz, 1H), 
7.85 (d, J = 7.2 Hz, 1H), 7.82 (d, J = 7.2 Hz, 1H), 7.81-7.72 (m, 3H), 7.49 (d, J = 3.2 Hz, 1H), 7.47 
(d, J = 3.2 Hz, 1H), 7.32-7.25 (m, 3H), 7.20-7.10 (m, 4H), 6.81 (t, J = 7.5 Hz, 2H), 6.26 (d, J = 7.2 
Hz, 1H), 6.21 (d, J = 7.2 Hz, 1H), 6.02 (s, 2H) ppm. 
13C NMR (100 MHz, CD2Cl2) δ = 139.0, 138.1, 137.9, 136.5, 135.4, 130.0, 129.2, 129.0, 128.9, 
127.9, 127.1, 126.88, 126.85, 126.63, 126.59, 126.2, 125.1, 125.0, 124.3, 122.8, 122.6, 122.4, 
122.3, 120.9, 120.7, 117.2, 117.0, 112.4, 110.8, 109.9, 108.2, 47.3 ppm. 
MS (EI) m/z (%): 496 (100), 404 (25). 
HRMS (ESI) m/z calculated for C37H24N2Na (M+Na
+) 519.183169, found 519.183398. 
HPLC: Chiralpak OD-3R column, MeCN/H2O = 80:20, 1 mL/min, λ = 254 nm, τmin = 17.1 min, 
τmaj = 19.0 min. 
 
 Transformations of Azahelicenes 7.3.4.
 
Oxidation of dihydroazahelicene 115a 
 
A reaction vial was charged with dihydroazahelicene (P)-115a (1 equiv.), chloranil (5 equiv.) 
and DPP (1 equiv.). CHCl3 (0.01 M) was added and the mixture was stirred for 5 h at 50 °C. 
The reaction mixture was diluted with CH2Cl2 and extracted with aq. NaOH (2 M). The 
combined organic layers were washed with H2O, brine and dried over Na2SO4. The solvent 
was removed under reduced pressure and the residue was submitted to column 
chromatography on SiO2.  
 
(P)-7-(4-Iodobenzyl)-9,11-dimethyl-7H-phenanthro[3,4-c]carbazole (168) 
 
Purification: hexane: EtOAc (10:1), yellow solid, 21.3 mg, 76% yield. 
98.7:1.3 er (after crystallization),   25D  +1162, (c = 0.16, CH2Cl2). 
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1H NMR (500 MHz, CD2Cl2) δ = 8.10 (d, J = 8.5 Hz, 1H), 7.99-7.94 (m, 5H), 7.81 (d, J = 8.3 Hz, 
1H), 7.71 (d, J = 8.5 Hz, 1H), 7.63 (d, J = 8.3 Hz, 2H), 7.47 (t, J = 7.3 Hz, 1H), 7.09 (s, 1H), 7.01 
(t, J = 7.3 Hz, 1H), 6.95 (d, J = 8.3 Hz, 2H), 6.51 (s, 1H), 5.67 (d, J = 17.5 Hz, 1H), 5.63 (d, J = 
17.5 Hz, 1H), 2.43 (s, 3H), 1.06 (s, 3H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 140.9, 140.7, 138.3, 137.6, 135.5, 135.1, 132.0, 131.9, 131.6, 
128.8, 128.8, 128.1, 128.0, 127.8, 127.3, 126.7, 126.6, 126.2, 125.8, 125.5, 124.9, 124.2, 
123.7, 123.3, 118.8, 110.1, 106.2, 92.9, 46.6, 21.9, 21.5 ppm. 
MS (EI) m/z (%): 561 (100), 344 (16), 329 (34), 217 (5). 
HRMS (ESI) m/z calculated for C33H24NI (M
+) 561.095342, found 561.095289. 
HPLC: Chiralpak OD-3R column, MeCN/H2O = 85:15, 0.5 mL/min, λ = 335 nm, τmin = 31.4 min, 
τmaj = 33.5 min. 
 
Protection of bisazahelicene 165a 
 
Azahelicene 165a (1 equiv.) was dissolved in anhydrous DMF (0.01 M) and NaH (60% 
dispersion in mineral oil, 10 equiv.) was added slowly at 0 °C. The mixture was stirred for 
30 min at room temperature after which the corresponding benzyl bromide (1.4 equiv.) was 
added dropwise. After stirring the reaction for 1 h at rt, H2O was added slowly at 0 °C. The 
aqueous layer was extracted with CH2Cl2 and the combined organic layers were washed with 
H2O, brine and dried over Na2SO4. The crude product was purified by flash chromatography 
on SiO2. 
 
(P)-7,12-Dibenzyl-7,12-dihydrobenzo[c]benzo[5,6]carbazolo[4,3-g]carbazole (165b) 
 
The reaction was conducted on a 0.018 mmol scale. 
  25D  +382.6 (c = 1.0, CH2Cl2). 
Purification: hexane: EtOAc (7:1), yellow solid, 9.4 mg, 89% yield. 
1H NMR (600 MHz, CD2Cl2) δ = 8.15 (d, J = 8.6 Hz, 2H), 7.85 (d, J = 8.5 Hz, 2H), 7.77 (d, J = 8.8 
Hz, 2H), 7.73 (d, J = 8.8 Hz, 2H), 7.47 (d, J = 7.9 Hz, 2H), 7.31-7.17 (m, 10H), 7.09 (d, J = 8.4 Hz, 
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2H), 6.82-6.80 (m, 2H), 6.24-6.21 (m, 2H), 6.04 (d, J = 18.3 Hz, 2H), 6.01 (d, J = 18.1 Hz, 2H) 
ppm. 
13C NMR (150 MHz, CD2Cl2) δ = 139.0, 138.1, 136.5, 129.8, 129.2, 128.9, 127.9, 127.1, 126.8, 
126.58, 126.57, 126.1, 124.9, 124.2, 122.6, 122.3, 120.6, 116.9, 110.8, 108.2, 47.3 ppm. 
HRMS (ESI) m/z calculated for C44H30N2 (M
+) 586.240346, found 586.240590. 
 
(P)-7-Benzyl-12-(4-iodobenzyl)-7,12-dihydrobenzo[c]benzo[5,6]carbazolo[4,3-g]carbazole 
(165c) 
 
The reaction was conducted on a 0.016 mmol scale. 
  25D  +538.0, (c = 0.1, CH2Cl2). 
Purification: hexane: EtOAc (7:1), yellow solid, 10.0 mg, 88% yield. 
1H NMR (300 MHz, CD2Cl2) δ = 8.14 (d, J = 8.4 Hz, 2H), 7.85 (d, J = 8.5 Hz, 1H), 7.80 (d, J = 8.5 
Hz, 1H), 7.77 (d, J = 8.8 Hz, 1H), 7.75-7.71 (m, 3H), 7.63-7.61 (m, 2H), 7.47 (d, J = 7.9 Hz, 2H), 
7.31-7.24 (m, 3H), 7.17 (d, J = 7.1 Hz, 2H), 7.07 (t, J = 8.7 Hz, 2H), 6.92 (d, J = 8.6 Hz, 2H), 
6.83-6.80 (m, 2H), 6.25-6.21 (m, 2H), 6.04 (d, J = 18.0 Hz, 1H), 6.01 (d, J = 18.4 Hz, 1H), 5.97 
(d, J = 17.5 Hz, 1H), 5.94 (d, J = 17.4 Hz, 1H) ppm. 
13C NMR (150 MHz, CD2Cl2) δ = 139.0, 138.8, 138.3, 138.1, 137.9, 136.5, 136.3, 129.83, 
129.82, 129.2, 128.91, 128.88, 128.6, 127.9, 127.11, 127.10, 126.9, 126.8, 126.7, 126.62, 
126.58, 126.1, 124.9, 124.8, 124.2, 122.71, 122.65, 122.44, 122.36, 120.7, 120.6, 117.0, 
116.9, 110.8, 110.6, 108.3, 108.0, 93.0, 47.3, 46.9 ppm. 
HRMS (ESI) m/z calculated for C44H29N2I (M
+) 712.136998, found 712.137120. 
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 Investigations of Azahelicenes 7.3.5.
 
 CD Spectroscopy 7.3.5.1.
 
The CD-spectra of (P)-115a (blue line, c = 6.37 x 10-5 M), (P)-168 (red line, c = 8.87 x 10-5 M) 
and (M)-115a (blue dashed line, c = 4.07 x 10-5 M) were recorded in MeOH (HPLC grade) at 
20 °C and compared to the literature known spectra of (+)-(P)-[6]helicene. Remarkably, a 
significant agreement of the CD characteristics between (P)-115a, (blue line) (P)-168 (red 
line) and those reported for (+)-(P)-[6]helicene could be observed.[129-130] As expected, the 
spectra of (M)-115a and (P)-115a, derived from (R)-19c, are inverted (Figure 7.1).  
 
 
Figure 7.1 CD-spectra of (P)-115a (blue line, 6.37 x 10-5 M), (P)-168 (red line,                
8.87 x 10-5 M) and (M)-115a (blue dashed line, 4.07 x 10-5 M) in MeOH. 
The CD-spectra of (P)-166a (red line) was recorded in MeOH (HPLC grade, c = 1.27 x 10-4 M) 
at 20 °C and compared with the corresponding TD-DFT calculated CD spectra (blue line). 
After a UV correction of −2 nm and a correction of the -value of 0.28 eV, the CD 
characteristics of the calculated spectra (blue graph) were in good agreement with the 
experimental spectra (red graph) thus, allowing the assignment of the absolute 
configuration of bisazahelicene 166a which was found to be (P)-configured, using the (S)-
enantiomer of the catalyst (Figure 7.2).  
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Figure 7.2 Calculated (blue line) and experimental (red line) CD spectra of bis-
azahelicene 166a. 
 Thermal Racemization of Azahelicenes 7.3.5.2.
 
Thermal Racemization of (P)-168 
 
Optically enriched (+)-168 (2 mg, 98.7:1.3 er) was dissolved in tetraglyme (2 mL) and 
distributed in 20 vials. The mixtures were heated at 513 K and the racemization was 
followed by HPLC on a chiral stationary phase (Chiralcel OD-3R column, MeCN:H2O 85:15). 
From the corresponding data, half life time (t1/2), inversion constant (ki) and racemisation  
 
entry 
time 
(sec) 
ee (P)-168 
(%) 
entry 
time 
(sec) 
ee (P)-168 
(%) 
1 0 98.7 10 5160 82.3 
2 60 98.6 11 6540 80.5 
3 180 98.6 12 8820 76.4 
4 360 98.1 13 11400 72.9 
5 600 97.7 14 14100 66.0 
6 900 95.6 15 17760 60.8 
7 1320 95.5 16 21780 60.8 
8 2460 90.9 17 26220 55.9 
9 3480 86.4    
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Model: ExpDec1 
R
2
 = 0.99453 
Chi
2
/DoF = 1.27368 
Equation: y = A1*exp(-x/t1)+y0 
 
y0 48.57428 ± 2.37206 
A1 50.51664 ± 2.24055 
t1 13962.31217 ± 1292.546 
 
T: 513 K 
Solvent: Tetraglyme 
t1/2 = 9677.9 s 
ki = 3.58x10
-5
 s
-1
 
 
ΔG
≠
 = 172.2 ± 0.4 KJ/mol 
 
energy were obtained. The resulting data allowed us to calculate the racemization barrier 
(ΔG≠) which was found to be 172.2 ± 0.4 kJmol−1 (Figure 7.3). 
 
 
Figure 7.3 Thermal racemization of (P)-168 in tetraglyme (1 M) at 240 °C. 
 Nonlinear Effect Study 7.3.5.3.
 
 
 
For nonlinear effect studies, stock solutions of (R)- and (S)-19c were prepared and mixed in 
different ratios to get mixtures of approximately 1:1, 3:2, 7:3, 4:1, 9:1 and 1:0 (S:R). Half of 
the solution was used for the reaction, the rest was used for determining the enantiomeric 
excess by HPLC analysis on a chiral stationary phase (Chiralpak AD-3, n-heptane:iPrOH:TFA 
96:4:0.1, 1 mL/min). A stock solution (0.1 M in CH2Cl2) of ketone 113a (1 equiv.) and 
hydrazine 114a (1 equiv.) was distributed into 6 reaction vials, each containing CG50 
(500 mg/mmol). Each vial was charged with the corresponding amount of catalyst stock 
solution (5 mol% of catalyst). The reactions were conducted under the same conditions as 
mentioned above (−7 °C, 3 d, 0.1 M in CH2Cl2). After full conversion, the reactions were 
filtered over silica (CH2Cl2), concentrated and purified by preparative TLC to determine the 
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enantiomeric excess of (M)-115a by HPLC analysis on a chiral stationary phase (OD-3R, 
MeCN:H2O 88:12, 0.5 mL/min) (Table 7.1). 
 
Table 7.1 Enantiomeric excess of different mixtures of catalyst 19c and of the 
corresponding product 115a. 
Entry er 19c (S:R) ee 19c (%) er 115a (M:P) ee 115a (%) 
1 51.2:48.8 2.4 51:49 2 
2 60:40 20 58:42 16 
3 69.1:30.9 38.2 66.4:33.6 32.8 
4 77.6:22.4 55.2 73.7:26.3 47.4 
5 86:14 72 81.2:18.8 62.4 
6 100:0 100 93.5:6.5 87 
 
The enantiomeric excess of the catalyst solutions was plotted against the enantiomeric 
excess of the corresponding product 115a, resulting in a linear graph, indicating that there is 
no nonlinear effect present in our reaction (Figure 7.4). 
 
 
Figure 7.4 Nonlinear effect study of catalytic asymmetric synthesis of azahelicene 115a.  
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 Catalytic Asymmetric Dearomatizing Approach to 1,4-Diketones 7.4.
 
 Synthesis of Hydrazines 7.4.1.
 
General Procedure for the preparation of naphthalen-1-ylhydrazine hydrochlorides: 
 
 
 
Synthesis of aryl bromides: 
Unless otherwise stated, non-commercially available naphthalene derived bromides were 
synthesized via bromination of the corresponding aromatic compound. The naphthalene 
derivative (1 equiv.) was dissolved in MeCN (0.5 M) and N-bromosuccinimide (1.0 equiv.) 
was added portion wise. The solution was stirred at room temperature until full 
consumption of the starting material. After addition of NaOH (2 M), the aqueous layer was 
extracted with CH2Cl2. The combined organic layers were washed with brine and dried over 
Na2SO4. After removal of the solvent, the crude mixture was purified by flash 
chromatography. 
 
Synthesis of aryl magnesium bromides: 
Magnesium turnings (35.3 mmol, 1.1 equiv.) were pestled, flame-dried under vacuum and 
set under argon. The magnesium was layered with anhydrous THF (5 mL) and part of the 
corresponding aryl bromide (0.2 mL of solution: 32.1 mmol, 1.0 equiv., dissolved in 
anhydrous THF (5 mL)) was added dropwise. A few drops of 1,2-dibromoethane were added 
and the Grignard reaction was initiated by local heating (heat gun). The remaining THF 
(30 mL) and aryl bromide solution were added dropwise. After complete addition, the 
reaction was refluxed for 2 h and cooled down to room temperature. 
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Hydrazine salts were synthesized following a modified literature procedure.[134] 
 
Synthesis of Boc-protected hydrazines 172: 
Azodicarboxylate 171 (5 mmol) was dissolved in dry THF (15 mL) under argon atmosphere 
and a solution of the corresponding naphthalen-1-ylmagnesium bromide (1.5 equiv.) was 
added dropwise at –78 °C. The mixture was stirred at –78 °C for 1-2 h after which acetic acid 
(7.5 mmol) was added. After warming up to rt, H2O (10 mL) was added to the reaction 
mixture and the aqueous layer was extracted with Et2O (3 x 10 mL). The combined organic 
layers were washed with brine (10 mL), dried over Na2SO4 and concentrated to give the 
crude product, which was directly used for the next step. 
 
Synthesis of hydrazine hydrochlorides 116·HCl: 
The crude Boc-hydrazine 172 (5 mmol) was dissolved in i-PrOH (HPLC grade, 12.5 mL) under 
argon and HCl (4 M in dioxane, 12.5 mL, 50 mmol) was added to the solution. The reaction 
mixture was refluxed for 30-60 min. After full consumption of the starting material, the 
mixture was cooled to 0 °C and diluted with Et2O (10 mL). The formed precipitate was 
collected by filtration, washed with Et2O and dried under high-vacuum to give the 
corresponding naphthalen-1-ylhydrazine hydrochloride 116·HCl as a colourless to gray solid. 
Due to their poor solubility and poor stability towards oxygen and light, 116a-f·HCl were only 
characterized by HRMS.  
 
(2-Methylnaphthalen-1-yl)hydrazine hydrochloride (116a·HCl) 
 
1H NMR (500 MHz, D2O) δ = 8.12 (d, J = 8.3 Hz, 1H), 7.86 (d, J = 7.9 Hz, 1H), 7.74 (d, J = 8.3 
Hz, 1H), 7.62 (t, J = 7.4 Hz, 1H), 7.51 (t, J = 7.2 Hz, 1H), 7.35 (d, J = 8.2 Hz, 1H), 2.52 (s, 3H). 
13C NMR (125 MHz, D2O) δ = 134.2, 132.7, 132.7, 129.4, 129.1, 128.4, 128.4, 127.3, 125.9, 
121.1, 16.8. 
HRMS (EI) m/z calculated for C11H12N2 172.1000 (M-[HCl]
+), found 172.0999. 
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(2,4-Dimethylnaphthalen-1-yl)hydrazine hydrochloride (116b·HCl) 
 
HRMS (ESI) m/z calculated for C12H15N2 187.1230 (M-[Cl]
+), found 187.1230. 
 
(2,6-Dimethylnaphthalen-1-yl)hydrazine hydrochloride (116c·HCl) 
 
HRMS (EI) m/z calculated for C12H14N2 186.1157 (M-[HCl]
+), found 186.1158. 
 
(2,3-Dimethylnaphthalen-1-yl)hydrazine hydrochloride (116d·HCl) 
 
HRMS (ESI) m/z calculated for C12H15N2 187.1230 (M-[Cl]
+), found 187.1230. 
 
(10-Methylphenanthren-9-yl)hydrazine hydrochloride (116e·HCl) 
 
The corresponding aryl bromide was synthesized following a literature procedure.[168] 
HRMS (ESI) m/z calculated for C15H15N2 223.1230 (M-[Cl]
+), found 223.1230. 
 
(2-Ethylnaphthalen-1-yl)hydrazine hydrochloride (116f·HCl) 
 
HRMS (ESI) m/z calculated for C12H15N2 187.1230 (M-[Cl]
+), found 187.1230. 
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 Synthesis of Ketone 173b 7.4.2.
 
1-Tosylpiperidin-4-one (173b) 
 
Ketone 173b was synthesized following a literature procedure.[135] 
Piperidone hydrochloride 173a·HCl (2.00 g, 13.0 mmol) was dissolved in a mixture of H2O 
(16 mL) and CHCl3 (16 mL) and K2CO3 (4.49 g, 32.5 mmol) was added. After stirring the 
reaction for 10 min at room temperature, tosyl chloride (3.72 g, 19.5 mmol) was added and 
the mixture was stirred at ambient temperature overnight. The reaction was extracted with 
CH2Cl2, washed with brine and the organic layer was dried over Na2SO4. After removing the 
solvent under reduced pressure, the crude reaction mixture was purified by flash column 
chromatography. 
 
Purification: hexane:EtOAc (3:2), colourless solid, 3.13 g, 95% yield. 
1H NMR (500 MHz, CDCl3) δ = 7.68-7.65 (m, 2H), 7.34-7.32 (m, 2H), 3.37 (t, J = 6.2 Hz, 4H), 
2.52 (t, J = 6.3 Hz, 4H), 2.42 (s, 3H) ppm. 
13C NMR (125 MHz, CDCl3) δ = 205.8, 144.2, 133.4, 130.0, 127.6, 46.0, 40.7, 21.6 ppm. 
MS (EI) m/z (%): 253 (65), 155 (33), 98 (91); 91 (100), 65 (24), 56 (22). 
HRMS (ESI) m/z calculated for C12H15NO3SNa (M+Na
+) 276.066485, found 276.066530. 
The obtained data are in agreement with those reported in literature.[169] 
 
 Enantioselective Synthesis of 1,4-Diketones  7.4.3.
 
Procedure for the basic extraction of hydrazine salts 116·HCl: 
 
(Caution: Some hydrazines were found to be sensitive towards light and oxygen. Thus, all the 
solvents were degassed by bubbling argon for 60 min prior to use). An oven-dried Schlenk 
tube was set under argon and charged with the corresponding aryl hydrazine hydrochloride 
116·HCl (100 mg), anhydrous CH2Cl2 (4 mL) and sat. NaHCO3 (4 mL). The mixture was stirred 
until all solids were dissolved. The organic layer was transferred to a flame dried Schlenk 
tube containing anhydrous Na2SO4 under argon. This extraction step was repeated four 
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times. The combined organic layers were dried over Na2SO4 and filtered through a syringe 
filter into another flame dried Schlenk tube under argon. The solvent was removed under 
reduced pressure to give the corresponding free aryl hydrazine 116 which was used 
immediately without further purification. The spectroscopic analyses of some hydrazines 
were found to be difficult under regular protocol due to their poor stability towards oxygen 
and light. 
 
General procedure for the catalytic asymmetric synthesis of 1,4-diketones 118: 
 
A flame-dried Schlenk tube was charged with (R)-STRIP (19a) (3.59 mg, 0.005 mmol, 5 mol%), 
PhCO2H (3.66 mg, 0.03 mmol, 0.3 equiv.), Amberlite® CG50 (100 mg, 1000 mg/mmol), H2O 
(18 µL, 1.0 mmol, 10 equiv.) and the corresponding ketone 117 (0.1 mmol, 1.0 equiv.) under 
argon atmosphere. A solution of freshly prepared hydrazine stock solution 116 (0.1 mmol, 
1.0 equiv.) in degassed p-xylene (1.0 mL) was added and the reaction mixture was stirred for 
3-7 d at 40 °C. The crude reaction mixture was filtered through a short celite column, 
concentrated and purified by silica gel flash column chromatography (hexane/EtOAc = 9:1 to 
7:3). 
The racemates were prepared using diphenyl phosphate as the catalyst, following the 
general procedure described above. 
 
(S)-2-Methyl-2-((R)-2-oxocyclohexyl)naphthalen-1(2H)-one (118a) 
 
Compound 118a was obtained as a light yellow solid in 70% yield.  
17:1 dr, 96:4 er,   25D  +39.1 (c = 1.0, CH2Cl2). 
1H NMR (500 MHz, CDCl3) δ = 8.11-8.05 (m, 1H), 7.56 (td, J = 7.5, 1.4 Hz, 1H), 7.37 (td, J = 7.6, 
1.2 Hz, 1H), 7.28 (d, J = 7.5 Hz, 1H), 6.65 (d, J = 9.9 Hz, 1H), 6.09 (d, J = 9.9 Hz, 1H), 3.43 (dd, J 
= 13.4, 5.6 Hz, 1H), 2.29 (m, 3H), 2.10-1.96 (m, 2H), 1.78 (m, 1H), 1.67 (m, 1H), 1.57 (m, 1H), 
1.10 (s, 3H).  
13C NMR (125 MHz, CDCl3) δ = 209.8, 202.7, 137.8, 135.7, 134.0, 129.3, 127.9, 127.7, 127.1, 
124.5, 60.1, 48.2, 41.9, 26.9, 26.9, 25.5, 23.1. 
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HRMS (ESI) m/z calculated for C17H18O2Na 277.1199 (M+Na
+), found 277.1199. 
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 95:5, 1.0 mL/min, λ = 220 nm, tmaj = 
8.89 min, tmin= 10.5 min. 
 
(S)-2-((R)-5,5-Dimethyl-2-oxocyclohexyl)-2-methylnaphthalen-1(2H)-one (118b) 
 
Compound 118b was obtained as a light yellow solid in 64% yield.  
>20:1 dr, 99:1 er,   25D  +61.8 (c = 0.45, CH2Cl2). 
1H NMR (500 MHz, CDCl3) δ = 8.11-8.05 (m, 1H), 7.56 (td, J = 7.5, 1.4 Hz, 1H), 7.37 (td, J = 7.6, 
1.2 Hz, 1H), 7.28 (d, J = 7.3 Hz, 1H), 6.66 (d, J = 9.9 Hz, 1H), 6.07 (d, J = 9.9 Hz, 1H), 3.58 (dd, 
J = 14.1, 5.6 Hz, 1H), 2.46-2.34 (m, 1H), 2.18 (ddd, J = 15.2, 4.8, 2.6 Hz, 1H), 1.88 (m, 1H), 
1.74-1.62 (m, 2H), 1.55 (m, 1H), 1.29 (s, 3H), 1.11 (s, 3H), 1.07 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ = 210.2, 202.8, 137.7, 135.6, 134.0, 129.3, 128.0, 127.7, 127.1, 
124.6, 55.9, 48.0, 39.3, 38.9, 38.0, 32.2, 31.1, 24.5, 23.0. 
HRMS (ESI) m/z calculated for C19H22O2Na 305.1512 (M+Na
+), found 305.1512. 
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 95:5, 1.0 mL/min, λ = 220 nm, tmaj = 
5.82 min, tmin= 6.87 min. 
 
(R)-7-((S)-2-Methyl-1-oxo-1,2-dihydronaphthalen-2-yl)-1,4-dioxaspiro[4.5]decan-8-one 
(118c) 
 
Compound 118c was obtained as a colourless solid in 75% yield.  
>20:1 dr, 97:3 er,   25D  +109.0 (c = 1.0, CH2Cl2). 
1H NMR (500 MHz, CDCl3) δ = 8.11-8.05 (m, 1H), 7.56 (td, J = 7.5, 1.4 Hz, 1H), 7.37 (td, J = 7.6, 
1.2 Hz, 1H), 7.28 (d, J = 7.6 Hz, 1H), 6.67 (d, J = 9.9 Hz, 1H), 6.02 (d, J = 9.9 Hz, 1H), 4.17-4.00 
(m, 4H), 3.82 (dd, J = 14.2, 6.0 Hz, 1H), 2.66-2.55 (m, 1H), 2.31–2.18 (m, 2H), 2.08-1.95 (m, 
2H), 1.91 (td, J = 13.7, 5.2 Hz, 1H), 1.08 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ = 208.6, 202.1, 137.7, 135.0, 134.1, 129.3, 128.1, 127.7, 127.1, 
125.0, 107.9, 65.0, 65.0, 55.9, 47.8, 37.8, 34.5, 33.9, 22.9. 
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HRMS (ESI) m/z calculated for C19H20O4Na 335.1254 (M+Na
+), found 335.1253. 
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 95:5, 1.0 mL/min, λ = 220 nm, tmin = 
14.8 min, tmaj= 16.7 min. 
 
(R)-3-((S)-2-Methyl-1-oxo-1,2-dihydronaphthalen-2-yl)tetrahydro-4H-thiopyran-4-one 
(118d) 
 
Compound 118d was obtained as a light yellow solid in 61% yield.  
>20:1 dr, 97:3 er,   25D  +47.3 (c = 0.6, CH2Cl2). 
1H NMR (500 MHz, CDCl3) δ = 8.10-8.04 (m, 1H), 7.58 (td, J = 7.5, 1.4 Hz, 1H), 7.38 (td, J = 7.6, 
1.2 Hz, 1H), 7.30-7.26 (m, 1H), 6.66 (d, J = 9.9 Hz, 1H), 6.04 (d, J = 9.9 Hz, 1H), 3.77 (dd, J = 
12.6, 4.9 Hz, 1H), 3.12 (ddd, J = 13.3, 4.9, 1.9 Hz, 1H), 3.00 (m, 1H), 2.94-2.85 (m, 2H), 2.72-
2.61 (m, 2H), 1.17 (s, 3H).  
13C NMR (125 MHz, CDCl3) δ = 207.1, 201.7, 137.6, 134.9, 134.2, 129.2, 128.2, 127.8, 127.2, 
124.9, 62.1, 48.9, 44.7, 30.1, 30.0, 23.1. 
HRMS (ESI) m/z calculated for C16H16O2SNa 295.0763 (M+Na
+), found 295.0763. 
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 95:5, 1.0 mL/min, λ = 220 nm, tmaj = 
12.0 min, tmin= 21.4 min. 
 
(S)-3-((S)-2-Methyl-1-oxo-1,2-dihydronaphthalen-2-yl)tetrahydro-4H-pyran-4-one (118e) 
 
Compound 118e was obtained as a light yellow solid in 65% yield.  
20:1 dr, 87.3:12.7 er,   25D  +41.4 (c = 0.7, CH2Cl2). 
1H NMR (500 MHz, CDCl3) δ = 8.11-8.06 (m, 1H), 7.58 (td, J = 7.5, 1.4 Hz, 1H), 7.39 (td, J = 7.6, 
1.2 Hz, 1H), 7.27 (d, J = 7.4 Hz, 1H), 6.65 (d, J = 9.9 Hz, 1H), 5.98 (d, J = 9.9 Hz, 1H), 4.49 (ddd, 
J = 10.8, 6.5, 1.5 Hz, 1H), 4.29-4.20 (m, 1H), 3.81-3.72 (m, 1H), 3.70-3.57 (m, 2H), 2.62 (m, 
1H), 2.30 (ddd, J = 14.9, 2.9, 1.5 Hz, 1H), 1.15 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ = 205.1, 201.2, 137.5, 134.9, 134.3, 129.2, 128.3, 127.8, 127.3, 
125.2, 68.2, 68.1, 59.2, 47.3, 42.4, 22.7. 
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HRMS (ESI) m/z calculated for C16H16O3Na 279.0992 (M+Na
+), found 279.0991. 
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 95:5, 1.0 mL/min, λ = 220 nm, tmaj = 
14.6 min, tmin= 19.7 min. 
 
tert-Butyl-(S)-3-((S)-2-methyl-1-oxo-1,2-dihydronaphthalen-2-yl)-4-oxopiperidine-1-
carboxylate (118f) 
 
Compound 118f was obtained as colorless oil in 73% yield.  
10:1 dr, 92:8 er,   25D  +63.8 (c = 0.8, CH2Cl2). 
1H NMR (500 MHz, CD3CN, 323 K) δ = 8.02-7.97 (m, 1H), 7.64 (td, J = 7.5, 1.4 Hz, 1H), 7.42 
(td, J = 7.6, 1.2 Hz, 1H), 7.36 (d, J = 7.6 Hz, 1H), 6.69 (d, J = 9.9 Hz, 1H), 6.11 (d, J = 9.9 Hz, 1H), 
4.45 (ddd, J = 12.9, 5.9, 2.2 Hz, 1H), 4.19-4.09 (m, 1H), 3.39 (dd, J = 11.5, 5.9 Hz, 1H), 3.29 
(dd, J = 12.8, 11.6 Hz, 1H), 3.18 (m, 1H), 2.44 (m, 1H), 2.25 (ddd, J = 15.3, 4.2, 3.5 Hz, 1H), 
1.51 (s, 9H), 1.18 (s, 3H).  
13C NMR (125 MHz, CD3CN, 323 K) δ = 207.9, 202.4, 156.2, 139.4, 137.1, 135.7, 130.9, 129.6, 
129.3, 128.1, 126.0, 81.6, 59.8, 49.3, 44.9, 44.4, 41.9, 29.3, 23.9. 
HRMS (ESI) m/z calculated for C21H25NO4Na 378.1676 (M+Na
+), found 378.1676. 
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 90:10, 1.0 mL/min, λ = 220 nm, tmaj = 
7.99 min, tmin = 16.1 min. 
 
Benzyl-(S)-3-((S)-2-methyl-1-oxo-1,2-dihydronaphthalen-2-yl)-4-oxopiperidine-1-
carboxylate (118g) 
 
Compound 118g was obtained as a light yellow solid in 69% yield.  
11:1 dr, 90.9:9.1 er,   25D  +97.4 (c = 1.0, CH2Cl2). 
1H NMR (500 MHz, CD3CN) δ = 8.01-7.95 (m, 1H), 7.64 (td, J = 7.5, 1.4 Hz, 1H), 7.51-7.31 (m, 
7H), 6.68 (d, J = 9.9 Hz, 1H), 6.09 (d, J = 9.8 Hz, 1H), 5.17 (q, J = 12.6 Hz, 2H), 4.52 (dd, J = 
12.2, 4.7 Hz, 1H), 4.19 (br s, 1H), 3.45 (dd, J = 11.8, 6.0 Hz, 1H), 3.34 (br s, 1H), 3.23 (br s, 1H), 
2.46 (m, 1H), 2.24 (dt, J = 15.4, 3.7 Hz, 1H), 1.12 (br s, 3H). 
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13C NMR (125 MHz, CD3CN) δ = 207.4, 202.0, 156.5, 139.0, 138.5, 136.7, 135.5, 130.3, 129.9, 
129.4, 129.3, 129.1, 129.0, 127.8, 125.6, 68.4, 68.3, 59.2, 48.8, 44.4, 44.0, 41.4, 23.4. 
HRMS (ESI) m/z calculated for C24H23O4NNa 412.1519 (M+Na
+), found 412.1518. 
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 80:20, 1.0 mL/min, λ = 220 nm, tmaj = 
14.4 min, tmin = 24.9 min. 
 
(S)-3-((S)-2-Methyl-1-oxo-1,2-dihydronaphthalen-2-yl)-1-tosylpiperidin-4-one (118h) 
 
Compound 118h was obtained as a colourless solid in 61% yield.  
13:1 dr, 95:5 er,   25D  +21.3 (c = 0.79, CH2Cl2). 
1H NMR (500 MHz, CDCl3) δ = 8.06 (d, J = 7.8 Hz, 1H), 7.73 (t, J = 8.9 Hz, 2H), 7.57 (td, J = 7.5, 
1.4 Hz, 1H), 7.43-7.34 (m, 3H), 7.25 (d, J = 6.9 Hz, 1H), 6.61 (d, J = 9.9 Hz, 1H), 5.87 (d, J = 9.9 
Hz, 1H), 4.27 (m, 1H), 4.01 (m, 1H), 3.67 (dd, J = 11.9, 6.3 Hz, 1H), 2.84 (t, J = 11.9 Hz, 1H), 
2.75 (td, J = 12.1, 3.6 Hz, 1H), 2.67-2.50 (m, 1H), 2.47 (s, 3H), 2.37-2.26 (m, 1H), 1.18 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ = 204.5, 200.9, 144.5, 137.3, 134.4, 134.2, 133.8, 130.3, 129.0, 
128.4, 127.8, 127.7, 127.3, 125.4, 57.5, 47.7, 46.1, 45.8, 40.3, 22.9, 21.8. 
HRMS (ESI) m/z calculated for C23H23O4NNa 432.1240 (M+Na
+), found 432.1238. 
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 80:20, 1.0 mL/min, λ = 220 nm, tmaj = 
15.2 min, tmin = 17.5 min. 
 
(S)-2-Methyl-2-((R)-2-oxocyclopentyl)naphthalen-1(2H)-one (118i) 
 
Compound 118i was obtained as a light yellow solid in 29% yield.  
2:5 dr, 78.4:21.6 er. 
1H NMR (500 MHz, CDCl3) δ = 8.10 (d, J = 7.8 Hz, 1H), 7.56 (td, J = 7.5, 1.3 Hz, 1H), 7.38 (td, 
J = 7.6, 1.1 Hz, 1H), 7.24 (d, J = 7.5 Hz, 1H), 6.62 (d, J = 9.9 Hz, 1H), 6.07 (d, J = 9.9 Hz, 1H), 
3.11 (m, 1H), 2.32-2.16 (m, 2H), 2.13-2.00 (m, 2H), 1.89-1.76 (m, 2H), 1.26 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ = 217.3, 202.8, 137.9, 135.2, 134.4, 129.6, 128.3, 127.7, 127.2, 
125.4, 58.1, 49.5, 38.1, 24.9, 23.7, 21.1. 
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HRMS (ESI) m/z calculated for C16H16O2Na 263.1042 (M+Na
+), found 263.1042. 
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 95:5, 1.0 mL/min, λ = 220 nm, tmaj = 
12.0 min, tmin = 13.0 min. 
 
(S)-2,4-Dimethyl-2-((R)-2-oxocyclohexyl)naphthalen-1(2H)-one (118j) 
 
Compound 118j was obtained as a light yellow solid in 54% yield.  
>20:1 dr, 96.4:3.6 er,   25D  +72.8 (c = 0.5, CH2Cl2). 
1H NMR (500 MHz, CDCl3) δ = 8.12 (dd, J = 7.7, 1.2 Hz, 1H), 7.62 (td, J = 7.8, 1.4 Hz, 1H), 7.43 
(d, J = 7.7 Hz, 1H), 7.41-7.35 (m, 1H), 5.88 (d, J = 1.2 Hz, 1H), 3.43-3.34 (m, 1H), 2.34-2.22 (m, 
3H), 2.18 (d, J = 1.3 Hz, 3H), 2.09-2.01 (m, 2H), 1.84-1.65 (m, 2H), 1.64-1.54 (m, 1H), 1.08 (s, 
3H). 
13C NMR (125 MHz, CDCl3) δ = 209.7, 203.2, 138.8, 133.9, 132.6, 129.2, 128.2, 127.6, 127.3, 
124.5, 60.0, 47.8, 42.0, 26.9, 26.8, 25.6, 23.4, 20.0. 
HRMS (ESI) m/z calculated for C18H20O2Na 291.1355 (M+Na
+), found 291.1356. 
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 95:5, 1.0 mL/min, λ = 220 nm, tmin = 
6.38 min, tmaj = 7.44 min. 
 
(S)-2,6-Dimethyl-2-((R)-2-oxocyclohexyl)naphthalen-1(2H)-one (118k) 
 
Compound 118k was obtained as a light yellow solid in 81% yield.  
>20:1 dr, 95:5 er,   25D  +104.6 (c = 1.0, CH2Cl2). 
1H NMR (500 MHz, CDCl3) δ = 7.97 (d, J = 7.9 Hz, 1H), 7.18 (dd, J = 7.9, 0.9 Hz, 1H), 7.08 (s, 
1H), 6.61 (d, J = 9.9 Hz, 1H), 6.08 (d, J = 9.9 Hz, 1H), 3.41 (dd, J = 13.4, 5.5 Hz, 1H), 2.41 (s, 
3H), 2.34-2.24 (m, 3H), 2.09-1.96 (m, 2H), 1.88-1.50 (m, 3H), 1.09 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ = 209.7, 202.5, 144.8, 137.8, 135.9, 128.9, 128.1, 127.2, 127.1, 
124.5, 59.9, 48.2, 41.9, 27.0, 26.9, 25.5, 23.2, 22.0. 
HRMS (ESI) m/z calculated for C18H20O2Na 291.1355 (M+Na
+), found 291.1355. 
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HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 95:5, 1.0 mL/min, λ = 220 nm, tmaj = 
11.4 min, tmin = 13.5 min. 
 
(R)-2,3-Dimethyl-2-((R)-2-oxocyclohexyl)naphthalen-1(2H)-one (118l) 
 
Compound 118l was obtained as a light yellow solid in 37% yield.  
>20:1 dr, 89.5:10.5 er,   25D  +35.0 (c = 0.5, CH2Cl2). 
1H NMR (500 MHz, CDCl3) δ = 8.00 (d, J = 7.8 Hz, 1H), 7.57-7.49 (m, 1H), 7.29 (t, J = 7.5 Hz, 
1H), 7.18 (d, J = 7.6 Hz, 1H), 6.40 (s, 1H), 3.55 (dd, J = 12.7, 6.2 Hz, 1H), 2.55-2.39 (m, 1H), 
2.36-2.16 (m, 2H), 2.13-1.96 (m, 2H), 1.93 (d, J = 4.3 Hz, 3H), 1.91-1.82 (m, 1H), 1.75-1.58 (m, 
2H), 1.17 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ = 210.1, 203.3, 146.6, 138.6, 134.3, 127.5, 127.1, 126.9, 122.7, 
57.4, 53.2, 41.6, 28.5, 25.7, 25.5, 22.9, 22.9.  
HRMS (ESI) m/z calculated for C18H20O2Na 291.1355 (M+Na
+), found 291.1355. 
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 95:5, 1.0 mL/min, λ = 220 nm, tmaj = 
9.08 min, tmin = 11.7 min. 
 
(R)-10-Methyl-10-((R)-2-oxocyclohexyl)phenanthren-9(10H)-one (118m) 
 
Compound 118m was obtained as yellow oil in 43% yield.  
>20:1 dr, 93.6:6.4 er,   25D  +43.0 (c = 0.7, CH2Cl2). 
1H NMR (500 MHz, CDCl3) δ = 8.09-7.97 (m, 3H), 7.72-7.63 (m, 1H), 7.56 (dd, J = 7.6, 1.4 Hz, 
1H), 7.42 (dd, J = 11.3, 4.4 Hz, 1H), 7.38-7.28 (m, 2H), 3.29 (dd, J = 13.0, 4.4 Hz, 1H), 2.31-
2.09 (m, 3H), 1.98-1.86 (m, 2H), 1.85-1.72 (m, 1H), 1.60 (s, 3H), 1.59-1.51 (m, 2H).  
13C NMR (125 MHz, CDCl3) δ = 209.7, 202.9, 141.4, 137.6, 134.3, 130.5, 129.5, 128.8, 128.3, 
128.1, 127.7, 127.2, 124.2, 123.0, 60.3, 51.7, 42.7, 29.9, 26.7, 25.7, 22.1. 
HRMS (ESI) m/z calculated for C21H20O2Na 327.1355 (M+Na
+), found 327.1356. 
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HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 95:5, 1.0 mL/min, λ = 220 nm, tmin = 
11.0 min, tmaj = 22.4 min. 
 
(S)-2-Ethyl-2-((R)-2-oxocyclohexyl)naphthalen-1(2H)-one (118n) 
 
Compound 118n was obtained as a light yellow solid in 49% yield.  
9:1 dr, 91.2:8.8 er,   25D  +103.4 (c = 0.75, CH2Cl2). 
1H NMR (500 MHz, CDCl3) δ = 8.04 (d, J = 7.8 Hz, 1H), 7.54 (td, J = 7.5, 1.3 Hz, 1H), 7.35 (td, 
J = 7.6, 1.1 Hz, 1H), 7.28 (d, J = 7.7 Hz, 1H), 6.78 (d, J = 9.9 Hz, 1H), 6.01 (d, J = 9.9 Hz, 1H), 
3.44 (dd, J = 13.3, 5.5 Hz, 1H), 2.37-2.18 (m, 3H), 2.09-1.95 (m, 2H), 1.83-1.63 (m, 3H), 1.58-
1.50 (m, 2H), 0.61 (t, J = 7.4 Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ = 209.8, 203.2, 138.0, 134.4, 133.8, 131.0, 127.9, 127.8, 126.6, 
126.2, 60.7, 52.4, 42.0, 30.7, 27.0, 26.9, 25.6, 7.69. 
HRMS (ESI) m/z calculated for C18H20O2Na 291.1355 (M+Na
+), found 291.1355. 
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 95:5, 1.0 mL/min, λ 220nm, tmaj = 8.07 min, 
tmin = 11.6 min. 
 
(1S,1'R)-1,3-Dimethyl-[1,1'-bi(cyclohexane)]-3,5-diene-2,2'-dione (118o) 
 
Compound 118o was obtained as colorless oil in <5% yield.  
>20:1 dr, 77.6:22.4 er. 
1H NMR (500 MHz, CDCl3) δ = 6.88-6.81 (m, 1H), 6.25-6.14 (m, 2H), 3.34 (ddd, J = 13.6, 5.7, 
1.0 Hz, 1H), 2.35-2.20 (m, 3H), 2.09-1.99 (m, 2H), 1.93 (d, J = 1.2 Hz, 3H), 1.80-1.70 (m, 1H), 
1.61-1.53 (m, 2H), 1.01 (s, 3H).  
13C NMR (125 MHz, CDCl3) δ = 209.7, 205.4, 141.1, 136.7, 133.1, 121.1, 60.2, 50.0, 42.0, 27.1, 
25.6, 23.2, 16.0. 
HRMS (ESI) m/z calculated for C14H18O2Na 241.1199 (M+Na
+), found 241.1198. 
HPLC: cellucoat RP, CH3CN/H2O = 50:50, 1.0 mL/min, λ = 220 nm, tmin = 5.38 min, tmaj = 
5.69 min. 
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2-Methyl-2-(2-oxopropyl)naphthalen-1(2H)-one (118p) 
Racemate synthesis of compound 118p: 
 
A flame-dried Schlenk tube was charged with diphenyl phosphate (0.22 mmol, 55.0 mg, 
2 equiv.) and acetone (0.11 mmol, 8.1 µL, 1.0 equiv.) under argon atmosphere. A solution of 
freshly prepared hydrazine 116a (0.11 mmol, 18.9 mg, 1.0 equiv.) in degassed toluene 
(1.1 mL, 0.1 M) was added and the reaction mixture was stirred for 4-5 d at 45 °C. The crude 
reaction mixture was filtered through a short celite column, concentrated and purified by 
silica gel flash column chromatography. 
 
 
Compound 118p was obtained as colorless oil in 57% yield.  
 
Preparation of enantioenriched compound 118p: 
A flame-dried Schlenk tube was charged with catalyst 19e (20 mol%), PhCO2H (0.3 equiv.), 
Amberlite® CG50 (1000 mg/mmol), H2O (10 equiv.), and acetone (1.0 equiv.) under argon 
atmosphere. A solution of freshly prepared hydrazine 116a (1.0 equiv.) in degassed toluene 
(0.1 M) was added and the reaction mixture was stirred for 3 days at 50 °C. The crude 
reaction mixture was filtered through a short celite column, concentrated, and purified by 
preparative TLC. 
 
Compound 118p (enantioenriched) was obtained as colorless oil in <5% yield.  
70:30 er. 
1H NMR (500 MHz, CDCl3) δ = 8.10-8.05 (m, 1H), 7.57 (td, J = 7.5, 1.4 Hz, 1H), 7.37 (td, J = 7.6, 
1.2 Hz, 1H), 7.28 (d, J = 7.5Hz, 1H), 6.61 (d, J = 9.7 Hz, 1H), 6.02 (d, J = 9.7 Hz, 1H), 3.49 (d, J = 
17.8 Hz, 1H), 2.78 (d, J = 17.8 Hz, 1H), 2.06 (s, 3H), 1.20 (s, 3H).  
13C NMR (125 MHz, CDCl3) δ = 205.6, 202.3, 138.8, 138.3, 134.3, 129.2, 128.0, 127.7, 127.1, 
124.3, 54.4, 46.5, 29.7, 25.6. 
HRMS (ESI) m/z calculated for C14H14O2Na 237.0887 (M+Na
+), found 237.0886. 
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 95:5, 1.0 mL/min, λ = 237nm, tmin = 
8.27 min, tmaj = 10.7 min.   
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 Catalytic Asymmetric Synthesis of 2H- and 3H-Pyrroles 7.5.
 
 Synthesis of Hydrazines 7.5.1.
 
Hydrazine salts 116·HCl were synthesized following the procedure described in chapter 
7.4.1. The corresponding free hydrazines were obtained via basic extraction, using aq. 
NaHCO3 (see chapter 7.4.1). 
 
 Enantioselective Synthesis of 3H-Pyrroles 7.5.2.
 
Amberlite® CG50 was dried under high vacuum at 100 °C overnight and stored in a Schlenk 
tube under argon. 4Å Molecular sieves were flame dried under high vacuum and stored in a 
Schlenk tube under argon. 
 
General procedure for the catalytic asymmetric synthesis of 3H-pyrroles 119 
 
A flame-dried Schlenk tube was charged with (R)-STRIP or (S)-STRIP (19a) (0.01 mmol, 
10 mol%), PhCO2H (0.1 mmol, 1.0 equiv.), Amberlite® CG50 (50 mg, 500 mg/mmol), 4Å MS 
(50 mg, 500 mg/mmol) and the corresponding ketone 117 (0.1 mmol, 1.0 equiv.) under 
argon atmosphere. A solution of freshly prepared hydrazine stock solution 116 (0.1 mmol, 
1.0 equiv.) in degassed p-xylene (0.1 M) was added and the reaction was stirred for 3-7 d at 
20 °C. The crude reaction mixture was directly purified by column chromatography. In some 
cases, byproduct exo-119 could not be completely separated from the desired product via 
column chromatography. These products were additionally purified by preparative TLC on 
aluminium oxide. 
 
General procedure for the racemate synthesis of 3H-pyrroles 120 
 
The racemates were prepared using diphenyl phosphate (0.5 equiv.), Amberlite® CG50 
(500 mg/mmol), 4Å MS (500 mg/mmol), the corresponding ketone 117 (1 equiv.) and 
hydrazine stock solution 116 in toluene (1 equiv., 0.1 M). The reaction was performed at 
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20 °C for 3-5 d. The crude reaction mixture was directly submitted to column 
chromatography.  
 
(S)-6a-Methyl-6a,8,9,10-tetrahydro-7H-benzo[a]carbazole (119a) 
 
The reaction was performed at 20 °C for 7 d, using (R)-STRIP (19a) as catalyst. 
Purification: hexane:EtOAc (15:1) (Aluminium oxide, activity III), yellow oil, 13.1 mg, 56% 
yield. 
98:2 er,   25D  −40 (c = 0.47, CH2Cl2). 
1H NMR (500 MHz, CD2Cl2) δ =7.76 (d, J = 7.6 Hz, 1H), 7.36 (dt, J = 1.3, 7.5 Hz, 1H), 7.30 (dt, J 
= 1.2, 7.5 Hz, 1H), 7.18 (d, J = 7.5 Hz, 1H), 6.36 (d, J = 9.4 Hz, 1H), 6.31 (d, J = 9.3 Hz, 1H), 
2.54-2.44 (m, 2H), 2.32-2.17 (m, 2H), 1.83-1.73 (m, 4H), 1.27 (s, 3H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 184.4, 149.1, 136.9, 134.8, 133.6, 130.7, 130.1, 128.5, 127.7, 
126.9, 124.4, 60.4, 26.4, 25.8, 23.6, 23.1, 21.4 ppm. 
MS (EI) m/z (%): 235 (100), 220 (55), 207 (23), 194 (20), 180 (10), 165 (16), 152 (9). 
HRMS (ESI) m/z calculated for C17H18N (M+H
+) 236.143374, found 236.143250.  
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 97:3, 1.0 mL/min, λ = 254 nm, tmin = 
4.08 min, tmaj = 5.67 min. 
 
(R)-6a,8,8-Trimethyl-6a,8,9,10-tetrahydro-7H-benzo[a]carbazole (119b) 
 
The reaction was performed on a 0.05 mmol scale at 20 °C for 5 d, using (S)-STRIP (19a) as 
catalyst. 
Purification: hexane:EtOAc (20:1) (Aluminium oxide, activity III), yellow oil, 10.9 mg, 83% 
yield. 
99:1 er,   25D  +104 (c = 0.37, CH2Cl2). 
1H NMR (500 MHz, CD2Cl2) δ = 7.77-7.75 (m, 1H), 7.36 (td, J = 7.5, 1.4 Hz, 1H), 7.30 (td, J = 
7.5, 1.3 Hz, 1H), 7.18 (dd, J = 7.6, 0.7 Hz, 1H), 6.36 (d, J = 9.3 Hz, 1H), 6.28 (d, J = 9.3 Hz, 1H), 
 7. Experimental Part   
173 
2.58-2.43 (m, 2H), 2.12-2.07 (m, 1H), 1.99-1.94 (m, 1H), 1.60-1.51 (m, 2H), 1.25 (s, 3H), 1.02 
(s, 3H), 0.97 (s, 3H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 184.6, 147.8, 136.9, 134.2, 133.5, 130.8, 130.0, 128.5, 127.7, 
126.9, 124.3, 60.3, 36.6, 35.5, 30.2, 29.0, 27.5, 26.4, 23.4 ppm. 
MS (EI) m/z (%): 263 (100), 248 (46), 235 (11), 207 (44), 194 (95), 165 (16), 152 (8). 
HRMS (ESI) m/z calculated for C19H22N (M+H
+) 264.174674, found 264.174390.  
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 97:3, 1.0 mL/min, λ = 254 nm, tmaj = 
3.55 min, tmin = 5.82 min. 
 
(R)-6a-Methyl-8,8-dipropyl-6a,8,9,10-tetrahydro-7H-benzo[a]carbazole (119c) 
 
The reaction was performed on a 0.125 mmol scale at 20 °C for 3 d, using (S)-STRIP (19a) as 
catalyst. 
Purification: hexane:EtOAc (15:1) (Alox III), yellow oil, 30.2 mg, 76% yield. 
97:3 er,   25D  +67 (c = 1.30, CH2Cl2). 
1H NMR (500 MHz, CD2Cl2) δ = 7.76 (d, J = 7.5 Hz, 1H), 7.36 (td, J = 7.5, 1.3 Hz, 1H), 7.30 (td, J 
= 7.5, 1.2 Hz, 1H), 7.18 (d, J = 7.5 Hz, 1H), 6.36 (d, J = 9.3 Hz, 1H), 6.29 (d, J = 9.3 Hz, 1H), 
2.53-2.39 (m, 2H), 2.11-2.07 (m, 1H), 2.00-1.96 (m, 1H), 1.66-1.55 (m, 2H), 1.37-1.27 (m, 7H), 
1.25 (s, 3H), 1.24-1.20 (m, 1H), 0.92-0.88 (m, 6H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 184.6, 148.1, 136.9, 134.1, 133.6, 130.8, 130.1, 128.5, 127.7, 
126.9, 124.3, 60.5, 40.5, 38.7, 35.4, 33.0, 32.9, 26.5, 22.9, 15.2 ppm. 
MS (EI) m/z (%): 319 (29), 304 (16), 276 (17), 207 (27), 194 (100), 165 (8), 152 (3). 
HRMS (ESI) m/z calculated for C23H30N (M+H
+) 320. 237274, found 320. 237220.  
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 97:3, 1.0 mL/min, λ = 254 nm, tmaj = 
2.92 min, tmin = 4.80 min. 
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(S)-8,8-Difluoro-6a-methyl-6a,8,9,10-tetrahydro-7H-benzo[a]carbazole (119d) 
 
The reaction was conducted at 30 °C for 5 d, using (R)-STRIP (19a) as catalyst. 
Purification: hexane:EtOAc (15:1) (Aluminium oxide, activity III), yellow oil, 11.4 mg, 
42% yield. 
99.5:0.5 er,   25D  −80 (c = 0.22, CH2Cl2). 
1H NMR (500 MHz, CD2Cl2) δ = 7.79-7.77 (m, 1H), 7.40 (td, J = 7.5, 1.4 Hz, 1H), 7.33 (td, J = 
7.5, 1.2 Hz, 1H), 7.21 (dd, J = 7.6, 0.9 Hz, 1H), 6.40 (d, J = 9.3 Hz, 1H), 6.28 (d, J = 9.3 Hz, 1H), 
2.89-2.69 (m, 4H), 2.28-2.19 (m, 2H), 1.30 (s, 3H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 186.7, 147.8, 136.8, 132.4, 131.4, 129.7 (dd, J = 6.7, 5.1 Hz), 
129.6, 128.8, 127.9, 127.3, 124.6, 124.0 (t, J = 241 Hz), 60.8, 32.0 (t, J = 28 Hz), 31.4 (t, J = 25 
Hz), 26.2, 23.2 (dd, J = 6.4, 5.2 Hz) ppm. 
19F NMR (282 MHz, CD2Cl2) δ = -95.5 (d, J = 235 Hz, 1F), -97.2 (d, J = 237Hz, 1F) ppm. 
MS (EI) m/z (%): 271 (100), 256 (23), 236 (26), 207 (18), 192 (6), 165 (12), 152 (5). 
HRMS (ESI) m/z calculated for C17H16NF2 (M+H
+) 272.124531, found 272.124340.  
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 97:3, 1.0 mL/min, λ = 254 nm, tmin = 
6.67 min, tmaj = 10.6 min. 
 
(R)-5,6a,8,8-Tetramethyl-6a,8,9,10-tetrahydro-7H-benzo[a]carbazole (119e) 
 
The reaction was performed at 20 °C for 3 d, using (S)-STRIP (19a) as catalyst. 
Purification: hexane:EtOAc (20:1) (Aluminium oxide, activity III), yellow oil, 15.8 mg, 
57% yield. 
99:1 er,   25D  +97 (c = 0.45, CH2Cl2). 
1H NMR (500 MHz, CD2Cl2) δ = 7.77-7.75 (m, 1H), 7.44-7.40 (m, 1H), 7.34-7.31 (m, 2H), 6.07 
(q, J = 1.5 Hz, 1H), 2.57-2.42 (m, 2H), 2.09 (dt, J = 17.0, 2.9 Hz, 1H), 2.03 (d, J = 1.5 Hz, 3H), 
1.96 (dt, J = 17.5, 2.4 Hz, 1H), 1.60 (m, 2H), 1.20 (s, 3H), 1.02 (s, 3H), 0.97 (s, 3H) ppm. 
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13C NMR (125 MHz, CD2Cl2) δ = 185.1, 147.9, 138.0, 134.6, 131.8, 130.7, 130.1, 129.7, 128.2, 
124.9, 124.3, 59.8, 36.6, 35.5, 30.2, 28.9, 27.6, 25.8, 23.4, 20.0 ppm. 
MS (EI) m/z (%): 277 (74), 262 (44), 221 (66), 208 (100), 191 (29), 178 (39), 165 (58), 152 (25). 
HRMS (ESI) m/z calculated for C20H24N (M+H
+) 278.190324, found 278.190400.  
HPLC: Daicel Chiralpak AD-3, n-heptane/i-PrOH = 97:3, 1.0 mL/min, λ = 254 nm, tmaj = 
3.27 min, tmin = 4.42 min. 
 
(R)-3,6a,8,8-Tetramethyl-6a,8,9,10-tetrahydro-7H-benzo[a]carbazole (119f) 
 
The reaction was performed at 20 °C for 3 d, using (S)-STRIP (19a) as catalyst. 
Purification: hexane:EtOAc (20:1) (Aluminium oxide, activity III), yellow oil, 16.8 mg, 
61% yield. 
>99.5:0.5 er,   25D  +146 (c = 0.25, CH2Cl2). 
1H NMR (500 MHz, CD2Cl2) δ = 7.66 (d, J = 7.8 Hz, 1H), 7.12 (d, J = 7.8 Hz, 1H), 7.01 (s, 1H), 
6.32 (d, J = 9.3 Hz, 1H), 6.27 (d, J = 9.3 Hz, 1H), 2.56-2.41 (m, 2H), 2.36 (s, 3H), 2.09 (dt, J = 
17.0, 2.8 Hz, 1H), 1.96 (dt, J = 17.5, 2.2 Hz, 1H), 1.59 (m, 2H), 1.23 (s, 3H), 1.02 (s, 3H), 0.97 (s, 
3H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 184.8, 147.7, 141.1, 136.8, 133.8, 133.6, 129.3, 128.4, 127.4, 
127.0, 124.3, 60.4, 36.6, 35.5, 30.2, 29.0, 27.5, 26.7, 23.4, 21.6 ppm. 
MS (EI) m/z (%): 277 (100), 262 (40), 249 (11), 221 (36), 208 (72), 191 (9), 165 (5). 
HRMS (ESI) m/z calculated for C20H24N (M+H
+) 278.190324, found 278.190110.  
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 97:3, 1.0 mL/min, λ = 254 nm, tmaj = 
4.55 min, tmin = 6.81 min.  
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 Enantioselective Synthesis of 2H-Pyrroles 7.5.3.
 
General procedure for the catalytic asymmetric synthesis of 2H-pyrroles 120 
 
A flame-dried Schlenk tube was charged with (R)-STRIP or (S)-STRIP (19a) (0.01 mmol, 
10 mol%), PhCO2H (0.1 mmol, 1.0 equiv.), Amberlite® CG50 (50 mg, 500 mg/mmol), 4Å MS 
(50 mg, 500 mg/mmol) and the corresponding ketone 117 (0.1 mmol, 1.0 equiv.) under 
argon atmosphere. A solution of freshly prepared hydrazine stock solution 116 (0.1 mmol, 
1.0 equiv.) in degassed p-xylene (0.1 M) was added and the reaction was stirred at 40 °C. 
After full conversion of the hydrazone, diphenyl phosphate (0.5-1 equiv.) was added and the 
reaction was stirred at 40 °C overnight. The crude reaction mixture was directly purified by 
column chromatography.  
 
Given reaction times are based on full conversion of the hydrazone and before addition of 
diphenyl phosphate. 
 
General procedure for the racemate synthesis of 2H-pyrroles 120 
 
The racemates were prepared using diphenyl phosphate (1 equiv.), Amberlite® CG50 
(500 mg/mmol), 4Å molecular sieves (500 mg/mmol), the corresponding ketone 117 
(1 equiv.) and hydrazine stock solution 116 in toluene (1 equiv., 0.1 M). The reaction was 
performed at 40 °C for 3-5 d. The crude reaction mixture was directly submitted to column 
chromatography. 
 
(R)-11a-Methyl-8,9,10,11a-tetrahydro-7H-benzo[a]carbazole (120a) 
 
The reaction was performed at 40 °C for 8 d, using (S)-STRIP (19a) as catalyst. 
Purification: hexane:EtOAc (15:1) (Aluminium oxide, activity III), yellow oil, 14.1 mg, 
60% yield. 
90:10 er,   25D  +621 (c = 0.60, CH2Cl2). 
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1H NMR (500 MHz, CD2Cl2) δ = 7.67-7.65 (m, 1H), 7.20-7.13 (m, 3H), 6.60 (d, J = 9.5 Hz, 1H), 
6.57 (d, J = 9.5 Hz, 1H), 2.69-2.66 (m, 2H), 2.60-2.54 (m, 1H), 2.46-2.40 (m, 1H), 1.88-.1.81 
(m, 1H), 1.79-1.64 (m, 3H), 1.37 (s, 3H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 174.3, 160.9, 144.9, 133.2, 131.9, 131.3, 129.5, 128.3, 126.8, 
125.5, 119.9, 81.6, 32.5, 29.6, 23.5, 23.2 ppm. 
MS (ESI) m/z (%): 236 (100). 
HRMS (ESI) m/z calculated for C17H18N (M+H
+) 236.143374, found 236.143220.  
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 97:3, 1.0 mL/min, λ = 254 nm, tmin = 
4.18 min, tmaj = 11.9 min. 
 
(R)-8,8,11a-Trimethyl-8,9,10,11a-tetrahydro-7H-benzo[a]carbazole (120b) 
 
The reaction was performed on a 0.05 mmol scale at 30 °C for 5 d, using (S)-STRIP (19a) as 
catalyst. 
Purification: hexane:EtOAc (20:1) (Aluminium oxide, activity III), yellow oil, 11.9 mg, 
90% yield. 
95:5 er,   25D  +705 (c = 0.5, CH2Cl2). 
1H NMR (500 MHz, CD2Cl2) δ = 7.68-7.66 (m, 1H), 7.20-7.13 (m, 3H), 6.59 (d, J = 9.6 Hz, 1H), 
6.57 (d, J = 9.8 Hz, 1H), 2.76-2.65 (m, 2H), 2.34 (d, J = 17.0 Hz, 1H), 2.22 (d, J = 17.0 Hz, 1H), 
1.68-1.60 (m, 2H), 1.37 (s, 3H), 1.00 (s, 3H), 0.99 (s, 3H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 173.6, 161.7, 145.0, 133.3, 131.8, 131.2, 129.5, 128.3, 126.8, 
125.5, 119.9, 82.3, 37.0, 36.1, 32.9, 30.4, 28.7, 27.5, 25.5 ppm. 
15N NMR (51 MHz, CD2Cl2) δ = −56.9 ppm. 
MS (EI) m/z (%): 263 (100), 248 (51), 235 (13), 217 (12), 207 (55), 194 (75), 165 (27), 152 (12). 
HRMS (ESI) m/z calculated for C19H22N (M+H
+) 264.174674, found 264.174600.  
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 97:3, 1.0 mL/min, λ = 254 nm, tmin = 
3.98 min, tmaj = 8.94 min. 
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Two step procedure: 
Compound (R)-(119b) (10.4 mg, 0.04 mmol) was dissolved in toluene (0.1 M) and diphenyl 
phosphate (4.9 mg, 0.02 mmol) was added. The reaction mixture was stirred at 40 °C over 
night and directly purified by column chromatography. 
Purification: hexane:EtOAc (20:1) (Aluminium oxide, activity III), yellow oil, 7.1 mg, 68% yield 
(56% yield over two steps). 
99:1 er. 
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 97:3, 1.0 mL/min, λ = 254 nm, tmin = 
3.97 min, tmaj = 9.09 min. 
 
For the structure assignment of 2H-pyrroles 120, compound 120b was fully characterized by 
NMR-spectroscopy. The [1,5]-methyl shift could be confirmed by 1H-15N-HMBC 
measurements which showed that the methyl group is positioned next to the nitrogen 
(N12). Moreover, 1H-15N-HMBC measurements showed the coupling of the methyl group 
(H11) to N12. Additionally, the cross peaks of H3, H11 and H9 to C7 in the 1H-13C-HMBC 
indicated the [1,5]-methyl shift. Moreover, the shift of C13 was in agreement with similar 
literature reported 2H-pyrroles.[106]  
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 (R)-11a-Methyl-8,8-dipropyl-8,9,10,11a-tetrahydro-7H-benzo[a]carbazole (120c) 
 
The reaction was performed at 40 °C for 2 d, using (S)-STRIP (19a) as catalyst. 
Purification: hexane:EtOAc (10:1) (Aluminium oxide, activity III), yellow oil, mg, 69% yield. 
92.5:7.5 er,   25D  +600 (c = 0.9, CH2Cl2). 
1H NMR (500 MHz, CD2Cl2) δ = 7.68-7.66 (m, 1H), 7.20-7.13 (m, 3H), 6.59 (d, J = 9.5 Hz, 1H), 
6.57 (d, J = 9.5 Hz, 1H), 2.71-2.60 (m, 2H), 2.36 (dd, J = 17.0, 1.0 Hz, 1H), 2.22 (d, J = 17.0 Hz, 
1H), 1.71-1.59 (m, 2H), 1.37 (s, 3H), 1.30-1.16 (m, 8H), 0.92-0-85 (m, 6H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 174.1, 161.7, 144.9, 133.3, 131.7, 131.1, 129.5, 128.3, 126.8, 
125.5, 119.9, 82.3, 40.0, 39.0, 35.4, 34.4, 32.9, 32.3, 24.9, 16.8, 15.12, 15.05 ppm. 
MS (EI) m/z (%): 319(57), 304 (25), 276 (29), 218 (9), 194 (100), 165 (10), 152 (4). 
HRMS (ESI) m/z calculated for C23H30N (M+H
+) 320.237274, found 320.237220.  
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 97:3, 1.0 mL/min, λ = 254, tmin = 3.62 min, 
tmaj = 7.41 min. 
 
(S)-12a-Methyl-7,8,9,10,11,12a-hexahydrobenzo[g]cyclohepta[b]indole (120d) 
 
The reaction was performed on a 0.09 mmol scale at 40 °C for 23 d, using (R)-STRIP (19a) as 
catalyst. 
Purification: hexane:EtOAc (8:1) (Aluminium oxide, activity III), yellow oil, 12 mg, 53% yield. 
90:10 er,   25D  −435 (c = 0.4, CH2Cl2). 
1H NMR (500 MHz, CD2Cl2) δ = 7.67 (d, J = 7.35 Hz, 1H), 7.21-7.13 (m, 3H), 6.61 (d, J = 9.4 Hz, 
1H), 6.57 (d, J = 9.5 Hz, 1H), 2.77-2.67 (m, 2H), 2.52-2.47 (m, 1H), 2.43-2.37 (m, 1H), 1.84-
1.75 (m, 2H), 1.74-1.61 (m, 3H), 1.59-1.52 (m, 1H), 1.36 (s, 3H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 178.7, 160.3, 144.6, 137.0, 133.3, 131.1, 129.3, 128.3, 126.8, 
125.5, 119.9, 81.0, 34.8, 32.7, 32.6, 29.7, 27.7, 26.2 ppm. 
MS (EI) m/z (%): 249 (100), 234 (44), 220 (26), 206 (24), 194 (95), 178 (14), 165 (25), 152 (13). 
HRMS (ESI) m/z calculated for C18H20N (M+H
+) 250.159024, found 250.158900.  
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HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 97:3, 1.0 mL/min, λ = 254 nm, tmaj = 
3.65 min, tmin = 11.9 min. 
 
(S)-8,8-Difluoro-11a-methyl-8,9,10,11a-tetrahydro-7H-benzo[a]carbazole (120e) 
 
The reaction was performed on a 0.09 mmol scale at 40 °C for 8 d, using (R)-STRIP (19a) as 
catalyst. 
Purification: hexane:EtOAc (10:1) (Aluminium oxide, activity III), yellow oil, 12.9 mg, 
53% yield. 
94:6 er,   25D  −643 (c = 0.625, CH2Cl2). 
1H NMR (500 MHz, CD2Cl2) δ = 7.69-7.67 (m, 1H), 7.23-7.16 (m, 3H), 6.66 (d, J = 9.5 Hz,m 1H), 
6.57 (d, J = 9.5 Hz, 1H), 3.14-3.05 (m, 1H), 3.00-2.86 (m, 3H), 2.38-2.20 (m, 2H), 1.41 (s, 3H) 
ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 170.7, 164.9, 144.5, 133.0, 132.7, 129.9, 128.7, 127.1, 126.0 
(dd, J = 5.3, 7.4 Hz), 125.5, 123.7 (t, J = 240 Hz), 119.0, 83.9, 33.0 (t, J = 27 Hz), 32.7, 31.3 (t, 
J = 25 Hz), 25.1 (dd, J = 5.3, 5.9 Hz) ppm. 
19F NMR (282 MHz, CD2Cl2) δ = -96.0 (d, J = 239 Hz, 1F), -97.3 (d, J = 239 Hz, 1F) ppm. 
MS (EI) m/z (%): 271 (100), 256 (13), 236 (28), 207 (19), 192 (6), 178 (3), 165 (19), 152 (6). 
HRMS (ESI) m/z calculated for C17H16NF2 (M+H
+) 272.124531, found 272.124300.  
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 97:3, 1.0 mL/min, λ = 254 nm, tmaj = 
6.01 min, tmin = 15.6 min. 
 
(S)-11a-Methyl-7,9,10,11a-tetrahydrospiro[benzo[a]carbazole-8,2'-[1,3]dioxolane] (120f) 
 
The reaction was performed on a 0.09 mmol scale at 40 °C for 9 d, using (R)-STRIP (19a) as 
catalyst. 
Purification: hexane:EtOAc (8:1 → 1:1) (Aluminium oxide, activity III), yellow oil, 11.3 mg, 
43% yield. 
89:11 er,   25D  −514 (c = 0.45, CH2Cl2). 
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1H NMR (500 MHz, CD2Cl2) δ = 7.67-7.66 (m, 1H), 7.20-7.14 (m, 3H), 6.60 (d, J = 9.6 Hz, 1H), 
6.56 (d, J = 9.4 Hz, 1H), 4.01-3.95 (m, 4H), 2.90-2.78 (m, 2H), 2.75 (d, J = 17.5 Hz, 1H), 2.65 (d, 
J = 17.5 Hz, 1H), 2.04-1.93 (m, 2H), 1.39 (s, 3H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 172.7, 162.8, 144.8, 133.1, 132.0, 129.9, 129.6, 128.5, 126.9, 
125.6, 119.5, 108.6, 83.2, 65.1, 65.0, 33.7, 32.6, 31.9, 26.3 ppm. 
MS (EI) m/z (%): 293 (100), 278 (8), 249 (19), 234 (7), 220 (11), 207 (57), 194 (21), 178 (12), 
165 (20), 152 (10), 99 (44). 
HRMS (ESI) m/z calculated for C19H20NO2 (M+H
+) 294.148854, found 294.148570.  
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 90:10, 1.0 mL/min, λ = 254 nm, tmaj = 
5.02 min, tmin = 14.1 min. 
 
(S)-11a-Methyl-7,9,10,11a-tetrahydrobenzo[g]thiopyrano[4,3-b]indole (120g) 
 
The reaction was performed on a 0.09 mmol scale at 40 °C for 9 d, using (R)-STRIP (19a) as 
catalyst. 
Purification: hexane:EtOAc (6:1) (Aluminium oxide, activity III), yellow oil,12.3 mg, 54% yield. 
91:9 er,   25D  −662 (c = 0.35, CH2Cl2). 
1H NMR (500 MHz, CD2Cl2) δ = 7.69-7.67 (m, 1H), 7.23-7.16 (m, 3H), 6.65 (d, J = 9.5 Hz, 1H), 
6.60 (d, J = 9.5 Hz, 1H), 3.64 (d, J = 16.5 Hz, 1H), 3.56 (d, J = 16.5 Hz, 1H), 3.05-3.02 (m, 2H), 
2.95-2.85 (m, 2H), 1.40 (s, 3H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 171.5, 161.7, 144.4, 132.9, 132.6, 129.8, 128.6, 127.1, 125.6, 
119.1, 80.7, 32.5, 32.0, 27.4, 25.5 ppm. 
MS (EI) m/z (%): 253 (99), 238 (30), 220 (12), 207 (100), 194 (22), 178 (10), 165 (28), 152 (14). 
HRMS (ESI) m/z calculated for C16H16NS (M+H
+) 254.099796, found 254.099800.  
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 97:3, 1.0 mL/min, λ = 254 nm, tmaj = 
7.93 min, tmin = 19.2 min. 
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(R)-11a-Methyl-7,9,10,11a-tetrahydrobenzo[g]pyrano[4,3-b]indole (120h) 
 
The reaction was performed at 40 °C for 9 d, using (S)-STRIP (19a) as catalyst. 
Purification: hexane:EtOAc (4:1) (Aluminium oxide, activity III), yellow oil,6.1 mg, 26% yield. 
81.5:18.5 er,   25D  +208 (c = 0.25, CH2Cl2). 
1H NMR (500 MHz, CD2Cl2) δ = 7.69-7.68 (m, 1H), 7.23-7.16 (m, 3H), 6.62 (d, J = 9.4 Hz, 1H), 
6.52 (d, J = 9.4 Hz, 1H), 4.70 (d, J = 16 Hz, 1H), 4.53 (d, J = 16 Hz, 1H), 4.00-3.96 (m, 1H), 3.85-
3.79 (m, 1H), 2.88-2.82 (m, 1H), 2.80-2.75 (m, 1H), 1.41 (s, 3H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 170.1, 160.0, 144.5, 132.8, 132.5, 129.8, 128.6, 127.0, 125.6, 
119.1, 82.7, 65.5, 32.5, 30.4 ppm. 
MS (EI) m/z (%): 237 (100), 222 (7), 207 (92), 192 (22), 180 (13), 165 (34), 152 (15), 139 (12). 
HRMS (ESI) m/z calculated for C16H16NO (M+H
+) 238.122639, found 238.122740.  
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 97:3, 1.0 mL/min, λ = 254, tmin = 12.4 min, 
tmaj = 18.0 min. 
 
(R)-tert-Butyl-11a-methyl-7,9,10,11a-tetrahydro-8H-benzo[g]pyrido[4,3-b]indole-8-
carboxylate (120i) 
 
The reaction was performed at 40 °C for 7 d, using (S)-STRIP (19a) as catalyst. 
Purification: hexane:EtOAc (5:1) (Aluminium oxide, activity III), yellow oil, 15.1 mg, 
45% yield. 
84:16 er,   25D  +460 (c = 0.29, CH2Cl2). 
1H NMR (500 MHz, CD2Cl2) δ = 7.68 (d, J = 7.2 Hz, 1H), 7.22-7.15 (m, 3H), 6.64 (d, J = 9.5 Hz, 
1H), 6.60 (d, J = 9.5 Hz, 1H), 4.56 (b, 1H), 4.27 (d, J = 18.0 Hz, 1H), 3.82 (dt, J = 13.5, 5.4 Hz, 
1H), 3.53 (b, 1H), 2.81-2.70 (m, 2H), 1.46 (s, 9H), 1.41 (s, 3H) ppm. 
13C NMR (151 MHz, CD3CN) δ = 172.1, 161.5, 155.6, 145.0, 133.5, 133.1, 130.6, 129.3, 128.3, 
127.8, 126.1, 119.9, 83.2, 80.6, 42.6 (b), 32.8, 29.9, 28.5 ppm. 
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Slice of 1H-13C-HSQC spectrum in CD3CN, showing the cross signals between the two 
broadened CH2N-signals at around 42.6 ppm and their attached protons. 
 
 
MS (EI) m/z (%): 336 (2), 279 (100), 264 (8), 235 (27), 207 (12), 194 (25), 165 (7), 149 (8), 57 
(33). 
HRMS (ESI) m/z calculated for C21H25N2O2 (M+H
+) 337.191053, found 337.190870.  
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 80:20, 1.0 mL/min, λ = 254 nm, tmin = 
3.11 min, tmaj = 5.15 min. 
 
(R)-11a-Methyl-8-tosyl-8,9,10,11a-tetrahydro-7H-benzo[g]pyrido[4,3-b]indole (120j) 
 
The reaction was performed at 40 °C for 7d, using (S)-STRIP (19a) as catalyst. 
Purification: hexane:EtOAc (8:1  4:1) (Aluminium oxide, activity III), yellow oil, 17.1 mg, 
44% yield. 
79.5:20.5 er,   25D  +382 (c = 0.79, CH2Cl2). 
1H NMR (500 MHz, CD2Cl2) δ = 7.68-7.66 (m, 2H), 7.63-7.61 (m, 1H), 7.30-7.28 (m, 2H), 7.21-
7.15 (m, 3H), 6.65 (d, J = 9.5 Hz, 1H), 6.56 (d, J = 9.5 Hz, 1H), 4.31 (d, J = 16 Hz, 1H), 3.92 (d, 
J = 16 Hz, 1H), 3.62-3.57 (m, 1H), 3.25-3.20 (m, 1H), 2.89-2.77 (m, 2H), 2.37 (s, 3H), 1.36 (s, 
3H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 169.6, 162.5, 144.5, 144.3, 134.1, 133.2, 132.5, 130.2, 129.9, 
128.8, 127.9, 127.1, 125.6, 125.3, 118.7, 83.2, 44.7, 44.6, 32.4, 29.2, 21.6 ppm. 
MS (EI) m/z (%): 390 (46), 234 (100), 219 (29), 207 (75), 194 (60), 180 (17), 165 (22), 152 (8), 
91 (19). 
HRMS (ESI) m/z calculated for C23H23N2O2S (M+H
+) 391.147475, found 391.147340.  
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HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 80:20, 1.0 mL/min, λ = 254, tmin = 7.66 min, 
tmaj = 15.9 min. 
 
(R)-8b,12,12-Trimethyl-8b,11,12,13-tetrahydro-10H-dibenzo[a,c]carbazole (120k) 
 
The reaction was performed at 40°C for 5d, using (S)-STRIP (19a) as catalyst. 
Purification: hexane:EtOAc (12:1) (Aluminium oxide, activity III), yellow oil, 12.8 mg, 
41% yield. 
84:16 er,   25D  +355 (c = 0.45, CH2Cl2). 
1H NMR (500 MHz, CD2Cl2) δ = 7.93 (d, J = 7.8 Hz, 1H), 7.80-7.77 (m, 2H), 7.46 (dd, J = 7.4, 1.3 
Hz, 1H), 7.42 (td, J = 7.4, 1.3 Hz, 1H), 7.37 (td, J = 7.4, 1.3 Hz, 1H), 7.30-7.26 (m, 2H), 2.84-
2.78 (m, 1H), 2.73-2.66 (m, 1H), 2.59 (d, J = 17 Hz, 1H), 2.40 (dd, J = 17. 1.4 Hz, 1H), 1.77-1.71 
(m, 1H), 1.69-1.63 (m, 1H), 1.35 (s, 3H), 1.11 (s, 3H), 0.89 (s, 3H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 173.8, 160.2, 141.7, 134.7, 132.8, 130.7, 130.4, 129.3, 128.6, 
128.2, 127.4, 126.8, 126.3, 125.3, 124.3, 81.5, 38.2, 35.9, 30.5, 29.9, 29.6, 26.6, 25.4 ppm. 
MS (EI) m/z (%): 313 (100), 298 (34), 285 (49), 258 (62), 244 (57), 215 (32), 202 (15), 165 (4). 
HRMS (ESI) m/z calculated for C23H24N (M+H
+) 314.190324, found 314.190290.  
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 97:3, 1.0 mL/min, λ = 254 nm, tmin = 
3.82 min, tmaj = 4.59 min. 
 
(R)-11a-Ethyl-8,8-dimethyl-8,9,10,11a-tetrahydro-7H-benzo[a]carbazole (120l) 
 
The reaction was performed at 40 °C for 3 d, using (S)-STRIP (19a) as catalyst. 
Purification: hexane:EtOAc (12:1) (Aluminium oxide, activity III), yellow oil, 23 mg, 83% yield. 
80.5:19.5 er,   25D  +512 (c = 0.25, CH2Cl2). 
1H NMR (500 MHz, CD2Cl2) δ = 7.65-7.62 (m, 1H), 7.20-7.13 (m, 3H), 6.55 (d, J = 9.6 Hz, 1H), 
6.53 (d, J = 9.6 Hz, 1H), 2.80-2.67 (m, 2H), 2.37 (dd, J = 17.0, 0.9 Hz, 1H), 2.20 (d, J = 17.0 Hz, 
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1H), 2.11-2.04 (m, 1H), 1.70-1.63 (m, 2H), 1.62-1.55 (m, 1H), 1.01 (s, 6H), 0.52 (t, J = 7.3 Hz, 
3H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 174.5, 159.8, 144.7, 133.5, 132.9, 131.4, 129.4, 127.9, 126.8, 
126.2, 119.9, 85.4, 38.1, 37.0, 36.1, 30.3, 29.2, 27.0, 25.2, 8.75 ppm.  
MS (EI) m/z (%): 277 (100), 262 (37), 248 (66), 221 (30), 208 (30), 193 (45), 180 (12), 165 (14). 
HRMS (ESI) m/z calculated for C20H24N (M+H
+) 278.190324, found 278.190110.  
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 97:3, 1.0 mL/min, λ = 254 nm, tmaj = 
3.04 min, tmin = 3.87 min. 
 
(R)-3,8,8,11a-Tetramethyl-8,9,10,11a-tetrahydro-7H-benzo[a]carbazole (120m) 
 
The reaction was performed at 40 °C for 2 d, using (S)-STRIP (19a) as catalyst. 
Purification: hexane:EtOAc (12:1) (Aluminium oxide, activity III), yellow oil, 23.2 mg, 
84% yield. 
95:5 er,   25D  +603 (c = 1.15, CH2Cl2). 
1H NMR (500 MHz, CD2Cl2) δ = 7.57-7.55 (m, 1H), 7.02-7.00 (m, 2H), 6.56 (d, J = 9.5 Hz, 1H), 
6.53 (d, J = 9.5 Hz, 1H), 2.76-2.65 (m, 2H), 2.33 (d, J = 17.0 Hz, 1H), 2.29 (s, 3H), 2.21 (d, J = 
17.0 Hz, 1H), 1.68-1.61 (m, 2H), 1.35 (s, 3H), 1.00 (s, 3H), 0.99 (s, 3H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 173.7, 162.2, 141.9, 136.5, 133.1, 131.6, 131.5, 130.2, 128.9, 
125.5, 119.8, 82.2, 37.0, 36.1, 32.9, 30.3, 28.7, 27.5, 25.4, 21.1 ppm. 
MS (EI) m/z (%): 277 (100), 262 (47), 249 (15), 232 (6), 221 (38), 208 (54), 191 (8), 156 (7). 
HRMS (ESI) m/z calculated for C20H24N (M+H
+) 278.190324, found 278.190170.  
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 97:3, 1.0 mL/min, λ = 254 nm, tmin = 
3.67 min, tmaj = 4.92 min. 
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(R)-5,8,8,11a-Tetramethyl-8,9,10,11a-tetrahydro-7H-benzo[a]carbazole (120n) 
 
The reaction was performed on a 0.05 mmol scale at 30 °C for 3 d, using (S)-STRIP (19a) as 
catalyst. 
Purification: hexane:EtOAc (15:1) (Aluminium oxide, activity III), yellow oil, 11.5 mg, 
83% yield. 
95:5 er,   25D  +796 (c = 0.45, CH2Cl2). 
1H NMR (500 MHz, CD2Cl2) δ = 7.71-7.69 (m, 1H), 7.41-7.37 (m, 1H), 7.23-7.19 (m, 2H), 6.46 
(s, 1H), 2.75-2.64 (m, 2H), 2.31 (d, J = 17.0 Hz, 1H), 2.26 (d, J = 0.5 Hz, 3H), 2.20 (d, J = 17.0 
Hz, 1H), 1.67-1.60 (m, 2H), 1.37 (s, 3H), 1.00 (s, 3H), 0.98 (s, 3H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 174.1, 162.0, 144.5, 137.4, 134.4, 129.8, 128.2, 126.7, 126.1, 
125.6, 118.4, 82.0, 36.9, 36.1, 33.0, 30.3, 28.7, 27.6, 25.4, 20.1 ppm. 
MS (EI) m/z (%): 277 (67), 262 (44), 249 (15), 232 (11), 221 (64), 208 (100), 191 (28), 178 (29), 
165 (56), 152 (23). 
HRMS (ESI) m/z calculated for C20H24N (M+H
+) 278.190324, found 278.190390.  
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 98:2, 1.0 mL/min, λ = 254 nm, tmaj = 
3.99 min, tmin = 4.75 min. 
 
(R)-6,8,8,11a-Tetramethyl-8,9,10,11a-tetrahydro-7H-benzo[a]carbazole (120o) 
 
The reaction was performed on a 0.075 mmol scale at 40 °C for 4 d, using (S)-STRIP (19a) as 
catalyst. 
Purification: hexane:EtOAc (15:1) (Aluminium oxide, activity III), yellow oil, 11.3 mg, 
54% yield. 
90.5:9.5 er,   25D  +614 (c = 0.325, CH2Cl2). 
1H NMR (500 MHz, CD2Cl2) δ = 7.62-7.59 (m, 1H), 7.13-7.07 (m, 3H), 6.29 (s, 1H), 2.76-2.65 
(m, 2H), 2.53 (d, J = 17.0 Hz, 1H), 2.37 (d, J = 17.0 Hz, 1H), 2.17 (d, J = 1.4 Hz, 3H), 1.67-1.58 
(m, 2H), 1.36 (s, 3H), 1.01 (s, 3H), 0.99 (s, 3H) ppm. 
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13C NMR (125 MHz, CD2Cl2) δ = 173.5, 163.6, 143.6, 134.0, 131.5, 131.3, 128.6, 128.2, 127.3, 
126.8, 125.2, 82.9, 39.1, 35.7, 32.2, 30.4, 28.7, 27.9, 25.5, 19.8 ppm. 
MS (EI) m/z (%): 277 (75), 262 (50), 249 (19), 232 (13), 221 (60), 208 (100), 191 (28), 178 (29), 
165 (64), 152 (26). 
HRMS (ESI) m/z calculated for C20H24N (M+H
+) 278.190324, found 278.190340.  
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 97:3, 1.0 mL/min, λ = 254 nm, tmin = 
3.34 min, tmaj = 4.68 min. 
 
(R)-11a-Methyl-7,9,10,11a-tetrahydrobenzo[g]thiopyrano[4,3-b]indole 8,8-dioxide (120u) 
 
The reaction was performed at 40 °C for 8d, using (S)-STRIP (19a) as catalyst. 
Purification: hexane:EtOAc (8:1) (Aluminium oxide, activity III), yellow oil, 11.3 mg, 
40% yield. 
51.5:48.5 er 
1H NMR (500 MHz, CD2Cl2) δ = 7.70-7.68 (m, 1H), 7.26-7.19 (m, 3H), 6.73 (d, J = 10.7 Hz, 1H), 
6.54 (d, J = 10.7 Hz, 1H), 4.15 (d, J = 17 Hz, 1H), 4.06 (d, J = 17 Hz, 1H), 3.39-3.27 (m, 4H), 1.45 
(s, 3H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 168.8, 166.5, 144.0, 134.6, 132.2, 130.3, 129.1, 127.4, 125.5, 
121.5, 118.0, 84.1, 50.6, 48.3, 32.8, 27.7 ppm. 
HPLC: Daicel Chiralpak AD-3, n-heptane/i-PrOH = 85:15, 1.0 mL/min, λ = 254, tmin = 8.58 min, 
tmaj = 9.73 min.  
 
(S)-10,10-Dibromo-8,8,11a-trimethyl-8,9,10,11a-tetrahydro-7H-benzo[a]carbazole (178b) 
 
To a solution of 2H-pyrrole 120b (16.8 mg, 0.06 mmol) in CHCl3 (0.1 M), N-bromosuccinimide 
(34.1 mg, 0.19 mmol) was added portion wise. The reaction was stirred at rt for 1.5 h and 
the crude mixture was directly submitted to column chromatography. 
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Compound 178b was found to be highly unstable and could not be characterized via 13C-
NMR and MS analysis. 
Purification: hexane:EtOAc (20:1) (Aluminium oxide, activity III), yellow oil, 18.0 mg, 
67% yield. 
1H NMR (500 MHz, CD2Cl2) δ = 7.80 (d, J = 7.2 Hz, 1H), 7.27-7.19 (m, 3H), 6.70 (d, J = 9.4 Hz, 
1H), 6.58 (d, J = 9.6 Hz, 1H), 3.13 (d, J = 16 Hz, 1H), 3.09 (d, J = 16 Hz, 1H), 2.47 (d, J = 17 Hz, 
1H), 2.34 (d, J = 17 Hz, 1H), 1.46 (s, 3H), 1.15 (3H), 1.07 (s, 3H) ppm. 
 
(S)-10-Bromo-8,8,11a-trimethyl-8,11a-dihydro-7H-benzo[a]carbazole (180) 
 
Dibromo pyrrole 178b (18.0 mg, 0.04 mmol) was dissolved in anhydrous THF (0.1 M) and 
KOtBu was added (9.59 mg, 0.08 mmol). The reaction was stirred at 40 °C for 5 h and the 
crude mixture was directly submitted to column chromatography.  
 
Purification: hexane:EtOAc (20:1) (Aluminium oxide, activity III), yellow solid, 6.1 mg, 
42% yield. 
1H NMR (500 MHz, CD2Cl2) δ = 7.75 (d, J = 6.4 Hz, 1H), 7.24-7.17 (m, 3H), 6.72 (s, 1H), 6.64 (d, 
J = 9.6 Hz, 1H), 6.61 (d, J = 9.1 Hz, 1H), 2.57 (d, J = 17 Hz, 1H), 2.49 (d, J = 16 Hz, 1H), 1.46 (s, 
3H), 1.15 (s, 3H), 1.13 (s, 3H) ppm. 
MS (EI) m/z (%): 339 (28), 260 (35), 245 (100), 230 (27), 202 (10), 165 (5), 115 (12). 
HRMS (ESI) m/z calculated for C19H19NBr (M+H
+) 340.069549, found 340.069470.  
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Compounds 120p-t were synthesized as racemates under non-optimized reaction conditions. 
 
rac-3,11a-Dimethyl-8,9,10,11a-tetrahydro-7H-benzo[a]carbazole (120p) 
 
The reaction was conducted on a 0.140 mmol scale. 
Purification: hexane:EtOAc (8:1) (Aluminium oxide, activity III), yellow oil, 13.6 mg, 
39% yield. 
1H NMR (500 MHz, CD2Cl2) δ = 7.54 (d, J = 8.3 Hz, 1H), 7.01-7.00 (m, 2H), 6.58 (d, J = 9.5 Hz, 
1H), 6.53 (d, J = 9.5 Hz, 1H), 2.67 (d, J = 6.1 Hz, 1H), 2.66 (d, J = 6.5 Hz, 1H), 2.59-2.53 (m, 1H), 
2.46-2.39 (m, 1H), 2.28 (s, 3H), 1.86-1.81 (m, 1H), 1.78-1.65 (m, 3H), 1.35 (s, 3H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 174.2, 161.2, 142.0, 136.4, 133.1, 131.7, 131.4, 130.2, 128.9, 
125.4, 119.9, 81.5, 32.5, 29.6, 23.6, 23.3, 23.2, 21.1 ppm. 
MS (EI) m/z (%):249 (100), 234 (58), 221 (21), 208 (15), 191 (8), 178 (8), 165 (12), 152 (4). 
HRMS (ESI) m/z calculated for C18H20N (M+H
+) 250.159024, found 250.159120.  
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 97:3, 1.0 mL/min, λ = 254nm, t1 = 3.64 min, 
t2 = 5.58 min. 
 
rac-5,11a-Dimethyl-8,9,10,11a-tetrahydro-7H-benzo[a]carbazole (120q) 
 
The reaction was conducted on a 0.147 mmol scale. 
Purification: hexane:EtOAc (8:1) (Aluminium oxide, activity III), yellow oil, 7.6 mg, 21% yield. 
1H NMR (500 MHz, CD2Cl2) δ = 7.70-7-67 (m, 1H), 7.40-7.37 (m, 1H), 7.22-7.18 (m, 2H), 6.48 
(s, 1H), 2.67-2.64 (m, 2H), 2.57-2.51 (m, 1H), 2.43-2.37 (m, 1H), 2.26 (s, 3H), 1.87-1.80 (m, 
1H), 1.77-1.65 (m, 3H), 1.36 (s, 3H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 174.5, 161.1, 144.6, 137.3, 134.5, 130.0, 128.2, 126.7, 126.1, 
125.6, 118.5, 81.4, 32.6, 29.6, 23.6, 23.3, 23.1, 20.0 ppm. 
MS (EI) m/z (%):249 (100), 234 (47), 221 (20), 208 (11), 191 (6), 178 (8), 165 (11), 152 (4). 
HRMS (ESI) m/z calculated for C18H20N (M+H
+) 250.159024, found 250.158960.  
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HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 99:1, 1.0 mL/min, λ = 254 nm, t1 = 
6.26 min, t2 = 7.77 min. 
 
rac-6,11a-Dimethyl-8,9,10,11a-tetrahydro-7H-benzo[a]carbazole (120r) 
 
The reaction was conducted on a 0.115 mmol scale. 
Purification: hexane:EtOAc (8:1) (Aluminium oxide, activity III), yellow oil, 8.03 mg, 
28% yield. 
1H NMR (500 MHz, CD2Cl2) δ = 7.71-7.69 (m, 1H), 7.17-7.09 (m, 3H), 6.35 (s, 1H), 2.80-2.75 
(m, 3H), 2.63-2.57 (m, 1H), 2.19 (s, 3H), 1.85-1.71 (m, 4H), 1.44 (s, 3H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 175.7, 164.2, 142.7, 133.5, 131.2, 131.0, 129.8, 128.5, 127.7, 
127.2, 125.5, 81.8, 32.0, 29.4, 24.9, 23.3, 22.7, 19.7 ppm. 
MS (EI) m/z (%):249 (100), 234 (53), 221 (20), 208 (25), 191 (9), 178 (12), 165 (20), 152 (5). 
HRMS (ESI) m/z calculated for C18H20N (M+H
+) 250.159024, found 250.159180.  
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 97:3, 1.0 mL/min, λ = 254 nm, t1 = 
3.07 min, t2 = 4.27 min. 
 
rac-11a-Ethyl-8,9,10,11a-tetrahydro-7H-benzo[a]carbazole (120s) 
 
The reaction was conducted on a 0.182 mmol scale. 
Purification: hexane:EtOAc (8:1) (Aluminium oxide, activity III), yellow oil, 15.8 mg, 
35% yield. 
1H NMR (500 MHz, CD2Cl2) δ = 7.65-7.63 (m, 1H), 7.20-7.14 (m, 3H), 6.55 (d, J = 9.6 Hz, 1H), 
6.53 (d, J = 9.6 Hz, 1H), 2.80-2.67 (m, 2H), 2.37 (dd, J = 17, 0.9 Hz, 1H), 2.20 (d, J = 17 Hz, 1H), 
2.12-2.04 (m, 1H), 1.68-1.63 (m, 2H), 1.62-1.55 (m, 1H), 1.01 (s, 6H),  
13C NMR (125 MHz, CD2Cl2) δ = 175.4, 159.5, 144.4, 133.5, 132.7, 131.7, 129.5, 128.0, 126.8, 
126.3, 119.9, 84.6, 38.0, 29.3, 23.6, 23.3, 23.1, 8.82 ppm. 
MS (EI) m/z (%):249 (58), 234 (37), 220 (100), 204 (11), 193 (28), 178 (13), 165 (21), 152 (11). 
HRMS (ESI) m/z calculated for C18H20N (M+H
+) 250.159024, found 250.159090.  
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HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 98:2, 1.0 mL/min, λ = 254 nm, t1 = 
4.31 min, t2 = 5.61 min. 
 
rac-8b-Methyl-8b,11,12,13-tetrahydro-10H-dibenzo[a,c]carbazole (120t) 
 
The reaction was conducted on a 0.125 mmol scale. 
Purification: hexane:EtOAc (8:1) (Aluminium oxide, activity III), yellow oil, 10.9 mg, 
31% yield. 
1H NMR (500 MHz, CD2Cl2) δ = 7.94-7.92 (m, 1H), 7.80-7.76 (m, 2H), 7.47 (dd, J = 1.5, 7.4 Hz, 
1H), 7.41 (dt, J = 1.6, 7.5 Hz, 1H), 7.37 (dt, J = 1.3, 7.4 Hz, 1H), 7.30-7.25 (m, 2H), 2.85-2.75 
(m, 2H), 2.66-2.59 (m, 2H), 1.89-1.84 (m, 2H), 1.82-1.76 (m, 1H), 1.67-1.58 (m, 1H), 1.35 (s, 
3H) ppm. 
13C NMR (125 MHz, CD2Cl2) δ = 174.6, 159.4, 141.6, 134.7, 132.8, 130.9, 130.4, 129.3, 128.6, 
128.3, 127.4, 126.8, 126.3, 125.4, 124.3, 80.8, 29.6, 29.3, 24.4, 23.5, 23.3 ppm. 
MS (EI) m/z (%):285 (100), 270 (29), 257 (16), 244 (49), 215 (31), 202 (14), 189 (8), 165 (4). 
HRMS (ESI) m/z calculated for C21H20N (M+H
+) 286.159024, found 286.158770.  
HPLC: Daicel Chiralpak OD-3, n-heptane/i-PrOH = 99:1, 1.0 mL/min, λ = 254 nm, t1 = 
7.47 min, t2 = 8.85 min. 
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 In situ [1,5]-Methyl Shift and its Application to a Kinetic Resolution 7.5.4.
 
A solution of enantiopure 3H-pyrrole 119a (98:2 er) in toluene-d8 (0.1 M) was treated with 
diphenyl phosphate (1 equiv.) and stirred at 45 °C. After 15 h 3H-pyrrole 119a was fully 
converted into the corresponding 2H-pyrrole 120a without loss of enantiopurity  
 
 
 
For further investigations of this reactivity, a kinetic resolution of 3H-pyrroles 119 via a [1,5]-
methyl shift was explored. Racemic 3H-pyrrole 119a was dissolved in anhydrous toluene 
(0.035 M) and treated with (R)-STRIP (19a) (5 mol%) and Amberlite® CG50 (500 mg/mmol). 
The mixture was stirred at 45 °C for 23 h, after which 37% of 119a was converted into 2H-
pyrrole 120a, resulting in an s-factor of 6 under non-optimized conditions. 
 
s-factor and conversion were calculated using the Kagan equation.[170] 
 
 
 
 CD Spectroscopical Investigations of 3H- and 2H-Pyrroles  7.5.5.
 
The CD-spectra of (S)-119b (c = 1.0 x 10-4 M) and (S)-120b (c = 1.0 x 10-4 M) were recorded in 
MeOH (HPLC grade) at 20 °C and compared with the corresponding TD-DFT calculated CD 
spectra of both possible conformers (S)-119b-1/2 and (S)-120b-1/2 (blue graph). After a UV 
correction of −9 nm to −17 nm and a correction of the -value of 0.3 eV to 0.4 eV, the CD 
characteristics of the calculated spectra (blue graph) were in good agreement with the 
experimental spectra (red graph), thus allowing the assignment of the absolute 
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configuration of pyrroles 119b and 120b, which were found to be (S)-configured, using the 
(R)-enantiomer of the catalyst. This result is in perfect agreement with our investigations on 
the catalytic asymmetric synthesis of 1,4-diketones 118 (see: chapter 4.4.4.1). Moreover, it 
strongly indicates that the [1,5]-alkyl shift is indeed stereospecific and occurs in a suprafacial 
mode, preserving the absolute configuration in our system.  
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 Calculations 7.5.6.
 Calculation of the [1,5]-Methyl Shift  7.5.6.1.
 
 
 
 
 
 
Selected distances for all computed species at the B3LYP-D3/TZVP level (distance in Å). 
 C0-C1 C0-C2 
119a-1 1.56 2.50 
TSa-1 2.07 2.05 
120a-1 2.50 1.55 
119a-2 1.56 2.50 
TSa-2 2.07 2.05 
120a-2 2.50 1.55 
 
Computed relative energy (E), enthalpy (H), and free energy (G) at the B3LYP-D3/TZVP level 
(energy in kcal/mol). 
 ∆E ∆H ∆G 
119a-1 0 0 0 
TSa-1 29.7 29.7 29.8 
120a-1 -5.1 -5.2 -4.9 
119a-2 0 0 0 
TSa-2 29.7 29.7 29.7 
120a-2 -4.9 -5.0 -4.8 
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Selected distances for all computed species at the B3LYP-D3/TZVP level (distance in Å). 
 C0-C1 C0-C2 
119a-H1 1.59 2.45 
TSa-H1 2.08 2.05 
120a-H1 2.50 1.56 
119a-H2 1.59 2.56 
TSa-H2 2.07 2.05 
120a-H2 2.49 1.56 
 
Computed relative energy (E), enthalpy (H), and free energy (G) at the B3LYP-D3/TZVP level 
(energy in kcal/mol). 
 ∆E ∆H ∆G 
119a-H1 0 0 0 
TSa-H1 19.2 19.3 19.0 
120a-H1 -9.2 -9.2 -9.1 
119a-H2 0.1 0.1 0.1 
TSa-H2 19.2 19.3 19.0 
120a-H2 -9.0 -9.0 -9.0 
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Selected distances for all computed species at the B3LYP-D3/TZVP level (distance in Å). 
 C0-C1 C0-C2 
119b-1 1.56 2.50 
TSb-1 2.07 2.05 
120b-1 2.50 1.55 
119b-2 1.56 2.50 
TSb-2 2.08 2.05 
120b-2 2.50 1.55 
 
Computed relative energy (E), enthalpy (H), and free energy (G) at the B3LYP-D3/TZVP level 
(energy in kcal/mol). 
 ∆E ∆H ∆G 
119b-1 0 0 0 
TSb-1 29.7 29.8 29.7 
120b-1 -4.8 -4.9 -4.9 
119b-2 0.1 0.2 0 
TSb-2 29.8 29.9 29.8 
120b-2 -4.8 -4.9 -4.9 
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Selected distances for all computed species at the B3LYP-D3/TZVP level (distance in Å). 
 C0-C1 C0-C2 
119b-H1 1.59 2.45 
TSb-H1 2.08 2.05 
120b-H1 2.49 1.56 
119b-H2 1.59 2.46 
TSb-H2 2.08 2.05 
120b-H2 2.49 1.56 
 
Computed relative energy (E), enthalpy (H), and free energy (G) at the B3LYP-D3/TZVP level 
(energy in kcal/mol). 
 ∆E ∆H ∆G 
119b-H1 0 0 0 
TSb-H1 19.2 19.4 19.1 
120b-H1 -9.0 -9.0 -9.0 
119b-H2 0.2 0.3 0.2 
TSb-H2 19.3 19.6 18.8 
120b-H2 -9.0 -9.0 -9.1 
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The [1,5]-methyl shift was calculated for room temperature (298.15 K) for two possible 
conformers of pyrroles 119a-1/2 and 120a-1/2 which were found to be very similar in energy 
(difference ≈0.1-0.2 kcal/mol) and presumably coexist in the reaction. In the absence of an 
acid, the energy barrier of the [1,5]-methyl shift is for both conformers of 119a-1/2 
≈30 kcal/mol. Upon full protonation of the nitrogen via a strong acid, the energy barrier is 
lowered significantly to ≈20 kcal/mol. For weaker acids, the energy barrier is lowered less. 
The calculated energies for the [1,5]-methyl shift of 3H-pyrrole 119b-1/2 were found to be 
very similar to those of 3H-pyrrole 119a-1/2. 
 
 Computational Methods 7.5.6.2.
 
All computations were carried out using the Gaussian 09 program package.[171] Geometries 
were optimized using the B3LYP-D3 functional[172-174] and TZVP basis set.[175-176] Each 
stationary point was confirmed to be either a minimum or transition state (TS) structure by 
using both frequency and intrinsic reaction coordinate (IRC)[177-178] calculations. The 
electronic circular dichroism (ECD) spectra were predicted using time-dependent density 
functional theory (TD-DFT)[179-180] with the TD-B3LYP-D3/TZVP method with inclusion of 
continuum solvation[181-183] (MeOH). The ECD spectra were generated using the program 
SpecDis.[184-185] The corresponding settings are given in the individual experiments. 
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 X-Ray Crystal Structure Data 7.6.
 
X-ray Crystallographic Data for Compound (M)-115a 
   
 
Table 1. Crystal data and structure refinement. 
 
Identification code  7859sadabs 
Empirical formula  C33H26IN 
Color  orange 
Formula weight  563.45  g · mol-1  
Temperature  100 K 
Wavelength  1.54184 Å 
Crystal system  MONOCLINIC 
Space group  p 21 ,  (no. 4)  
Unit cell dimensions a = 11.595(3) Å α= 90°. 
 b = 8.301(2) Å β= 104.403(6)°. 
 c = 13.141(3) Å γ = 90°. 
Volume 1225.1(5) Å3 
Z 2 
Density (calculated) 1.527  Mg · m-3 
Absorption coefficient 10.425 mm-1 
F(000) 568 e 
Crystal size 0.57 x 0.34 x 0.13 mm3 
 range for data collection 3.47 to 65.08°. 
Index ranges -12  h  13, -9 k  8, -13  l  15 
Reflections collected 41725 
Independent reflections 3529 [Rint = 0.0594] 
Reflections with I>2(I) 3527 
Completeness to  = 65.08° 94.2 %  
Absorption correction Gaussian 
Max. and min. transmission 0.33497 and 0.02099 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3529 / 1 / 318 
Goodness-of-fit on F2 1.078 
Final R indices [I>2(I)] R1 = 0.0318 wR
2 = 0.0827 
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R indices (all data) R1 = 0.0318 wR
2 = 0.0827 
Absolute structure parameter 0.005(5) 
Largest diff. peak and hole 0.473 and -1.585 e · Å-3 
 
Table 2.   Bond lengths [Å] and angles [°]. 
 
___________________________________________________________________  __  
C(1)-C(28) 1.522(7)  C(1)-N(1) 1.464(6) 
C(2)-C(3) 1.495(6)  C(2)-C(19) 1.380(6) 
C(2)-N(1) 1.363(6)  C(3)-C(4) 1.531(6) 
C(4)-C(5) 1.516(6)  C(5)-C(6) 1.401(7) 
C(5)-C(18) 1.409(6)  C(6)-C(7) 1.370(7) 
C(7)-C(8) 1.405(7)  C(8)-C(9) 1.423(6) 
C(8)-C(17) 1.426(7)  C(9)-C(10) 1.353(7) 
C(10)-C(11) 1.426(7)  C(11)-C(12) 1.426(7) 
C(11)-C(16) 1.419(6)  C(12)-C(13) 1.360(7) 
C(13)-C(14) 1.397(8)  C(14)-C(15) 1.395(7) 
C(15)-C(16) 1.409(7)  C(16)-C(17) 1.465(6) 
C(17)-C(18) 1.434(6)  C(18)-C(19) 1.480(6) 
C(19)-C(20) 1.466(6)  C(20)-C(21) 1.411(7) 
C(20)-C(25) 1.418(7)  C(21)-C(22) 1.396(6) 
C(21)-N(1) 1.397(6)  C(22)-C(23) 1.395(6) 
C(23)-C(24) 1.412(7)  C(23)-C(26) 1.499(6) 
C(24)-C(25) 1.394(6)  C(25)-C(27) 1.506(6) 
C(28)-C(29) 1.384(7)  C(28)-C(33) 1.386(7) 
C(29)-C(30) 1.390(7)  C(30)-C(31) 1.391(7) 
C(31)-C(32) 1.382(6)  C(31)-I(1) 2.102(4) 
C(32)-C(33) 1.388(7)  
N(1)-C(1)-C(28) 112.4(4)  C(19)-C(2)-C(3) 121.6(4) 
N(1)-C(2)-C(3) 125.8(4)  N(1)-C(2)-C(19) 111.4(4) 
C(2)-C(3)-C(4) 104.9(4)  C(5)-C(4)-C(3) 111.0(3) 
C(6)-C(5)-C(4) 120.1(4)  C(6)-C(5)-C(18) 120.1(4) 
C(18)-C(5)-C(4) 119.8(4)  C(7)-C(6)-C(5) 121.0(4) 
C(6)-C(7)-C(8) 120.5(4)  C(7)-C(8)-C(9) 120.0(4) 
C(7)-C(8)-C(17) 119.6(5)  C(9)-C(8)-C(17) 120.4(4) 
C(10)-C(9)-C(8) 121.6(4)  C(9)-C(10)-C(11) 120.1(4) 
C(10)-C(11)-C(12) 120.2(4)  C(16)-C(11)-C(10) 120.6(4) 
C(16)-C(11)-C(12) 119.1(4)  C(13)-C(12)-C(11) 121.5(4) 
C(12)-C(13)-C(14) 119.7(4)  C(15)-C(14)-C(13) 120.3(5) 
C(14)-C(15)-C(16) 121.1(4)  C(11)-C(16)-C(17) 118.9(4) 
C(15)-C(16)-C(11) 118.0(4)  C(15)-C(16)-C(17) 123.0(4) 
C(8)-C(17)-C(16) 117.2(4)  C(8)-C(17)-C(18) 118.4(4) 
C(18)-C(17)-C(16) 124.3(4)  C(5)-C(18)-C(17) 118.4(4) 
C(5)-C(18)-C(19) 114.2(4)  C(17)-C(18)-C(19) 127.3(4) 
C(2)-C(19)-C(18) 119.1(4)  C(2)-C(19)-C(20) 105.7(4) 
C(20)-C(19)-C(18) 133.8(4)  C(21)-C(20)-C(19) 106.1(4) 
C(21)-C(20)-C(25) 117.9(4)  C(25)-C(20)-C(19) 135.4(5) 
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C(22)-C(21)-C(20) 124.4(4)  C(22)-C(21)-N(1) 126.2(4) 
N(1)-C(21)-C(20) 108.7(4)  C(23)-C(22)-C(21) 117.5(4) 
C(22)-C(23)-C(24) 118.9(4)  C(22)-C(23)-C(26) 120.0(4) 
C(24)-C(23)-C(26) 120.9(4)  C(25)-C(24)-C(23) 123.8(4) 
C(20)-C(25)-C(27) 123.8(4)  C(24)-C(25)-C(20) 117.5(4) 
C(24)-C(25)-C(27) 118.3(4)  C(29)-C(28)-C(1) 120.1(4) 
C(29)-C(28)-C(33) 119.2(4)  C(33)-C(28)-C(1) 120.7(4) 
C(28)-C(29)-C(30) 120.7(4)  C(29)-C(30)-C(31) 118.9(4) 
C(30)-C(31)-I(1) 119.0(3)  C(32)-C(31)-C(30) 121.3(4) 
C(32)-C(31)-I(1) 119.7(3)  C(31)-C(32)-C(33) 118.6(4) 
C(28)-C(33)-C(32) 121.2(4)  C(2)-N(1)-C(1) 127.8(4) 
C(2)-N(1)-C(21) 108.0(3)  C(21)-N(1)-C(1) 124.1(3) 
___________________________________________________________________  __  
Symmetry transformations used to generate equivalent atoms:   
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X-ray Crystallographic Data for Compound (M)-115f 
 
  
 
Table 1.  Crystal data and structure refinement. 
 
Identification code  8532 
Empirical formula  C31 H24 I N S 
Color  orange-red 
Formula weight  569.47 g·mol-1  
Temperature  100 K 
Wavelength  0.61993 Å 
Crystal system  monoclinic 
Space group  p 21,  (no. 4)  
Unit cell dimensions a = 11.675(2) Å α= 90°. 
 b = 8.0277(16) Å β= 103.86(3)°. 
 c = 13.098(3) Å γ = 90°. 
Volume 1191.9(4) Å3 
Z 2 
Density (calculated) 1.587 Mg·m-3 
Absorption coefficient 1.452 mm-1 
F(000) 572 e 
Crystal size 0.048 x 0.035 x 0.022 mm3 
 range for data collection 1.397 to 28.614°. 
Index ranges -17  h  17, -12 k  12, -20 l  20 
Reflections collected 42007 
Independent reflections 9124 [Rint = 0.0611] 
Reflections with I>2(I) 8866 
Completeness to  = 21.836° 99.9 %  
Absorption correction semi-empirical from equivalents 
Max. and min. transmission 1.0 and 1.0 
Refinement method full-matrix least-squares on F2 
Data / restraints / parameters 9124 / 1 / 310 
Goodness-of-fit on F2 1.095 
Final R indices [I>2(I)] R1 = 0.0412 wR
2 = 0.1004 
R indices (all data) R1 = 0.0420 wR
2 = 0.1009 
Absolute structure parameter 0.038(5) 
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Extinction coefficient 0.112(6) 
Largest diff. peak and hole 1.465 and -1.837 e·Å-3 
 
Table 2.  Atomic coordinates and equivalent isotropic displacement parameters (Å2). 
 
Ueq is defined as one third of the trace of the orthogonalized Uij tensor. 
____________________________________________________________________ 
 x y z Ueq 
____________________________________________________________________ 
C(1) 0.7470(3) 0.7556(4) 0.3188(3) 0.025(1) 
C(2) 0.6988(3) 0.6018(3) 0.3289(2) 0.021(1) 
C(3) 0.6003(2) 0.5632(3) 0.2432(2) 0.018(1) 
C(4) 0.5771(3) 0.6928(4) 0.1693(2) 0.020(1) 
C(5) 0.4807(3) 0.6906(4) 0.0798(3) 0.024(1) 
C(6) 0.4038(3) 0.5600(4) 0.0694(3) 0.023(1) 
C(7) 0.4204(2) 0.4277(4) 0.1441(2) 0.020(1) 
C(8) 0.3297(3) 0.3080(4) 0.1379(3) 0.026(1) 
C(9) 0.3398(3) 0.1893(4) 0.2155(3) 0.025(1) 
C(10) 0.4452(2) 0.1710(4) 0.2941(3) 0.021(1) 
C(11) 0.4560(2) 0.0347(5) 0.3753(3) 0.025(1) 
C(12) 0.5346(3) 0.0906(4) 0.4818(3) 0.023(1) 
C(13) 0.6493(2) 0.1402(3) 0.4587(2) 0.018(1) 
C(14) 0.6541(2) 0.2250(3) 0.3677(2) 0.016(1) 
C(15) 0.5420(2) 0.2761(3) 0.2957(2) 0.017(1) 
C(16) 0.5238(2) 0.4193(3) 0.2285(2) 0.017(1) 
C(17) 0.8377(2) 0.1236(3) 0.4490(2) 0.016(1) 
C(18) 0.7751(2) 0.2099(3) 0.3579(2) 0.016(1) 
C(19) 0.8351(2) 0.2399(3) 0.2773(2) 0.017(1) 
C(20) 0.9532(2) 0.1896(4) 0.2954(2) 0.020(1) 
C(21) 1.0142(2) 0.1078(4) 0.3874(2) 0.019(1) 
C(22) 0.9560(2) 0.0737(4) 0.4656(2) 0.018(1) 
C(23) 0.7757(3) 0.3090(4) 0.1706(2) 0.023(1) 
C(24) 1.1394(3) 0.0497(4) 0.3982(3) 0.024(1) 
C(25) 0.7924(3) -0.0029(4) 0.6110(2) 0.021(1) 
C(26) 0.8370(3) 0.1165(4) 0.7009(2) 0.019(1) 
C(27) 0.7593(3) 0.1870(4) 0.7546(2) 0.022(1) 
C(28) 0.7994(3) 0.2984(4) 0.8361(3) 0.024(1) 
C(29) 0.9184(3) 0.3439(4) 0.8621(2) 0.022(1) 
C(30) 0.9975(3) 0.2757(5) 0.8102(3) 0.025(1) 
C(31) 0.9571(3) 0.1599(5) 0.7305(2) 0.024(1) 
I(1) 0.9779(1) 0.5176(1) 0.9819(1) 0.029(1) 
N(1) 0.7592(2) 0.0826(3) 0.5093(2) 0.018(1) 
S(1) 0.6748(1) 0.8573(1) 0.2054(1) 0.025(1) 
_____________________________________________________________________ 
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Table 3.  Bond lengths [Å] and angles [°]. 
 
___________________________________________________________________  __  
C(1)-C(2) 1.376(4)  C(1)-S(1) 1.727(4) 
C(2)-C(3) 1.435(4)  C(3)-C(4) 1.403(4) 
C(3)-C(16) 1.445(4)  C(4)-C(5) 1.418(4) 
C(4)-S(1) 1.735(3)  C(5)-C(6) 1.366(5) 
C(6)-C(7) 1.425(4)  C(7)-C(8) 1.418(4) 
C(7)-C(16) 1.430(4)  C(8)-C(9) 1.377(5) 
C(9)-C(10) 1.411(4)  C(10)-C(15) 1.407(4) 
C(10)-C(11) 1.510(5)  C(11)-C(12) 1.541(5) 
C(12)-C(13) 1.496(4)  C(13)-N(1) 1.376(4) 
C(13)-C(14) 1.385(4)  C(14)-C(18) 1.455(4) 
C(14)-C(15) 1.476(4)  C(15)-C(16) 1.432(4) 
C(17)-N(1) 1.385(4)  C(17)-C(22) 1.404(4) 
C(17)-C(18) 1.421(4)  C(18)-C(19) 1.421(4) 
C(19)-C(20) 1.401(4)  C(19)-C(23) 1.509(4) 
C(20)-C(21) 1.406(4)  C(21)-C(22) 1.386(4) 
C(21)-C(24) 1.509(4)  C(25)-N(1) 1.465(4) 
C(25)-C(26) 1.511(4)  C(26)-C(27) 1.394(4) 
C(26)-C(31) 1.406(4)  C(27)-C(28) 1.386(5) 
C(28)-C(29) 1.397(4)  C(29)-C(30) 1.384(5) 
C(29)-I(1) 2.090(3)  C(30)-C(31) 1.394(5)  
C(2)-C(1)-S(1) 112.4(2)  C(1)-C(2)-C(3) 112.8(3) 
C(4)-C(3)-C(2) 111.4(2)  C(4)-C(3)-C(16) 119.3(2) 
C(2)-C(3)-C(16) 129.1(3)  C(3)-C(4)-C(5) 123.0(3) 
C(3)-C(4)-S(1) 111.8(2)  C(5)-C(4)-S(1) 125.1(2) 
C(6)-C(5)-C(4) 117.7(3)  C(5)-C(6)-C(7) 121.7(3) 
C(8)-C(7)-C(6) 119.3(3)  C(8)-C(7)-C(16) 119.5(3) 
C(6)-C(7)-C(16) 121.1(3)  C(9)-C(8)-C(7) 119.7(3) 
C(8)-C(9)-C(10) 121.1(3)  C(15)-C(10)-C(9) 120.4(3) 
C(15)-C(10)-C(11) 119.5(3)  C(9)-C(10)-C(11) 120.1(3) 
C(10)-C(11)-C(12) 111.0(3)  C(13)-C(12)-C(11) 105.1(2) 
N(1)-C(13)-C(14) 110.8(2)  N(1)-C(13)-C(12) 126.1(3) 
C(14)-C(13)-C(12) 121.8(2)  C(13)-C(14)-C(18) 106.0(2) 
C(13)-C(14)-C(15) 118.3(2)  C(18)-C(14)-C(15) 134.3(2) 
C(10)-C(15)-C(16) 118.1(2)  C(10)-C(15)-C(14) 115.4(2) 
C(16)-C(15)-C(14) 126.5(2)  C(7)-C(16)-C(15) 119.1(2) 
C(7)-C(16)-C(3) 116.5(3)  C(15)-C(16)-C(3) 124.3(2) 
N(1)-C(17)-C(22) 127.1(3)  N(1)-C(17)-C(18) 108.5(2) 
C(22)-C(17)-C(18) 123.9(3)  C(17)-C(18)-C(19) 117.4(2) 
C(17)-C(18)-C(14) 106.4(2)  C(19)-C(18)-C(14) 135.6(2) 
C(20)-C(19)-C(18) 117.8(2)  C(20)-C(19)-C(23) 118.5(2) 
C(18)-C(19)-C(23) 123.5(2)  C(19)-C(20)-C(21) 123.7(3) 
C(22)-C(21)-C(20) 119.2(3)  C(22)-C(21)-C(24) 120.3(3) 
C(20)-C(21)-C(24) 120.3(3)  C(21)-C(22)-C(17) 117.8(3) 
N(1)-C(25)-C(26) 112.2(2)  C(27)-C(26)-C(31) 119.1(3) 
C(27)-C(26)-C(25) 120.4(3)  C(31)-C(26)-C(25) 120.4(3) 
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C(28)-C(27)-C(26) 120.7(3)  C(27)-C(28)-C(29) 119.3(3) 
C(30)-C(29)-C(28) 121.2(3)  C(30)-C(29)-I(1) 119.5(2) 
C(28)-C(29)-I(1) 119.3(2)  C(29)-C(30)-C(31) 119.1(3) 
C(30)-C(31)-C(26) 120.5(3)  C(13)-N(1)-C(17) 108.2(2) 
C(13)-N(1)-C(25) 127.5(2)  C(17)-N(1)-C(25) 124.3(2) 
C(1)-S(1)-C(4) 91.60(15)  
___________________________________________________________________  __  
Symmetry transformations used to generate equivalent atoms:   
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X-ray Crystallographic Data for Compound (S,S)-118e 
 
    
 
Table 1.  Crystal data and structure refinement. 
 
Identification code  8791 
Empirical formula  C16 H16 O3 
Color  colorless 
Formula weight  256.29 g mol-1  
Temperature  100 K 
Wavelength  1.54178 Å 
Crystal system  MONOCLINIC 
Space group  P 21,  (no. 4)  
Unit cell dimensions a = 6.7791(2) Å α= 90°. 
 b = 10.1381(4) Å β= 105.9253(11)°. 
 c = 9.7026(3) Å γ = 90°. 
Volume 641.24(4) Å3 
Z 2 
Density (calculated) 1.327 Mg m-3 
Absorption coefficient 0.736 mm-1 
F(000) 272 e 
Crystal size 0.34 x 0.10 x 0.08 mm3 
 range for data collection 4.739 to 67.537°. 
Index ranges -8  h  7, -12 k  12, -11  l  11 
Reflections collected 29234 
Independent reflections 2231 [Rint = 0.0338] 
Reflections with I>2(I) 2198 
Completeness to  = 67.679° 97.9 %  
Absorption correction Gaussian 
Max. and min. transmission 0.95 and 0.85 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2231 / 1 / 173 
Goodness-of-fit on F2 1.078 
Final R indices [I>2(I)] R1 = 0.0311 wR
2 = 0.0793 
R indices (all data) R1 = 0.0315 wR
2 = 0.0797 
Abs. structure param. (Flack / Hooft) -0.01(9) / 0.04(4) 
Largest diff. peak and hole   0.1and -0.2  e · Å-3  
C15
C14
O2
C9
O3
C10
C13
C16
C7 C8
C12
C1
C6
C3 C2
C11
C5 C4
O1
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Table 2.   Bond lengths [Å] and angles [°]. 
___________________________________________________________________  __  
O(1)-C(2) 1.224(3)  O(2)-C(13) 1.218(3) 
O(3)-C(15) 1.425(3)  O(3)-C(16) 1.426(3) 
C(1)-C(2) 1.535(3)  C(1)-C(10) 1.503(3) 
C(1)-C(11) 1.556(3)  C(1)-C(12) 1.539(3) 
C(2)-C(3) 1.480(3)  C(3)-C(4) 1.395(3) 
C(3)-C(8) 1.409(3)  C(4)-C(5) 1.382(3) 
C(5)-C(6) 1.396(3)  C(6)-C(7) 1.387(3) 
C(7)-C(8) 1.400(3)  C(8)-C(9) 1.456(3) 
C(9)-C(10) 1.336(3)  C(12)-C(13) 1.510(3) 
C(12)-C(16) 1.538(3)  C(13)-C(14) 1.501(3) 
C(14)-C(15) 1.525(3)  
 
C(15)-O(3)-C(16) 111.36(16)  C(2)-C(1)-C(11) 104.62(16) 
C(2)-C(1)-C(12) 107.58(16)  C(10)-C(1)-C(2) 113.32(18) 
C(10)-C(1)-C(11) 107.06(17)  C(10)-C(1)-C(12) 114.15(17) 
C(12)-C(1)-C(11) 109.67(17)  O(1)-C(2)-C(1) 119.4(2) 
O(1)-C(2)-C(3) 121.22(18)  C(3)-C(2)-C(1) 119.23(18) 
C(4)-C(3)-C(2) 119.77(19)  C(4)-C(3)-C(8) 120.2(2) 
C(8)-C(3)-C(2) 120.00(18)  C(5)-C(4)-C(3) 120.5(2) 
C(4)-C(5)-C(6) 119.8(2)  C(7)-C(6)-C(5) 120.3(2) 
C(6)-C(7)-C(8) 120.6(2)  C(3)-C(8)-C(9) 119.98(19) 
C(7)-C(8)-C(3) 118.60(19)  C(7)-C(8)-C(9) 121.42(19) 
C(10)-C(9)-C(8) 122.29(19)  C(9)-C(10)-C(1) 123.46(19) 
C(13)-C(12)-C(1) 112.91(17)  C(13)-C(12)-C(16) 108.16(17) 
C(16)-C(12)-C(1) 115.81(17)  O(2)-C(13)-C(12) 122.66(19) 
O(2)-C(13)-C(14) 123.45(19)  C(14)-C(13)-C(12) 113.89(18) 
C(13)-C(14)-C(15) 110.83(18)  O(3)-C(15)-C(14) 111.78(18) 
O(3)-C(16)-C(12) 110.55(17)  
___________________________________________________________________  __  
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X-ray Crystallographic Data for Compound (S,S)-118h 
 
    
 
Table 1.  Crystal data and structure refinement. 
 
Identification code  8992 
Empirical formula  C23 H23 N O4 S 
Color  colorless 
Formula weight  409.48 g mol-1  
Temperature  100 K 
Wavelength  1.54178 Å 
Crystal system  TRICLINIC 
Space group  P 1¯, (no. 2)  
Unit cell dimensions a = 9.1382(3) Å α= 69.4491(13)°. 
 b = 9.9898(3) Å β= 84.6054(14)°. 
 c = 11.5919(4) Å γ = 80.4413(15)°. 
Volume 976.38(6) Å3 
Z 2 
Density (calculated) 1.393 Mg m-3 
Absorption coefficient 1.729 mm-1 
F(000) 432 e 
Crystal size 0.42 x 0.28 x 0.12 mm3 
 range for data collection 4.076 to 67.376°. 
Index ranges -10  h  10, -11 k  11, -13  l  13 
Reflections collected 42514 
Independent reflections 3404 [Rint = 0.0509] 
Reflections with I>2(I) 3126 
Completeness to  = 67.679° 97.0 %  
Absorption correction Gaussian 
Max. and min. transmission 0.89 and 0.67 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3404 / 0 / 264 
Goodness-of-fit on F2 1.066 
Final R indices [I>2(I)] R1 = 0.0393 wR
2 = 0.0945 
R indices (all data) R1 = 0.0436 wR
2 = 0.0974 
Largest diff. peak and hole 0.379 and -0.462 e · Å-3 
C23
C21
C20
C22
C19
C17
O2
C18
C14
C15
C16
S1
C12
C5
C13
C6
O1
N1
C11
C4
C8
C7
C1
C10
C3
C9
O3
O4
C2
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Table 2.   Bond lengths [Å] and angles [°]. 
___________________________________________________________________  __  
S(1)-O(1) 1.4324(14)  S(1)-O(2) 1.4317(14) 
S(1)-N(1) 1.6546(16)  S(1)-C(17) 1.759(2) 
O(3)-C(3) 1.214(2)  O(4)-C(7) 1.213(2) 
N(1)-C(1) 1.481(2)  N(1)-C(5) 1.479(2) 
C(1)-C(2) 1.525(3)  C(2)-C(3) 1.504(2) 
C(3)-C(4) 1.523(3)  C(4)-C(5) 1.537(3) 
C(4)-C(6) 1.543(2)  C(6)-C(7) 1.535(3) 
C(6)-C(15) 1.512(3)  C(6)-C(16) 1.555(3) 
C(7)-C(8) 1.493(3)  C(8)-C(9) 1.381(3) 
C(8)-C(13) 1.407(3)  C(9)-C(10) 1.386(3) 
C(10)-C(11) 1.391(3)  C(11)-C(12) 1.379(3) 
C(12)-C(13) 1.398(3)  C(13)-C(14) 1.457(3) 
C(14)-C(15) 1.328(3)  C(17)-C(18) 1.390(3) 
C(17)-C(22) 1.393(3)  C(18)-C(19) 1.387(3) 
C(19)-C(20) 1.396(3)  C(20)-C(21) 1.391(3) 
C(20)-C(23) 1.503(3)  C(21)-C(22) 1.387(3)  
 
O(1)-S(1)-N(1) 105.98(8)  O(1)-S(1)-C(17) 108.18(8) 
O(2)-S(1)-O(1) 119.79(9)  O(2)-S(1)-N(1) 106.97(8) 
O(2)-S(1)-C(17) 107.64(9)  N(1)-S(1)-C(17) 107.76(8) 
C(1)-N(1)-S(1) 114.14(12)  C(5)-N(1)-S(1) 114.54(12) 
C(5)-N(1)-C(1) 112.64(14)  N(1)-C(1)-C(2) 109.48(15) 
C(3)-C(2)-C(1) 111.54(15)  O(3)-C(3)-C(2) 123.38(17) 
O(3)-C(3)-C(4) 122.42(16)  C(2)-C(3)-C(4) 114.19(16) 
C(3)-C(4)-C(5) 108.75(15)  C(3)-C(4)-C(6) 111.70(15) 
C(5)-C(4)-C(6) 114.84(15)  N(1)-C(5)-C(4) 109.32(15) 
C(4)-C(6)-C(16) 110.05(15)  C(7)-C(6)-C(4) 108.72(15) 
C(7)-C(6)-C(16) 104.41(15)  C(15)-C(6)-C(4) 112.11(15) 
C(15)-C(6)-C(7) 113.59(16)  C(15)-C(6)-C(16) 107.66(15) 
O(4)-C(7)-C(6) 119.57(17)  O(4)-C(7)-C(8) 121.25(18) 
C(8)-C(7)-C(6) 119.00(16)  C(9)-C(8)-C(7) 120.66(18) 
C(9)-C(8)-C(13) 119.97(18)  C(13)-C(8)-C(7) 119.37(17) 
C(8)-C(9)-C(10) 120.7(2)  C(9)-C(10)-C(11) 119.7(2) 
C(12)-C(11)-C(10) 120.25(19)  C(11)-C(12)-C(13) 120.6(2) 
C(8)-C(13)-C(14) 120.84(17)  C(12)-C(13)-C(8) 118.87(19) 
C(12)-C(13)-C(14) 120.28(18)  C(15)-C(14)-C(13) 122.05(18) 
C(14)-C(15)-C(6) 123.66(18)  C(18)-C(17)-S(1) 119.87(14) 
C(18)-C(17)-C(22) 120.42(18)  C(22)-C(17)-S(1) 119.71(15) 
C(19)-C(18)-C(17) 119.35(18)  C(18)-C(19)-C(20) 121.18(18) 
C(19)-C(20)-C(23) 120.05(18)  C(21)-C(20)-C(19) 118.45(18) 
C(21)-C(20)-C(23) 121.49(18)  C(22)-C(21)-C(20) 121.21(18) 
C(21)-C(22)-C(17) 119.38(18)  
___________________________________________________________________  __  
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X-ray Crystallographic Data for Compound 179 
 
  
 
Table 1.  Crystal data and structure refinement. 
Identification code  KOM-KD-092 (9560) 
Empirical formula  C19 H18 Br0.74 Cl0.26 N O 
Color  colourless 
Formula weight  344.49  g·mol-1  
Temperature  100 K 
Wavelength  1.54178 Å 
Crystal system  monoclinic 
Space group  P 21/n,  (no. 14)  
Unit cell dimensions a = 5.5204(8) Å a= 90°. 
 b = 13.3443(18) Å b= 93.353(4)°. 
 c = 21.257(3) Å g = 90°. 
Volume 1563.2(4) Å3 
Z 4 
Density (calculated) 1.464  Mg·m-3 
Absorption coefficient 3.205 mm-1 
F(000) 709 e 
Crystal size 0.168 x 0.109 x 0.080 mm3 
 range for data collection 3.913 to 67.741°. 
Index ranges -6  h  6, -15 k  15, -25 l  25 
Reflections collected 68824 
Independent reflections 2819 [Rint = 0.0724] 
Reflections with I>2 (I) 2555 
Completeness to  = 67.679° 99.5 %  
Absorption correction Gaussian 
Max. and min. transmission 0.84400 and 0.72937 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2819 / 0 / 206 
Goodness-of-fit on F2 1.192 
Final R indices [I>2 (I)] R1 = 0.0773 wR
2 = 0.2232 
R indices (all data) R1 = 0.0825 wR
2 = 0.2278 
Extinction coefficient 0 
Largest diff. peak and hole 3.017 and -1.152 e·Å-3 
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Table 2.  Atomic coordinates and equivalent isotropic displacement parameters (Å2). 
 Ueq is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________ 
 x y z Ueq 
________________________________________________________________ 
C(1) 0.3692(9) 0.4994(3) 0.3669(2) 0.029(1) 
C(2) 0.3301(9) 0.5765(3) 0.3208(2) 0.029(1) 
C(3) 0.1479(9) 0.6496(4) 0.3241(2) 0.034(1) 
C(4) 0.1224(11) 0.7237(4) 0.2788(3) 0.040(1) 
C(5) 0.2763(10) 0.7243(4) 0.2285(3) 0.040(1) 
C(6) 0.4515(10) 0.6523(4) 0.2240(2) 0.038(1) 
C(7) 0.4880(9) 0.5760(4) 0.2696(2) 0.033(1) 
C(8) 0.6729(9) 0.5001(4) 0.2652(2) 0.033(1) 
C(9) 0.7037(9) 0.4280(4) 0.3107(2) 0.033(1) 
C(10) 0.5530(9) 0.4268(3) 0.3627(2) 0.029(1) 
C(11) 0.5451(8) 0.3641(3) 0.4167(2) 0.029(1) 
C(12) 0.6952(9) 0.2758(3) 0.4374(2) 0.033(1) 
C(13) 0.5625(8) 0.2097(3) 0.4842(2) 0.031(1) 
C(14) 0.4583(9) 0.2758(3) 0.5355(2) 0.031(1) 
C(15) 0.2982(8) 0.3616(3) 0.5110(2) 0.028(1) 
C(16) 0.3617(8) 0.4013(3) 0.4518(2) 0.028(1) 
C(18) 0.3587(9) 0.1498(4) 0.4485(2) 0.035(1) 
C(19) 0.7437(10) 0.1363(4) 0.5163(3) 0.040(1) 
N(1) 0.2527(7) 0.4835(3) 0.4207(2) 0.030(1) 
O(1) 0.1324(7) 0.3941(3) 0.5419(2) 0.036(1) 
Br(1) 0.6695(2) 0.4534(1) 0.1345(1) 0.048(1) 
C(17A) 0.8355(10) 0.4989(5) 0.2117(3) 0.044(1) 
Cl(1) 1.0495(11) 0.4161(5) 0.2019(3) 0.051(2) 
C(17B) 0.8355(10) 0.4989(5) 0.2117(3) 0.044(1) 
 
 
Table 3.  Bond lengths [Å] and angles [°]. 
___________________________________________________________________  __  
C(1)-N(1) 1.361(6) C(1)-C(10) 1.410(7)
C(1)-C(2) 1.428(7) C(2)-C(3) 1.406(7)
C(2)-C(7) 1.434(7) C(3)-C(4) 1.382(7)
C(3)-H(3) 0.9500 C(4)-C(5) 1.404(8)
C(4)-H(4) 0.9500 C(5)-C(6) 1.371(8)
C(5)-H(5) 0.9500 C(6)-C(7) 1.410(7)
C(6)-H(6) 0.9500 C(7)-C(8) 1.445(7)
C(8)-C(9) 1.370(7) C(8)-C(17B) 1.488(7)
C(8)-C(17A) 1.488(7) C(9)-C(10) 1.421(7)
C(9)-H(9) 0.9500 C(10)-C(11) 1.423(7)
C(11)-C(16) 1.385(6) C(11)-C(12) 1.492(7)
C(12)-C(13) 1.546(7) C(12)-H(12A) 0.9900
C(12)-H(12B) 0.9900 C(13)-C(19) 1.532(7)
C(13)-C(14) 1.540(6) C(13)-C(18) 1.543(7)
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C(14)-C(15) 1.519(6) C(14)-H(14A) 0.9900
C(14)-H(14B) 0.9900 C(15)-O(1) 1.237(6)
C(15)-C(16) 1.429(6) C(16)-N(1) 1.398(6)
C(18)-H(18A) 0.9800 C(18)-H(18B) 0.9800
C(18)-H(18C) 0.9800 C(19)-H(19A) 0.9800
C(19)-H(19B) 0.9800 C(19)-H(19C) 0.9800
N(1)-H(1) 0.8800 Br(1)-C(17A) 1.930(6)
C(17A)-H(17A) 0.9900 C(17A)-H(17B) 0.9900
Cl(1)-C(17B) 1.640(8) C(17B)-H(17C) 0.9900
C(17B)-H(17D) 0.9900 
 
N(1)-C(1)-C(10) 108.9(4) N(1)-C(1)-C(2) 129.0(4)
C(10)-C(1)-C(2) 122.1(4) C(3)-C(2)-C(1) 123.0(4)
C(3)-C(2)-C(7) 120.6(4) C(1)-C(2)-C(7) 116.4(4)
C(4)-C(3)-C(2) 120.3(5) C(4)-C(3)-H(3) 119.8
C(2)-C(3)-H(3) 119.8 C(3)-C(4)-C(5) 119.6(5)
C(3)-C(4)-H(4) 120.2 C(5)-C(4)-H(4) 120.2
C(6)-C(5)-C(4) 120.6(5) C(6)-C(5)-H(5) 119.7
C(4)-C(5)-H(5) 119.7 C(5)-C(6)-C(7) 122.1(5)
C(5)-C(6)-H(6) 118.9 C(7)-C(6)-H(6) 118.9
C(6)-C(7)-C(2) 116.7(5) C(6)-C(7)-C(8) 122.3(5)
C(2)-C(7)-C(8) 121.0(4) C(9)-C(8)-C(7) 120.4(5)
C(9)-C(8)-C(17B) 118.4(5) C(7)-C(8)-C(17B) 121.2(5)
C(9)-C(8)-C(17A) 118.4(5) C(7)-C(8)-C(17A) 121.2(5)
C(8)-C(9)-C(10) 120.2(5) C(8)-C(9)-H(9) 119.9
C(10)-C(9)-H(9) 119.9 C(1)-C(10)-C(9) 119.9(4)
C(1)-C(10)-C(11) 107.3(4) C(9)-C(10)-C(11) 132.8(4)
C(16)-C(11)-C(10) 106.3(4) C(16)-C(11)-C(12) 122.4(4)
C(10)-C(11)-C(12) 131.3(4) C(11)-C(12)-C(13) 111.4(4)
C(11)-C(12)-H(12A) 109.3 C(13)-C(12)-H(12A) 109.3
C(11)-C(12)-H(12B) 109.3 C(13)-C(12)-H(12B) 109.3
H(12A)-C(12)-H(12B) 108.0 C(19)-C(13)-C(14) 108.1(4)
C(19)-C(13)-C(18) 109.1(4) C(14)-C(13)-C(18) 110.7(4)
C(19)-C(13)-C(12) 109.3(4) C(14)-C(13)-C(12) 109.8(4)
C(18)-C(13)-C(12) 109.8(4) C(15)-C(14)-C(13) 115.0(4)
C(15)-C(14)-H(14A) 108.5 C(13)-C(14)-H(14A) 108.5
C(15)-C(14)-H(14B) 108.5 C(13)-C(14)-H(14B) 108.5
H(14A)-C(14)-H(14B) 107.5 O(1)-C(15)-C(16) 124.4(4)
O(1)-C(15)-C(14) 121.1(4) C(16)-C(15)-C(14) 114.4(4)
C(11)-C(16)-N(1) 109.6(4) C(11)-C(16)-C(15) 124.5(4)
N(1)-C(16)-C(15) 125.9(4) C(13)-C(18)-H(18A) 109.5
C(13)-C(18)-H(18B) 109.5 H(18A)-C(18)-H(18B) 109.5
C(13)-C(18)-H(18C) 109.5 H(18A)-C(18)-H(18C) 109.5
H(18B)-C(18)-H(18C) 109.5 C(13)-C(19)-H(19A) 109.5
C(13)-C(19)-H(19B) 109.5 H(19A)-C(19)-H(19B) 109.5
C(13)-C(19)-H(19C) 109.5 H(19A)-C(19)-H(19C) 109.5
H(19B)-C(19)-H(19C) 109.5 C(1)-N(1)-C(16) 107.9(4)
C(1)-N(1)-H(1) 126.0 C(16)-N(1)-H(1) 126.0
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C(8)-C(17A)-Br(1) 112.0(4) C(8)-C(17A)-H(17A) 109.2
Br(1)-C(17A)-H(17A) 109.2 C(8)-C(17A)-H(17B) 109.2
Br(1)-C(17A)-H(17B) 109.2 H(17A)-C(17A)-H(17B) 107.9
C(8)-C(17B)-Cl(1) 125.2(5) C(8)-C(17B)-H(17C) 106.0
Cl(1)-C(17B)-H(17C) 106.0 C(8)-C(17B)-H(17D) 106.0
Cl(1)-C(17B)-H(17D) 106.0 H(17C)-C(17B)-H(17D) 106.3  
Symmetry transformations used to generate equivalent atoms:  
 
 
Table 4.   Anisotropic displacement parameters (Å2).  
The anisotropic displacement factor exponent takes the form:  
 -2p2[ h2a*2U11 + ... + 2 h k a* b* U12 ]. 
___________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
___________________________________________________________________ 
C(1) 0.038(2)  0.021(2) 0.029(2)  -0.002(2) 0.003(2)  0.002(2) 
C(2) 0.038(2)  0.023(2) 0.027(2)  -0.002(2) 0.003(2)  -0.003(2) 
C(3) 0.045(3)  0.028(2) 0.029(2)  0.001(2) 0.003(2)  0.002(2) 
C(4) 0.055(3)  0.029(3) 0.037(3)  0.005(2) 0.003(2)  0.005(2) 
C(5) 0.050(3)  0.035(3) 0.036(3)  0.012(2) 0.002(2)  0.000(2) 
C(6) 0.048(3)  0.032(3) 0.034(3)  0.005(2) 0.009(2)  -0.002(2) 
C(7) 0.043(3)  0.028(2) 0.029(2)  -0.002(2) 0.005(2)  -0.006(2) 
C(8) 0.038(2)  0.027(2) 0.035(3)  0.000(2) 0.006(2)  -0.005(2) 
C(9) 0.035(2)  0.024(2) 0.039(3)  -0.003(2) 0.007(2)  -0.001(2) 
C(10) 0.035(2)  0.023(2) 0.029(2)  -0.002(2) 0.004(2)  0.000(2) 
C(11) 0.034(2)  0.022(2) 0.031(2)  -0.002(2) 0.005(2)  0.000(2) 
C(12) 0.038(2)  0.024(2) 0.037(3)  0.002(2) 0.008(2)  0.003(2) 
C(13) 0.035(2)  0.022(2) 0.035(3)  0.001(2) 0.006(2)  0.002(2) 
C(14) 0.041(3)  0.021(2) 0.029(2)  0.003(2) 0.005(2)  0.004(2) 
C(15) 0.035(2)  0.020(2) 0.029(2)  -0.001(2) 0.004(2)  0.004(2) 
C(16) 0.035(2)  0.021(2) 0.028(2)  0.000(2) 0.003(2)  0.002(2) 
C(18) 0.041(3)  0.024(2) 0.040(3)  -0.002(2) 0.010(2)  0.000(2) 
C(19) 0.044(3)  0.030(3) 0.046(3)  0.009(2) 0.010(2)  0.008(2) 
N(1) 0.041(2)  0.021(2) 0.027(2)  0.001(2) 0.007(2)  0.004(2) 
O(1) 0.049(2)  0.029(2) 0.032(2)  0.001(1) 0.009(2)  0.010(2) 
Br(1) 0.079(1)  0.038(1) 0.029(1)  -0.006(1) 0.015(1)  -0.018(1) 
Cl(1) 0.060(3)  0.052(3) 0.042(3)  0.001(2) 0.014(2)  0.003(3) 
___________________________________________________________________
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Table 5.   Hydrogen coordinates and isotropic displacement parameters (Å2).  
_________________________________________________________________ 
 x  y  z  Ueq 
_________________________________________________________________ 
 
H(3) 0.0418 0.6481 0.3577 0.041 
H(4) 0.0014 0.7738 0.2816 0.048 
H(5) 0.2589 0.7751 0.1972 0.048 
H(6) 0.5515 0.6537 0.1892 0.046 
H(9) 0.8263 0.3785 0.3076 0.039 
H(12A) 0.8508 0.2994 0.4577 0.039 
H(12B) 0.7322 0.2354 0.4001 0.039 
H(14A) 0.3626 0.2328 0.5628 0.037 
H(14B) 0.5950 0.3040 0.5620 0.037 
H(18A) 0.2412 0.1964 0.4282 0.052 
H(18B) 0.2768 0.1072 0.4782 0.052 
H(18C) 0.4286 0.1078 0.4163 0.052 
H(19A) 0.8057 0.0910 0.4847 0.060 
H(19B) 0.6624 0.0971 0.5479 0.060 
H(19C) 0.8789 0.1737 0.5369 0.060 
H(1) 0.1304 0.5187 0.4337 0.036 
H(17A) 0.9750 0.4541 0.2224 0.053 
H(17B) 0.8995 0.5672 0.2054 0.053 
H(17C) 0.9160 0.5652 0.2120 0.053 
H(17D) 0.7275 0.4966 0.1729 0.053 
_________________________________________________________________ 
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 Appendix 9.
 Cartesian Coordinates for Calculations of the [1,5]-Methyl Shift 9.1.
 
Cartesian coordinates (Å) for all computed species and imaginary frequencies for transition 
state species. 
119a-1: 
 C                  4.56931600   -0.39390200   -0.19883700 
 C                  3.80584200    0.71595100   -0.53391400 
 C                  2.41758700    0.69690400   -0.39303900 
 C                  1.80126500   -0.48157400    0.08913900 
 C                  2.57338000   -1.59771900    0.40120600 
 C                  3.95376000   -1.55248600    0.26817800 
 H                  2.09200100    2.64871400   -1.31196700 
 H                  5.64557600   -0.35954900   -0.30849700 
 H                  4.28647400    1.60839600   -0.91607000 
 C                  1.59398500    1.84037200   -0.78916100 
 C                  0.35029600   -0.46811200    0.15800800 
 H                  2.07549600   -2.49278200    0.74927900 
 H                  4.55074300   -2.41803500    0.52422000 
 C                  0.28520100    1.91591800   -0.52687700 
 H                 -0.29566700    2.78333600   -0.81713900 
 C                 -1.78805900    0.40321500    0.01658100 
 N                 -0.44353400   -1.47119100   -0.01167500 
 C                 -0.37613400    0.85158500    0.30178000 
 C                 -0.30145800    1.29884200    1.79680900 
 H                 -0.88178900    2.21142000    1.93637400 
 H                 -0.70834100    0.51982600    2.44167600 
 H                  0.73164100    1.49871500    2.07841400 
 C                 -1.76035500   -0.93697500   -0.08984600 
 C                 -3.02911700    1.22742400   -0.01153500 
 H                 -3.01283200    1.98136200    0.78275900 
 H                 -3.08407800    1.79111700   -0.95233500 
 C                 -2.95601300   -1.80018500   -0.30271800 
 H                 -2.73690300   -2.55243400   -1.06470200 
 H                 -3.17781100   -2.35609000    0.61576500 
 C                 -4.26758500    0.33088300    0.13899200 
 C                 -4.15792500   -0.93809300   -0.71372700 
 H                 -4.04682900   -0.65134700   -1.76429200 
 H                 -5.07862800   -1.52038300   -0.64129000 
 H                 -5.16768400    0.88904900   -0.12712800 
 H                 -4.37055400    0.04472200    1.19042400 
 
TSa-1: (imaginary frequency: 595.3616i cm-1) 
 C                  4.51438000   -0.40283900   -0.35108400 
 C                  3.79840300    0.78139500   -0.41344600 
 C                  2.40866000    0.79128400   -0.24547400 
 C                  1.74836400   -0.43676800   -0.00078900 
 C                  2.47442100   -1.62353200    0.04683900 
 C                  3.85070700   -1.60780900   -0.12445400 
 H                  2.20952700    2.93026900   -0.57411500 
 H                  5.58831700   -0.39217200   -0.48428600 
 H                  4.31222700    1.71662300   -0.60055500 
 C                  1.65193600    2.02786000   -0.35351800 
 C                  0.30398600   -0.40265200    0.17494200 
 H                  1.93979500   -2.54880800    0.21348400 
 H                  4.41000200   -2.53357700   -0.08412300 
 C                  0.31125700    2.08253800   -0.21579500 
 H                 -0.22487700    3.01524800   -0.33790600 
 C                 -1.77456900    0.49781800   -0.07210300 
 N                 -0.53931500   -1.45063500    0.08387000 
 C                 -0.41879000    0.86871200    0.06923500 
 C                  0.06057900    0.42383200    2.03647500 
 H                 -0.15338400    1.45562500    2.28195400 
 H                 -0.71359100   -0.26857200    2.33519400 
 H                  1.06140800    0.13944500    2.33744500 
 C                 -1.77145300   -0.90010800   -0.05891600 
 C                 -3.00535800    1.33910400   -0.21404500 
 H                 -2.98885900    2.18148600    0.48489100 
 H                 -3.05324900    1.78159000   -1.21710800 
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 C                 -3.01915500   -1.71381100   -0.16763700 
 H                 -2.83529800   -2.58022700   -0.80656400 
 H                 -3.27368200   -2.11345100    0.82086900 
 C                 -4.26144500    0.48744700    0.02419500 
 C                 -4.17702200   -0.86009300   -0.69963800 
 H                 -4.03179100   -0.68167700   -1.77008100 
 H                 -5.11836100   -1.40361400   -0.59572400 
 H                 -4.37319000    0.30574600    1.09844400 
 H                 -5.14919000    1.03623600   -0.29763800 
 
120a-1: 
 C                  4.26166800   -0.40571400   -0.89408400 
 C                  3.63127200    0.80476600   -0.64216200 
 C                  2.31861900    0.84311800   -0.16355600 
 C                  1.65193900   -0.37360800    0.08945000 
 C                  2.28490200   -1.57857900   -0.16715000 
 C                  3.58370200   -1.59806000   -0.66914500 
 H                  2.19854100    3.02057200   -0.12961300 
 H                  5.27555300   -0.41869400   -1.27248900 
 H                  4.15169400    1.73646500   -0.82973900 
 C                  1.62235200    2.11336500    0.00786500 
 C                  0.29592900   -0.29900900    0.75215300 
 H                  1.75054300   -2.49942400    0.02351600 
 H                  4.06509000   -2.54425100   -0.88058300 
 C                  0.28873200    2.17931700    0.21075900 
 H                 -0.22784700    3.13137600    0.20189000 
 C                 -1.70398700    0.58633300    0.01760300 
 N                 -0.62301600   -1.41131800    0.49198600 
 C                 -0.44115500    0.94966000    0.33332100 
 C                  0.52869600   -0.27684300    2.28773000 
 H                 -0.42694300   -0.17505300    2.80231100 
 H                  1.00272600   -1.20866000    2.59118000 
 H                  1.17444000    0.55906700    2.55625400 
 C                 -1.74083700   -0.88165100    0.13546700 
 C                 -2.86963900    1.38557200   -0.47606100 
 H                 -2.96100800    2.32421300    0.07641700 
 H                 -2.69162600    1.66452800   -1.52160800 
 C                 -3.00069300   -1.64891000   -0.12733300 
 H                 -2.75805300   -2.60429100   -0.59422900 
 H                 -3.46076900   -1.88223700    0.83941800 
 C                 -4.17191600    0.57743700   -0.39624900 
 C                 -3.98968600   -0.83118600   -0.96773200 
 H                 -3.62493700   -0.75720000   -1.99774100 
 H                 -4.94921200   -1.34977300   -1.01172300 
 H                 -4.49253300    0.50077500    0.64803000 
 H                 -4.96393400    1.10576300   -0.93045200 
 
119a-2: 
 C                  4.57026800   -0.38755800   -0.21614200 
 C                  3.80883900    0.74119800   -0.48688900 
 C                  2.42031600    0.71539200   -0.35086900 
 C                  1.80139700   -0.48837100    0.05981700 
 C                  2.57132900   -1.62196800    0.30715800 
 C                  3.95218400   -1.57083300    0.17998700 
 H                  2.09777900    2.71773300   -1.15542700 
 H                  5.64682300   -0.34820600   -0.32109600 
 H                  4.29134600    1.65411200   -0.81442700 
 C                  1.59833100    1.88065200   -0.68149100 
 C                  0.35006700   -0.47658400    0.12556900 
 H                  2.07155800   -2.53541600    0.60046000 
 H                  4.54743700   -2.45095400    0.38533800 
 C                  0.28937600    1.94213800   -0.41678300 
 H                 -0.28960500    2.82630200   -0.65605600 
 C                 -1.78644400    0.40459200    0.02977700 
 N                 -0.44429400   -1.46614400   -0.10773200 
 C                 -0.37545800    0.83296200    0.34764200 
 C                 -0.30790600    1.19688200    1.86562800 
 H                 -0.88938100    2.10027900    2.05280700 
 H                 -0.71854300    0.38333800    2.46383600 
 H                  0.72379400    1.38023700    2.16349800 
 C                 -1.76136700   -0.92795100   -0.14824000 
 C                 -3.02298700    1.23515900    0.02475200 
 H                 -3.26847000    1.56072800    1.04425900 
 H                 -2.87101500    2.15465500   -0.55111000 
 C                 -2.96184900   -1.78190800   -0.37376700 
 H                 -2.98899100   -2.10994600   -1.41924700 
 H                 -2.88610900   -2.69269400    0.22547900 
 C                 -4.19299700    0.43252400   -0.56574200 
 C                 -4.23416600   -0.99887200   -0.02016500 
 H                 -5.11390000   -1.52124000   -0.40125800 
 H                 -4.33714200   -0.96023100    1.06910700 
 H                 -5.13576200    0.94343900   -0.35954800 
 9. Appendix   
227 
 H                 -4.08336800    0.39613900   -1.65394700 
 
TSa-2: (imaginary frequency: 600.8037i cm-1) 
 C                  4.51504700   -0.38854700   -0.36717100 
 C                  3.79977500    0.79774000   -0.36886300 
 C                  2.40975800    0.79973600   -0.20350300 
 C                  1.74803200   -0.43896200   -0.02486900 
 C                  2.47337000   -1.62703000   -0.03862400 
 C                  3.85013800   -1.60324300   -0.20592600 
 H                  2.21331800    2.95298400   -0.42269100 
 H                  5.58926200   -0.37150300   -0.49744600 
 H                  4.31440200    1.74117900   -0.50595100 
 C                  1.65450500    2.04111200   -0.24914200 
 C                  0.30329500   -0.41230300    0.15113600 
 H                  1.93797800   -2.55944900    0.07831100 
 H                  4.40879000   -2.53023700   -0.21318600 
 C                  0.31391100    2.09018000   -0.10990200 
 H                 -0.22051500    3.02895600   -0.18309400 
 C                 -1.77323700    0.50244400   -0.05169800 
 N                 -0.54193000   -1.45311100    0.00864200 
 C                 -0.41759600    0.86406100    0.11207800 
 C                  0.06042600    0.31690700    2.05285200 
 H                  1.05966500    0.01371200    2.34033300 
 H                 -0.15005100    1.33547400    2.35129700 
 H                 -0.71682100   -0.38740200    2.31298500 
 C                 -1.77373600   -0.89471500   -0.10483200 
 C                 -3.00295800    1.35058200   -0.13635000 
 H                 -3.27066500    1.74223600    0.85387100 
 H                 -2.83513100    2.22619100   -0.77115400 
 C                 -3.02266800   -1.70028000   -0.26560600 
 H                 -3.05416100   -2.09579500   -1.28716500 
 H                 -2.98955900   -2.57035700    0.39357800 
 C                 -4.17380100    0.52265200   -0.68418300 
 C                 -4.26679600   -0.84284000    0.00365600 
 H                 -5.16193700   -1.37323800   -0.32766900 
 H                 -4.37383900   -0.68997900    1.08296600 
 H                 -4.03314900    0.37087600   -1.75921400 
 H                 -5.10887500    1.07316900   -0.56058000 
 
120a-2: 
 C                  4.26841100   -0.38733200   -0.89245700 
 C                  3.64081000    0.81547500   -0.59997700 
 C                  2.32514800    0.84094500   -0.12882200 
 C                  1.65283900   -0.38207800    0.07530000 
 C                  2.28267100   -1.57913400   -0.22219400 
 C                  3.58465800   -1.58463200   -0.71630500 
 H                  2.21187700    3.01572600   -0.01712600 
 H                  5.28478600   -0.39030400   -1.26433100 
 H                  4.16589400    1.75148400   -0.74912900 
 C                  1.63135100    2.10636300    0.08306000 
 C                  0.29398900   -0.32284800    0.73227400 
 H                  1.74377000   -2.50430300   -0.06906900 
 H                  4.06425300   -2.52408600   -0.95950900 
 C                  0.29617400    2.17114500    0.27840900 
 H                 -0.21506300    3.12552600    0.30183400 
 C                 -1.70349800    0.58903900    0.02563200 
 N                 -0.62511000   -1.42427300    0.43566300 
 C                 -0.43861900    0.94018300    0.34890600 
 C                  0.51923500   -0.34156800    2.26942900 
 H                 -0.43851600   -0.24732600    2.78148300 
 H                  0.98433100   -1.28521100    2.54941400 
 H                  1.16974800    0.48150100    2.56436300 
 C                 -1.73868800   -0.88279900    0.08345500 
 C                 -2.89796400    1.41153200   -0.34507200 
 H                 -3.32995700    1.84604200    0.56462100 
 H                 -2.60652100    2.25491400   -0.97601100 
 C                 -2.97287900   -1.64561000   -0.29426500 
 H                 -2.82713100   -2.03812300   -1.30660000 
 H                 -3.08439100   -2.51162500    0.35950700 
 C                 -3.96965400    0.55741500   -1.03697100 
 C                 -4.21606500   -0.74869000   -0.27683500 
 H                 -5.06216100   -1.28565900   -0.70969400 
 H                 -4.48872500   -0.51578500    0.75809200 
 H                 -3.64868000    0.32277300   -2.05712000 
 H                 -4.89526600    1.12994600   -1.12177300 
 
119a-H1: 
 C                  4.56881700   -0.38714300   -0.25399200 
 C                  3.81343300    0.74128000   -0.53510300 
 C                  2.42904400    0.73444200   -0.36607400 
 C                  1.81767700   -0.46605700    0.09038000 
 C                  2.59115000   -1.60467000    0.35619200 
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 C                  3.96146600   -1.56226600    0.19436000 
 H                  2.12627700    2.74013000   -1.15754400 
 H                  5.64206800   -0.35747800   -0.38646900 
 H                  4.29779500    1.63982800   -0.89391000 
 C                  1.61898900    1.90061900   -0.70016300 
 C                  0.39702400   -0.43193300    0.17251300 
 H                  2.12097600   -2.50839500    0.72368800 
 H                  4.56216900   -2.43296600    0.41678800 
 C                  0.30912100    1.96578900   -0.44507200 
 H                 -0.26991500    2.85578200   -0.65140700 
 C                 -1.78025700    0.41511500   -0.00861900 
 N                 -0.47276100   -1.41178700    0.05766500 
 C                 -0.36475500    0.84581700    0.28795300 
 C                 -0.32535300    1.22728600    1.82824700 
 H                 -0.92515000    2.12389000    1.96819400 
 H                 -0.74144000    0.42138800    2.43065100 
 H                  0.69912700    1.43049300    2.13043400 
 C                 -1.80751200   -0.92302800   -0.06799000 
 C                 -3.00280300    1.26016400   -0.09316300 
 H                 -2.98052100    2.04474900    0.66840800 
 H                 -3.01311900    1.78184100   -1.05732300 
 C                 -2.99933700   -1.79127300   -0.25498300 
 H                 -2.79605000   -2.57834500   -0.98651600 
 H                 -3.24782600   -2.29393500    0.68579600 
 C                 -4.26361700    0.39502600    0.06772900 
 C                 -4.17210900   -0.91317900   -0.72496600 
 H                 -4.04089100   -0.68648500   -1.78628400 
 H                 -5.10178500   -1.47384000   -0.63316500 
 H                 -0.22567400   -2.38760200   -0.03671500 
 H                 -5.13880800    0.96160800   -0.24964300 
 H                 -4.40377300    0.16593100    1.12787000 
 
TSa-H1: (imaginary frequency: 479.5455i cm-1) 
 C                  4.53168100   -0.36810700   -0.38055600 
 C                  3.80509100    0.80689700   -0.44765700 
 C                  2.41723100    0.80269300   -0.25834600 
 C                  1.77655000   -0.43360900    0.01044400 
 C                  2.51871800   -1.61175600    0.07519300 
 C                  3.88919500   -1.57929800   -0.12135400 
 H                  2.19383700    2.93416400   -0.58009200 
 H                  5.60232600   -0.34888200   -0.53143500 
 H                  4.30586700    1.74437200   -0.65172200 
 C                  1.65008900    2.02535600   -0.35541100 
 C                  0.34549200   -0.37946300    0.20058200 
 H                  2.03324800   -2.55709600    0.28177900 
 H                  4.46161200   -2.49539400   -0.07306000 
 C                  0.30871000    2.07236600   -0.19538700 
 H                 -0.24273600    2.99646700   -0.29445800 
 C                 -1.78036300    0.48748700   -0.06942200 
 N                 -0.55759300   -1.39860400    0.07216100 
 C                 -0.39866500    0.84972600    0.07644100 
 C                  0.07255900    0.44080200    2.05637400 
 H                 -0.54399000    1.29677500    2.29027800 
 H                 -0.33565000   -0.48767800    2.43317000 
 H                  1.12192400    0.60578300    2.25699800 
 C                 -1.83325700   -0.87917100   -0.07187700 
 C                 -2.98956900    1.35814000   -0.20396300 
 H                 -2.94624000    2.18568200    0.50892800 
 H                 -3.00643100    1.81516000   -1.19884900 
 C                 -3.06780900   -1.69755000   -0.19361300 
 H                 -2.89828900   -2.54646200   -0.86100400 
 H                 -3.32163400   -2.11792300    0.78589800 
 C                 -4.26588900    0.53195000    0.02032500 
 C                 -4.21518700   -0.81393900   -0.70867200 
 H                 -4.08130000   -0.64419300   -1.78028900 
 H                 -5.15913200   -1.34462100   -0.58802200 
 H                 -0.33848900   -2.37957400    0.11661600 
 H                 -4.39599500    0.35579200    1.09234300 
 H                 -5.13323600    1.10271000   -0.31081000 
 
120a-H1: 
 C                  4.33756600   -0.31087500   -0.84695300 
 C                  3.66345800    0.87625500   -0.60245200 
 C                  2.33687500    0.86492800   -0.15910800 
 C                  1.70214500   -0.37478300    0.06152400 
 C                  2.38263900   -1.55452100   -0.17173700 
 C                  3.69492700   -1.52500300   -0.64301100 
 H                  2.15409300    3.02814400   -0.11831500 
 H                  5.35945200   -0.29033900   -1.19945700 
 H                  4.15858600    1.82539900   -0.76281000 
 C                  1.60637200    2.10377700    0.01730300 
 C                  0.33301700   -0.32439300    0.69832700 
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 H                  1.90663400   -2.51180400    0.00004000 
 H                  4.21100300   -2.45319100   -0.84760400 
 C                  0.26537600    2.14497700    0.22749600 
 H                 -0.27438300    3.08167800    0.21087000 
 C                 -1.72977200    0.57051200    0.01730100 
 N                 -0.62637800   -1.37572200    0.34623200 
 C                 -0.43414800    0.91190900    0.31679400 
 C                  0.51949800   -0.35428300    2.24490000 
 H                 -0.44647000   -0.28366100    2.74386800 
 H                  1.01832200   -1.27914800    2.53145800 
 H                  1.14263400    0.48465500    2.54699100 
 C                 -1.80228800   -0.85158100    0.04573900 
 C                 -2.89858200    1.41683500   -0.38370300 
 H                 -2.95039500    2.30958200    0.24184800 
 H                 -2.74658200    1.76885300   -1.40942700 
 C                 -3.04236800   -1.62378300   -0.21653900 
 H                 -2.81218800   -2.54144000   -0.76211800 
 H                 -3.44544100   -1.93279600    0.75575600 
 C                 -4.20919800    0.62154500   -0.30208400 
 C                 -4.07513600   -0.75639200   -0.95272500 
 H                 -3.77500800   -0.64452100   -1.99803500 
 H                 -5.03353400   -1.27424300   -0.95355300 
 H                 -0.47773900   -2.35580700    0.53052000 
 H                 -4.50084700    0.50185300    0.74557100 
 H                 -5.00578300    1.18610300   -0.78566100 
 
119a-H2: 
 C                  4.57024600   -0.38079000   -0.26508900 
 C                  3.81818900    0.76343400   -0.48451300 
 C                  2.43306300    0.74960300   -0.32245900 
 C                  1.81737700   -0.47338300    0.06256700 
 C                  2.58750100   -1.62705300    0.26574600 
 C                  3.95862500   -1.57837900    0.11231100 
 H                  2.13676800    2.79739600   -1.00050400 
 H                  5.64413800   -0.34583400   -0.39089600 
 H                  4.30567800    1.68014500   -0.78902600 
 C                  1.62629100    1.93411800   -0.59371100 
 C                  0.39641100   -0.44068700    0.14117900 
 H                  2.11399000   -2.54952500    0.57838900 
 H                  4.55664700   -2.46177900    0.28663400 
 C                  0.31566300    1.98725200   -0.34017400 
 H                 -0.26004300    2.88942200   -0.49666500 
 C                 -1.77862600    0.41885100    0.00147200 
 N                 -0.47441400   -1.41085700   -0.03220200 
 C                 -0.36358700    0.82989800    0.32687100 
 C                 -0.33124100    1.12995900    1.88560600 
 H                 -0.93038800    2.01928900    2.06895700 
 H                 -0.75261200    0.29444000    2.44222700 
 H                  0.69192100    1.31468200    2.20381200 
 C                 -1.80930500   -0.91464200   -0.12521700 
 C                 -2.99740100    1.27092500   -0.05476600 
 H                 -3.24035000    1.63705500    0.94960900 
 H                 -2.81137700    2.16075500   -0.66229100 
 C                 -3.00620300   -1.77395900   -0.32674600 
 H                 -3.02855900   -2.14923600   -1.35542500 
 H                 -2.96730700   -2.65073000    0.32538700 
 C                 -4.17599200    0.46713500   -0.62925800 
 C                 -4.26358100   -0.93848300   -0.02722500 
 H                 -5.14173700   -1.45773200   -0.40971600 
 H                 -4.38728100   -0.86193500    1.05639700 
 H                 -0.22850200   -2.38077400   -0.17690900 
 H                 -5.10566300    1.00691900   -0.45052700 
 H                 -4.05901200    0.39065000   -1.71360500 
 
TSa-H2: (imaginary frequency: 483.3233i cm-1) 
 C                  4.53177900   -0.35169800   -0.39630000 
 C                  3.80616000    0.82575000   -0.40007100 
 C                  2.41784600    0.81223400   -0.21442600 
 C                  1.77554100   -0.43653900   -0.01576400 
 C                  2.51674600   -1.61710900   -0.01543200 
 C                  3.88773000   -1.57489900   -0.20663800 
 H                  2.19708700    2.95840500   -0.41808100 
 H                  5.60281800   -0.32499300   -0.54318600 
 H                  4.30804600    1.77267200   -0.55089500 
 C                  1.65219700    2.03915700   -0.24441500 
 C                  0.34429000   -0.39151700    0.17558900 
 H                  2.02990500   -2.57206000    0.13655700 
 H                  4.45935400   -2.49275800   -0.20807500 
 C                  0.31096200    2.07884500   -0.08131500 
 H                 -0.23835000    3.00830100   -0.12646100 
 C                 -1.78004400    0.49238900   -0.04483700 
 N                 -0.56076800   -1.40069100   -0.00734400 
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 C                 -0.39799300    0.84394400    0.12300800 
 C                  0.08031800    0.32720200    2.07442600 
 H                 -0.56884300    1.14282600    2.35933500 
 H                 -0.28658600   -0.63576400    2.40441600 
 H                  1.12442300    0.52255500    2.27451100 
 C                 -1.83687300   -0.87215000   -0.11556000 
 C                 -2.98590900    1.37104700   -0.14083000 
 H                 -3.22929200    1.77803500    0.84718200 
 H                 -2.78242800    2.23111900   -0.78290200 
 C                 -3.07437500   -1.68134700   -0.27275400 
 H                 -3.10515900   -2.08872400   -1.28925200 
 H                 -3.06049300   -2.54061600    0.40304400 
 C                 -4.17778800    0.57064700   -0.68679800 
 C                 -4.30538200   -0.79764000   -0.01151800 
 H                 -5.19824300   -1.31243100   -0.36497700 
 H                 -4.42509700   -0.66147500    1.06691100 
 H                 -0.34472400   -2.38333400   -0.00288400 
 H                 -4.05255200    0.43183700   -1.76442800 
 H                 -5.09571600    1.14134600   -0.54759700 
 
120a-H2: 
 C                  4.33662100   -0.28642900   -0.85795200 
 C                  3.66684500    0.89072100   -0.55931800 
 C                  2.33956400    0.86387900   -0.11862000 
 C                  1.69986100   -0.38237200    0.04364300 
 C                  2.37562200   -1.55259600   -0.24424100 
 C                  3.68877700   -1.50612200   -0.71204500 
 H                  2.16472500    3.02328800    0.02202800 
 H                  5.35917500   -0.25368300   -1.20757600 
 H                  4.16602300    1.84432400   -0.67417400 
 C                  1.61318100    2.09576200    0.11372500 
 C                  0.33139900   -0.35422000    0.68289700 
 H                  1.89556100   -2.51494400   -0.11823800 
 H                  4.20147200   -2.42577000   -0.95930500 
 C                  0.27190200    2.13292900    0.32438100 
 H                 -0.26292100    3.07189500    0.35349600 
 C                 -1.72975900    0.57405000    0.04265700 
 N                 -0.63092600   -1.38700600    0.29107300 
 C                 -0.43251900    0.89962500    0.35562200 
 C                  0.51997300   -0.44599300    2.22711200 
 H                 -0.44502300   -0.38926700    2.72964900 
 H                  1.01230900   -1.38533900    2.47530900 
 H                  1.14934600    0.37567100    2.56165800 
 C                 -1.80394400   -0.84751200    0.00522300 
 C                 -2.90963400    1.44026300   -0.27422200 
 H                 -3.30002500    1.86337300    0.65709800 
 H                 -2.60011700    2.28717500   -0.88923200 
 C                 -3.03220000   -1.60601100   -0.34187000 
 H                 -2.90200700   -1.98721000   -1.36171400 
 H                 -3.13040800   -2.48364800    0.30179800 
 C                 -4.01512500    0.63713900   -0.97468500 
 C                 -4.26970200   -0.70002400   -0.27589000 
 H                 -5.11146800   -1.21733700   -0.73477800 
 H                 -4.53826900   -0.52564600    0.76950900 
 H                 -0.48418500   -2.37424100    0.43262700 
 H                 -3.73205000    0.45480000   -2.01565500 
 H                 -4.93083500    1.22706200   -0.99852300 
 
119b-1: 
 C                 -5.16705600    0.22889200   -0.10869000 
 C                 -4.36799600   -0.86399100   -0.41495400 
 C                 -2.97751400   -0.77778200   -0.33248600 
 C                 -2.39668800    0.45049900    0.06114800 
 C                 -3.20566300    1.54819600    0.34436500 
 C                 -4.58664000    1.43683400    0.27000300 
 H                 -2.60157500   -2.76052600   -1.16105600 
 H                 -6.24411200    0.14255800   -0.17224600 
 H                 -4.82240600   -1.79589100   -0.72890800 
 C                 -2.11988100   -1.90471400   -0.70246600 
 C                 -0.94520800    0.50323200    0.07266800 
 H                 -2.73542400    2.48149600    0.62366500 
 H                 -5.21161900    2.28897600    0.50316100 
 C                 -0.79955400   -1.90983400   -0.49250500 
 H                 -0.19235500   -2.76588700   -0.76178700 
 C                  1.22376000   -0.28118900   -0.11386600 
 N                 -0.20377400    1.53028900   -0.17400800 
 C                 -0.15445800   -0.77522700    0.25097800 
 C                 -0.14730000   -1.14506600    1.76893500 
 H                  0.48056800   -2.02181300    1.93052200 
 H                  0.24831000   -0.31572700    2.35535600 
 H                 -1.15787400   -1.37533200    2.10383800 
 C                  1.13121300    1.04941600   -0.27854200 
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 C                  2.49575700   -1.05272300   -0.15590600 
 H                  2.52594800   -1.79811500    0.64708900 
 H                  2.55404700   -1.62523000   -1.09082000 
 C                  2.28503400    1.94722100   -0.55196900 
 H                  2.03211000    2.64492900   -1.35429500 
 H                  2.48711300    2.56685000    0.32882100 
 C                  3.73015600   -0.12753500   -0.03909400 
 C                  3.51716700    1.11539600   -0.93119400 
 H                  3.40835100    0.77730900   -1.96635800 
 H                  4.41362400    1.73985600   -0.89798900 
 C                  3.91758400    0.29351800    1.42392800 
 H                  4.73824500    1.00788300    1.52007100 
 H                  3.01703400    0.75658300    1.82787700 
 H                  4.15361800   -0.57325100    2.04523400 
 C                  4.97543500   -0.87993000   -0.51073500 
 H                  5.12184900   -1.79558000    0.06756000 
 H                  4.89111000   -1.15709600   -1.56400600 
 H                  5.87097900   -0.26530200   -0.39537600 
 
TSb-1: (imaginary frequency: 594.5028i cm-1) 
 C                  5.11933100   -0.18358400   -0.27245400 
 C                  4.33452600    0.95696100   -0.32041400 
 C                  2.94192100    0.87735500   -0.20306300 
 C                  2.35056400   -0.39640000   -0.02504400 
 C                  3.14586500   -1.53837500    0.00811900 
 C                  4.52369300   -1.43385100   -0.11217000 
 H                  2.62402800    3.01098400   -0.46702600 
 H                  6.19454300   -0.10330700   -0.36561700 
 H                  4.79642500    1.92737600   -0.45702400 
 C                  2.11521500    2.06961400   -0.29721200 
 C                  0.90161500   -0.45512400    0.10120100 
 H                  2.66306500   -2.49924600    0.12379000 
 H                  5.13705300   -2.32515700   -0.08326500 
 C                  0.76970800    2.03874200   -0.20786300 
 H                  0.18181800    2.94119300   -0.31888100 
 C                 -1.21846300    0.32804500   -0.18933500 
 N                  0.12606000   -1.54796500   -0.04983200 
 C                  0.10642000    0.77408700    0.00997200 
 C                  0.54913100    0.29203600    1.97897900 
 H                  0.25525900    1.29755000    2.24905700 
 H                 -0.18260800   -0.46216300    2.23099900 
 H                  1.55783500    0.06759600    2.30313700 
 C                 -1.13175400   -1.06602600   -0.21669700 
 C                 -2.48999800    1.09943300   -0.34759100 
 H                 -2.51779100    1.95632400    0.33460100 
 H                 -2.55787700    1.51901300   -1.35890500 
 C                 -2.33083400   -1.94031100   -0.36693200 
 H                 -2.10880300   -2.75257900   -1.06259200 
 H                 -2.54530500   -2.42118400    0.59315600 
 C                 -3.72925400    0.20947100   -0.09766100 
 C                 -3.54170800   -1.12894900   -0.84390000 
 H                 -3.42668900   -0.90943600   -1.90997900 
 H                 -4.45100200   -1.72731600   -0.74402000 
 C                 -3.90080800   -0.03361400    1.40721200 
 H                 -4.72186900   -0.72863400    1.59787500 
 H                 -2.99794800   -0.44701100    1.85700000 
 H                 -4.12869300    0.90260800    1.92161300 
 C                 -4.97621200    0.91441300   -0.63506500 
 H                 -5.10275800    1.89508600   -0.16963400 
 H                 -4.90933900    1.06163700   -1.71539400 
 H                 -5.87549800    0.32889100   -0.43057500 
 
120b-1: 
 C                  4.87288500   -0.09797200   -0.89448600 
 C                  4.15046600    1.04071900   -0.56662500 
 C                  2.83299700    0.94659100   -0.10883700 
 C                  2.25711500   -0.33170400    0.04448000 
 C                  2.98093900   -1.46428000   -0.28945900 
 C                  4.28347600   -1.35049700   -0.76910100 
 H                  2.54945700    3.10080800    0.07753600 
 H                  5.88937100   -0.00818400   -1.25509800 
 H                  4.60177500    2.01965500   -0.67671600 
 C                  2.04179800    2.14584000    0.14309500 
 C                  0.89538000   -0.40591800    0.69390300 
 H                  2.51519700   -2.43379000   -0.17516800 
 H                  4.83687000   -2.24033800   -1.04059600 
 C                  0.70522200    2.09753400    0.33231000 
 H                  0.11816600    3.00651300    0.38317200 
 C                 -1.16329300    0.37926200    0.01164200 
 N                  0.06132500   -1.56152500    0.35136100 
 C                  0.06907900    0.81175300    0.35876500 
 C                  1.11765700   -0.47383700    2.23050400 
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 H                  0.15445600   -0.47468800    2.74105700 
 H                  1.65451800   -1.38896700    2.47401900 
 H                  1.70107500    0.38480100    2.56236700 
 C                 -1.09250800   -1.09095900    0.02641700 
 C                 -2.38460800    1.12089900   -0.42577500 
 H                 -2.50349400    2.04845500    0.14176500 
 H                 -2.26400500    1.41896000   -1.47416200 
 C                 -2.29729500   -1.92618900   -0.28137500 
 H                 -2.00346300   -2.78275000   -0.88983600 
 H                 -2.67218800   -2.33828900    0.65983100 
 C                 -3.66206200    0.26199400   -0.30881800 
 C                 -3.39616900   -1.10710900   -0.96969100 
 H                 -3.11762100   -0.93238500   -2.01395800 
 H                 -4.32303900   -1.68560700   -0.98913000 
 C                 -4.04397500    0.09168900    1.16705300 
 H                 -4.90161200   -0.57664000    1.27208400 
 H                 -3.22454600   -0.31717300    1.75915300 
 H                 -4.31475200    1.05543000    1.60340700 
 C                 -4.80548100    0.96119800   -1.04659700 
 H                 -4.97872000    1.96093400   -0.64135400 
 H                 -4.58118700    1.06372400   -2.11072200 
 H                 -5.73527700    0.39612500   -0.95161200 
 
119b-2: 
 C                 -5.12511600    0.16325100   -0.39296300 
 C                 -4.27943300   -0.92169800   -0.57989100 
 C                 -2.90643800   -0.80293200   -0.36071800 
 C                 -2.39083600    0.44939500    0.04750500 
 C                 -3.24375900    1.53790500    0.21046800 
 C                 -4.60808300    1.39463500    0.00114700 
 H                 -2.41016200   -2.80257400   -1.07883600 
 H                 -6.18840100    0.05190900   -0.56196300 
 H                 -4.68277700   -1.87275200   -0.90594300 
 C                 -1.99439800   -1.92228600   -0.60240000 
 C                 -0.94857200    0.53230500    0.20188900 
 H                 -2.82133100    2.48950600    0.50405700 
 H                 -5.26871500    2.24023100    0.14121000 
 C                 -0.70361700   -1.89250700   -0.25609400 
 H                 -0.05676300   -2.74426300   -0.43017300 
 C                  1.24001800   -0.21440400    0.26657000 
 N                 -0.20320300    1.56256300   -0.01666000 
 C                 -0.15908600   -0.72185900    0.51172600 
 C                 -0.30093500   -1.04601800    2.03344700 
 H                  0.32120200   -1.90576000    2.28464600 
 H                  0.02091600   -0.19195600    2.62955300 
 H                 -1.33657400   -1.28484200    2.27248800 
 C                  1.14409500    1.10665200    0.04056100 
 C                  2.52072400   -0.96543200    0.36674800 
 H                  2.73930000   -1.20386300    1.41571900 
 H                  2.44769400   -1.93140100   -0.14687200 
 C                  2.30535200    2.01373700   -0.16543300 
 H                  2.34668400    2.32538300   -1.21484900 
 H                  2.16956300    2.93200800    0.41137700 
 C                  3.69689500   -0.15783900   -0.23184200 
 C                  3.60226100    1.30570800    0.24957900 
 H                  4.46680000    1.86237200   -0.12089000 
 H                  3.67189800    1.30948400    1.34191700 
 C                  5.01920700   -0.76098800    0.24585800 
 H                  5.86964900   -0.24146200   -0.20136600 
 H                  5.11453700   -0.68914300    1.33183700 
 H                  5.09006200   -1.81615200   -0.02929600 
 C                  3.63866700   -0.22092900   -1.76349500 
 H                  3.78580300   -1.24631000   -2.10993300 
 H                  2.67816000    0.12435200   -2.14618700 
 H                  4.42320000    0.39713500   -2.20583700 
 
TSb-2: (imaginary frequency: 595.8766i cm-1) 
 C                  5.05576900   -0.14644800   -0.56187600 
 C                  4.26647300    0.98849400   -0.47185300 
 C                  2.89371600    0.89158200   -0.21575900 
 C                  2.32824600   -0.39424100   -0.04110400 
 C                  3.12627300   -1.52990200   -0.14742500 
 C                  4.48396500   -1.40803600   -0.40368200 
 H                  2.54214400    3.03255800   -0.34190400 
 H                  6.11523300   -0.05276300   -0.76176600 
 H                  4.70868900    1.96824900   -0.60677100 
 C                  2.05751000    2.07989600   -0.16455700 
 C                  0.90068400   -0.47108800    0.23219400 
 H                  2.66136700   -2.49942000   -0.03041300 
 H                  5.09988600   -2.29455600   -0.48235600 
 C                  0.72951300    2.03351700    0.06716000 
 H                  0.13089900    2.93569100    0.06539200 
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 C                 -1.24076900    0.30746200    0.21228200 
 N                  0.11686700   -1.56084700    0.10748000 
 C                  0.09698400    0.75456200    0.29237100 
 C                  0.74888100    0.17500800    2.17562000 
 H                  1.78309300   -0.07256100    2.38020700 
 H                  0.49720600    1.16739700    2.52571400 
 H                  0.03728400   -0.58652600    2.46110900 
 C                 -1.15340200   -1.08255200    0.10336300 
 C                 -2.52487900    1.07140100    0.25764600 
 H                 -2.75543500    1.37252500    1.28770600 
 H                 -2.45229500    2.00092700   -0.31755400 
 C                 -2.35755200   -1.95600200   -0.01514700 
 H                 -2.41102300   -2.34261600   -1.03812000 
 H                 -2.24648500   -2.83191200    0.62756200 
 C                 -3.70215800    0.22886800   -0.28512200 
 C                 -3.63407200   -1.18243300    0.33641200 
 H                 -4.51163600   -1.75551900    0.02604100 
 H                 -3.69964900   -1.07669100    1.42421600 
 C                 -5.02315400    0.88995300    0.11260500 
 H                 -5.87432800    0.33934200   -0.29430100 
 H                 -5.13411700    0.92588500    1.19888200 
 H                 -5.07651600    1.91421900   -0.26460600 
 C                 -3.62124800    0.14747700   -1.81522400 
 H                 -3.76652600    1.13546200   -2.25762100 
 H                 -2.65381000   -0.22591900   -2.15088100 
 H                 -4.39673700   -0.51295700   -2.21032300 
 
120b-2: 
 C                  4.67011600   -0.01310500   -1.20921800 
 C                  3.99826800    1.09043100   -0.70219400 
 C                  2.74767600    0.95070700   -0.09363400 
 C                  2.19108300   -0.33967800    0.02682900 
 C                  2.86399000   -1.43667700   -0.48489200 
 C                  4.09677100   -1.27557100   -1.11270300 
 H                  2.49541900    3.08118700    0.29656900 
 H                  5.63372700    0.11246700   -1.68567800 
 H                  4.43532600    2.07820600   -0.78818900 
 C                  1.99602400    2.12087100    0.34578100 
 C                  0.91722600   -0.47215200    0.82804300 
 H                  2.41280800   -2.41526700   -0.39206500 
 H                  4.60900800   -2.13692100   -1.52188900 
 C                  0.69131100    2.05010100    0.68851800 
 H                  0.12000500    2.94910400    0.88361400 
 C                 -1.20684900    0.34630400    0.45674600 
 N                  0.04880600   -1.60369700    0.49343100 
 C                  0.05879800    0.76172500    0.68528300 
 C                  1.32069300   -0.65109000    2.31762000 
 H                  0.42505500   -0.69629100    2.93738700 
 H                  1.88007600   -1.57866100    2.42667800 
 H                  1.94214600    0.18370800    2.64093100 
 C                 -1.13328100   -1.11893100    0.33274900 
 C                 -2.48676800    1.10253700    0.31048500 
 H                 -2.89383700    1.31780300    1.30583100 
 H                 -2.31296300    2.07185500   -0.16510900 
 C                 -2.34462500   -1.92947100   -0.01750500 
 H                 -2.22653900   -2.28321300   -1.04530800 
 H                 -2.37984800   -2.82426800    0.60600500 
 C                 -3.54585600    0.30576000   -0.48214100 
 C                 -3.63685200   -1.11413700    0.11454800 
 H                 -4.45846300   -1.65497100   -0.36158800 
 H                 -3.90030500   -1.02039000    1.17319300 
 C                 -4.90302400    0.99737600   -0.34020200 
 H                 -5.66783800    0.48080700   -0.92417700 
 H                 -5.22881800    1.01234200    0.70247900 
 H                 -4.85402200    2.03042700   -0.69217500 
 C                 -3.15831900    0.25425800   -1.96545900 
 H                 -3.18357000    1.25589800   -2.39988800 
 H                 -2.15298900   -0.14084500   -2.11514300 
 H                 -3.85432300   -0.37264500   -2.52740900 
 
119b-H1: 
 C                 -5.16574700    0.19687600   -0.16729100 
 C                 -4.36360600   -0.90436700   -0.42523600 
 C                 -2.97594400   -0.81951400   -0.31261700 
 C                 -2.41134700    0.43079900    0.06272200 
 C                 -3.23270800    1.54073200    0.30519600 
 C                 -4.60405100    1.42169700    0.20022600 
 H                 -2.59951800   -2.84283400   -1.02310000 
 H                 -6.24024100    0.10675300   -0.25474200 
 H                 -4.81356400   -1.84268900   -0.72158400 
 C                 -2.11966500   -1.95834800   -0.62466700 
 C                 -0.98873900    0.47179700    0.09380700 
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 H                 -2.79692000    2.48401100    0.61043400 
 H                 -5.24054000    2.27105600    0.40495300 
 C                 -0.79952300   -1.94533700   -0.41924300 
 H                 -0.18271200   -2.81344300   -0.60868800 
 C                  1.22241100   -0.27303600   -0.13142600 
 N                 -0.17436000    1.48776000   -0.09205500 
 C                 -0.15832400   -0.75985500    0.23505600 
 C                 -0.12040900   -1.07057500    1.79151100 
 H                  0.53140700   -1.92727300    1.94758600 
 H                  0.27421200   -0.21764800    2.34105500 
 H                 -1.12094500   -1.31187200    2.14193600 
 C                  1.17820700    1.06057500   -0.24430700 
 C                  2.48089500   -1.05894600   -0.22238800 
 H                  2.49945800   -1.84508500    0.53845400 
 H                  2.50821400   -1.57903800   -1.18703600 
 C                  2.32499900    1.97268900   -0.47706200 
 H                  2.08978600    2.70818500   -1.25139500 
 H                  2.54272200    2.53939500    0.43396700 
 C                  3.73119900   -0.15801200   -0.06950100 
 C                  3.53873900    1.12901200   -0.90218000 
 H                  3.42162500    0.85150100   -1.95290000 
 H                  4.43999400    1.73948300   -0.83620600 
 C                  3.93718300    0.18687900    1.41099500 
 H                  4.77637500    0.87337200    1.53385400 
 H                  3.05583100    0.65414100    1.85400000 
 H                  4.15867900   -0.71262800    1.98767000 
 C                  4.95607500   -0.91083600   -0.59166900 
 H                  5.09248800   -1.85326400   -0.05756900 
 H                  4.85789700   -1.13685500   -1.65532900 
 H                  5.86212400   -0.31834900   -0.45620100 
 H                 -0.47372900    2.44538400   -0.21632300 
 
TSb-H1: (imaginary frequency: 478.2103i cm-1) 
 C                  5.13214200   -0.13562200   -0.29717900 
 C                  4.33359800    0.99234700   -0.35273700 
 C                  2.94307700    0.89335200   -0.21621200 
 C                  2.37510800   -0.39017200   -0.01327000 
 C                  3.18946200   -1.52038200    0.03954400 
 C                  4.56102900   -1.39391300   -0.10355000 
 H                  2.59381400    3.01641200   -0.47585600 
 H                  6.20400500   -0.04272000   -0.40629700 
 H                  4.77972700    1.96626100   -0.50690700 
 C                  2.10244600    2.06769100   -0.30107300 
 C                  0.93803000   -0.43422300    0.12571700 
 H                  2.75883000   -2.50136800    0.19527600 
 H                  5.18966000   -2.27283900   -0.06428900 
 C                  0.75612100    2.02329000   -0.18874400 
 H                  0.14933100    2.91305500   -0.27813500 
 C                 -1.22942100    0.30724200   -0.18798500 
 N                  0.10592500   -1.50288200   -0.06331800 
 C                  0.12066200    0.74955700    0.01618600 
 C                  0.55682400    0.30658800    1.99929400 
 H                 -0.15631900    1.08148600    2.24108600 
 H                  0.24442000   -0.67231800    2.33796600 
 H                  1.57749900    0.57649500    2.23134300 
 C                 -1.19554700   -1.05834600   -0.23158800 
 C                 -2.48434100    1.10549700   -0.33262200 
 H                 -2.48544000    1.94612000    0.36747400 
 H                 -2.52621700    1.54568200   -1.33420500 
 C                 -2.37868900   -1.93937500   -0.38831700 
 H                 -2.16949900   -2.73996000   -1.10268000 
 H                 -2.59315800   -2.42923900    0.56721100 
 C                 -3.74103800    0.23383500   -0.09623300 
 C                 -3.58029800   -1.10223600   -0.85325400 
 H                 -3.47032100   -0.88877200   -1.91955700 
 H                 -4.49064300   -1.69261800   -0.74322200 
 C                 -3.92277600   -0.01643300    1.40666100 
 H                 -4.75999700   -0.69252900    1.58787400 
 H                 -3.03475200   -0.45466300    1.86631400 
 H                 -4.13443000    0.91908500    1.92690900 
 C                 -4.96837900    0.96848500   -0.63851900 
 H                 -5.07862300    1.94631600   -0.16558600 
 H                 -4.89300400    1.12235500   -1.71674900 
 H                 -5.87895900    0.40011900   -0.44285000 
 H                  0.38454400   -2.46928800   -0.03860400 
 
120b-H1: 
 C                  4.94355400   -0.00927300   -0.81840000 
 C                  4.17756600    1.10584900   -0.51353200 
 C                  2.84755300    0.96754600   -0.10261700 
 C                  2.30438600   -0.32771600    0.02241700 
 C                  3.07528300   -1.43579900   -0.27290700 
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 C                  4.39026200   -1.27841800   -0.71017100 
 H                  2.50193500    3.10386900    0.07151100 
 H                  5.96747200    0.11024200   -1.14438300 
 H                  4.60308200    2.09740100   -0.60061800 
 C                  2.02316200    2.13471200    0.13767400 
 C                  0.92724800   -0.42082800    0.63548400 
 H                  2.66917000   -2.43479400   -0.17512300 
 H                  4.97825300   -2.15029900   -0.96280400 
 C                  0.68005700    2.06215400    0.32369000 
 H                  0.07109700    2.95495800    0.35561700 
 C                 -1.19020400    0.36156700   -0.01479300 
 N                  0.05193500   -1.51554900    0.20537500 
 C                  0.07378000    0.77750400    0.32223800 
 C                  1.09637700   -0.53441700    2.18066000 
 H                  0.12168000   -0.56491500    2.66656300 
 H                  1.65821200   -1.43684800    2.41786100 
 H                  1.65235000    0.32698100    2.54431000 
 C                 -1.15794100   -1.06030700   -0.07414000 
 C                 -2.41532700    1.14036600   -0.37345600 
 H                 -2.49933200    2.02540500    0.26069800 
 H                 -2.31543000    1.50643700   -1.40066400 
 C                 -2.34151100   -1.89903800   -0.38023700 
 H                 -2.06104100   -2.72530300   -1.03753100 
 H                 -2.67061000   -2.35615400    0.55952400 
 C                 -3.69952900    0.28822400   -0.26253300 
 C                 -3.46972800   -1.05278700   -0.98894200 
 H                 -3.23754300   -0.85076600   -2.03775900 
 H                 -4.38991000   -1.63764700   -0.97970000 
 C                 -4.05039300    0.05834600    1.21345900 
 H                 -4.91304300   -0.60327800    1.30817100 
 H                 -3.22726500   -0.38243800    1.77982300 
 H                 -4.30328300    1.00365600    1.69544900 
 C                 -4.84899400    1.03092000   -0.94679700 
 H                 -5.00283400    2.01167700   -0.49331200 
 H                 -4.64768100    1.17833900   -2.00962900 
 H                 -5.78148000    0.47205600   -0.85497200 
 H                  0.26905400   -2.49136300    0.33675900 
 
119b-H2: 
 C                 -5.11635600    0.14826600   -0.44582400 
 C                 -4.28017300   -0.94953900   -0.58308200 
 C                 -2.91185800   -0.84027600   -0.33634200 
 C                 -2.40148300    0.43047300    0.04748900 
 C                 -3.25501500    1.53583800    0.16776500 
 C                 -4.60788900    1.39297100   -0.06817800 
 H                 -2.44203400   -2.88173900   -0.93026200 
 H                 -6.17564600    0.03944800   -0.63654200 
 H                 -4.68781300   -1.90417800   -0.88846300 
 C                 -2.01499500   -1.97628500   -0.51893600 
 C                 -0.98890400    0.49280800    0.21492200 
 H                 -2.86238900    2.49511000    0.48160200 
 H                 -5.27106900    2.23938600    0.04244200 
 C                 -0.72297000   -1.93647800   -0.18162000 
 H                 -0.08156500   -2.80252400   -0.27375300 
 C                  1.24154000   -0.22699300    0.24409900 
 N                 -0.17139200    1.51136900    0.06213500 
 C                 -0.16367100   -0.71958500    0.49075400 
 C                 -0.28016800   -0.97766300    2.05302900 
 H                  0.35842600   -1.82254500    2.30184700 
 H                  0.05333800   -0.10238100    2.60810900 
 H                 -1.30895500   -1.21671300    2.31130200 
 C                  1.19479500    1.10002600    0.07162700 
 C                  2.51058900   -0.99858700    0.30409500 
 H                  2.71941700   -1.28042600    1.34274900 
 H                  2.41275800   -1.93831600   -0.24779200 
 C                  2.34861100    2.01663400   -0.10663000 
 H                  2.39443000    2.36333700   -1.14405000 
 H                  2.23754100    2.90933800    0.51465300 
 C                  3.69863200   -0.18198200   -0.26439400 
 C                  3.63258900    1.26214500    0.27810700 
 H                  4.49819900    1.82157500   -0.07829800 
 H                  3.70571100    1.22911400    1.36835600 
 C                  5.00835200   -0.82669300    0.19346800 
 H                  5.86649200   -0.30380800   -0.23134500 
 H                  5.10391000   -0.80204600    1.28097700 
 H                  5.06278000   -1.86895800   -0.12694600 
 C                  3.63967600   -0.18500100   -1.79768200 
 H                  3.77030700   -1.19729700   -2.18338500 
 H                  2.68878000    0.19207000   -2.17757000 
 H                  4.43694300    0.43291400   -2.21382300 
 H                 -0.46762600    2.45858400   -0.13075900 
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TSb-H2: (imaginary frequency: 482.5328i cm-1) 
 C                  5.06804300   -0.09348300   -0.58483800 
 C                  4.26475900    1.02874300   -0.49265400 
 C                  2.89618400    0.90972700   -0.21938900 
 C                  2.35592400   -0.38788200   -0.03269700 
 C                  3.17452800   -1.51203800   -0.12891500 
 C                  4.52356300   -1.36557800   -0.40576200 
 H                  2.51515900    3.04083500   -0.32129300 
 H                  6.12244200    0.01478700   -0.79919200 
 H                  4.68960400    2.01376100   -0.63598500 
 C                  2.04753300    2.07944900   -0.15056800 
 C                  0.94080400   -0.45215000    0.25157600 
 H                  2.76561900   -2.50413500    0.01458200 
 H                  5.15530000   -2.23982900   -0.48207800 
 C                  0.72048800    2.01710100    0.09894200 
 H                  0.10620700    2.90571000    0.12629100 
 C                 -1.25023100    0.28568000    0.20795300 
 N                  0.09700100   -1.51553700    0.08344500 
 C                  0.11293800    0.72848000    0.29704000 
 C                  0.75170300    0.17114700    2.19108600 
 H                  0.08957400    0.94740900    2.54728300 
 H                  0.44301100   -0.81857800    2.50049800 
 H                  1.79711800    0.40276300    2.33956800 
 C                 -1.21639600   -1.07497000    0.08310500 
 C                 -2.51608000    1.07781800    0.24290400 
 H                 -2.72028300    1.40047600    1.27013400 
 H                 -2.41251400    1.99206900   -0.34751400 
 C                 -2.40547200   -1.95473800   -0.03722100 
 H                 -2.46527200   -2.33492400   -1.06216200 
 H                 -2.30435900   -2.83127700    0.60824500 
 C                 -3.71574400    0.25522200   -0.28618500 
 C                 -3.66953600   -1.16102700    0.32644600 
 H                 -4.54823100   -1.72285400    0.00764600 
 H                 -3.73077200   -1.07326600    1.41461600 
 C                 -5.01577500    0.93941900    0.14049600 
 H                 -5.88216700    0.40968900   -0.25836300 
 H                 -5.11052500    0.96871400    1.22793600 
 H                 -5.05493400    1.96592000   -0.22915500 
 C                 -3.65974600    0.18269400   -1.81818400 
 H                 -3.79115700    1.17516500   -2.25188000 
 H                 -2.70956500   -0.21064000   -2.18324200 
 H                 -4.45757700   -0.45477400   -2.20305400 
 H                  0.37939700   -2.47994500    0.03419800 
 
120b-H2: 
 C                  4.76458900    0.09736500   -1.12334000 
 C                  4.03788600    1.17013000   -0.62867900 
 C                  2.76777600    0.97723900   -0.07544100 
 C                  2.24721100   -0.33116500   -0.00362200 
 C                  2.98025100   -1.39776600   -0.48762900 
 C                  4.23233300   -1.18383900   -1.06384300 
 H                  2.44043200    3.08418200    0.33290000 
 H                  5.74133900    0.25958400   -1.55762600 
 H                  4.44694600    2.17125100   -0.67582100 
 C                  1.97480000    2.10692300    0.36577000 
 C                  0.95257900   -0.49635000    0.75752300 
 H                  2.59272000   -2.40726900   -0.43109000 
 H                  4.78820100   -2.02174500   -1.46213100 
 C                  0.66381200    2.00086800    0.70300900 
 H                  0.06355900    2.87946600    0.89322400 
 C                 -1.22907100    0.31132700    0.42759800 
 N                  0.03832500   -1.55970400    0.33331800 
 C                  0.06405500    0.71343300    0.65425300 
 C                  1.30448900   -0.74191300    2.25553800 
 H                  0.39460800   -0.82783700    2.84856000 
 H                  1.89197200   -1.65482200    2.34394000 
 H                  1.89813300    0.09116000    2.62547500 
 C                 -1.19580200   -1.09713300    0.22338400 
 C                 -2.49784700    1.09724300    0.33298500 
 H                 -2.85450200    1.31694900    1.34457600 
 H                 -2.30815900    2.06228200   -0.14180100 
 C                 -2.38921900   -1.91011800   -0.11370600 
 H                 -2.29272200   -2.21544800   -1.16098900 
 H                 -2.39318200   -2.83427500    0.47012700 
 C                 -3.60199300    0.33806500   -0.43757300 
 C                 -3.67900600   -1.10577600    0.09959900 
 H                 -4.50437100   -1.63219200   -0.38068500 
 H                 -3.90809100   -1.07347300    1.16796300 
 C                 -4.94398000    1.03088100   -0.19372700 
 H                 -5.73986500    0.54598200   -0.76093800 
 H                 -5.21791000    1.00344000    0.86268100 
 H                 -4.90331400    2.07627600   -0.50466100 
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 C                 -3.29105700    0.34742800   -1.94042400 
 H                 -3.33961700    1.36454300   -2.33142700 
 H                 -2.29494800   -0.03724600   -2.16890700 
 H                 -4.01658100   -0.25468200   -2.48990300 
 H                  0.27624100   -2.53923500    0.33325900 
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 Erklärung 9.2.
 
„Ich versichere, dass ich die von mir vorgelegte Dissertation selbständig angefertigt, die 
benutzten Quellen und Hilfsmittel vollständig angegeben und die Stellen der Arbeit ‐ 
einschließlich Tabellen, Karten und Abbildungen ‐, die anderen Werken im Wortlaut oder 
dem Sinn nach entnommen sind, in jedem Einzelfall als Entlehnung kenntlich gemacht habe; 
dass diese Dissertation noch keiner anderen Fakultät oder Universität zur Prüfung 
vorgelegen hat; dass sie ‐ abgesehen von unten angegebenen Teilpublikationen ‐ noch nicht 
veröffentlicht worden ist sowie, dass ich eine solche Veröffentlichung vor Abschluss des 
Promotionsverfahrens nicht vornehmen werde. Die Bestimmungen dieser 
Promotionsordnung sind mir bekannt. Die von mir vorgelegte Dissertation ist von Prof. Dr. 
Benjamin List betreut worden." 
 
Mülheim an der Ruhr, April 2016 
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“Catalytic Asymmetric Dearomatizing Redox Cross Coupling of Ketones with Aryl Hydrazines 
Giving 1,4-Diketones”, S. Huang, L. Kötzner, C. K. De, B. List, J. Am. Chem. Soc. 2015, 137, 
3446-3449. 
 
“Asymmetric Catalysis on the Nanoscale: The Organocatalytic Approach to Helicenes”, L. 
Kötzner, M. J. Webber, A. Martínez, C. De Fusco, B. List, Angew. Chem. Int. Ed. 2014, 53, 
5202-5205, Angew. Chem. 2014, 126, 5303-5306. 
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